Pharmaceuticals & Healthcare

Zach Lomis, a Partner at Palo Santo VC in New York, is actively involved in the healthcare sector, particularly focusing on Therapeutics (Seed), (Series A), and (Series B) investments. His recent investments include Seed Therapeutics. With a current fund size of $50M, Zach Lomis typically invests in the range of $100K to $5.0M, with a sweet spot of $1.5M. Throughout his career, he has held roles such as Director of Biz Ops at Heading Health, Founder at Stealth Mode, and Venture Partner at Oncology Ventures. Zach’s academic background includes a Bachelor of Science in Finance from Washington University in St. Louis. He values collaboration and partnership in his professional endeavors, seeking to create successful synergies in the healthcare industry.

Sarah Douglas is a Director at CincyTech, overseeing financing and exit transactions for new investments, with a focus on innovative founders tackling complex challenges. She has led over 100 financings and works closely with research institutions. Sarah has a background in venture capital and enjoys the outdoors and national park travel.

Thibault De Keersmaecker is an investor focused on early-stage investments, with a geographical preference that is not explicitly defined. He has a professional career related to gene pathways and inflammation research. The specifics of his investment thesis, investment focus areas, previous investments, and partnership and collaboration styles were not found in the search results. His investment check size is related to financial processes and providing real-time insights for businesses of all sizes.

Arches Capital, an angel group based in Amsterdam, Netherlands, focuses on investing in financial technology, data science, commerce, cybersecurity, medical technology, and software sectors.

Tal Simantov is a Vice President of AOL and the Co-founder of 5min. He has participated in investments focusing on technology vendors, corporate venture capital, consumer, insurance, healthcare, and financial services. His investments include Apester in a Series A round. Tal Simantov’s check size for investments ranges from $5 million to $12 million. He has a partnership style that involves collaborating with co-investors like Blumberg Capital, Mangrove Capital Partners, and Tal Karret to support startups such as Apester. Tal Simantov has a track record of active investments and successful exits, indicating strategic investment decisions.

NA Capital Partners is a private equity firm based in Fort Wayne, Indiana, focusing on small & mid-size investments and acquisitions. The firm’s previous investments and geographical preference are not available. They are known for their partnership and collaboration styles.

iAngels is a Venture Capital and Angel Investment firm that provides investor audience the opportunity to invest in early-stage start-ups.

Thomas Wylly, Senior Partner at Brentwood Capital Advisors, brings a wealth of experience in the investment industry. As the Chairman of Westminster Home Connection, he is dedicated to empowering older adults and individuals with disabilities to age in place safely and with dignity through critical repairs and mobility modifications. His tenure as Chairman at Brentwood Capital Advisors solidifies his expertise in providing strategic and financial advice to middle-market healthcare, technology, and tech-enabled services companies. Previously, he served as Chairman of Nashville Capital Network, accelerating the growth of early-stage companies by connecting them with experienced investors. Through his role as Co-Head Corporate Finance at JC Bradford & Co and as a Banking Officer at Wachovia Bank, Thomas has honed his financial acumen. His investment focus areas likely revolve around healthcare, technology, and tech-enabled services, given his background in these sectors. His partnership and collaboration styles are likely hands-on, given his active role at various organizations. He has a track record of successfully supporting over 60 companies in raising early-stage equity capital. Thomas Wylly’s investment check size and geographical preferences can be inferred from his professional journey and affiliations with growth-oriented companies in Tennessee and beyond.

Carl Press serves as a Partner at Thoma Bravo, leading the Explore fund that focuses on equity investments ranging from $50 million to $250 million in various sectors such as applications, infrastructure, cybersecurity, financial technology, healthcare, and information technology. Thoma Bravo’s three distinct buyout funds – Explore, Flagship, and Discover – cover software investments from the lower middle market to the bulge bracket, ranging from $100 million to $12 billion of enterprise value. Carl Press is known for his strategic approach to identifying potential, fostering leadership, and making control investments in the software sector.

Matt Mullenweg, the Founder and CEO of Automattic and WordPress, is an angel investor who generally invests between $25,000 and $75,000 in young, emerging companies with a focus on the seed stage. His investments span a range of industries including technology, healthcare, food, and finance. Matt Mullenweg’s past investments include companies like Calm and Hike, with a track record of 32 investments, 11 exits, and 5 unicorn companies. He is known for advocating distributed work and open source technology. Matt is committed to building intricate worlds through his investments and endeavors, fostering collaboration against spammers, and supporting the mission of democratizing publishing and commerce. He values collective decision-making and believes in the superiority of open-source software over proprietary solutions.

Martin Rost is a Vice President Market Access at Pfizer with experience from previous roles at Pfizer Pharmaceuticals and Novartis. His investment focuses may include areas such as Minimum Advertised Price Policy ensuring proper product advertising. In his professional career, he demonstrates skills in team leadership, pharmaceutical sales, biotechnology, and market access. Martin Rost has held positions of responsibility in the pharmaceutical industry, particularly in market access and sales, suggesting a track record of successful investments and collaborations.

Lynn Polakoff Baine is the General Partner at Golden Seeds, an early-stage investment firm that focuses on women entrepreneurs. Golden Seeds invests in various sectors like Artificial Intelligence & Machine Learning, Healthcare, Software, and more. Their investments cover stages from Pre-Seed to Series D. Lynn Polakoff Baine leads investor relations and corporate development for the Golden Seeds portfolio companies. The geographical preference is not specified. Previous investments and specific investment check sizes are not available. Lynn’s track record and professional career details are limited. Partnership and collaboration styles at Golden Seeds remain undisclosed.

Yongbai Choi is an investor at Vulcan Capital focusing on early-stage venture capital investments. He has been involved in investments in companies such as Rebellyous Foods, AdaptX, Blokable, Kevala, Nifty Games, Gentem, and AI.Reverie. His investments cover a range of sectors including food tech, healthcare, real estate, gaming, and AI. Yongbai Choi’s investments vary in size and include Seed Rounds and Series A and B investments. He brings valuable experience and expertise in evaluating and supporting startups in their growth journey.

Mr. Mikael Lövgren serves as Senior Partner at Bridgepoint Advisers. He has a 20-year tenure at the Boston Consulting Group, where he led the Nordic Operations and Nordic Healthcare Practice group. Mikael is also a Board Member at Stronghold Invest and Cuptronic Technology. He holds an MBA from Stockholm School of Economics and Business Administration. Mikael Lövgren has diverse board roles, such as at Karolinska University hospital, TV4, Tre Vänner, and Solhagagruppen. Additionally, he was the chairman at Terveystalo Healthcare. His investments and professional experience demonstrate expertise in operational leadership and strategic healthcare initiatives.

Urbana-Champaign Angel Network focuses on innovative companies in fields such as engineering, computer science, healthcare, ag tech, and energy. They aim to support early-stage companies connected to the University of Illinois Urbana-Champaign’s expertise. The network follows a process where entrepreneurs submit registrations, present at membership meetings, and undergo a Due Diligence process. They are based in Champaign County, leveraging the technological resources and strategic location. There is no specific information about previous investments, geographical preference, investment check size, or partnership and collaboration styles available from the sources.

Jon-Michial Carter is the Chief Growth Officer & Founder at ChartSpan Medical Technologies, a healthcare technology company in Greenville, South Carolina. He has a track record of holding c-level and executive positions in companies like Iconixx and American Equity. Alongside his role at ChartSpan, he serves on various boards including SCRA, organizations supporting entrepreneurship. Jon-Michial Carter has a rich history of business leadership and innovation, contributing to the growth of startups and ventures. His collaboration style is focused on building strong partnerships and mentorship within the entrepreneurial ecosystem of Greenville and the broader South Carolina area.

Oleg Uritsky is a successful entrepreneur and the founder of Helge Capital, a real estate operating company specializing in multifamily housing in the Boston area. He focuses on undervalued or below replacement cost transit-oriented properties. Oleg has a background in various industries including healthcare, transportation, and venture funds. He is known for his hands-on approach and has a track record of successful investments and predictions. Oleg’s investment check size and partnership styles are not explicitly mentioned in available sources.

Minda Brusse is a venture partner at 2048 Ventures and the co-founder and managing director at First Row Partners. She focuses on pre-seed tech companies, primarily in data and software. Her investment check size was $3M for a seed round in ApertureData. Minda Brusse’s geographical preference is the Pacific Northwest, specifically Seattle and Portland. She aims to elevate women in investment leadership roles and invests in industries like digital health, genomics, AI, machine learning, and robotics. Her partnership and collaboration styles involve a founder-first perspective, optimism, diligence, and intellectual rigor in her portfolio.

Mattias Weinhandl is an impact investment angel known for supporting startups in Health, Food, and Agro Tech sectors. He invests in high-impact startups and is interested in all impactful ventures. Mattias has made investments in companies like Blue Call, All Ears, Prion, and others. His investment check size is exemplified by a recent investment round of SEK 3.5 million. As an active entrepreneur and investor since 2010, Mattias’s previous investments include Moments, Boards on Fire, PUSensor, Heja, and more. He is a former NHL pro turned investor and a Founding Partner at PlusCap. Mattias Weinhandl’s collaboration style reflects his passion for supporting entrepreneurs solving significant challenges and his desire to invest in impactful ventures.

Abel Gomez is a consultant at Solid and Sound Investments. Further details about his investment thesis, stage of investment, geographical preference, track record, professional career, investment check size, and partnership and collaboration styles are not available from the provided sources.

Oliver Heimes is a General Partner at Lakestar with a focus on US-based investments, particularly in the Healthcare sector. He has led investments in companies such as Oscar Health, Cedar Health, Rhino, and Public.com. Oliver’s geographical preference includes a focus on the US market with additional interests in the UK and Europe. His previous investments include partnerships with Auterion, Rhino, and Public.com. Oliver’s investment check size and partnership styles are not specifically mentioned on the Lakestar website.

Marceau Michel is the Founder and Managing Partner at Black Founders Matter, a $10-million venture fund focused on investing in Black founders. The fund looks for companies that are innovative in both products and operations across sectors like gaming, healthtech, and consumer products. Black Founders Matter has made about 10 investments so far, with half of the fund reserved for follow-on investments. They support diverse portfolio companies by introducing them to industry-specific leads for future fundraising rounds and act as a ‘connector fund’ to larger funds seeking diversity. The fund has invested in companies led by both men and women.

Adrien de Loes is an investor focusing on ventures addressing societal challenges in areas such as financial services, healthcare, education, and commerce. He invests in early-stage startups and has supported companies like Tallerator with a seed investment of â¬95K. In his professional career, Adrien de Loes has a track record in various fields, including athletics and investments. His partnership and collaboration style involves engaging in collaborative partnerships to address sustainability challenges. Geographically, his investments span regions focusing on societal impact. Specific investment check sizes are not disclosed.

Mr. Lester Grant is a Co-Founder and served as Board Member at Conductiv. Before founding MedPricer, Mr. Grant held various leadership roles at Corometrics, Siemens, and Oxford Instruments. After over 20 years in healthcare management positions negotiating contracts, Mr. Grant decided to found MedPricer, a company that would help hospitals, IDNs, and suppliers streamline the contracting process. He began his business career with Abbott Laboratories, after teaching in Newark, NJ, and at The School for the Foreign Born in Elizabeth, NJ. Mr. Grant holds a Bachelor’s Degree from Seton Hall University. He is a member of AHRMM and the HFMA.

SeedCapital Dortmund is an investor focused on providing a new boost to innovative ideas. They invest in startups within Dortmund’s technology fields, particularly those less than 18 months old. SeedCapital Dortmund’s investment check size can go up to 500,000 Euros in the first step. They have previously invested in companies like Comnovo GmbH, Kairos GmbH, Volterion GmbH, and Scienion AG. Their partnership and collaboration style involves being a sparringspartner for operational and strategic questions to increase company value together.

Dr. Kostas Alevizopoulos brings over 20 years of expertise in developing and commercializing therapeutic, diagnostic, medical device, and OTC products. He focuses on mid-stage investments in the biotech and healthcare sectors and has a broad geographical reach in Europe, the US, and more. With a biology degree, a PhD in Molecular Biology, and post-doctoral studies in oncology research, he has a strong publication and patent record. His previous roles include CSO of Gerolymatos International SA and CEO of Medexis SA. Dr. Alevizopoulos is actively involved in evaluating technology opportunities, serving as a strategic advisor, and has a collaborative partnership style.

Mr. Paul Gaffney is an angel investor with a focus on seed round investments. His industry focus includes Healthcare, Consumer Internet, Financial Technology (FinTech), Technology, Media and Telecom (TMT), E-Commerce, Enterprise Software, and Mobile. He has a professional background as Chief Digital Officer at Omni Logistics and has held various technology leadership roles. Mr. Gaffney’s investing style pertains to collaboration, with a preference for expressive collaboration that involves visual engagement and freewheeling brainstorming. He values human connection and deep work, emphasizing the importance of face-to-face interactions and researching ideas thoroughly.

ID8 Investments is an Investment Firm Focused on Partnering with Mission-Driven Consumer and Technology Companies.

Town Hall Ventures is an investment firm aimed at transforming the woefully broken U.S. health care market through technology.

West Suburban Angels is an angel network based in Naperville, Illinois, specializing in early-stage investments. Their investment focus areas include innovative information technology, business services, industrial technology, consumer or industrial products, and healthcare services or technology. The investment targets include an initial investment size of at least $500,000, early-stage or early-growth companies, a strong management team, and a large or rapidly growing market. Geographically, they prefer companies headquartered in the Midwest. The team comprises professionals with experience in mentoring startups. West Suburban Angels’ check size ranges up to $5 million per investment, with a hands-on partnership and collaboration style, offering mentorship to startup companies.

Susanne Schorsch is a Partner at Amadeus Capital with a focus on European early-growth deep tech investments. She has led over 20 investments in deeptech, particularly in health and biotech sectors. Susanne’s previous experience includes being a Partner at Verve Ventures, where she actively contributed to the success of companies like CREAL, MemoTherapeutics, and Nagi Bioscience. Some of her notable investments include Alaya (acquired by Benevity) and Onward and Astrocast (both went public in 2021). With a background in international business at BASF, Susanne brings a wealth of experience in strategy and innovation. She has a strong educational background, having completed executive programs in Venture Capital and Innovation at UC Berkeley. Susanne holds an MSc and BSc in Industrial Engineering from the Karlsruhe Institute of Technology and is an alumna of the University of Pennsylvania’s Wharton School.

Varadh Jain is an angel investor based in San Francisco, California. His investment focus areas include Technology, Venture Capital, Insurance, Healthcare, and Financial Services. Varadh’s previous investment in Causal, a London-based startup, totaled $4.2 million in a Seed round. He collaborates with partners and is known for having a track record as a Techpreneur and Angel Investor. Varadh Jain typically invests in early-stage startups and prefers a hands-on approach in guiding portfolio companies. Geographically, his investments have been in San Francisco, California, United States. Varadh Jain’s strategy includes investing significant amounts in innovative startups, such as Causal, while actively engaging with the entrepreneurial ecosystem.

Mr. Douglas Davenport serves as Chief Financial Officer & Senior Vice President at Maplewood Surgery Center. He is an angel investor. He serves as Board Member at RetraceHealth. Doug came to HealthEast in 2014, bringing more than 25 years of experience driving the strategic financial direction and health of multi-entity health care organizations. He leads finance, revenue cycle, materials management, managed care strategy and shared services, working across the organization to achieve the most affordable health care for our patients. Recognized for his innovative leadership, Doug is helping transform HealthEast to a value based health care system.

David Studer is an experienced investor who actively invests in Swiss early-stage startups, with 29 direct investments over the past six years. Some of his previous investments include Moodtalk, Agrinorm, contactify, and CareerLunch. Studer’s partnership and collaboration approach involves community collaboration to achieve outcomes aligning individuals across organizations. His investment check sizes vary based on the startups and their needs.

CRV is a venture capital firm that invests in early-stage investments in technology companies.

Mathew Farkash is an Advisor to Epsilon Health Investors and a Founding Partner of Blueprint Health, a healthcare-focused accelerator fund. He is involved in business development, sales, fundraising strategies for startups in the health and technology sector. Mr. Farkash has a track record of supporting over 70 health tech companies and evaluating innovation strategies for large healthcare organizations. His educational background includes Brown University (B.A., 2003) and NYU Stern School of Business (M.B.A., 2009). Blueprint Health focuses on investments in healthcare, medical, information technology, software, and mHealth sectors. They support startups at the seed stage and have a geographical preference for companies in New York. Mr. Farkash’s check sizes for investments are not specified, and Blueprint Health emphasizes mentorship-driven programs to support entrepreneurs building health and tech companies.

Igor Tulchinsky, the Founder and CEO of WorldQuant Ventures, focuses on disruptive technology companies in finance and data. The firm’s investment thesis is to invest in innovative entrepreneurs driving emerging technologies for real-world change. WorldQuant Ventures evaluates a wide range of alternative investments and actively supports companies in Fintech, Cleantech, Quantum Computing, Healthcare, Data, and AI sectors. The geographic preference includes North America, Europe, Southeast Asia, and South America. The investment check size varies, as evidenced by investments in finance news site Benzinga. Igor Tulchinsky’s collaboration style involves establishing initiatives and supporting strategic needs, as seen with partnerships with institutions like Weill Cornell Medicine.

D. Randall Winn, Founder and Managing Member at FiveW Capital, is an experienced investor known for his leadership at Capital IQ. He brings a wealth of expertise to the table, having served as the CEO and Executive Managing Partner at Capital IQ. His diverse portfolio includes roles as Chairman at Dealogic and a Board Member at Meritsoft, eMarketer, and The TEAK Fellowship. Mr. Winn’s investment focus areas are well-established, with a particular interest in healthcare and other industries. He has a history of strategic partnerships and collaboration, evident from his tenure at leading companies. His investment check sizes vary based on industry and opportunity, demonstrating flexibility and adaptability in deal structuring. With a track record of successful investments, D. Randall Winn’s partnership and collaboration styles emphasize long-term relationships and value creation.

Max Klement is a Principal at BGV (BioGeneration Ventures), a venture capital firm based in Amsterdam, Netherlands. The firm’s investment thesis focuses on early-stage European biotech companies. Max’s investment areas include Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services. He primarily invests in seed-stage startups in these sectors. Max’s geographical preference is not specified. His previous investments include Complement Therapeutics Ltd, where BGV provided seed funding. Max is known for his professional career in identifying promising opportunities in complement biology. His check sizes range from $100K to $1M. Max’s partnership and collaboration style at BGV emphasizes co-investing with firms like Forbion and engaging in seed financing rounds.

Lindsey Brown, a Senior Associate at Echo Health Ventures, based in Portland, Oregon, supports the firm in all aspects of the investment process. With a background in healthcare finance, Lindsey plays a crucial role in deal sourcing, evaluation, and transaction management. She brings expertise from executing transactions at Cambia Health Solutions and overseeing streamlined reporting structures for the investment portfolio. Her investment focus areas include fostering the growth of companies in the healthcare sector, particularly in women’s health and digital health. Lindsey has a track record of success in supporting startups through strategic investments and providing financial and market support. Echo Health Ventures’ geographic preference leans towards the West Coast and Western US regions, with a partnership style that drives the success of the portfolio companies.

Joanna Lichter Cohen is a Senior Associate in Venture Capital at Emerson Collective, with an investment range of $100K – $5.0M and a sweet spot at $1.5M. She focuses on Retail (Series A), Food and Beverage (Series A), Health & Hospital Services (Series A), and Health IT (Series A) sectors. Joanna’s recent investments include companies in the digital health and retail sectors. With a diverse professional career spanning roles such as Head of Content, Creative Director at Fidelity Investments, and Director of Content Strategy at Fidelity Investments, she holds a track record of success. Joanna Cohen’s educational background includes an Ed.M from Harvard University and a B.S in Human Development and Family Studies from Cornell University.

Patrick M. Hanrahan, an Angel Investor, focuses on rendering algorithms, graphics processing units, scientific illustration, and visualization. His investments cover promising companies in exchange for equity. He invests personal funds into companies. Dr. Hanrahan’s research includes high-performance graphics architectures and graphical interaction systems. Further details about his partnership and collaboration styles are not available.

Therese Liechtenstein is an experienced Senior Investment Director in the Biotechnology team at M Ventures. She joined M Ventures in 2018 and has been instrumental in the creation and financing of companies in M Ventures’ portfolio, such as FoRx Therapeutics and Anavo Therapeutics. With a background in Immuno-Oncology and Biomedical Sciences, Therese actively leads investments, sits on multiple portfolio company boards, and has a professional career including managing strategic projects for Merck KGaA. The investment check size of M Ventures ranges between $500K to $1.5M. Therese’s investment focus areas include early-stage therapeutics companies in the fields of Oncology, Immunology, and Fertility. Geographically, she is involved in early-stage therapeutics and life science companies. Therese Liechtenstein’s track record showcases her commitment to the biotechnology field and her hands-on approach to investment.

Pablo Frias, a professional with a Master’s degree in Stock Market and Financial Markets, specializes in finance, financial analysis, investment banking, and M&A. His investment focus areas include financial analysis, KYC, credit portfolio reporting, stock market analysis, private equity, and market risk analysis. He has experience in various roles such as Credit Risk Analyst and inventory manager. Pablo’s geographical preference is the US. His previous investments include BMF-219, a menin inhibitor for type 2 and type 1 diabetes. Pablo has run as a candidate for the Arlington City Council in Texas, campaigning on transparency, accountability, and city priorities. His investment check size and partnership styles are not explicitly mentioned in the available information.

Marco Vietor is an investor with a diverse portfolio of investments spanning companies like Famly, Parcelperform, Caroobi, and Movinga. He co-founded Audibene and led it to a successful acquisition. Marco’s check size for investments is sizable, with a maximum check size of $4,000,000. His partnership and collaboration styles focus on strategic alliances and hands-on guidance, as seen in his track record and professional career evolving Audibene into a leading platform for hearing care solutions.

Viola Ventures is a venture capital firm that invests in Israeli related early stage companies.

David Karp is the Founder and CEO of Tumblr with over 25 years of experience in providing financial investment and wealth strategies. He has been recognized as a Top Financial Advisor by Barron’s and a member of the Young Presidents’ Organization (YPO). David has made 8 investments, including Splash and Sherpaa Health, with investment check sizes varying. He has a background in special situations, distressed investments, and counterparty credit risk. David’s partnership and collaboration styles are evident from his philanthropic efforts, such as building a ‘Home of Hope’ in the Dominican Republic. Geographically, David is active in the Virginia area and is associated with Cresset Family Office.

Kevin Lösch is an Investment Manager at Inventure with a focus on fintech, healthtech, marketplaces, and consumer-facing tech. He actively builds the talent pool of experienced founders and works with startups such as Anyday, Yeply, anotherblock, and Medoma. With a background in investment banking and entrepreneurship, Kevin approaches investments with an operational mindset and a dedication to solving complex problems for end users. He has led seed rounds for companies like Anyday and Yeply. Kevin is based in Sweden and has a gender of male. He has a track record of success in multi-billion M&A transactions and bootstrapped his own D2C brand before joining Inventure. Kevin is known for partnering and collaborating with founders who are committed to addressing challenging issues with a customer-centric approach.

Philip Hodges focuses on high growth small businesses within the health care, life science, and technology sectors. His investment strategy includes previous investments in companies like allvivo, Entegreat, Reliant Medical Products, and Vaxin. As a Managing Partner at Enhanced Capital Partners in Birmingham, Alabama, he primarily operates in the Southern US region. Philip’s check size for investments is substantial, managing funds totaling $14 billion at BlackRock. He has a background in finance and computer modeling of financial markets.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new health-tech startups. Founded in 2010, they invest in technologies that democratize access to quality care for all. Their focus areas include Providers, Payers, Pharma, Patients, and Self-Insured Employers. HealthTech Capital invests in capital-efficient companies at the seed and series A rounds. They have a track record of success, raising over $1 billion and providing mentoring programs. Their previous investments include companies in the Biotechnology, Surgical Devices, and Devices and Supplies industries. The check size of their investments varies based on the company’s stage. HealthTech Capital engages in strategic partnerships and collaborations with healthtech startups to drive innovation and growth.

Picus Capital is an early-stage technology investment firm with a long-term investment philosophy.

Mary McCarthy is a Partner at Brightlands Venture Partners, located in the Netherlands. Her investment focus areas include Seed Consumer Health, BioTech, Health IT, ClimateTech/CleanTech across different investment stages. Mary’s current investing position involves investments ranging from $100K to $5.0M, with a sweet spot at $1.5M. She has a track record of investments such as Circularise in Series A in Nov 2022 and Qorium in Jul 2021. Mary collaborates with co-investors like Guillaume Baxter from Soffinova Partners. Her professional career includes prior roles at SABIC, Boostani, and Brightlands Maastricht Health Campus.

Albert Armengol focuses his investment thesis on Consumer Internet, Enterprise Software, Healthcare, and SaaS, with previous investments in companies like Nester and Piper. He has a track record as the CEO and co-founder of Doctoralia and founder of eConozco. Armengol typically invests in the seed VC stage and collaborates with co-investors like Jaime Carvajal, Jesus Menendez, Juanjo Mostazo, Marina Planas, and Sergio Furio. His investments range between $100,000 and $500,000 per company, with a focus on marketplace, fintech, and e-commerce sectors. Armengol’s geographical preference is in Barcelona, Spain, and he has made 14 investments to date, with one portfolio exit involving Nautal.

Gunnar Berning is an angel investor based in Germany. With a vision of ‘Shaping the world of work,’ he is the CEO and co-founder of twago (teamwork across global offices). Gunnar has made investments in companies like Circus as part of their Seed VC. He has experience in various industries including technology and consulting. Gunnar’s professional career includes roles such as CEO, COO, Managing Director, start-up coach, mentor, and blogger. He has been involved in successful M&A sales, team growth, data-driven organizations, and securing key deals. Gunnar’s investments reflect his interest in areas such as Technology, Corporate Strategy, Corporate Venture Capital, Insurance, Healthcare, and Financial Services. His geographical preference seems to be focused on initiatives that shape the world of work and impact various industries globally.

Salomon Horowitz is a passionate investor and Managing Partner at Operators VC. With a focus on early-stage healthcare startups, Salomon collaborates on the Hikeish initiative to promote diversity in outdoor spaces. Past investments include Lyft and Vendy, demonstrating a successful track record. Salomon’s collaboration styles emphasize partnerships that enhance accessibility and inclusivity, as seen in the Hikeish program. Check sizes vary based on the initiative, and Salomon leverages a hands-on approach to foster growth and innovation.

David Gandara is a highly distinguished Professor at UC Davis Comprehensive Cancer Center where he serves as the Director of Thoracic Oncology. With a track record of over 450 peer-reviewed papers, he focuses on developmental therapeutics and biomarker development in lung cancer. Prof. Gandara collaborates with experts to identify differences in cancer treatments. Cabin Ventures, an enterprise with 2-10 employees, is one of his partnership ventures. He is involved in technology incubation projects for global betterment. The investment check size is undisclosed, but his collaborations highlight a commitment to advance drug development in lung cancer.

Matthew McCall serves as Partner at Pritzker Group Venture Capital and is involved in various investments. He has a background in consultation and banking, with a focus on telecommunications, healthcare, and financial services. McCall has received recognition for his venture activities and contributions. He is the Founder of the McCall Family Foundation, which promotes social entrepreneurship and global human/girls’ rights. McCall’s investment check size is not specified, but he has been associated with significant investments in various companies. His collaboration style is likely flexible, given his diverse background and involvement in multiple boards and advisory roles in the technology sector.

Impact51 is an investor focusing on early-stage funding for technology-oriented, digitally driven start-ups with scalable business potential primarily in B2B segments. They actively engage with 3-5 new investments per year and act as an investment syndicate through their network. Their geographical presence includes Germany, Switzerland, Czech Republic, Austria, and the United States. The team comprises experienced former executives with expertise in entrepreneurship, corporate management, consulting, and venture capital. Impact51’s mission is to share entrepreneurial and management experience with startups and provide hands-on operational support for growth. They have made 20 investments with 3 exits over the last 4 years, investing over 4 million euros.

Sebastian Schaefer is a Partner at Picus Capital with a focus on pre-seed investments, supporting early-stage founders on growth and operations topics. He graduated from the London School of Economics with a master’s degree in Economic Sociology. Sebastian’s investment thesis includes a focus on pre-seed investments in sectors like Human Capital/HRTech, EnergyTech, Insurance, TransportationTech, Real Estate/PropTech, Health IT, E-commerce, and FinTech. His investment range is typically between $250K and $750K, with a sweet spot at $500k. Sebastian has been involved in previous investments such as Avi Medical, Everstores, and more, emphasizing collaborations and partnerships in the venture capital space.

Will Ventures is an early-stage venture capital firm that prefers to invest across the consumer, healthcare, and media markets.

Logan Capital AG focuses on Consumer, Enterprise, Bio/Healthcare, and Agriculture sectors for their investments. Their stage of investment includes early stage and seed funding. They are based in St. Gallen, Switzerland, and invest in early-stage companies. Previous investments and investment check size details are not available.

Mark Hirschfield is an Angel Investor with a focus on Seed Round investments in industries like Healthcare, Consumer Internet, Energy & Clean Tech, Real Estate & Construction, Enterprise Software, and Mobile. He has invested in companies such as Example example company Inc, Example & Company, and Example. Mark Hirschfield is based in Europe, specifically in London, United Kingdom. He has a track record of successful investments in startups at various funding stages, such as Seed rounds and Series C funding. His investment check sizes vary based on the company and round. He is known for his entrepreneurial background and collaborative approach in working with startups.

Tony Xu is an investor with a focus on Life Sciences & Healthcare (23%), Consumer Products & Services (21%), and Business Services (16%). He has invested in blockchain technology providers like Alchemy, as well as ghost kitchens such as All Day Kitchens and Local Kitchens. Tony Xu writes early checks ranging from $250K to $5M. He operates primarily in North America with a partnership style that emphasizes strategic thinking and empathy, focused on growing local economies.

Nicholas Benedict is an investor with over 20 years of experience in the pharma industry, specializing in finance, marketing, and sales. He focuses on the pharma industry, finance, marketing, and sales, with a seed investment stage. Nicholas prefers to invest in Europe, Middle East, and Africa (EMEA) regions. His previous investment includes Allecra Therapeutics in a Series B round valued at â¬22M. Nicholas has a successful track record in leading fundraising efforts and has held key roles at companies like Novartis and Basilea Pharmaceutica. He has a check size of â¬22M for investments. Nicholas Benedict’s professional career includes positions such as Founder and CEO at Allecra Therapeutics, COO of Novartis UK, and Global Head of Anti-infectives Business Unit at Novartis AG.

Oxana Kukhaneva joined Seventure Partners in 2016 as a Venture Partner, focusing on investments in Benelux, Scandinavia, Northern Switzerland, and the United States. Her investment areas include nutrition, foodtech, digital food, and microbiome applications. She has over 12 years of experience in capital innovation and development, specializing in health, nutrition, and consumer goods. Oxana was previously responsible for investments at Inventages, with a BA in Economics, and MA and MBA from IMD, Switzerland. Her check size details are not available, but she is known for her collaborative and adventurous approach in entrepreneurship.

415 Capital is a venture capital firm specializing in breakthrough and life-saving medical innovation. They provide exceptional entrepreneurs with capital, clinical, scientific, and business expertise, as well as market access. With over 50 funded medical technology companies and 25 realized exits, their investment strategy focuses on value creation. Some of their investments include Laza Medical, Supira Medical, R3 Vascular, Moray Medical, CorFlow, Cardiac Success, Aktiia, Distalmotion, and TRiCares. Located in Munich, Germany, they are dedicated to collaborating closely with entrepreneurs to drive success and innovation in the medical field.

Alex Mace, Vice President at Thompson Street Capital Partners, focuses on investments with a value creation approach in business and healthcare services, as well as engineered products sectors. The firm’s investment thesis emphasizes the importance of ESG factors. Alex Mace’s investment check size typically ranges between $5 million to $50 million, with a sweet spot around $25 million. Thompson Street Capital Partners’ previous investments span a wide range, with a typical investment size of $5 to $20 million for EBITDA investments and $25 to $150 million for equity investments. Though specific details on partnership and collaboration styles are not available, the firm is known for its thesis-driven approach and commitment to value creation within its portfolio companies. Alex Mace and Thompson Street Capital Partners maintain a track record of successful investments in line with their strategic focus areas.

Roger Ingold is the founder of RS Investments, a venture capital firm based in San Francisco. The firm focuses on investments in Health Care, Biotechnology, Information Technology, Artificial Intelligence, and Therapeutics. With a total of 7 investments and an average round size of $85M, RS Investments has a track record of 6 exits. One of the popular portfolio startups is Four51. Roger Ingold’s fund was most active in 2000, and the average startup value when receiving investment from RS Investments is highlighted on the (website)[http://www.rsinvestments.com].

Vincenzo Iozzo is an investor with a focus on software development applications, healthcare technology systems, and consulting services (B2B). His previous investments include companies like Pulley and Get Harley. Vincenzo Iozzo has a professional background in cybersecurity and was the CEO and Co-Founder of SlashID. He is known for a collaborative partnership style in his investments.

Matthew Ocko is a Co-Founder and Co-Managing Partner at Data Collective, with investments spanning computational and synthetic biology, geospatial and space access. His investments focus on funding deep technology companies at the early stage. He has a track record of over 30 years as a tech entrepreneur and VC, with successful investments including Zoom, Fortinet, D-Wave Systems, Uber, AngelList, Xensource, and Facebook. Matthew Ocko’s check size for investments ranges from $1 million to $15 million, with a partnership approach that emphasizes the importance of collaborations for meaningful innovation and driving better healthcare outcomes.

Carl Byers is an Executive Partner at F-Prime Capital Partners. He focuses on investing in digital health and healthcare sectors. His recent investments include companies like Devoted Health, Doceree, SpectrumAi, Spry, Eleos Health, AmplifyMD, Rialtic, and Notable. Carl’s investment style includes leading rounds of financing and joining the board of directors of companies he invests in. He has led investments in Wellframe, a mobile-enabled care management provider, where he led a Series B round of financing. He primarily invests in Seed and Series A stages. Additionally, Carl Byers has experience in healthcare finance and serves as a key advisor to the senior leadership team. F-Prime Capital’s Investment Check Size is around $400M. In partnerships, Carl collaborates actively with other investors and industry partners to translate innovative ideas into real impact.

Florian Müellershausen, PhD, is a Managing Director at the Novartis Venture Fund in Basel, Switzerland. He focuses on Pharmaceuticals (Series A), Pharmaceuticals (Seed), BioTech (Seed), and BioTech (Series A). Florian aims to invest in the development of novel therapeutics and platforms, medical devices, diagnostics, or drug delivery systems. He prefers the early stage for initial investments, with additional funding as companies progress. Florian anticipates total investments up to USD 30 to 50 million per company over its life. His partnership and collaboration styles are hands-on, leveraging his expertise in drug discovery and biochemistry to guide portfolio companies towards successful acquisitions. Previous investments include Anaveon, Granite Bio, and LoQus23 Therapeutics.

Antoine Boulanger Piette, an Associate at Forbion, has an impressive track record in venture capital investments. With experience in various roles at Forbion, including Analyst and Senior Associate, Antoine has been actively involved in the European venture capital scene. He specializes in Life Sciences and Biomedical Technology companies, focusing on late-stage preclinical and early-stage clinical development programs. Throughout his career, Antoine has contributed to the success of numerous portfolio companies, demonstrating a commitment to responsible investments that positively impact patients’ health and well-being.

Speedinvest is a venture capital fund investing in pre-seed, seed, and early-stage tech startups.

Leona Baker, an angel investor based in Houston, Texas, has a professional background as an Expediter at the United States Postal Service in North Houston from April 1979 to June 1995. Leona’s investment activities as an angel investor are not prominently featured on the online profiles available.

Laura Seifert focuses on early stage investments in the DACH region. In venture capital, she values partnerships with seasoned investors and emphasizes the importance of the people behind the money. She has a track record of investing in companies like Token, Shift One, and Paloma Health. Laura’s investment check sizes range from â¬500k to â¬60m. She co-founded WeSpace and brings a wealth of entrepreneurial and operational experience to her role, cherishing the industry for its big ideas and inspiring people.

Lifeline Ventures is a team of serial entrepreneurs that invest in sectors we know by heart from our years as founders and startup leaders.

Amy Kobe, a Principal at Baird Capital, focuses on sustainability sectors, with an investment thesis centered on proven solutions addressing global sustainability demands, above-market growth, and digitalizing the customer experience. She is part of the Venture team that invests $10-20 million in equity over the life of an investment in healthcare and technology firms. Amy has been involved in investments like AEGIS Energy Risk, Cala Health, ChurnZero, and Greenlight Biosciences. Baird Capital’s investment check size ranges from $10 to $20 million. Amy Kobe’s partnership style involves active support and strategic guidance to address bleeding complication challenges in ventures like Virtual Incision.

Trevor Zimmerman is the Founder and Managing Partner at Blackhorn Ventures. He primarily focuses on investing in companies within the HealthTech and Life Sciences sectors. Blackhorn Ventures, which was founded in 2016, seeks venture capital investments in resource-efficient technologies. Trevor’s previous investments include Aether Bio, and the company’s total funding exceeds 1.5M+. Blackhorn Ventures invests in early-stage ventures and is positioned to invest in resource-efficient technologies. The firm aims to redefine resource productivity and addresses the impact of global consumption on Earth’s resource capacity.

Dieter Manstein is an individual angel investor with a primary focus on seed-stage investments. He has invested in GME Medical Engineering with a check size of â¬750K. His investment focus areas are in dermatology-related procedures for scars, burns, aging skin, and fat removal. Dieter Manstein’s professional career includes roles as a Clinical Consultant and Assistant Professor of Dermatology at Harvard Medical School, and he is the Co-Founder of GME Medical Engineering in Nuremberg, Germany. His partnership and collaboration styles involve co-founding ventures like GME Medical Engineering and R2 Technologies.

Fuchsia Venture Capital Company focuses on strategic investments in Insurtech, Healthtech, Foodtech, and technologies aimed at improving consumers’ health, wealth, and wellness. The company has 2-10 employees and operates in the Venture Capital and Private Equity Principals industry. Unfortunately, specific previous investments and the stage of investment are not available. However, there is no information on the track record and professional career of Fuchsia Venture Capital on the sources visited.

Chris Dixon’s investment thesis focuses on forward-thinking ideas, particularly in technology that impacts real-world sectors like transportation and healthcare. He prioritizes addressing billion-dollar markets and is open to investing in smaller markets as well. His professional career includes insights into the startup ecosystem and inspirational quotes for entrepreneurs. Chris Dixon’s involvement in crypto investing at Andreessen Horowitz showcases his commitment to the field despite market challenges. Specific details about his stage of investment, previous investments, investment check size, and partnership styles are not available.

Mr. Alan Hartman serves as Partner at Centerview Partners. He is also an angel investor. He has established himself as a leading advisor in the healthcare industry. Prior to Centerview, Alan spent several years with Merrill Lynch where he was Head of Americas Mergers & Acquisitions. He was twice named one of the ‘Dealmakers of the Year’ by Dealmaker Magazine. Prior to joining Merrill Lynch in 1993, Alan spent four years as a Mergers & Acquisitions attorney at Skadden, Arps, Meagher & Flom in New York. He received a B.S. in economics from the Wharton School of Finance and a J.D. from Harvard Law School.

NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.

Northpond Ventures is a science-driven project capital firm that focuses on biotechnology and affiliated industries.

MED Angels invests liberally across healthcare focusing on companies that can yield high potential impact with a focus on disease management.

James Beshara is an Angel investor with a focus on investing in direct-to-consumer (D2C) startups. His criteria for evaluating startups include product quality, founder capability, brand universe, growth potential, and market space. Beshara has made investments in various sectors and stages, such as Health & Hospital Services, Health IT, Consumer Internet, and FinTech. He typically invests in the Seed and Series A stages with an investment range of $100K to $100K per company. Some of his notable investments include Clinikally, Superorder, BOND, Frond, Meez Culinary Solutions, Rye, Kona, and Showplace. Beshara’s track record includes founding Tilt and Magic Mind, emphasizing the importance of creating products people love, growth strategies, and learning from failures.

Nikki Bogopolskaya focuses on investing in health, wealth, and community with a focus on female founders. Her investments include startups such as Amboy Street Ventures, Aplos, Brightland, Character, Esker Beauty, House of Wise, and more. She is skilled at building and scaling revenue and partnerships products and teams, with over a decade of experience in leading high-performing teams. Nikki takes pride in being a connector, brand builder, and data devotee. She is actively involved in teaching yoga, prenatal yoga, and megaformer pilates, alongside making angel investments in health, wealth, and community.

Jim Bruene is actively involved in the fintech industry, particularly in areas such as fintech products and trends, banking, mortgage, lending, AI, insurtech, payments, and more. He has a strong focus on organizing and participating in major conferences and events within the financial services and technology sectors. In terms of investment focus, Jim Bruene is associated with payments, financial services, personal finance, and consumer lending markets. While specific details about his stage of investment are not readily available, his involvement with fintech startups and his recognition for driving above-market returns suggest a focus on early to mid-stage investments. Previous investments include Crelate, Datasembly, Lulabop Inc, and SoundCommerce. His track record highlights expertise in the technology sector and success in driving market returns.

Belle Capital USA focuses on building great companies in underserved capital markets across the USA. They invest in digital/mobile/internet (IT), technology-enabled products and services, life sciences/medical devices/health IT (Digital Health), and CleanTech sectors, primarily in early-stage companies. Their geographical preference is in underserved capital markets across the USA. Some of their previous investments include Current Motor, Unopsec, US Bancorp, among others. Belle Capital USA is known for being active investors, providing both financial and human capital. They seek enterprises that welcome their expertise insight and prefer teams with strong domain expertise and proven commercialization and entrepreneurial experience.

B Capital Group is a venture capital firm that backs global entrepreneurs in the field of information technology.

Zann Ali, a Partner at 2048 Ventures, is a thesis-driven investor focused on early-stage investments in next-generation B2B platforms, including Biotechnology, Health Tech, AI/ML Applications, Robotics, IoT, and AR/VR. He leads pre-seed or seed rounds in North America or the UK. 2048 Ventures has invested in over 200 startups and is supported by top founders, family offices, and venture capital firms. Previous investments include Century Health, accelerating drug development with AI in clinical data. Zann Ali’s investment range is typically between $150K and $600K.

Christer Arvidsson is an individual angel investor based in Eslöv, Skane Lan, Sweden. His investment focus areas include health care, software, and fitness. Christer mainly invests at the seed stage and has made investments in companies such as Simpliday. He has a track record as the Founder and CEO of Delvator. Christer’s investment check size ranges with his latest investment in Simpliday being SEK5.5M. Geographically, Christer prefers investments in the Nordic countries and Scandinavia, with a focus on startups within the European Union (EU). Through his partnership and collaboration styles, Christer actively supports startups in their growth journey, providing not only funding but also mentorship and strategic guidance to help them succeed.

David Gardner, a Fund Manager, Entrepreneur, and Writer, is actively involved in funding promising ventures through the Cofounders Lab and Fund program, supporting entrepreneurs in modeling, vetting their startup ideas, prototyping, and securing investors. His investment portfolio includes cutting-edge technologies across sectors like machine performance analytics, advanced CRM for higher education, and healthcare informatics engines.

Mihir Bhanot focuses on investments in Mobile, Consumer Internet, Digital Media, Social Media, SaaS, Financial Services, Analytics, Mobile Commerce, Big Data, Enterprise Software, Clean Technology, and Healthcare. His investment check size ranges from $1K to $10K. He has made 113 investments in various startups with a diverse portfolio. Some of his previous investments include Notion, Twist Home, Zeel, and Armorway. Mihir Bhanot’s partnership and collaboration styles are not specified on the available sources.

Carl-Johan Dalsgaard, a Venture Partner at HealthCap, based in Stockholm, Sweden, focuses on investments in Therapeutics (Series B), BioTech (Series B), Health IT (Series B), Digital Health (Series B), and Health & Hospital Services (Series B). He typically invests in the range of $100K to $5.0M with a sweet spot at $1.5M. Carl-Johan has a current fund size of â¬1.2B and collaborates with investors like Alex Valcu, Anki Forsberg, Björn Odlander, Carl Kilander, and Eugen Steiner. His track record includes leadership roles in various biotech companies and a successful career in the management of healthcare-related ventures.

Supernode Ventures is a venture capital firm investing in early stage technology companies.

John Palmer, Chairman of Gulf South Capital Inc, is a seasoned investor known for investing in early-stage companies. With a geographical preference for Jackson, Mississippi, John focuses on collaborations and holds a Master of Business Administration from Indiana University Bloomington. Gulf South Capital specializes in wireless and Internet technologies, targeting early-stage start-ups. Previous investments include Bomgar in computer software. John’s career boasts a generous track record in supporting arts, education, technology, athletics, and health care. Investment check sizes vary, as evidenced by a $5 million round for Bomgar. Gulf South Capital stands out for its hands-on partnership style, unlocking community knowledge through collaborative articles.

Susan Lyne is the Founding Partner, President & Managing Partner at BBG Ventures, leading investments in women & diverse founders solving problems for the 99%. BBG Ventures focuses on early-stage investments in sectors like healthcare, education, and consumer products. Some of their previous investments include OOVA, Canela Media, Winky Lux, and Maverick. The fund’s average check size ranges from $500K to $1M, targeting ownership percentages of 7.5% to 10%. BBG Ventures prefers to lead or co-lead rounds at the pre-seed or seed stage. They have a geographically inclusive approach, supporting founders building for our polycultural future. Partnering with underestimated founders, BBG Ventures catalyzes innovation in overlooked sectors.

Stefan Koenig is an investor with a focus on technology vendors, corporate strategy, corporate venture capital, venture capital, and determining tech strategy. He has a track record of leading the Advanced Heart Failure Research Program and contributing to the development and testing of mechanical circulatory support devices. Stefan Koenig’s investment check size varies, with his latest investment being in Polymorph Labs in 2014 and the latest portfolio exit being of Polymorph Labs in 2019. He has a collaborative style that values human connections and expresses creativity through visual engagement. His collaboration strategy involves accommodating both introspective and relational collaborators to enhance team productivity.

George Carlin is an investor with over $800M available for investments in any sector worldwide. He is actively seeking individuals with projects in need of funding, offering options for loans, partnerships, and project sponsorship. George specializes in Property Management, Valuation of Commercial Property, Real Estate Law, Real Estate Development, and Capital Markets. His investment fields include Commercial real estate, Healthcare properties, Shopping mall investment, Industrial plants, Retail business units, Logistic facilities, Office buildings, Energy projects, Oil and Gas, and various other industries. To reach out for investment opportunities, you can contact him at georgecarlin588@gmail.com. Thank you.

Kevin Mckim is the CEO of Creative Medical, LLC, where he specializes in the sale and full-service distribution of healthcare products for the animal market. He serves as the President at RecoverCare LLC and was the President/Founder of MedaSTAT USA. Kevin’s previous experience includes being the CEO of PharmaSTAT. His track record includes increasing company revenue, capturing market share, and leading national project teams to measurable results. In terms of investment, his focus areas include healthcare equipment solutions, therapeutic support surfaces, bariatric products, and more. Kevin McKim’s investment check sizes and partnership styles are tailored to the healthcare industry, with a hands-on approach to drive growth and innovation.

Ravi Berry is an Angel investor at Angel Physicians Fund, based in Cincinnati, Ohio. His investment thesis focuses on Therapeutics, Medical Devices, Pharmaceuticals, Marketplaces, BioTech, Digital Health, Health & Hospital Services, and Health IT at both Seed and Series A stages. Ravi’s investment range is $5K – $50K, with a sweet spot at $25K. His previous investments include startups in various healthcare sectors. Collaborates with scouts & angels like Angie Willmott, Anil Verma, Ann Weichert, Arshdeep Tindni, and Clay Willmott.

Kiran Shinde is an Angel Investor with experience as a Liasoning Officer at Sanjivani International School, Kharghar Navi Mumbai. His current role and investment details are not specifically mentioned on the linked profile.

Altitude Ventures provides early-stage venture capital financing to healthcare services and technology startups that improve healthcare.

Advanced Technology Ventures focuses on investing in the ICT, infrastructure, consumer technology, bio-pharmaceuticals and medical industry.

Entrée Capital is a venture capital firm that funds multi-stage startups and companies all over the world.

Estelle Botbol is a seasoned investor on the Speedinvest Health team, committed to identifying and supporting early-stage European healthtech and digital health startups. With a focus on the TechBio space, Estelle seeks out exciting companies in Digital Health. Her background includes working at Inkef, specializing in Life Sciences and MedTech. Estelle is known for her collaboration and partnership styles, leveraging her experience to forge strategic alliances. She holds a Master’s degree in Applied Biosciences and Biotechnology from Imperial College London and a Bachelor’s in Microbiology and Immunology from McGill University. Alongside her professional pursuits, Estelle is a talented songwriter, piano composer, and singer in a Funk & Disco band in Paris.

Joseph Chan is an angel investor with a focus on markets such as Mobile, Consumer Internet, Enterprise Software, Clean Technology, and Healthcare. He specializes in seed round investments and prefers locations like New York City and the San Francisco Bay Area. Some of his previous investments have been in these markets. Joseph Chan has a proven track record in business development, strategic leadership, and operational management across various industries. His typical check size is around $100k. He is a visionary technology and capital markets leader, emphasizing operational excellence, top talent recruitment, and leading transformative projects.

Kate Murdock is an angel investor with a focus on later stage VC investments in industries such as Security & Privacy, Cloud Infrastructure, SaaS, Enterprise Software, and Healthcare. Some of her past investments include Deputy, UserTesting, and Mashery. Kate’s check sizes typically range between $2-5 million. She has a collaborative partnership style and seeks ventures that require funding to bridge the gap to securing external funds. Geographically, Kate has invested in diverse regions. She has a strong professional career in the field of venture capital. Kate Murdock demonstrates a track record of successful investments and plays an active role in supporting startups.

Moment Ventures is an early-stage venture capital firm investing in the future of work.

Health Velocity Capital is a health care focused venture and growth capital partnership

John Payton, Senior Portfolio Analyst at Frazier Healthcare Partners, focuses on investment in BioTech, Digital Health, Health & Hospital Services, and Health IT. He specializes in seed to Series B stages with an investment range from $100K to $5.0M. His track record includes successful investments in these sectors with a sweet spot of $1.5M. John has worked with investors like Albert Cha, Angel Martin, Danica Elliott, Daniel Estes, and Elizabeth Park.

Francesca Baillieu focuses on Synthetic bio and invests between 1 to 10 million USD in a round aiming for ownership between 10% and 20% depending on the stage. Her investment focus areas include TechBio, Sustainability Tech, and Digital Health. She is involved in screening businesses for the Partner Programme at True, injecting innovative solutions into corporate partners’ strategies. Francesca’s partnership and collaboration styles align with Project A’s operational VC model, offering hands-on support without imposing obligations on the teams backed. Project A has a conviction-driven investment team and an operational value-add team of 140 experts covering engineering, product, sales, marketing, data, brand, communications, and recruiting.

Dalmore Investments is an angel fund based in Minneapolis, focusing on emerging healthcare businesses with high growth potential. Led by Dr. John Blank, the fund is committed to investing in lower volatility infrastructure assets primarily in the UK but also manages assets in Ireland, continental Europe, and Canada. Notable investments include companies like Beyond Lucid Technologies. Dr. John Blank, with over 30 years of experience in healthcare leadership, leads the fund and is dedicated to providing more than just capital. The fund’s collaboration style emphasizes building long-term relationships with aligned interests.

Arin Maercks, Managing Partner at New Frontier Capital Partners, focuses on investing in companies in the healthcare, education, internet, and technology sectors in China. The firm also invests in medical buildings. The Healthcare New Frontier Investment Fund, managed by Eucalia, invests in software and healthcare companies. Mr. Maercks’ previous investments include various companies such as JetSmarter and Verzasca Group. Additional information about his track record, professional career, investment check size, and partnership and collaboration styles is not available through the current search methods.

Ger van Jeveren is an investor at Peak Capital III Opportunity Fund with an investment range of $260K to $4.2M and a sweet spot of $2.2M. He focuses on Series B investments in Pharmaceuticals and Digital Health. Previous investments include Photon Ventures Fund 1, Quadrum Investment Fund III and IV, Slingshot Ventures 3, and more. Ger van Jeveren has a background as the founder and previous CEO of Fagron and Arseus, and his partnership and collaboration style revolves around working with a select group of investors like Calin Fabri and David King.

Patrick Bauer is a seasoned investor with a strong track record in growing businesses. He joined Heartland Dental in 1997 and played a pivotal role in its expansion to become the largest DSO globally. As the President and CEO of Heartland Dental, he oversaw all company operations and functions. New Harbor Capital, under his leadership, successfully exited an investment in Heartland Dental in 2012. Pat Bauer’s expertise lies in growing physician practices and multi-unit businesses, making him an invaluable asset to New Harbor Capital. He is a graduate of the Minnesota School of Business and serves on the Board of Directors of Quigley Eye Specialists.

Laurel Touby, a former business journalist and exited tech CEO, is the Founding Partner at Supernode Ventures, focusing on pre-seed/seed stage tech startups across various sectors including FinTech, Healthcare, eCommerce, and Supply Chain tech. She primarily invests in seed-stage startups with a check size range of $500K to $1M. Laurel Touby has a solid track record as the founder of mediabistro.com, where she navigated the company through two recessions, showcasing her ability to manage growth with minimal resources. She is known for her active involvement in the entrepreneurial community through events like the Flatiron Investor meetings and Startup Digital Dinners. Laurel Touby is a seasoned investor with a diverse portfolio including investments in companies such as AdYapper, Appboy, Apploi, Buddie, Clef, CreativeWorx, Fashion GPS, Learn Immersive, and Pivit.

Raviv Sapir is a venture capital investor with a keen focus on minimizing risks in venture capital investments. He emphasizes the importance of strategic measures for risk mitigation, portfolio diversification, and recognizing potential in unconventional opportunities. His previous investments can be explored through Blue Future Partners. Raviv’s investment focus covers Marketplaces, E-commerce, AI, Health & Hospital Services, SaaS, Health IT, Enterprise, Consumer Internet, and FinTech, primarily in Series A and Seed stages. His investment range typically spans from $100K to $5.0M, with a sweet spot at $1.5M. Raviv’s collaboration involves working with a diverse group of investors to support startups in their growth journey.

WI Harper Group is a venture capital firm that focuses on early and expansion investments in Mainland China, Taiwan and Silicon Valley.

Alexandra Pine is a Ventures Analyst at Plug & Play Ventures, the investment arm of Plug and Play Tech Center. The firm focuses on pre-seed and seed-stage investments globally within various industries, with check sizes typically ranging between $100,000 and $150,000. Alexandra Pine’s preferred investment areas include insurtech, fintech, proptech, digital health, pharma, and enterprise. Plug and Play Ventures has a track record of investing in a diverse range of industries, with a partnership style that prioritizes collaboration, innovation, and access to specialized talent. The firm has a successful history of investing in numerous startups and actively participates in corporate-startup collaborations to drive technological innovation and business growth.

Bauke Anninga is the Investment Director at M Ventures, focusing on the biotechnology team and leading investments in companies like Immunitas, Nucleome, NanoSyrinx, PictorLabs, Multitude, Rewind, Synaffix BV, and Outrun Therapeutics. His professional career showcases successful investments and strategic decisions in the biotechnology sector. The collaboration style at M Ventures involves a team effort with key roles such as Managing Directors, CFO, Head of Business Operations, and various investment-related positions.

Launchpad Venture Group is a Boston, Massachusetts based angel investment group and venture capital firm. They focus on software, IT, e-commerce, media, healthcare, clean-tech, and renewable energy sectors in the United States. They have made 115 investments with 25 exits. The firm provides funding to early-stage technology and life science companies.

Arch Meredith is the Managing Partner of Kite Hill Capital, a private venture capital firm. He is also the Co-Founder of the Chroma Group and manages Chroma Group equity interests in various companies. Previously, he was the founder and CEO of TeleTix and held positions at Salomon Brothers and McKinsey & Company. Arch Meredith’s investments cover industries like Energy Storage, Healthcare Technology Systems, and Information Services. He serves on the boards of Chroma Group, Quantitative Imaging, and New Scholars. His academic background includes a B.A. degree from Stanford University and an M.B.A. from the Stanford Graduate School of Business.

Mr. Deepak Vinchhi is a Co-Founder and serves as Chief Operating Officer and Board Member at Julia Computing. He also founded Aquila Technologies and served as the CEO there. His investment focus areas include aerospace, defense, and pharma. Deepak Vinchhi has made previous investments, including in Innoviti’s Seed Round in 2014. His partnership and collaboration styles revolve around making JuliaHub and JuliaSim successful with large customers, particularly in aerospace, defense, and pharma sectors.

Joe Zhou is a seasoned VC with a focus on technology, mobile internet, healthcare IT, and devices. He has a track record of investments in companies like Huifu Payment, Cloudminds, and Analogix. Joe’s career includes roles at SAIF Partners, Kleiner Perkins, and Keytone Ventures. He has been recognized as a top VC in China and was named VC of the Year in 2010. Joe invests in early-stage companies and has a strong background in technology and wireless applications. His previous roles include VP at UTStarcom China and teaching at Beijing University of Technology.

Key Ventures is a venture capital investment firm based in Paris, France. The firm focuses on early-stage investing in the technology sector. Their investment thesis is built upon a tripartite foundation: Team, Technology, and Traction. Key Ventures collaborates with Key Opinion Leaders and early adopters to build traction for investments, validating technological choices and accelerating the commercialization process. They have made investments in companies like PEP-Therapy, Inspeere, and Hoplunch within the Drug Discovery, Database Software, and Commercial Services industries. Key Ventures utilizes an active approach in engagement, ensuring a legacy of impact in outpatient spine surgery technology. The firm invests in early-stage tech companies and has a flexible approach, investing individually or as a syndicate depending on the situation. The geographical preference of Key Ventures is global, and their investment check size varies based on the opportunity.

Randolph Seidler, a Venture Partner at Anterra Capital BV, focuses on providing capital and resources to founders to achieve their goals and preserve the culture they’ve built. His investment areas include consumer services, manufacturing, food, and beverage. While his investment check size is significant, as reflected in the $1.25B size of Seidler Equity Partners VIII, his partnership and collaboration style aim to actively drive growth by partnering with exceptional management teams. Randolph Seidler has a track record that demonstrates a commitment to nurturing mid-market businesses and facilitating strategic growth opportunities.

Kyle Hendrick is a Venture Capital investor managing AAF Management Ltd. He specializes in pre-seed investments in sectors like Human Capital/HRTech, DeepTech, Consumer Health, Health IT, Consumer Internet, Enterprise, and FinTech. His typical investment check size ranges from $100K to $1M, with a sweet spot at $500K. Based in Washington, D.C., his partnership and collaboration style involves engaging in unique national collaboration and licensing programs. Unfortunately, specific previous investments were not available in the search results.

Annie Lamont, Co-Founder and Managing Partner at Oak HC/FT, focuses exclusively on healthcare and fintech entrepreneurs. She has a successful track record with prior investments in companies like athenahealth, Castlight Health, and Devoted Health. Annie has been named the top-ranking investor in healthcare several times and has received multiple lifetime achievement awards for transforming the healthcare industry. Her approach involves investing in companies that improve health outcomes and lower costs. Currently, her active investments include companies like Blend, Carebridge, Devoted, and VillageMD. Annie is known for her strategic insight, commitment, and strong network in the industry.

Gaurav Garg, Founding Partner at Wing Venture Capital, has a focus on data infrastructure and companies reshaping healthcare with AI. Notable investments include Cohesity, Path, Clear Labs, Obsidian Security, Gather, Vevo Therapeutics, and more. With a track record of building successful companies from incubation to public listings, Gaurav’s investments range from early to late-stage tech firms. His partnership style emphasizes hands-on involvement, leveraging decades of experience in tech investing.

Isabel Nilson is an Investment Manager at Spintop Ventures, with a focus on tech investments. She is interested in advancements in all sectors and finds most companies are becoming tech companies to some degree. Isabel has a background in law and finance, having worked with start-up teams and new innovations in tech, healthcare, and real estate sectors. She enjoys fundraising for unlisted ventures, M&A transactions, and IPO exits. Isabel’s geographical preference and contact information are based in Sweden. She has a diverse background with experience in various countries and speaks multiple languages. Isabel Nilson’s partnership and collaboration style information is not available on the provided webpage.

Cheryl Cheng, General Partner at BlueRun Ventures, focuses on early stage mobile software opportunities with a focus on retail, health, and vertical marketplaces. She invests in sectors like Consumer Internet at pre-seed and seed stages, particularly in the San Francisco Bay Area. Cheryl has a strong track record with recent investments in various companies, contributing to her reputation for strategic investments. She collaborates with a network of co-investors and brings a wealth of experience from her Brand Manager role at Clorox. Cheryl’s investment check size varies based on the opportunity, and she is known for her partnership and collaboration styles that emphasize strategic alignment and mutual growth.

Investment arm of R/GA. We’re helping industry leaders capitalize on disruptive technologies through access to the startup ecosystem.

Dimitri Panayotopoulos invests in markets such as biopharma, biotechnology, health care, and pharmaceuticals. His previous investments include Legacy Healthcare. With a career at Procter & Gamble and a track record of overseeing P&G’s global brands and business units, Panayotopoulos brings extensive experience to the table. He also serves on the boards of other companies like British American Tobacco Company and JBS Foods International. Collaboration styles of Dimitri Panayotopoulos are not explicitly available from the sources found.

Jason Will is the President & Chief Investment Officer of JW Asset Management with a track record of success in leveraging his background as a pharmacist to find undervalued pharmaceutical companies. He leads an SEC-registered investment adviser managing over $600 million in assets. Jason Will’s investment thesis includes defining opportunities, risks, and a summary for guiding investments. His focus areas are not specified. Previous investments, investment check size, and partnership and collaboration styles information for Jason Will are not available.

Eli Alroy is a serial investor with over 30 years of experience in hi-tech investments, venture capital investments, and capital markets. His investment focus areas include prevention and personalized medicine, nutrition, mental health and sleep, wellness sustainability, remote and self-care, longevity, and physical activity. Some of his previous investments include companies like Hedonia, Quris, Alike, CalmiGO, MDI Health, Vuze Medical, Antidote, XTrodes, Amai, and Behavidence. Eli Alroy invests in early-stage entrepreneurs with big ideas and a focus on wellness technology. His investments span across a diverse range of sectors seeking to improve health and wellness.

4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies

Ron Seubert is the founder of RareCyte, Inc., a company that focuses on characterizing and isolating rare cells in the blood, providing tools for cancer and cardiovascular research. He has a significant track record in developing innovative technologies and collaborating with industry experts. Previous investments include RareCyte, with a focus on life science research and diagnostics. Specific partnership and collaboration styles are not explicitly mentioned, but Ron Seubert engages in webinars and collaborations within the industry.

Belle Michigan Impact Fund is an early stage venture capital fund that invests in women-led startups, focusing on Michigan. They have a track record of supporting companies such as Lightwater Biosciences Inc, Wearwell, and Matriark Foods among others. Their investment check size ranges between $25K to $250K, with a preference for companies located in or impacting Michigan and other underserved markets. Partnership and collaboration styles include a focus on building great companies in Michigan and the Midwest through early-stage investments. The fund is led by a team with leadership styles that emphasize collaboration and community involvement.

Chad Keck is an investor with a focus on the semiconductors and semiconductor equipment industries. He is known for his involvement in building the firm’s business in Asia, assisting in underwriting IPOs of China-based companies in the semiconductor and solar sectors. His investment preferences and geographical focus are not explicitly mentioned in the available search results. The search did not provide specific details about his previous investments, track record, professional career, investment check size, or partnership and collaboration styles.

Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by

Carol Matthews, Managing Partner at Prosper Women Entrepreneurs, leads an organization focused on increasing women entrepreneurs’ access to growth capital. The organization, based in St Louis, Missouri, was founded in 2014 by Carol Matthews and others. They specialize in Seed stage investments with a focus on software, healthcare, and mobile technologies. Prosper Women Entrepreneurs has made 34 investments, predominantly in diversity initiatives. The geographical preference is in the United States, particularly in the St Louis region. Carol has a track record of 35 past transactions and is actively involved in the Prosper Women Entrepreneurs accelerator program. The investment check size is not specified, but they offer mentorship and support to foster rapid growth.

Bio/Med Investor Network is an angel network that prefers to make early-stage investments in the biomedical, medtech, and healthcare-related companies based in the Southeast region of the United States and Georgia.

Philipp Mueller, a key member of the Boehringer Ingelheim Venture Fund team, has a strong focus on immuno-oncology and immuno-modulation investments. He serves on the board of ImCheck Therapeutics and Asgard Therapeutics, contributing to the fund’s portfolio in groundbreaking therapeutic potential in the field of anti-infectives. With a background in Molecular Biology and a PhD in Biochemistry, Philipp has extensive experience in translational immuno-oncology research and infectious diseases. He has built a global collaboration network with academic, biotech, and pharma partners, showing a hands-on partnership approach. Philipp’s career includes leading research and projects in Cancer Immunology and Immune Modulation within the pharmaceutical industry.

Dot Piper is an experienced investor specializing in commercial-stage businesses with strong growth prospects in sectors like healthcare, technology, consumer, and tech-enabled business services. Dot Piper focuses on high-growth companies with proven leadership, offering investments in equity, recapitalizations, and change of control transactions. Geographically, Dot Piper operates within the U.S., Europe, and Asia, with a strong emphasis on hands-on involvement and active guidance at the board level. Previous investments include Integrity Orthopaedics, Apkudo, and Graylog. Dot Piper’s track record showcases success in capital campaign assessments, frontline fundraising, and board development. The investment check size of Dot Piper is not specified, and collaboration styles emphasize personalized one-on-one service and direct interaction with investors.

HLM Venture Partners is a venture capital firm that invests in healthcare technology companies.

Alan Hoops is an Angel Investor with a focus on healthcare and managed care industries. He co-founded PacifiCare (NYSE: PHS) and has been Chairman of Benu, Inc. and Board Director for Corvel. His investment check size is undisclosed. Alan Hoops’ collaboration style is focused on understanding the three common collaboration styles: introspective, relational, and expressive, and how they can work better together.

Brian Roberts is an executive who previously served as the Chief Financial Officer of Insulet Corporation. He resigned from his role on November 6, 2014. Brian Roberts had extensive experience with public companies, including as CFO at Insulet Corporation. Insulet Corporation is an innovative medical device company focusing on making the lives of people with diabetes easier with the OmniPod Insulin Management System.

Eli Blee-Goldman is a Co-Founder & General Partner at Character, a VC firm investing up to $1M at seed stage in startups betting on big shifts in customer behavior. The firm, remote-native and located in the USA, collaborates with founders using the sprint method to find and expand product-market fit. Previous investments include Flatiron Health. No specific information found on track record, investment check size, or partnership styles.

Dr. Norm Gitis serves as Managing Partner at Lymo Ventures, actively funding and mentoring startups in medtech, biotech, nanotech, and scientific fields. With a Ph.D. in Mechanical Engineering, he has been a visiting professor at MIT and was a CEO of two highly profitable test instrumentation companies. His investment focus includes med-tech and biotech startups, with a track record of over 150 scientific papers, three books, and two dozen patents. Norm Gitis prefers investments in the later stages, with a keen interest in oncology, cardiology, and diagnostics. While his geographical preferences are not specific, his previous investments reveal a dedication to supporting innovative startups. His investment check size aligns with angel investors, typically under $30,000, showcasing a commitment to nurturing early-stage ventures. Norm Gitis showcases a hands-on partnership style, leveraging his extensive expertise to provide valuable guidance to portfolio companies.

John Pappajohn is a key figure known for his involvement in over 100 startups and 50 IPOs, with a notable investment in the home health care company Caremark. He is a self-made entrepreneur and visionary philanthropist. The Iowa Entrepreneurial Venture Competition, which he supports, awards $100,000 to early-stage Iowa startups. John Pappajohn’s investment focus includes health care and advanced technology ventures. His partnership and collaboration styles are highlighted through the UNI John Pappajohn Entrepreneurial Center’s collaborations in economic development with Iowa CORE. Further details on his investment check size were not available.

Life Science Angels, founded in 2004, is an angel investment group based in Sunnyvale, California, USA. The firm focuses on companies in the healthcare and life sciences sectors, including medical device, pharmaceuticals, biotechnology, and health care. Life Science Angels typically invests in early-stage ventures and seed rounds. They have a track record of 81 total investments with an average round size of $3 million. The portfolio includes companies in the United States and Netherlands. The firm has had 7 successful exits, with key areas of investment in biotechnology, health care, medical device, and pharmaceuticals. Life Science Angels seeks partnerships in the life sciences industry and shows a preference for companies with a higher percentage of exits and a higher IRR compared to other industry verticals.

Dr. Simon Fredriksson, Co-Founder and CEO of Pixelgen Technologies, has a diverse background in life science research and entrepreneurship. His investment focus areas include biotech and proteomics technologies. He has been involved in startups like Genagon Therapeutics and serves as a Partner at Colibri Ventures. Simon’s investments range in size, with a check size typically between $100K – $500K. His involvement spans across companies in the life science and technology sectors, showcasing his commitment to innovation and growth.

Steve Eskenazi is an active investor with a focus on Digital Media, Internet, SaaS, and microcap market with an interest in technology-life sciences convergence. His partnership and collaboration style involves seeking new healthcare technology sales opportunities and consulting roles. He has a background in sales and leadership in fields like National + Regional Sales, Eastern Regional Hospital Sales, Business Development, and PatientSafe solutions. His track record reflects a history of successful sales leadership and client relationship development in various sectors such as technology, healthcare, and life sciences.

Andreas Guggenbühl is an investor with Backbone Ventures, an early-stage venture capital firm based in Zurich and Frankfurt. Backbone Ventures focuses on industries such as HealthTech, B2B SaaS, and ClimateTech. They prefer to invest in teams mainly located in Switzerland but also in Germany, the US, and Israel. With a track record of 28 investments and three successful exits, Andreas has a professional career contributing to private markets. Backbone Ventures aims to achieve a positive impact by supporting outstanding entrepreneurs and becoming a trusted partner for founders and investors in pre-seed/seed venture capital in Germany and Switzerland.

David Cleevely is an entrepreneur with a strong focus on HealthTech, High Tech, and related sectors. His investments include companies like Netronome and Cambridge Communication. With a track record of advisory roles in telecommunication policy and entrepreneurship, David has a diverse portfolio in the UK and the USA. He is actively involved in contributing to government reports and servicing on various advisory boards. His investments have ranged from doppel to Cambridge Communication, showcasing his interest in impactful ventures. David’s check size for investments remains undisclosed, but his recent successes include IPOs and significant growth in his portfolio companies.

Threshold is an early-stage venture capital firm that focuses on conviction investment strategy.

Rosecliff invests in companies that are making life better, brighter, bolder, and more efficient.

Nikolaus Plaitakis is an investor with a focus on AI in life sciences and health. He has invested in startups such as HouseTab. His investments range between $100,000 and $500,000. Nikolaus shows preferences for North America in terms of geographic focus. His partnership and collaboration styles involve knowledge sharing and strategic collaborations with startup founders.

Baigo Capital is a private equity fund focusing on mid-market healthcare companies with an enterprise value up to �200m. Their investments cover traditional LBOs and MBOs, consolidations, corporate disposals, and more. They have previously invested in companies like Vanguard AG and EuroEyes group. Baigo Capital partners with management teams to create market leaders. Their investment check size is within the mid-market range. Baigo Capital collaborates strategically with a focus on the healthcare sector. For more information, you can visit their (website)[http://www.baigo-capital.com/].

Magnus Bergman is a Co-Founder and General Partner at Luminar Ventures, having made over 30 seed investments in the past 10 years. Luminar Ventures focuses on technology in healthcare as a transformation area. One of their portfolio exits was Soundtrap in 2017.

Ron Sheridan focuses his investments on companies within the healthcare industry, targeting control positions in healthcare businesses and partial recapitalizations or buyouts. His investment check size ranges from $15 to $100 million, with a focus on healthcare providers, healthcare outsourced services, and consumer health & products. Sheridan’s geographic focus is on companies headquartered in the United States or Canada. He has a track record of investing in healthcare businesses with a platform EBITDA of $3 to $20 million, and his hands-on approach in creating value post-close sets him apart as a disciplined, thesis-driven investor in the healthcare sector.

Tomas Mora-Morrison is the Co-founder and Owner of Cambio Healthcare Systems. He has a focus on investments in the healthcare sector, with previous investments including AlgoDx in a Seed VC round. His investment check size ranges between $500K to $1.5M per company. Tomas Mora-Morrison has a collaborative partnership style and has invested in companies in the European Union, particularly in the Nordic countries.

Sara Weinheimer, an Angel Investor and General Partner at Mayfair Trading Partners, focuses on early-stage companies in tech, media, and telecom. Sara’s investments range from $25k-$100k per company, with 3-6 investments annually. She prefers tech companies without a technical founder and invests in IT, consumer social, clean tech, and life science sectors. Sara’s partnership style includes managing deal flow, mentoring, advising startups, and serving on boards. Her career spans from Citibank to Goldman Sachs, and she is an LP at Golden Seeds Fund II.

Polaris Partners invests in healthcare and technology companies ,Äãacross all stages from founding to profitable growth.

Rethink Impact is a venture capital firm investing in female leaders using technology to solve the world,Äôs biggest problems.

Omar Amanat, the founder of Tradescape, is an investor with a focus on healthcare and education sectors in the MENA region. His investment thesis revolves around capturing market opportunities and creating long-term, sustainable stakeholder value. Amanat’s investments primarily target healthcare and education platforms, indicating a strategic focus in these areas. While specific details on investment stage, geographical preference, previous investments, track record, professional career, and partnership styles were not explicitly mentioned on the website, his commitment to the healthcare and education sectors signals a dedicated approach to these industries. Amanat’s investment check size and collaboration strategies may vary based on individual engagements and partnerships in the healthcare and education sectors within the MENA region.

Michael Palmer invests in technology and life sciences. The Band of Angels typically invests between $300K and $750K, with the largest investment made being $3.3M. In 2023, the Band invested in 22 companies. Geographically, there was no specific preference mentioned for investments.

Fatih Isbecer is an angel investor with a focus on Seed investments, particularly in sectors like Games, Gaming/eSports, Food and Beverage, Digital Health, Health & Hospital Services, Health IT, SaaS, and FinTech. His recent investments include Mindway VR, Flora, Gleam Games, JETRACT, Pubinno, EvdekiBakicim, and Intelrad. Fatih Isbecer’s investment check size ranges from $5K to $50K, with a sweet spot of $25K. He has a track record of 9 investments, with his latest investment in Mindway. Collaborating with co-investors like Arlan Hamilton, Ramakant Sharma, and Gokul Rajaram, Fatih Isbecer is actively involved in supporting startups across various industries.

Ms. Nancy Wang serves as Venture Partner at Felicis. She is a product & engineering executive, advisor, and investor with significant experience in cloud computing, cybersecurity, and SaaS. She advises Fortune 10 companies on accelerating revenue growth, and she advises startups on attracting their first 100K enterprise customers. Currently, she is the Director of Product & Engineering and General Manager at Amazon Web Services, where she leads P&L, product, engineering, and design for its data protection and data security businesses. Prior to Amazon, she led SaaS product development at Rubrik, the fastest-growing enterprise software unicorn, and built healthdata.gov for the U.S. Department of Health and Human Services. She is a Venture Partner for Felicis Ventures, where she works with early-stage data infra and security companies on their product-market fit, market segmentation, and product scaling. She earned a Bachelor of Applied Science from the University of Pennsylvania, where she serves on the Board of Directors for the UPenn School of Engineering Online.

Mustafa Patni is a mobile and e-commerce technology executive with 17+ years of experience in F500 and start-ups. He has deep industry knowledge in various verticals including CPG, retail, financial services, mobile payments, and healthcare. Mustafa’s investment focus areas include mobile payments, mobile wallets, mobile couponing, ticketing, in-store mobile marketing, shopper behavior, mobile commerce, and user experience. His past investments include KarmaCircles. Mustafa Patni’s partnership and collaboration styles are likely focused on open dialogue, structured communication, and understanding diverse team member preferences for effective teamwork.

Global Brain Corporation is a venture capital firm that invests in companies from seed/early to pre-IPO startups.

Builders VC is an early-stage VC focused on investing where technology meets new business models to modernize antiquated industries.

Scott Switzer is an angel investor based in New York City, United States. He has a diverse investment focus, including technology vendors, corporate strategy, corporate venture capital, venture capital, consumer, insurance, healthcare, and financial services. His preferred stage of investment is in HealthTech startups, with a check size typically ranging in the seed round. Scott Switzer has a geographical preference for investments in the United States. He has a track record of founding companies such as Sherpaa Health, AuthenticatedDigital, and Herefordshire & Ludlow College. Scott Switzer values collaborative partnerships, with a focus on establishing trust, preparing thorough agendas before meetings, and leveraging visual tools for brainstorming and idea sharing.

Dick Harryvan, at Finch Capital, brings a wealth of experience, having been the former CEO of ING Direct. He serves as an advisor in the European Growth investors firm, backing entrepreneurs in Finance, Health, and Real Estate Tech. With a track record including positions at NN Group N.V. and ANWB B.V., Dick focuses on fintech, healthtech, real estate tech, and regtech sectors. Primarily investing in the early to growth stages in the EU, he values collaborative partnerships to shape the future of finance and technology. Dick’s investment check sizes typically range to support innovative startups in their developmental phases.

Min-Sung Sean Kim is a Managing Partner at Digital Health Ventures in Berlin, specializing in digital health investments. He has a strong track record and professional career, having held positions at Allianz X GmbH and XLHealth AG as a Private Equity Investor and Director/Board Member, respectively. Min-Sung’s investment focus includes startups like mySugr, Amwell, Mimihearing, NeuroNation, medbelle, and thryve_health. His partnership and collaboration styles revolve around fostering impactful social change through innovative healthcare startups.

William Bahl, a member at Angel Physicians Fund, is part of a seed stage investor group of physicians and healthcare entrepreneurs exclusively focused on life science and healthcare investments. The fund’s geographical preference is in healthcare startups. Specific details about their investment check size, past investments, track record, and collaboration styles are not available from the search results.

Rally Ventures invests in early-stage enterprise technology companies.

Telegraph Hill Partners is a venture capital firm investing in life sciences, medical device, and healthcare technology companies.

Investitionsbank Berlin (IBB) focuses on promoting investment, innovation, startups, and growth in Berlin. Their Venture Capital fund ‘VC Fonds’ invests in high-growth companies in various tech sectors with initial investments ranging from EUR 0.2M to EUR 1M. They support companies with innovative and scalable products/services, primarily in industries like creative industries, life sciences, and ICT. Potential partners for funding rounds include venture capital firms, industrial companies, or business angels. IBB Ventures emphasizes minority participations in company shares and collaboration with other stakeholders. Past investments and activities are diverse, with a focus on funding history and acquisition trends. Funds are typically in the range of EUR 200,000 to EUR 1 million, with potential upward scaling in subsequent rounds. For collaboration, confidentiality and engagement with other partners play a key role, ensuring mutual growth and success.

Ellie Perlman is the founder of Blue Lake Capital, a commercial real estate investment firm specializing in multifamily investing throughout the United States. The investment thesis focuses on strategies for high inflation and interest rates in 2024, highlighting the impact of economic conditions on real estate investments. Blue Lake Capital’s geographical preference is the Sunbelt region, with a strong emphasis on multifamily properties. Specific sectors of interest for family offices include industries linked to artificial intelligence, healthcare services related to aging, and renewable energy sources. Previous investments and track record details were not directly available. Ellie Perlman partners with institutional investors, leveraging their resources and providing access to more investment opportunities.

Joshua Schachter’s previous investments include Orion Labs, Drift Marketplace, and Exact Media. He has made a total of 61 investments and has 28 portfolio exits. Notable investments are Reddit, which went public, and Stack Overflow, acquired by Prosus for $1.8B. Schachter’s diverse portfolio indicates a successful investing history with a focus on product development and seed stage investments.

Streamlined Ventures is a seed-stage investment firm focusing on Data Science, APIs, Blockchain/Web3, AI, and Software Automation.

Georgia Cavanaugh is a VC Analyst at SteelSky Ventures based in Chicago, Illinois. Her investment focus areas include Consumer Health and Digital Health at both pre-seed and seed stages. Georgia’s investment range is $100K to $5.0M with a sweet spot at $1.5M. She has collaborated with co-investors such as Buffy Alegria, Casey Santiago, Maria Velissaris, Maya Hardigan, and Nichole Jones.

CAVU Venture Partners is a venture capital firm that invests in firms in food and beverage and consumer goods sectors.

Oliver Heinrich is a Partner at Picus Capital since 2017, overseeing pre-seed stage portfolio companies. With a background in marketing & sales and organizational design at McKinsey & Company in Munich, Oliver focuses on finance, education, and healthcare sectors. He holds a master’s degree in Banking and Finance from the University of St. Gallen. Oliver’s investments range up to USD 3 million per company, participating actively post-Series A. Picus Capital plans significant investments in Asia, targeting around USD 250â300 million over the next three to five years, with a strategic approach to follow-up investments and collaboration.

Andrew Szymanski is an angel investor focusing on seed-stage investments across various industries such as Analytics, Retail Technology, Apps, Developer APIs, Developer Tools, Energy & Clean Tech, Enterprise Software, Healthcare IT, and Mobile. He has made previous investments in companies like Example example company Inc. Andrew Szymanski’s investment thesis includes SaaS startups, and he has a professional career centered on angel investing with a focus on seed rounds. His geographical preference appears to be in Europe, particularly the United Kingdom, with a strong presence in London.

Maulik Mehta, an Investor and Venture Associate at Arc Ventures, focuses on sectors like AutoTech, Pharmaceuticals, AgTech, Cybersecurity, TransportationTech, and Enterprise Applications. His investment range is $100K to $5.0M, with a sweet spot at $1.5M. Maulik has invested in various seed and series A/B startups in sectors such as AutoTech, Pharmaceuticals, AgTech, Cybersecurity, TransportationTech, Enterprise Applications, BioTech, Consumer Internet, Enterprise, and FinTech. He collaborates with Akbar Dawood, Eric Kohlmann, Irene Susmano, and Joe Korff from Arc Ventures.

Peter Jones is a British entrepreneur, businessman, investor, and reality television personality. He has interests in mobile phones, television, media, leisure, retail, and property. Jones is the founder of multiple businesses including Phones International Group, The Peter Jones Foundation, and The Peter Jones Enterprise Academy. He is the sole remaining original Dragon on the BBC’s Dragons’ Den and was appointed Commander of the Order of the British Empire (CBE). Jones has a keen focus on sustainable investing and emphasizes the importance of thorough research, detailed action plans, and convincing pitch presentations to secure funding. His investments range across various sectors, and he runs the PJ Investment Group, a private equity group investing in successful businesses. Jones’s collaborative style involves supporting fresh ideas, fostering partnerships, and bridging the gap between education and industry.

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem

Cherrystone Angel Group primarily invests in early-stage companies in New England across various industry verticals, including Life Sciences, Software, Consumer, Industrial Tech, Healthcare, and Fintech sectors. They aim to be active and trusted partners, providing industry expertise and business skills to their portfolio companies. Cherrystone’s investment check size, track record, and partnership collaboration styles are not explicitly mentioned on their website. They are based in Providence, RI, and have upcoming Pitch Night events to support startup ideas.

Amit Banka is an experienced investor with a broad private equity and own investment background. He has a strong Nordic network and industry expertise in financial services and healthcare. Amit excels in deal sourcing, active corporate governance, financing, and strategy. His investment focus areas include neuromodulation medical devices, orofacial disorder treatments, bone nanocoating technology, drug detection using exhaled breath, organic food retailing, and furniture logistics. Amit has significant experience as a Board Member and investor in various companies, showcasing his diverse investment portfolio and successful track record. Amit’s investment thesis involves a hands-on approach, emphasizing active involvement in guiding portfolio companies towards success.

Randi Zuckerberg is a prominent investor with a focus on supporting female-founded and predominantly female-focused businesses. She aims to invest in 5-10 companies annually, particularly interested in the maker movement, online education, tools/apps for busy parents, mindfulness tech, and quantified self. Randi has a track record as the former Facebook Marketing Director and Founder & CEO of Zuckerberg Media. She has made investments in companies like Brit + Co, Timehop, Trippy, ThingLink, Podo Labs, Votizen, and more. Randi Zuckerberg’s investment portfolio includes projects like Everyworld. She emphasizes mentorship and collaboration to propel women’s success and partners with companies like Activia. Check sizes vary, with notable investments in projects like NFTs to democratize access to art.

Irene Chen, as an investor, focuses on healthcare. Her stage of investment is active. Specific details about her previous investments, track record, professional career, investment check size, and partnership and collaboration styles could not be found.

Annegret de Baey is a Venture Partner at Seventure Partners SA, specializing in investments in the microbiome sector. Her investment focus areas include Digital Health (Series A), Health & Hospital Services (Series A), Health IT (Series A). She has a track record of investing in companies like Abalos Therapeutics and Dopavision. Her investment check size ranges from $685K to $27.0M, with a sweet spot of $14.0M. Annegret de Baey has collaborated with co-investors such as Sebastian Pünzeler and Isabelle de Cremoux. She has a geographic preference for investing in Munich, Bavaria, Germany. Annegret brings 20 years of experience in the life science and venture capital sectors to her investment endeavors, leveraging her expertise in Dermatology and Allergology.

Naveen Selvadurai is an angel investor with a focus on Marketplaces, Consumer Internet, Cloud Infrastructure, Developer Tools, Financial Technology, Education & Training, E-Commerce, Healthcare IT, and Health & Wellness. He invests in Seed Rounds, Early stage VC, and Later stage VC. His previous investments include Positive Food. Naveen has a track record of working with Lucent, Sony, Nokia, and Sun Microsystems before co-founding Foursquare. He serves as an Advisor at Future Perfect Ventures where he provides guidance in the investment process. The investment check size of Naveen Selvadurai varies based on the specific investment opportunity, and he adopts a collaborative and hands-on approach in his partnerships.

Joel Schreiber, CEO of Waterbridge Capital, focuses the firm’s investments on companies in digital media, financial services, IT, telecommunications, health, and homeland security sectors. Waterbridge has made notable investments, such as in a company called Riversby in December 2013. Despite the lack of explicit geographical preferences on public sources, Joel Schreiber has been active in deals in cities like Los Angeles and New York, as observed with the Broadway Trade Center investment. The track record and professional career details for Joel Schreiber are not readily available from the sources reviewed. In terms of investment check size, Schreiber has faced legal challenges related to loan payments and foreclosures, involving significant amounts around $100 million. Information on partnership and collaboration styles with Waterbridge Capital is not explicitly mentioned in the available sources.

Dana Sun, a Senior Associate at OCA Ventures, focuses on health technology companies in the digital health sector. She has worked on investments in companies like Regroup Therapy, HealthiPASS, mPulse, and Moving Analytics. Dana’s check sizes typically range from $1M-$3M with follow-on capacity, targeting Seed, Series A, and select Series B stages. Her geographical preference and partnership styles were not specified on the official OCA Ventures website.

Dimitri Krainc is a Venture Partner at OrbiMed with a current investing position focused on Digital Health, Health & Hospital Services, and Health IT at both Seed and Series A stages. His investment range varies from $1M to $75.0M, with a sweet spot of $4.0M. The current fund size associated with his investments is $18B. Located in Chicago, Illinois, Dimitri Krainc has collaborated with investors such as Alexandria Huynh, Anat Nursella, Brendan Weber, Carl Gordon, and Charles Steinman.

Sean Kwiat is a Director at CincyTech, actively involved in over 100 early-stage venture financings and exit transactions. His investment focus areas include IoT, Enterprise Applications, Cloud Infrastructure, and Digital Health at the Seed stage. Sean’s investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. His geographical preference includes the Midwest region. Previous investments can be explored on the CincyTech portfolio. Sean is inspired by founders’ compelling stories and vision, bringing their hard work to life.

Bruce Holland, President of Holland Construction Services, specializes in constructing Healthcare Facilities, Educational Facilities, Multi-Family and Student Housing, Retail & Shopping Centers, Financial Institutions, Office Buildings, Industrial/Warehouses, and Senior Care Facilities. Holland invests primarily in the creation of workplaces and industries that positively impact communities. He focuses on early career researchers investigating work behavior and health influences. While details on his investment check size and partnership styles are not explicitly available, Holland’s track record in business development and community involvement showcases his dedication to constructive growth and sustainable projects.

Heartcore is a venture capital firm that invests in founders building category-defining consumer internet brands.

Randy Brandoff is a Venture Partner in Tia Ventures and Co-Founder of Eleven James. His investment thesis focuses on luxury markets, rental experiences, and concierge services. Eleven James, a startup he founded, offers a subscription service for renting luxury watches, providing options for wearing different watches without buying them. Brandoff’s collaboration style involves creating experiences and communities around luxury products, emphasizing access to luxury in a world valuing experiences.

Romy Schnelle’s investment thesis focuses on climate tech, digital health, fintech, AI, and SaaS. She invests at the seed stage with a geographical preference for the EU. Her previous investments include Stocard, Kiwigrid, LG Electronics, and Aqton. Romy Schnelle has a strong track record, having worked with mp3 inventor Prof. Karlheinz Brandenburg and co-founded Fraunhofer spin-off IOSONO. She also chairs the Investment Committee of TX Group and serves on advisory boards of startups.

Joe Canterbury is an investor with a focus on investments in the Food and Agriculture and Consumer Goods sectors. He founded Pacific Springboard in 2016, where the company operates in health & wellness, lifestyle & entertainment, and food & beverage platforms. Joe Canterbury’s investments are primarily in the United States, with a recent Seed Round investment of $725K in Waka Coffee. Chaucer Global, founded in 2014 by Joe Canterbury, prefers to invest in B2C, food products, entertainment, healthcare, and technology sectors. The firm is headquartered in Austin, Texas. Joe Canterbury’s investment check size for recent investments is around $725K. The partnership and collaboration styles of Joe Canterbury are not specified in the available data.

Las Olas Venture Capital is an early-stage fund that invests in startups in a variety of industries.

Sebastian Kreuz is an investment manager at Boehringer Ingelheim Venture Fund focusing on strategic opportunities in the infectious diseases space. His geographical preference is to invest worldwide in innovative early-stage therapeutics and digital health companies. He has been involved in previous investments such as Centauri Therapeutics and Quantro Therapeutics. Sebastian’s track record includes roles in research and venture capital law. The investment check size for companies like QUANTRO Therapeutics is significant. His partnership and collaboration styles involve a focus on groundbreaking therapeutic approaches and technologies.

Brian Gill is an experienced Senior Communications and Investor Relations Consultant with previous roles at Gamida Cell, TYME Technologies Inc., and Celgene. His investment focus areas include biotech and medical innovation. With experience in global corporate communications, he brings expertise in fostering investor relations. Brian holds a Bachelor’s of Science with a major in Biology and a minor in Chemistry from West Chester University of Pennsylvania. He also holds Series 7 & Series 63 licenses from FINRA. Brian has been involved in the Value Of Medical Innovation Initiative project.,

PsyMed Ventures invests in transformational technologies that elevate mental health and wellness through it’s fund and angel syndicate.

MEDA Angels is a healthcare-focused angel investor group comprised of accredited investors with diverse backgrounds. They have made 8 investments, with the latest one in MimiVax as part of their Series C. The group is based in Washington, DC, United States.

Peter Frishauf is an Angel Investor known for his leadership in New York City’s entrepreneurial hi-tech digital health scene, founded Medscape in 1995. He has an extensive professional background and is an Advisor at various ventures. His investment focus areas include digital health and healthcare media. His partnership style involves advisory roles and director positions in established companies, showcasing a collaborative approach. The specifics of his investment stage, geographical preferences, previous investments, check size, and partnership styles vary and could be further explored for a comprehensive understanding.

Kyle Vogt is an Angel investor with a current investment range of $10K to $500K, focusing on sectors such as Food and Beverage, Enterprise Applications, AI, Health & Hospital Services, Health IT, and Consumer Internet across various stages from pre-seed to Series B. With a sweet spot of $100K, Kyle Vogt has made 41 investments to date. He collaborates with notable investors like Chris Hollod, Lorenzo Thione, and Gaingels. Kyle’s investment track record includes partnerships with organizations such as First Round Capital and Y Combinator. Based in San Francisco, California, Kyle Vogt is known for his active involvement in the San Francisco Bay Area investor community.

Ann Marie Mayuga is the owner and co-founder of AMM Communications, which offers public relations, content marketing, media relations, crisis communication, and talent acquisition services. The firm has been recognized as a top PR firm in St. Louis and a Woman-Owned Business Enterprise. Ann Marie Mayuga has experience in working with professional service, financial service, healthcare, and technology mid-sized businesses, not-for-profits, and government entities nationally and internationally. Her investments focus on the markets of digital media, publishing, and software. She collaborates with partners and has an investment check size that remains undisclosed.

HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry

Mariana Lozano is an Associate Attorney at Gibson, Dunn & Crutcher in Houston. She has experience as a Project Manager and in Social Media at Tolk. For more detailed investment information, please contact Mariana Lozano directly via email at [email protected]

Gintare Statkute is a Founder and Director at Forukis Ltd, with a focus on web-platform projects in agriculture, nutrition, beauty, health, well-being, education, and IT industries. The business idea follows the UK Clean Growth Strategy. Gintare seeks partners for various grants and welcomes investors. The investment check size for Venture Funds can be between $500K to $1.5M. Gintare’s collaboration style involves understanding three common styles: introspective, relational, and expressive, and finding ways to work better together with different styles. Professional background includes experience as a self-employed website programmer and past roles as a CEO and Researcher.

GoBeyond is a venture capital firm based in Zurich, focusing on investments in early-stage fintech companies. Their portfolio includes companies in industries like environment, health, education, food, housing, services, medtech, biotech, technology, and luxury sectors.

Tuff Yen is the Founder and President of Seraph Group, recognized for assisting investors in developing their portfolios with a focus on technology startups. Seraph Group invests in a diverse range of software, healthcare, and analytics companies. Tuff Yen has a track record of investing in over 130 companies, bridging the gap between Pre-Seed and Series A funding. The team is based in multiple cities, with a significant network of successful individuals. Notable investments include XSeed Capital, Reddy Capital, DHVC, Founder Collective, and Dreamit Ventures. Tuff Yen’s collaboration style involves investing in early-stage companies and providing constant support and guidance to entrepreneurs and investors, ensuring access to high-quality opportunities.

Samara Hernandez is the Founding Partner of Chingona Ventures, a venture capital fund with a focus on financial technology, female technology, food technology, health/wellness, and the future of learning. She has made investments in companies like Suma Wealth, Sigo Seguros, Empower3d, ConnectCareHero, Dame Products, Topl, and Toolchain. Samara has a track record of being tenacious and making an average check size of $100,000 to $250,000 in her first fund. Her partnership and collaboration style emphasize investing in overlooked founders and industries, aiming to bring change by empowering diverse voices in investment decisions.

Rohit Bhatia, a Senior Analyst at Grand Ventures, focuses on industries such as Consumer Goods & Retail, Healthcare, Infrastructure, and Agribusiness. Grand Ventures led a $5M seed round investment in Chain.io, a company building a modern supply chain data network. With previous venture capital experience at SixThirty Ventures and Cultivation, Rohit has a strong professional background in adding value to startups.

Shumway Capital is a growth focused investment firm that partners with management teams to help accelerate their companies’ growth.

Mission BioCapital is a life science venture capital firm that invests in early-stage companies.

Brigit van Dijk – van de Reijt, the CEO of DOB Equity, focuses on investing in innovative, scalable, and impactful companies across the East African market. The firm prioritizes social or environmental good alongside financial returns, with a strong interest in sectors like agribusiness, retail, transportation, warehousing, education, renewable energy, and healthcare. DOB Equity targets companies in their early stages, provides extensive support, and values partnerships with entrepreneurs. Previous investments include companies like Twiga Foods, Copia, and Africa Logistic Properties(ALP). Brigit’s diverse experience in private equity across different markets enhances her strategic investment decisions and growth impact.

Juan Lopez-Valcarcel is known for focusing on digital product strategy and technology delivery, particularly in the education sector. His investment stage includes Series A funding. He has made investments in various companies such as gloo networks, NBC Universal, Pearson, Kantar, and Booz Allen Hamilton. With 20 years of experience, Juan has helped companies transform their product strategy and technology operations, demonstrating a track record of successful digital transformation. The investment check size associated with Juan Lopez-Valcarcel is not explicitly mentioned in the available information. Regarding partnership and collaboration styles, he is involved in collaborations to improve contributions in healthcare, as seen through his involvement in European regional partnerships.

Marcel Legrand is a Co-Founder and Operating Partner at Vertical Knowledge, specializing in a wide spectrum of sectors and company stages. He is keen on small or mid-size market-leading companies showing entrepreneurship, high growth, and customer-centric values. Marcel focuses on technology, SaaS, healthcare, human capital/education, and more. He invests across start-ups, PE mid-sized, and public companies. Marcel is motivated by top talent, financial pragmatism, visionary thinking, proactive change, and honest collaboration. His investment check sizes vary based on the company stage and needs. Marcel Legrand also serves as Chief Executive Officer at RealMatch.

Virginia Giugliano is an Angel Investor with a portfolio including investments like Fruit Street. She focuses on healthcare startups and has invested in Fruit Street during their Seed round in 2015. Her partnership and collaboration styles are highlighted in her role at Isagenix International, where she serves as an Executive, showing her commitment to supporting and growing businesses. Virginia Giugliano has a significant background in healthcare and brings valuable experience to her investments.

DrPano Kroko Churchill is a legendary entrepreneur, Angel, VC, and PE investor focusing on innovation for solving major challenges. His investment emphasis is on Life Sciences. He has invested in startups such as Amrit Advanced Biotech at the Seed stage. Dr. Pano Kroko Churchill’s check size ranges between £150,000 to £1,500,000. His partnership and collaboration styles are individualized to the specific goals of the investment. With a track record in Potomak Ventures, DrPano Kroko Churchill has shown a commitment to supporting startups in the Life Sciences sector.

Hustle Fund is a seed fund that seeks to invest in early-stage startups.

Michael Tedesco focuses on comprehensive wealth advisory and risk management strategies for senior-level corporate executives and high net worth families. His investments are in technology vendors, IT, consumer, tech, insurance, and healthcare sectors. He has made previous investments in companies like Influential. The investment check size for Michael Tedesco is not available, and details about his partnership and collaboration styles are limited.

Lou Mazzucchelli is an investor with a focus on Big Data, Enterprise Software, Music, Health Care, and Information Technology. He is actively investing in VC stage companies. His geographical preferences are not specified. Lou Mazzucchelli has a track record in data communications, IT management, and consulting, and has overseen investments in semiconductor and software companies. The investment check size for companies he has been involved with ranges based on the specific company’s funding needs. Details on specific partnership and collaboration styles are not available at this time.

Niko Hrdy is the President of Valley Oak Investments, focusing on early-stage food, agriculture, and health and wellness companies. Previous investments include Seed Round – Farmeron, Seed Round – Caviar, Series A – Spoiler Alert, and Seed Round – Spoiler Alert. His check size for investments is approximately 10-30% of the post-money valuation. Niko Hrdy holds an AB in Economics with a citation in Spanish from Harvard University and an MBA from Harvard Business School. His partnership and collaboration styles emphasize a dynamic books approach in management. Geographically, Niko Hrdy is located in San Francisco, California, USA.

Esther Dyson is an angel investor, entrepreneur, and commentator focused on healthcare, open government, digital technology, biotechnology, logistics, and outer space industries. She is the Chairman of EDVentures Holdings and serves as a Board Member at various companies such as Swvl, StartUp Health, Luxoft, Bamf Health, and Yandex. Dyson’s investments range from startups globally, including winners like Evernote, Facebook, and Square. Her check sizes vary depending on the company’s needs. She actively collaborates with other organizations, showcasing a collaborative and systems change approach. Dyson’s professional career includes being a founding chairman of ICANN, and she holds a BA in economics from Harvard University.

Women Angels is an angel investor group that focuses on investing in female-founded startups primarily in technology, software, and healthcare sectors. They have a preference for companies based in Maryland, Virginia, and Washington, DC. Women Angels have made 14 investments, with a track record of 5 portfolio exits. Their check sizes reflect a strategy of making smaller investments across more companies to spread risk. The group meets monthly to consider investment opportunities and companies do not need to be woman-owned to apply for funding. They aim to provide capital, guidance, and mentorship to startups they invest in.

Scott Brun is a Venture Partner at Abingworth with over twenty years of experience in the pharmaceutical industry. He most recently served as AbbVie’s VP Scientific Affairs and Head of AbbVie Ventures, expanding the investment portfolio with over 20 active companies. Scott’s previous roles include leadership positions at Abbott Laboratories. His educational background includes an MD from Johns Hopkins University School of Medicine with a residency at Harvard Medical School. Scott collaborates with Axial Therapeutics and Horizon and has extensive expertise in the venture capital field.

Jeff Snellenburg is an Angel Investor specializing in Enterprise Software, Health Care, Information Technology, Mobile, Advertising, Big Data, E-Commerce, and more. His past investments include WizeHive, Carnegie Speech, Sidecar, Molecular Detection, CloudMine, Cloudnexav, and copious Software. Jeff Snellenburg serves as the President of the PA Angel Network and has experience in the investment coordination and executive director roles. His collaboration style emphasizes effective communication and task-oriented approach.

John Trefethen is the Chief of Product & Marketing at Radius XR and a Co-Founder/Partner at The Altitude Group. He has over twenty-five years of technology, education, marketing, and design experience. Previously, he has held roles such as Chief Marketing Officer at Heru, Vice President of Global Marketing & Product Design at Topcon Healthcare, and Global Head of Marketing at Topcon Healthcare. John is involved in early diagnosis for vision loss through Radius XR and provides go-to-market advantages through The Altitude Group, specializing in helping companies bring products to market. His career spans across various industries and leadership positions, showcasing a track record of building businesses and launching successful companies.

Adrian Lloyd is a Founding Partner at Episode 1 Ventures, a venture capital fund based in London, UK. The firm is passionate about investing in early-stage software companies in the UK. Adrian’s investment thesis revolves around supporting daring entrepreneurs from Seed to Series A, with a focus on software-enabled businesses showing early customer traction. Episode 1 Ventures typically invests in early-stage B2B software firms and has a track record of success stories such as the car-buying comparison site. Adrian’s investment focus areas include SaaS, technology, software, and the internet sectors. The firm’s geographical preference leans towards the UK market. With a partnership and collaboration style that values open communication, clear vision, and cultural fit, Episode 1 Ventures under Adrian Lloyd’s leadership seeks to build transformational teams and make strategic investments in the software industry.

Social Capital is a venture capital investment firm that partners with entrepreneurs at all stages.

Doris Qamar, MBA, C.E.T. is an experienced investor with a background in analytical chemistry and material science. She has a strong track record in the chemicals, biotechnology, medtech, and lifescience sectors. Doris has served as an Angel at York Angel Investors and has held roles in biotechnology business development and finance. She is the Founder and CEO of SPEC Labs, where she helps biotech companies achieve their milestones. Doris holds an MBA from Ivey Business School at Western University and a Bachelors Degree in Chemistry. Her expertise and connections make her a valuable partner for startups seeking growth and support.

Tove Larsson is a General Partner at Norrsken VC, a venture capital firm with a focus on impact entrepreneurs. The firm’s investment thesis revolves around supporting startups in sectors such as climate tech, energy, biotech AI, and health tech. Norrsken VC prefers to invest in early-stage companies and targets a global market. Tove Larsson has a track record of investments in companies like CEEZER, ClimateView, Yapevroc, and others. The fund typically invests between EUR 0.025 million to EUR 0.1 million per company. Norrsken VC’s partnership and collaboration style is centered around impact investing in deep tech.

Clayton Milburn is a Director at Thompson Street Capital Partners. For more detailed information, visit their (Investment Strategy) and (Our Portfolio) pages.

Mike Pykosz is the co-founder and CEO of Oak Street Health. His investment focus areas include Venture Capital, Corporate Innovation, Insurance, Healthcare, Industrials, and Financial Services. He has made investments in companies like Stellar Health. Mike Pykosz’s stage of investment involves Series B funding. Geographically, his preference is not specified. He has made previous investments in Oak Street Health, showing a strong commitment to the healthcare sector. A clear track record of professional success is evident in his role at Oak Street Health and past executive positions. The investment check size indicates involvement in transactions like the $10.6 billion deal involving Oak Street Health. His partnership and collaboration styles involve working with powerhouse brands and promoting collaboration and partnership in various industry events.

Deepak Singh is the Founder and Chief Technology Officer at Adeptia India Private Limited. He has more than 16 years of experience in application connectivity, data integration, middleware, and business process management technologies. Deepak has made investments in companies like HireHunch. Adeptia, a company he founded, is privately held and operates in the Business/Productivity Software industry with 174 employees. The company’s latest deal type was Private Equity Growth. Deepak’s investment check size at Adeptia is in the range of $0.5M for seed VC.

A pre-seed firm obsessively pursuing the near frontier ,Äì where software, hardware, & wetware intersect.

W. Bruce Lunsford serves as Chairman and Chief Executive Officer at Lunsford Capital, where the investment focus areas include healthcare, technology, entertainment, and real estate. The stage of investment ranges from early to late stages. Geographically, the preference indicates potential investments in diverse companies, although specific regions are not highlighted. Previous investments include participation in financing deals such as the Series A funding for Edumedics. Mr. Lunsford’s track record includes successful involvement in various ventures. The specific investment check sizes are not publicly available. Partnership and collaboration styles emphasize negotiation, accountability, shared values, clear communication, and respecting each collaborator’s roles and responsibilities to ensure productive and sustainable collaborations.

No answer

Angeli Parvi is an angel group based in Los Altos, California, founded in 2000. They invest in seed-stage, early-stage, and later-stage companies in sectors like business products, business services, healthcare, energy, and cleantech. Their investment focus areas include clean energy transition, energy storage, resource efficiency, critical infrastructure, industrial energy efficiency, carbon mitigation, sustainable mobility, and smart cities. Angeli Parvi follows three common collaboration styles for effective teamwork: introspective, relational, and expressive.

ECS Angels, led by Charles Sidman, has an investment thesis that focuses on early-stage companies as a distinct asset class with dual mandates for financial return and positive social impact. They have a track record of 5.5x return on capital and aim to democratize and broaden participation in early-stage investing. ECS Angels invests in early-stage enterprises in Buffalo, New York, United States, under the category of Venture Debt. Their investments focus on companies with positive social impact, specifically in health, sustainability, and other sectors. For further details, potential investors can contact csidman@ecs-angels.com.

Dr. Geraldine McGinty is an accomplished professional with a background in imaging economics and specialization in Women’s Imaging. She serves as the Chief Strategy and Contracting Officer at Weill Cornell Medicine Physician Organization. Her collaborative style can be seen through partnerships like the one with RadEqual and the American Association for Women in Radiology, where she signed a two-year MOU to support increased collaboration and promote educational initiatives in the radiology community. While specific details about previous investments and track record are not available, her role as a board member and advisor to various organizations demonstrates her expertise and influence in the field. She favors an investment style focused on imaging economics and Artificial Intelligence in Medical Imaging.

Activate Venture Partners is an early-stage venture capital for high growth technology companies.

Tommy C. is a Managing Associate at Allens specializing in intellectual property and technology law. He focuses on the IP aspects of mergers and acquisitions, capital raisings, joint ventures, and strategic investments. Tommy has expertise in sectors like Banks & Financial Institutions, Healthcare, Industrials, Private Capital, Technology, Media & Telecommunications. Previous investments and specific check sizes are not available. His track record includes advising on high-profile deals and disputes in patents, trademarks, and copyright. Tommy is known to work cooperatively and assertively to achieve win-win solutions in partnership and collaboration endeavors.

Jeff Marsden is an Angel Investor with a focus on seed round investments in industries like Healthcare, Consumer Internet, Financial Technology (FinTech), Energy & Clean Tech, Enterprise Software, and Mobile. His geographical preferences include Toronto, Ontario, Canada; Europe; and London, United Kingdom. He has a track record that includes roles as Chief Product Officer at PureFacts Financial Solutions, Board Director at Bristol Gate Capital Partners, and President at Oxygen Ventures Inc. Jeff Marsden typically invests in the seed round stage and works as an Advisor for various companies. His partnership and collaboration styles involve advisory roles in startups and companies such as ParameterInsights, BOON Rewards Inc., NetEffect Solutions, and Nest Wealth.

Zorba Lieberman serves as the Chairman at Pleio and Founder, Managing Director at ZL Investments. He has a focus on Enterprise Applications and Life Sciences, with investments primarily in the United States. Zorba Lieberman has invested in Comprehend during a Series A round in 2013. His investment check size ranges from $500K to $1.5M. Unfortunately, no specific information on his partnership and collaboration styles is available at this time.

Ben Franklin Partners focuses on technology-based ventures and innovative manufacturers, investing in sectors like healthcare and technology. They support companies in Pennsylvania, with a check size that varies. Ben Franklin has a track record of creating and retaining jobs. Their partnership style involves collaborating with universities, corporations, and regional leaders to support founders.

Ryan Petersen, founder of Flexport, has joined Founders Fund as an investment partner. He focuses on early- and growth-stage startups, leading investment rounds and taking board director seats. With a track record of about 150 personal investments, he invests as a generalist in both early-stage and growth funds. His recent investment was $260 million from Shopify to strengthen Flexport’s position.

Nilesh Jain is a seasoned finance professional with expertise in strategic investment selection across Health-Tech, Fin-Tech, AI, and IP-based Consumers Centric DTC Business sectors. He has a strong background in investment banking, equity research, and startup investments. Nilesh has made numerous investments in companies like Purple Style Labs, Subhag, and ActoFit. He specializes in providing startups with financing, strategic advice, SME IPOs, and valuation services. With certifications from prestigious institutions like IIMB and IIMA, his investments usually range between $900K and undisclosed amounts per company. Nilesh Jain is passionate about driving innovation, fostering growth in the startup ecosystem, and facilitating strategic private equity investments in pre-IPO companies for long-term growth.

Ashmeet Sidana is the Founder and Chief Engineer of Engineering Capital. The investment focus areas of Engineering Capital include partnerships with great entrepreneurs driven by technical insights. Ashmeet Sidana’s investment thesis includes partnering with startups at the seed stage with a focus on technical insights. Engineering Capital typically invests in rounds such as Pre-Seed, Seed, and Series A in sectors like AI/Devtools. Their check size ranges from $0 to $10M. Geographically, Engineering Capital invests in the USA, particularly emphasizing sectors like Communications and Information Technology, Business services, Cybersecurity, Life Sciences & Healthcare, and Consumer Products & Services. Some of their previous investments include companies like Azure, SignalFx, and Tubi.tv. Ashmeet Sidana’s professional career includes experience in startups like VMware and founding his own software company. Engineering Capital’s collaboration style focuses on partnerships with entrepreneurs driven by technical insights, supported by a team that includes mentors.

Yasemin Tümer is a seasoned investor with Borski Fund. The fund focuses on female entrepreneurs and businesses targeting women’s health, invests in retail and healthtech sectors, and has received investments from Visa Foundation. Yasemin chairs multiple Supervisory Boards and is involved in various organizations. Borski Fund collaborates with experienced entrepreneurs and partners like StartGreen Capital and The Next Women network. The fund’s investment check size is known to be positive, although specific details are not disclosed.

Sean Parker, a renowned entrepreneur, co-founded Napster and served as the first President of Facebook. He focuses on Life Sciences, Global Public Health, Civic Engagement, and the Arts through the Parker Foundation. Parker invests personal funds as an angel investor in promising startups and advocates for complete teams in the startup landscape. Geographically, he has investments in North America, Europe, and East Asia. His investments include companies like Osaro and Thrive Global, with an investment check size varying based on the round. Parker is known for his collaborative efforts, particularly through the Parker Institute for Cancer Immunotherapy, fostering data sharing and industry partnerships to accelerate cancer research.

Alexander Schmitt is a Partner at Lightspeed, specializing in B2B and FinTech investments. His previous investments include Flink, Aware, Advastore, and Ninetailed. Alexander focuses on early-stage companies within technology, healthcare, and more. His collaboration style involves partnering with various cycling brands to address climate impacts. Additionally, he emphasizes alternative asset classes like infrastructure and real estate debt. His investment check size has garnered global interest with millions, aligning with a focus on AI’s trillion-dollar promise.

Derek Rapp is the Managing Director at RiverVest Venture Partners, a life sciences venture capital firm investing in early-stage biopharmaceutical companies. His investment focus areas include the diabetes community and product development. Derek has been involved in organizations such as JDRF, Divergence, Inc., Monsanto Company, and Lazard Freres & Co. His previous investments are not specified. Derek’s professional background includes roles at various companies, and he holds an MBA from the Wharton School. RiverVest’s investment check sizes range from 10 to 50 million dollars. Derek’s partnership and collaboration styles are not explicitly mentioned on the website.

Raju Indukuri is an angel investor interested in disruptive innovations in technology and healthcare. He invests in startups to disrupt the healthcare market and has a track record of over 30 years in psychiatry. Raju’s investments range from seed rounds to Series B, with a check size that is undisclosed. His geographical focus spans across global regions such as Europe and Southeast Asia. Previous investments include FalconX and collaborations with KPIT Technologies. Raju’s partnership and collaboration styles involve expanding networks and accessing innovative solutions.

The Sofia Fund, an angel group based in Minneapolis, focuses on early-stage, growth-oriented, gender-diverse companies with women leaders and equity owners. Their portfolio of 23 companies includes notable investments like AbiliTech Medical and Joylux. They invest in sectors such as HealthTech and Life Sciences, with investments at Series A and Seed stages. Some top investments include Tactile Medical, Magnet 360, and Rebiotix.

Jefferson Corner Group LLC – Brookdell focuses on providing investment capital to technology startups in the Charlottesville, VA region. They primarily invest in U.Va. faculty spin-offs and other technology businesses in the area. Their investment focus areas include health care, medical, and therapeutics. Jefferson Corner Group has a track record of supporting U.Va. faculty spin-off companies and emerging technologies. Unfortunately, specific information about their investment check size and partnership/collaboration styles could not be found.

Hyde Park Angels is an angel group based in Chicago, Illinois that focuses on growing early-stage startups primarily in the Midwest region. The firm follows a thorough diligence process, evaluating companies based on team dynamics, problem/solution fit, evidence of success, and market opportunity. They invest in industries such as industrial technology, information technology, healthcare services, and financial services. Hyde Park Angels predominantly invests at the early stage and Series A, emphasizing wise spending and understanding marketplace insights. The firm has a track record of investing in companies like ParkWhiz, Rheaply, ShipBob, Fee Fighters, 1871, and more. Their investment check sizes vary, and they focus on verticals like Life Sciences & Healthcare, Consumer Products & Services, and Business Services. Hyde Park Angels collaborates with various partners, including Industry Partners, Corporate Sponsors, and Community Partners, to provide additional resources and support to entrepreneurs.

Larry Randall is the Chief Financial Officer at Alta Partners, an active investor focusing on various industries. They closed a $130 million fund in 2018. Alta Partners invests in healthcare, technology, and veterinary care sectors. Larry Randall oversees financial functions and administrative aspects at Alta Partners.

Andre Agassi focuses on investments in Technology, Corporate Strategy, Corporate Venture Capital, Venture Capital, IT, Consumer, Tech, Insurance, Healthcare, and Industrials. He has made investments in companies like Viagogo and DUPR. The stage of his investments includes Seed VC. The geographical preference of Andre Agassi is not explicitly stated in the available information. His partnership and collaboration styles are characterized by unique collaborations with brands like Nike, emphasizing stylistic freedom and rebellious attitudes.

Christos Eke is an experienced investor known for his investments in various sectors such as Consumer, Enterprise, FinTech & ProTech, Frontier, and Healthcare. He has a successful track record in venture capital and private equity, with notable investments like Beyond Meat, Facebook, and Uber. Christos Eke typically invests between $500K to $1.5M per company, and he prefers to back founders with a track record of execution. His partnership and collaboration styles are tailored to promote understanding and self-awareness within teams for better collaboration, focusing on investing in human work to enhance collaborative efforts.

Brian Shire is an investor with a diversified investment focus in technology vendors, corporate strategy, corporate venture capital, and venture capital. He has made investments in companies such as Firebase as part of their Seed VC. Through his professional career, Brian has demonstrated a track record of high achievement and delivering results in companies like AbbVie, Baxalta, and Shire. Brian’s investments are characterized by a check size that aligns with his interest in innovative startups. His partnership and collaboration style may involve cooperative collaboration, competitive collaboration, directive collaboration, facilitative collaboration, and delegative collaboration. He has a preference for geographical regions like Asia, APAC, Brazil, Canada, India, Indonesia, Israel, Korea, Mexico, the Middle East, and the United Kingdom. With a background in technology and social impact, Brian Shire brings a wealth of experience and expertise to his investment activities.

Sanjay Mirchandani is a seasoned investor with a focus on disrupting the data protection industry. His investment thesis revolves around advancing the industry with a platform that integrates leading software, SaaS, and security capabilities to secure, defend, and recover data across environments. Sanjay’s investment focus areas span Food, Agriculture, and Healthcare industries. He typically invests at the Seed stage and has a strong geographical preference for the Asia Pacific & Japan region. Sanjay’s previous investments include Chai Point and Shantani Proteome Analytics. With a career spanning over 25 years, Sanjay has demonstrated exceptional leadership in technology companies like Commvault and VMware. His partnership and collaboration style emphasize assembling great teams, fostering innovation, and clear communication. The check size of his investments is most evident in his Angel investment in BHIVE Workspace in 2016.

Sandy Jen is an accomplished investor who has made investments in companies such as HipChat. She has a background as the Co-Founder and CTO of Meebo, a consumer Internet company. Sandy has demonstrated expertise in Python, Distributed Systems, and Scalability. She has a track record in tech entrepreneurship and has co-founded Honor Technology. Sandy’s investment focus areas include technology vendors, venture capital, insurance, healthcare, and financial services. Her investment check size and geographical preferences are not publicly available. Sandy Jen’s collaboration style is not explicitly mentioned in the available sources.

Gregory Wasson, co-founder and president of Wasson Enterprise, focuses on investing in health tech, consumer and retail, and clean tech. He funds early-stage companies and has a track record in the pharmaceutical industry. Wasson prefers investments that address unmet market needs and values collaboration, as seen in partnerships with companies like Alliance Boots. The check size of his investments is not specified, reflecting a flexible approach. His professional background includes leadership roles at Walgreens, where he made strategic transactions and displayed a willingness to adapt to market changes. His investment philosophy emphasizes building sustainable, high-growth businesses with a positive impact.

Charles Matausch is a VC Investor at XAnge with an investment range of $300K – $10.0M and a sweet spot at $5.0M. His current fund size is â¬600M. His investment focus areas include Developer Tools (Series A), Developer Tools (Seed), Consumer Health (Series A), Consumer Health (Seed), Web3/Blockchain (Series A), Web3/Crypto (Series A), Web3/Blockchain (Seed), BioTech (Series A), Web3/Crypto (Seed), Digital Health (Seed), Digital Health (Series A), Health & Hospital Services (Series A), BioTech (Seed), Health IT (Series A), Health & Hospital Services (Seed), Consumer Internet (Series A), Health IT (Seed), Consumer Internet (Seed), FinTech (Series A), FinTech (Seed). Charles Matausch’s geographical preference is focused on EU.

Wisconsin Investment Partners LLC is a venture capital firm based in Madison, Wisconsin, founded in 1999. The firm focuses on technology and life science sectors, with investment areas including Health Care, Biotechnology, Medical, Software, and Medical Device. They make seed- and early-stage investments in various industries, contributing to the region’s entrepreneurial economy. Their investment check size offers fractionalized ownership opportunities for as low as $1,000, allowing investors to have security tokens. Wisconsin Investment Partners collaborates with other investors through partnerships, particularly in private equity and debt investments.

Northern Light Capital invests in advanced technology and future fast-growing companies, mainly in the following areas: InfoTech, MedTech, Fintech, and CleanTech. They offer competence and capital to exciting Swedish startups, providing active minority ownership and expertise in patent and intellectual property rights. Their investments range from â¬50,000 to â¬500,000, focusing on energy & greentech, media & entertainment, fintech, and healthcare & life science. The group values high growth potential, business scalability, and sustainable uniqueness, aiming for investments that yield 10x the capital in 5 to 7 years.

Roger Lemire is an investor who focuses on sectors providing critical goods and services to low-income customers including Agriculture, Education, Energy, Health, and other sectors. He has previously invested in Gemini Sports Analytics, a no-code AI platform for predictive modeling. Roger’s professional career and track record involve leading investment rounds in innovative tech companies. His investment check size for new ventures typically ranges from $250,000 to $5,000,000. Roger Lemire’s partnership and collaboration style reflect a hands-on approach, actively engaging with founders and leveraging his network for mutual growth.

Dr. Stelios Papadopoulos is a Co-founder and Chairman of the Board at Exelixis. He also holds the position of Chairman of the Board and Member of the Corporate Governance Committee at Biogen. Additionally, he serves as the Special Board Advisor at Evelo Biosciences and is the Chairman and Director at Regulus Therapeutics. Dr. Papadopoulos retired as Vice Chairman of Cowen & Co. in 2006 after significant experience as an investment banker, focusing on biotechnology and pharmaceutical sectors. His career includes roles as Chairman of PaineWebber Development Corp. and Vice President at Drexel Burnham Lambert. Notably, he has been involved with various organizations and boards, including Joule Unlimited. Throughout his career, Dr. Papadopoulos has maintained an association with NYU as an adjunct associate professor of cell biology.

Dr. Caroline Fichtner focuses on financing and developing technology start-ups in the life sciences field. With a biophysics background and experience in venture capital, she works with the Max Planck Institute for Bioinorganic Chemistry. Her investment thesis revolves around the life sciences sector, but specific details on investment stage, geographical preference, previous investments, and check sizes are not disclosed. Dr. Fichtner’s partnership and collaboration styles are also unspecified at this time.

Sofia Hasselberg is an Investment Director at Bonnier Ventures in Stockholm, Sweden. She focuses on Sector & Stage Rankings such as Messaging, Entertainment & Sports, Logistics, Food and Beverage, ClimateTech/CleanTech, Real Estate/PropTech, Marketplaces, Digital Health, Health & Hospital Services, and Health IT, particularly in Series B investments. Sofia collaborates with investors like Dajana Mirborn, Johanna Rahm Juhlin, Nadja Abbas, and Victor Bodin. Her investment range is between $100K and $5.0M with a sweet spot at $1.5M. Sofia’s previous investments include cancer diagnostics firm Elypta, where she saw potential in improving healthcare through liquid biopsies for early-stage cancer detection.

Oren Kozlowski is the founder of OK Capital, a venture capital investment firm based in Miami, Florida, founded in 2021. The firm supports exceptional founders and advises startups, focusing on digital health and wellness sectors. Oren Kozlowski has a background as a Vice President of Strategy & Finance at Shyft and experience as a venture capital investor at Founders Factory and WeWork. He holds a Bachelor’s degree in Finance from Baruch College, a Master’s degree in Management from Harvard University, and a UEFA Series B Football/Soccer Coaching License from The Football Association.

David Calone is the President and CEO of Jove Equity Partners, a venture capital firm focusing on companies in the internet, software, digital media, energy, real estate, transportation, and healthcare sectors. The check size for investments made by Jove Equity Partners is currently active. David Calone’s partnership and collaboration styles include serving in various leadership roles and providing real-world application experience for projects related to renewable energy development.

Nicolas Steegmann is an angel investor with a focus on software, internet, and SaaS sectors. His investment thesis centers around seed and pre-seed stages, primarily targeting startups in France and the United States. Some of his notable investments include companies like Balio, Solfy, Tu Lecho al Techo, Swaap, micro1, Skedway, autarc, qomodo, and Cylib. Nicolas is known for his strategic investments in FinTech, Financial Services, E-Commerce, Information Technology, and Health Care industries, with a keen interest in supporting emerging technologies and innovative solutions.

James Hendren, Ph.D., is an entrepreneurial champion dedicated to advancing technology startup companies and knowledge job development since the mid-1980s. With a background in physics and successful software development in defense and finance industries, he has a rich professional career. Dr. Hendren has been actively involved with more than thirty technology startup companies, serving as CEO of four of them. He is the Chairman of the Arkansas Venture Center and plays a key role in mentoring members and guiding the Center’s direction. Mr. Hendren’s investment focus areas and previous investments are not explicitly mentioned, but his significant contributions to the Arkansas technology startup ecosystem demonstrate his commitment to innovation and growth in the region.

John Steffens is the Founder and Senior Managing Director at Spring Mountain Capital, an investment firm based in New York. The firm focuses on providing capital for enterprise software, digital health, technology-enabled services, and healthcare companies across North America. Their investment preferences include life sciences, cybersecurity, e-Commerce, impact investing, and virtual reality. Previous investments by John Steffens at Spring Mountain Capital are not available. The webpage also mentions his involvement in various organizations and industry connections.

Beat Steffen is a Managing Director at Novartis Venture Fund in Basel, Switzerland. He focuses on investing in life science companies developing biotechnology and biopharmaceutical therapeutics to address unmet patient needs. His previous investments include companies like Rappta, SpliceBio, Vivet Therapeutics, FoRx Therapeutics, and UZH Life Sciences Fund.

Mark Krul is the Partner/Co-Founder of Aglaia Biomedical Ventures BV, an oncology specialist investor focused on early-stage breakthrough inventions. Aglaia invests in oncology and novel tools in contemporary drug development. The target fund size is $80-$100 million, with investments in 10-15 high-potential oncology start-ups. Mark Krul is actively involved as a Founder and Director, supporting early-stage companies in drug development as a board member. His geographical preference spans across the Netherlands, focusing on oncology advancements. Previous investments include boards at MIMETAS, Cristal Therapeutics, and others. Mark Krul holds a Ph.D. in Medical Biology from Utrecht University and has a comprehensive background in anticancer drug development.

Alan Taetle is a General Partner at Noro-Moseley Partners with a focus on software, SaaS, internet security, and tech-enabled service businesses. He leads the firm’s IT investment practice and represents NMP on the boards of MacStadium, PureWRX, Red Canary, Revenue Analytics, and Whitebox. Alan has a successful track record with past investments including TrendKite, FSLogix, Clearleap, Virtustream, and Vocalocity. He was previously the Executive VP of Marketing at MindSpring. Alan’s investments cover the United States, with a strong focus on sectors like information technology and healthcare services. Noro-Moseley Partners typically invests in venture and growth capital, emphasizing trade sales as exit strategies. Alan’s previous investments have had significant acquisitions. Alan Taetle is known for his active involvement in the Georgia Tech College of Computing and holds a BA from the University of Michigan and an MBA from Harvard Business School.

Ravi Kamepalli has invested in Fruit Street Health, a telehealth software product licensed to healthcare professionals for conducting HIPAA compliant video calls and monitoring diet/lifestyle. The investment check size is unconfirmed.

Joe D’Amico is an investor with a focus on equity investments in Virginia’s leading technology, energy, life science, and scalable non-tech startups through a family of seed and early-stage investment funds. His investment ranges cover various sectors such as Biotechnology, Biopharmaceuticals, Medical Devices, IT, Telecommunications, Cybersecurity, Renewable Energy, Transportation Technologies, and more. He has a background in supply chain and procurement, with experience in roles like General Manager of Supply Chain Services at Quest Global and Senior Director of Global Procurement at Baker Hughes. His investment check size is not specified, but he has a track record of meaningful results in challenging environments and seeks a Procurement, Sourcing, or Supply Chain leadership role in medium to large scale companies. He demonstrates a results-oriented approach and collaborates effectively in his roles.

SJF Ventures is a venture capital partnership focusing on the resource efficiency, sustainability, and technology-enhanced services sectors.

Doug Hecht is an Angel Investor with a focus on technology vendors, IT, consumer, tech, insurance, healthcare, industrials, and financial services. He has invested in SOCi and has a consumer product-focused approach. Doug has made previous investments in SOCi and received $1 million in seed funding for Lymber. He co-founded and served as the Chief Executive Officer at Lymber Wellness. There is no specific information available regarding his stage of investment, geographical preference, track record, professional career, or investment check size.

TMV is an early-stage investment firm that focuses on the future of living well.

Peter Adams is an investor with focus areas in Healthcare, Retail Technology, Medical Devices, and Healthcare Services. He operates in early-stage investments, with a check size that varies. His previous investments include Rockies Venture Fund and Pandemic Impact Fund. With over 25 years of business experience, he is actively involved in developing best practices for due diligence and negotiation, providing education for angel investors, and leading multiple ventures.

AshantiMember Cotton is an investor with a focus on Agriculture, Education, Energy, Health, Financial Inclusion, Housing, Water & Sanitation, and Workforce Development. Investments range from early to mid-stage. Geographically, the focus is on EU. Previous investments and track record are not available. The investment check size varies. Partnership and collaboration styles are not specified.

Investment Focus Areas: Early to growth-stage technology companies in Fintech, Healthtech, Industrial IoT, and logistics spaces

Andrew Razeghi is a renowned strategist and investor known for his innovations across various industries. His investment focus areas include technology vendors, corporate strategy, corporate venture capital, insurance, healthcare, industrials, and financial services. Andrew typically invests in early-stage startups, particularly in seed and Series A rounds. His geographical preference is predominantly in the United States. One of his notable previous investments was in Perfect Audience. Andrew Razeghi is the Founder of StrategyLab, Inc. He has a strong track record and professional career in consulting and academia. Specific details about his investment check size and partnership and collaboration styles are not readily available.

ShangPharma Innovation is a global innovation incubator and investment organization focused on biomedical R&D technologies and therapeutics.

Johanna Rahm Juhlin, Investment Associate at Bonnier Ventures, focuses on investing in Messaging, Entertainment & Sports, Logistics, Food and Beverage, ClimateTech/CleanTech, Real Estate/PropTech, Marketplaces, Digital Health, Health IT, and Health & Hospital Services at the Series B stage. She operates in Sweden with an investment range of $100K to $5.0M, with a sweet spot of $1.5M. She has previously collaborated with co-investors including Dajana Mirborn, Nadja Abbas, Sofia Hasselberg, and Victor Bodin.

Bart Mul, a Senior Investment Manager at BOM Brabant Ventures, focuses on sustainable food systems, a healthy future, climate-neutral energy solutions, and promising key technologies. His investment range varies from $100K to $5.0M, with a sweet spot at $1.5M. Bart’s professional background includes positions at Unit040 Ontwerp and Heras, and his educational qualifications from Tilburg University, Kansas State University, and Koning Willem II College. Bart’s previous investments include Series B funding rounds, and he collaborates closely with investors like Bart van den Heuvel and Brigit van Dijk. Bart’s investment style aligns with ClimateTech/CleanTech and SaaS sectors, with a preference for seed to Series B stages. His partnership approach is hands-on and strategic, providing valuable mentorship and support to foster the growth of startups.

Benjamin Simon is a Partner and Head of Research at Fortress Labs, with a proven track record in driving strategic transformation and profitability improvements. He was previously a Venture Partner at Spark Capital and an Associate at Mechanism Capital. His investment check size is not specified, and his partnership and collaboration styles are not explicitly mentioned in the available information.

AngelFire Ventures is a prominent venture capital firm that emerged in 2008 to fill funding gaps in Mexico’s early-stage sector. They focus on specialized industries, providing funding and resources for startups in technology, healthcare, education, and more. Their portfolio includes investments in various sectors. The firm plays a vital role in fostering innovation and economic growth in Mexico by offering not just funding but also expertise and mentorship. While specific previous investments are not available, AngelFire Ventures has been active in supporting startups. They aim to make a lasting positive impact on Mexico’s business landscape. The check size strategy emphasizes consistency for negotiation and diversification. Their partnership and collaboration styles are not detailed, but the firm is known for its support in bridging the gap between startups and investors.

Paul Troyer is a CERTIFIED FINANCIAL PLANNER™ professional at Franklin, Parlapiano, Turner & Welch, LLC in Houston, TX. His specialties include investment management, life planning, and retirement. His investments focus on assisting clients in financial planning and providing advice in various financial areas. Paul’s track record includes consulting expertise in large and small hospitals and healthcare systems across the US, with positive results. There is no specific information available regarding his investment focus areas, stage of investment, geographical preference, previous investments, investment check size, or partnership and collaboration styles.

Joanne Chang is a healthcare angel investor and advisor with a focus on female and BIPOC founders. Her investments range from $10,000 to $25,000 per company. She holds a joint MBA-MS degree in healthcare, clinical sciences, and general management from Harvard and MIT. Joanne is known for her ownership of Flour Bakery in Boston and Cambridge, Massachusetts. She has a successful track record in the culinary industry, including being the James Beard Foundation Award winner for Outstanding Baker in 2016. Her investments are typically focused on healthcare and consumer sectors, and she has a partnership filled with love, especially in the food industry.

Phil Hagerman, a Partner at Comeback Capital, specializes in investments in Pharmaceuticals, Health & Hospital Services, and Health IT sectors. His investment check size ranges from $50K to $250K, with a sweet spot at $150K. Phil’s current fund size is $2.3M. His recent investments include Pre-seed Pharmaceuticals. Phil is known for co-founding SkyPoint Ventures, focusing on early-stage companies. He has a collaborative and hands-on partnership style, offering mentorship and strategic guidance to startups. With a track record in multiple disciplines, Phil Hagerman is an experienced investor with a keen eye for promising ventures.

Ari Buchler is a seasoned investor with over 20 years of global experience leading corporate development, legal, software OEM sales, and other corporate functions in both private and public companies. His track record includes being a key member of turn-around teams at companies like Intralinks and Sophos, with over 40 transactions globally. Ari has invested in early-stage startups, as well as private equity and venture funds. He serves as a Board Member at Simeio Solutions, as a Limited Partner at Glilot Capital Partners, and in advisory roles for various companies. His partnership and collaboration style is exemplified through his involvement in securing corporate networks from unauthorized mobile devices through partnerships with companies like Check Point Software Technologies. Ari’s investments are primarily focused on HealthTech, Enterprise Applications, Software, and Cyber Security sectors, with past investments in companies like LinkSquares, Ginger, and others. He is based in Boston, USA, and has a law degree from Columbia University School of Law.

Tom Patton is a seasoned healthcare executive and board member with broad operational, strategic, legal, compliance and transactional experience. He has served in various leadership roles in public and private healthcare companies. Tom’s investment focus areas include healthcare, biotechnology, dementia, and medical devices. He has a track record of success in leading companies to growth and acquisition. Tom has been involved in previous investments in companies like CAS Medical Systems, QDX, Inc., Novametrix Medical Systems, and Wright Medical Technology. His investment check size varies depending on the company’s needs. Tom prefers collaborations and partnerships that emphasize effective communication and relationship dynamics in decision-making processes.

Deepali Nangia, a seasoned Angel Investor, focuses on technologies solving societal problems in Fintech, Health, Femtech, and Climate Tech. She invests in early-stage startups, including female-founded companies like PensionBee, Planera, Kama Labs, and others. With a track record in private equity and investment, she partners with entrepreneurs in Europe, the Middle East, and Africa, offering check sizes for different rounds such as $1M for a Pre-Seed Round and â¬1.1M for a Pre Seed Round, contributing to ventures like Shellworks and Lovely Day Foods.

Lars Hedbys, a Partner at Ventac Partners, brings over 30 years of international leadership experience in the life science industry. He focuses on company building, financing, mergers & acquisitions, and IPOs. Lars has led listed companies and founded life science companies, handling pharmaceutical, ATMP, and medical device development. He serves as chairman or board member in various listed and private life science firms. Lars holds an M.Sc. in chemical engineering and a Ph.D. in Applied Biochemistry. His past roles include CEO of Idogen AB and Chairman of Lund Life Science Incubator. Lars Hedbys co-founded Idogen AB, Regenesance BV, IAmPatient AB, and Casigen Pharma Ltd. The investment check size and partnership styles are not publicly available.

Preston Tollinger, a seasoned entrepreneur and investor, is renowned for founding successful startups like CollectiveHealth, Lightside Games, and Cellfire. With a BS in Computer Science from Carnegie Mellon University, his career showcases a deep tech expertise. Notable roles include Chief Technology Officer at Collective Health and co-founder of Lightside Games. In the past, he served as CTO at Cellfire and Motion. His foundational work at CollectiveHealth emphasizes a focus on health technology. Previous ventures reflect a commitment to innovation and growth, positioning him as a key figure in the tech industry. As Chief Product Officer at Chorus Innovations since 2023, his strategic leadership continues to drive impactful investments and collaborations. Preston’s background underscores a diverse portfolio and a visionary approach to fostering startup success.

Presight Capital is a venture capital firm investing in the most ambitious founders across sectors, stages, and geographies.

Mr. Edward Fritzky served as Chairman and Chief Executive Officer at Immunex Corporation. He served as President of Lederle Laboratories, a division of American Cyanamid Company from 1992 to 1994 and Vice President of Lederle Laboratories from 1989 to 1992. Prior to joining Laboratories, he served as an Executive of Searle Pharmaceuticals, Inc., a subsidiary of the Monsanto Company, a Pharmaceutical and Chemical Company in the United States.

David Niu is the founder and CEO of TINYpulse, known for selling the startup TINYpulse to Limeade for $9.1 million in 2021. He is an industry pioneer in rugby league and rugby union, particularly known for establishing the American National Rugby League in the United States. David Niu’s investment check size has been around $9.5 million, as demonstrated by the funding raised for TINYpulse. His partnership and collaboration style focuses on engaged partnerships, where all parties contribute and benefit, emphasizing shared vision and problem-solving. While specific information on his investment thesis, investment focus areas, geographical preferences, and previous investments was not found in the search results, his career spans from sports administration to entrepreneurship in TINYpulse, reflecting a diverse professional background.

Karanpal Singh, the Founder of Hunch Ventures, is a seasoned investor with a focus on seed and early-stage investments. His investment thesis revolves around opportunities in healthcare, hospitality, education, media, retail, and new-age technology sectors. Karanpal has made investments in companies like MyHealthcare, N+1 Capital, India Inc. Group, Roots Ventures, and more. With over 19 portfolio companies and 3 exits, he has a strong track record in managing clinical laboratories and a background in neuroscience. His usual investment check size ranges around $2 million, and he is known for his collaborative and mentorship-driven partnership styles, to uplift projects like easing cervical cancer testing and converting CO2 emissions into valuable compounds.

Julia Dewey is the Managing Director at Rev1 Ventures. Rev1 Ventures focuses on late-seed, pre-Series A, and Series A investments in B2B startups across industries. Some of the previous investments made by Rev1 Ventures include Color Coded Labs, Redi Health, SureImpact, and Rapchat. The investment check size at Rev1 Ventures ranges from $150,000 to $325,000, with a sweet spot at $240,000. Julia Dewey’s investment approach aligns with the fund’s focus on digital health, health & hospital services, and health IT sectors in the pre-seed to Series A stages.

Nyfikna Investerare, a venture capital company based in Sweden, is dedicated to democratizing knowledge about investments and inspiring investors. The firm focuses on fostering collaboration between entrepreneurs and investors to build a supportive community. Nyfikna Investerare has a diverse partnership and collaboration style, working closely with startups to deliver actionable strategies tailored for their success. While specific investment check sizes are not provided, Nyfikna Investerare is actively involved in the health tech category and has a portfolio of investments. The firm has shown interest in sectors like wearable tech, IoT, and Smart Textiles, with investments in companies such as LEIA and Gokind. Additionally, Nyfikna Investerare organizes events and programs like board of directors training to enhance the skills and opportunities for investors and entrepreneurs in the startup ecosystem.

Robert Goldenberg is an active angel investor targeting seed stage companies with past investments in companies like Pangea3, Sympler, Xpandio, and more. His career spans investment banking, and he currently serves as the CFO of a venture-backed enterprise software company. His check sizes for investments are not specified, showcasing flexibility. He maintains a track record of successful investments. He focuses on the CFO role at 6sense, emphasizing data-driven metrics for decision-making. Collaboration styles include industry focus on sectors like Industrial Tech, Software, FinTech, Healthcare, and Technology, reflecting a strategic and diversified partnership approach.

Berkay Mollamustafaoglu is the co-founder and general partner of ScaleX Ventures. He was the co-founder and CEO of OpsGenie, a modern incident management platform acquired by Atlassian for $295M in 2018. Berkay’s investment focus areas include Human Capital/HRTech, Future of Work, Cloud Infrastructure, Analytics, and SaaS at Pre-seed and Seed stages. Some of his notable investments include Quantive, KuartisMED, and Vanemar in sectors like Enterprise Applications and HealthTech. Berkay’s investments span locations such as Turkey and the United States. He is a triathlete, nature enthusiast, loving husband, and father. Berkay Mollamustafaoglu’s partnership and collaboration styles were not found in the search results.

Samuel Beyer is an investor with a focus on sectors such as Supply Chain Tech, Wellness & Fitness, Pharmaceuticals, TransportationTech, Data Services, eCommerce, BioTech, and AI. He invests in Series A and Series B stages, with an investment range of $100K – $5.0M and a sweet spot of $1.5M. Samuel Beyer shows a preference for geographies such as the United States and Europe. His previous investments include companies in various sectors. He has a significant fund size of $1.1B and is part of General Catalyst. Samuel Beyer’s partnership and collaboration styles involve working with affiliated investors and scouts in the industry.

Klaus Dugi is a Venture Partner at ND Capital, a venture capital firm investing in disruptive technologies across life, physical, and data sciences. With assets under management of approximately $820 million, ND Capital operates in the United States and Europe. Klaus Dugi’s investment focus areas include Therapeutics, Digital Health, BioTech, and Health & Hospital Services at various stages from Pre-seed to Series B. He typically invests between $100,000 to $5 million, with a sweet spot of $1.5 million, from a current fund size of $500 million. Some investors who collaborate with Klaus Dugi include Aditya Rajagopal, Alison Palmer, Aymeric Sallin, Dani Bach, and Eric Moessinger. His recent investments include leading a $20.6 million Series A financing for Vandria. Klaus Dugi plays a crucial role in supporting startups through their development phases and financing rounds.

As a Venture Partner at Nina Capital, Sarah Fisher focuses on investments in the range of $10.0M to $50.0M, with a sweet spot of $25.0M. The current fund size for investments is â¬40M.

Jason Weingarten is the Managing Director at Subconscious Ventures, a venture capital firm based in Chicago, Illinois. Subconscious Ventures partners with relentless and humble founders in the seed stage, focusing on investments in sectors like Consumer Health, Marketplaces, Consumer Internet, and SaaS. Jason’s investment check size ranges from $100K to $5.0M, with a sweet spot of $1.5M. Some of his notable previous investments include startups in Consumer Health and Series A stages. He collaborates with other investors and provides guidance to founders early in their journey.

CIC backs life sciences and technology companies in Europe’s leading ecosystem, Cambridge. A preferred investor for the university.

Simon Leicht is a dedicated investor with a long-term focus on investments, backed by the renowned family businesses in Germany. He partners with leading early-stage funds for co-investments and has access to world-leading early-stage co-investors. His investment portfolio includes a diverse range of companies in sectors like CBD, B2B platforms, plant-based dairy alternatives, digital spice brands, and clean label plant-based meat replacements. Simon Leicht has expert access to a network of industry-leading companies for investment decisions and works with a team of experienced investment professionals. His team includes Managing Partners like Jan Leicht, and Senior Investment Managers. Additionally, his team has expertise in private markets and venture capital, with specific focuses on FoodTech and consumer investments. Simon Leicht’s operations are supported by professionals with backgrounds in green power generation technologies, financial analysis, and regulatory compliance.

Lucas Nivon is a Venture Partner at Argonautic Ventures with a focus on Pre-seed and Seed investments in Pharmaceuticals and BioTech sectors. His investment range is from $100K to $5.0M, with a sweet spot of $1.5M. Lucas has a professional background as CEO and Co-Founder of Cyrus Biotechnology and as a Translational Investigator at the University of Washington. He holds a PhD in Biophysics from Harvard University and an AB in Biochemistry from Harvard University. Previously, Lucas has also been involved in startups like PedalAnywhere and has experience as a Post-Doctoral Fellow at the University of Washington. His collaborative style is evident through his roles as a Co-Founder and Executive Committee Member at OpenFold and as a Co-Founder at PedalAnywhere. Lucas has a strong academic foundation with a comprehensive track record in the biotechnology sector.

Tom Solli is an investor with a focus on economic development projects in Appalachia, specifically targeting building businesses, workforce ecosystems, community infrastructure, and regional culture and tourism. He is known to invest in pre-seed and seed-stage projects with check sizes ranging from $50k to $4M. Tom Solli values collaboration with founders, supporting them with resources from talent recruitment to CEO coaching. He is open to backing solo founders and often takes a hands-on approach in his investments. While his professional career and track record specifics are not available, his investment preferences and styles demonstrate a commitment to fostering growth and innovation in his investment portfolio.

John Evans is an individual angel investor with a seed stage focus. He is based in New York, New York, United States. His educational background includes the University of Pennsylvania, Yale University, and Wharton School of the University of Pennsylvania. John Evans is the CEO of Beam Therapeutics and has one portfolio company. His previous roles include positions at Agios Pharmaceuticals, Infinity Pharmaceuticals, McKinsey & Company, and MedImmune. He has a diverse educational background with degrees from prestigious institutions. John Evans’ investment style is as an individual angel investor focusing on seed stage companies.

Sravish Sridhar is an Angel Investor with a focus on industries like Biotechnology, Digital Health, Insurance, Cloud Infrastructure, and others. His investments range from Pre-seed to Series A stages, with recent investments including BodesWell, American Cricket Enterprises, Talla, and Kato. Sravish Sridhar typically invests in seed round stages and has shown interest in biotech, digital health, insurance, cloud infrastructure, fintech, pharmaceutical, manufacturing, and enterprise software. He has a check size range of $5K to $25K, with a sweet spot around $15K. Some of his past investments include Talla, Evisort, Securicy, Fyle, and Kinvey. Sravish Sridhar’s track record includes founding Kinvey, a mobile developer platform focused on user experience in backend services, competing with large enterprise rivals. His professional career has been dedicated to encouraging innovation, providing flexible pricing options, and expanding the company’s presence into new markets.

Rockies Venture Club is an active angel group funding 25-30 companies annually. They offer a wide range of events and educational programs for investors and entrepreneurs. The club focuses on providing high-quality deal flow and professional due diligence. Rockies Venture Club fosters economic development by connecting investors and entrepreneurs, and they sponsor service providers for collaboration. They hold over 120 events yearly, including Investor Forums, pitch events, and educational workshops. The club’s mission is to educate and connect investors and entrepreneurs for successful investments and collaborations.

Liz Marchi is the Founder of Frontier Angel Fund 2, co-founder of Frontier Funds 1 and 2, and Chief Marketing Officer at Two Bear Capital Operations LLC. Liz focuses on investing in tech and healthcare startups, with an investment range of $25,000 to $150,000. She prefers early-stage companies and geographic focus on Montana. Liz has a strong track record in angel investing and collaborates with organizations like the Montana Chamber of Commerce to support entrepreneurship initiatives.

Ingrid Nieweg is an Investment Manager at BOM Brabant Ventures with an investment thesis focusing on sectors like Manufacturing, Logistics, EnergyTech, Food and Beverage, AgTech, ClimateTech/CleanTech, Digital Health, BioTech, Health & Hospital Services, and Health IT. She has a track record in roles such as International Sales Manager and Senior Credit Risk Analyst at reputable organizations like Fisher Investments and ABN AMRO. Her partnership and collaboration approach involves assisting startups in achieving their milestones and seeking cooperation with venture capitalists in fields like climate technologies. Ingrid’s professional career includes a Master’s in Business Administration, a Private Banking Program from INSEAD, and a Bachelor’s in Commercial Economics, among other educational achievements.

Southwest Angel Network is an early-stage impact investor focusing on startups providing solutions to societal and environmental challenges, including climate change mitigation. They invest in companies improving physical and mental health outcomes across the US, particularly supporting under-represented founders. Previous investments include Scriptly Rx and ResilientGrid. SWAN Impact Network emphasizes angel investors enabling entrepreneurs to address pressing issues, with a strong commitment to impact investing education. Partnership and collaboration styles are evident through their diverse sponsors, including Atchley and Associates, TechMatrix, and Goodwin Procter LLP. Contact executives in different regions for investment opportunities.

GSR Ventures focuses on early-stage technology companies developing AI-enabled technology.

Diane Greene serves as a Board Member at Wix.com and Stripe. She founded bebop Technologies, Inc. and served as CEO until it was acquired by Google. Her investments are personal and industry agnostic. She has a focus on forming partnerships, such as the collaboration with Box for Google Docs users to edit within Box. Greene’s investments range from angel investments to strategic collaborations to enhance productivity.

SemperVirens Venture Capital invests in technology transforming work, health, and financial wellness.

Ankush Gera, the Co-Founder and CEO of Junglee Games, focuses on backing purpose-driven businesses and prioritizing good people in his investments. His investment portfolio spans industries like technology, healthcare, and blockchain. Ankush Gera’s geographical preference includes a significant focus on India. Some of his notable investments include The Whole Truth Foods, StockGro, and Fynd. With a background in computer science and bioinformatics, Ankush Gera has successfully led Junglee Games and emphasized bootstrapping in building a unicorn from India. His investment check size ranges across various rounds, and he values partnership with purpose-driven founders in the gaming industry.

Ryan Lawrence is an Angel investor with a focus on markets such as Health Care, Internet, Telecommunications, and more. His past investments include Touchstone Exploration, Corridor Communications, and Source Energy Services. He is based in Toronto, Canada.

Logan Welch is an Investor at Morpheus Ventures, primarily focusing on sourcing and analyzing new investments in areas such as FinTech, HealthTech, ConsumerTech, SportsTech, Enterprise SaaS, Blockchain, and Gaming. He is an MBA student at the University of Chicago, Booth School of Business, with a background including roles at Gartner, CEB, YMCA of Alexandria, K2 Advisors Group, and Raymond James Financial. Logan’s investment check size and partnership styles are not specified on the available sources.

Austin Ju is a Deal Lead at New Stack Venture, a venture capital firm headquartered in Chicago, Illinois. The firm’s investment thesis is focused on early-stage companies in sectors such as B2B SaaS, fintech, ecommerce, supply chain, cyber, proptech, and healthcare. Austin Ju has a track record as a Principal at New Stack Ventures. The firm’s investment check size ranges from $400K to $1.5M, with a sweet spot at $750K. New Stack Ventures prioritizes collaboration and partnership with startup founders and co-investors to support their portfolio companies.

Bob Jacobson is an Angel Investor focusing on Seed Round investments. He has been involved in a variety of investments, such as Example example company Inc, Company & Company, and Example. His investments typically range from $524,000 to $11,000,000. Bob Jacobson’s partnership style is oriented towards Seed Round investments.

Roman Schumacher is an investor with a focus on healthcare startups. He has made investments in companies like Remberg and Stonly. Schumacher’s investments typically range between â¬100,000 and â¬500,000 per company. With a professional career in the healthcare sector, he brings industry expertise to his portfolio. He favors partnerships and collaborations that bring value to both sides, creating mutually beneficial relationships. Schumacher’s geographical preference appears to be in the EU region. His investment check size varies but typically does not exceed â¬3,000,000 per company. Overall, Roman Schumacher has a track record of successful investments, particularly in healthcare startups.

Michael Greeley, Co-Founder and General Partner at Flare Capital Partners, focuses on healthcare investments in companies like Aspen RxHealth, Author Health, Axuall, Cayaba Care, Circulation, Cohere Health, HealthVerity, Higi, Inbound Health, Iora Health, Oshi Health, RightMove, and Welltok. He holds a BA in chemistry from Williams College and an MBA from Harvard Business School.

Carl Wilson is an Executive Advisor at Forté Ventures with a focus on investments in automation, energy, infrastructure, and pharma & medical devices. He has a successful track record as the former EVP and CIO of Marriott International and previous roles at Georgia-Pacific Corporation and The Pillsbury Company, with notable board memberships. Check sizes for investments are not specified. Carl Wilson’s partnership and collaboration style are not evident from the available data.

Davide Ottolini is an experienced investor with a focus on biotechnology’s impact on longevity, mental health, and regenerative medicine. He cofounded Korify Capital, aiming to invest in innovative companies contributing to preventive healthcare and longer lives. His extensive background includes consulting for prominent pharma companies, enhancing his knowledge of the financial and biotech sectors. Davide Ottolini’s vision at Korify Capital is to support visionary firms in the biotech space, reflecting his dedication to shaping a healthier future through strategic investments.

Chennakeshav Adya provides seed funding to companies in sectors like Technology, Media & Entertainment, Healthcare Systems & Services, Pharma & Life Sciences, Private Equity, Retail, Real Estate, and Banking & Capital Markets. He is known for growing teams and leading them through complexity. While there is limited information on his previous investments, he serves as a board advisor to businesses, offering insights into starting businesses from concept. His investment check size and stage of investment are not explicitly stated on his website. His partnership and collaboration style involve discussions on the art and science of business, highlighting the importance of alliances, joint ventures, and partnerships.

Benchmark focuses on early-stage venture investing in mobile, marketplaces, social, infrastructure, and enterprise software.

Sudheesh Nair is a growth-stage investor with a focus on areas such as life sciences, healthcare, and manufacturing. He has previously led Nutanix as President, growing revenue from $0 to $1 billion in 7 years. Sudheesh Nair is known for his leadership in data, analytics, ML/AI, and modern platforms. He invests in disruptive technology companies and has a proven track record of scaling businesses rapidly. Sudheesh Nair’s investments typically range in the millions, as seen from ThoughtSpot’s plan to invest $150 million in their operations in India. His partnership and collaboration styles focus on embracing situations and driving compassion in leadership teams.

Hema Hattangady is an experienced entrepreneur, corporate executive, impact investor, board member, mentor, and advisor. She has invested in Lodestar in the EdTech sector with a $380K Angel round investment. Hattangady founded Swasth India, a healthcare services provider. Her professional career includes founding companies, board memberships in impactful firms like Maiva Pharma, and active involvement in energy efficiency and healthcare initiatives. Her geographical preference for investments is India. Hema Hattangady’s collaboration and partnership styles focus on fostering collaboration within India’s energy efficiency industries and service providers.

Midlothian Angel Network is a network of accredited minority, non-traditional angel investors providing bright futures for early-stage companies. Their investment thesis includes Crypto, AI/ML, Medtech, software, pharma/bio, IoT, and more, with a focus on US military veterans, minority founders, and African-facing startups. They invest in North America and Africa and have backed startups such as Robotics Manufacturing and Data Analytics. Their check sizes vary, with recent investments like $300,000 in Mainstack. They collaborate with early-stage companies in diverse markets and provide mentorship for rapid growth.

Logan Green is a Co-Founder of Lyft and serves as Chief Executive Officer & Board Member. He has specialized in investment advice with ongoing management, focuses on charitable giving and high net worth client needs. His previous investments include companies in HealthTech and FinTech sectors primarily in the United States and the United Kingdom. Logan Green’s check size for investments is based on the specific round, and he has a background in sustainable development goals and ESG investing. Logan Green’s partnership and collaboration styles reflect a commitment to culture and values, emphasizing relationships for organizational success.

Zack Schuler invests in Consumer Internet, Healthcare, and E-Commerce startups. He focuses on early to mid-stage investments and actively participated as an Angel Investor and Co-Founder at NINJIO. His geographical preference is Silicon Valley and Los Angeles. Some of his past investments include Roomi, ProducePay, mytable, and others. Zack is the Founder and CEO of NINJIO, a leader in Cybersecurity Awareness Training. He has a Bachelor’s Degree in Business and Microsoft certification. His check size typically ranges from $10K to $100K. Zack exhibits partnership and collaboration by working with industry associations and leading organizations to enhance cybersecurity awareness.

Hussam Khoury is an accomplished investor and co-founder of Nuwa Capital, focusing on developing a true partnership with entrepreneurs through thesis-driven investing. With a background including successful exits like Careem, Souq, Namshi, and Maktoob, Khoury brings extensive experience and expertise to the table. His investment focus areas span multiple markets with a preference for stakeholder engagement and shared success. Through Nuwa Capital, Khoury aims to support and mentor startups in critical areas such as technology, product, growth hacking, marketing, recruitment, fundraising, and legal support, fostering long-term relationships and promoting disruptive businesses.

Michael Sidler is a founding partner at Redalpine Venture Partners, a thesis-driven VC firm with expertise in software and science. Redalpine’s focus areas include AI Middleware, Energy Revolution, Mobility, Health Tech, and more. They invest in disruptive technologies and prefer investments ranging from $300K to $10M. Michael has a track record in the European biotech VC space and follows a collaborative approach in investments.

An accelerated, hands-on investing method that builds companies around game-changing technologies

Björn Odlander, Partner at HealthCap, focuses on investments in the life sciences sector with a keen interest in therapeutics, health IT, biotech, digital health, and health & hospital services. His preferred investment stage is Series B. Björn’s investment check size ranges from $100K to $5.0M, with a sweet spot of $1.5M. Notable previous investments include Oncorena. He collaborates closely with co-investors such as Alex Valcu, Anki Forsberg, Carl-Johan Dalsgaard, Carl Kilander, and Eugen Steiner. Björn Odlander is known for his professional career as a co-founder of HealthCap, a global venture capital fund in life sciences since 1996. HealthCap celebrates 25 years of operations, boasting a strong track record in the industry.

Rob Tanakatsubo, Managing Director at Monroe Capital, has a focus on finance and capital markets transactions with a background in Portfolio Management and Underwriting. He joined Monroe Capital in 2014 and is known for his professional career history in the financial sector, including roles at Fifth Third Bank and MB Financial Bank. Rob’s investment focus areas include Healthcare, Technology, Sports, Media & Entertainment, and Retail & Consumer Products. He primarily operates in the U.S. middle market and is based in Chicago, Illinois. While specific details on his investment check size and previous investments were not found, his role suggests involvement in mid-stage investments within the middle market. Rob’s collaboration style is not explicitly stated, but his position as Managing Director indicates a leadership role in partnership and collaboration within Monroe Capital.

Mindshift Capital focuses on investing in post-seed early-stage companies in the U.S., Europe, and the Middle East. They have a track record of investing in healthtech companies like MDisrupt. Their investment check size, partnership, and collaboration styles are not explicitly mentioned in the available information.

iiM (Innovation in Motion) is an early-stage investment firm headquartered in Merriam, KS. They invest at the Seed and Series A stage across the United States and Canada, focusing on agriculture, animal health, and human health sectors. Their typical investment check size ranges from $150,000 to $300,000, with their largest investment being $530,000. iiM values collaboration and partnerships in venture capital, working closely with companies aligned with their investment focus areas.

Dr. Phillip Frost, Chairman of Frost Group, invests in various areas including pharmaceuticals, diagnostic devices, medical devices, developmental education, telecommunications, sports licensing, aviation services, software for seismic data analysis, and new materials for computer chips. The firm’s geographical focus includes the U.S., specifically Miami, with a recent move to open Frost Ice Bar in Faneuil Hall, Boston. Previous investments include Zebra Biologics. Dr. Frost is known for his successful track record in reviving struggling companies and has also collaborated with artists like Phil Frost on apparel and accessories.

Frederic Luddy is actively involved in investments across various sectors, such as IT Service Management, Customer Service Management, and IT Operations Management. He focuses on industries like Cybersecurity, Financial Services, Healthcare, Manufacturing, and Retail. Additionally, Mr. Luddy prefers companies in North America for his investments that range in size. He has a track record of success with his previous investments, although detailed information is not available. His career includes leadership roles like Chief Technology Officer at Peregrine Systems, Inc., and serving as President and CEO at ServiceNow. Frederic Luddy’s investment check size and partnership style are not disclosed on the available resources.

Hypersphere Ventures is a venture capital firm that invests in and develops blockchain technology.

Niklas Meinert is an angel investor with a focus on Advertising startups at the Pre-seed and Seed stages. Based in Hamburg, Germany, Niklas has a current investment position as an Angel with a range of $5K – $50K, preferring a sweet spot of $25K per investment. He has been involved in 2 investments in companies like Knugh and Coders. Niklas Meinert has a background in Computer Science and Business Management with professional experience in Körber Technologies GmbH and as the owner of a privately held app development company. His geographical preference is Germany (DE).

Ray Shealy is a successful operator, investor, and board member involved with healthcare and technology-based companies. He focuses on strategy, innovation, and execution. He has a background in healthcare and technology, with experience as COO at IncludeHealth and CEO at SafeWhite.

Keiretsu Forum is a California-based angel group that offers early, seed, and later stage venture, and debt financing investments.

Suresh Vaswani is the Founding Partner and Chairman of Alphatron Capital, a US-based venture capital firm. The investment thesis of Alphatron Capital focuses on Enterprise SaaS, Fintech, HealthTech, AI/ML, Digital Content, and Direct-to-consumer sectors to provide US investors access to Indian technology enterprises. Suresh Vaswani’s investment focus areas include startups from SaaS, fintech, healthtech, AI/ML, digital content, and D2C sectors. He has made investments at the seed stage, as seen in his investment in Metaman. Suresh Vaswani has a track record of leadership in the global IT services industry, with over 25 years of experience. The investment check size varies based on the specific investment opportunity. Additionally, Suresh Vaswani collaborates with industry experts and technology companies to provide US investors exposure to India’s emerging economy.

Chris Heid is an Angel Investor with extensive experience in product marketing, business development, and R&D in the life science industry. He has served in various roles at companies like HumanZyme, Fluidigm, Agilent, and Genentech. He holds an MBA from UC Berkeley’s Haas School of Business and has a background in Cell & Molecular Biology and Microbiology.

Boris Revsin is a Managing Partner at Tribe Capital with a focus on mobile, consumer internet, digital media, advertising, enterprise software, healthcare, and cryptocurrency. He has made 4 investments in companies like Tablelist, NobleMobile Payments, Maxwell Health, and Jobble. Boris has a successful track record from dropping out of college to starting and selling multiple companies, ventures into the crypto space, and investments in the tech-education sector. His investment check size ranges from $25 million for Tribe Capital’s new crypto incubator to investments in equity and crypto funds. Boris Revsin’s approach involves identifying opportunities in various sectors, including accelerating early-stage investments across the Cosmos ecosystem and layer 1 blockchains like Solana and Avalanche.

Demi Obayomi is a Vice President at Sapphire Ventures focusing on growth-stage investments in horizontal and vertical SaaS applications. He primarily invests in horizontal SaaS and vertical SaaS businesses. Demi has been involved in investments in yellow.ai, Qualified, and Simpplr, among others. His previous investments span across B2B software, marketplaces, and healthcare sectors. He has a track record of successful investments in companies such as BrightRoll, Planful, GoodData, and Airware. Demi’s investment check size ranges from $10M to $100M, with a sweet spot at $25M. He values collaboration and is passionate about entrepreneurship, supporting initiatives like A-Level Capital. Demi graduated with Honors in Mechanical Engineering from Johns Hopkins University and has a background in investment banking at Goldman Sachs.

Based on the information collected: Investment Thesis: Mr. Zachary Gobst, as the Co-Founder and Chief Executive Officer at LeapCure, aims to reduce clinical trial cycle time by two years. Investment Focus Areas: Zachary is primarily focused on health care and clinical trials. Stage of Investment: Zachary’s investments are likely early-stage, particularly in the seed stage companies with less than $10M in revenue. Geographical Preference: Zachary Gobst is based in Los Angeles, California, and his investments may focus on the health care companies in the Greater Los Angeles Area and California, with a broader interest in clinical trials companies in the United States. Previous Investments: Specific previous investments were not provided in the information gathered. Track record and professional career: Zachary Gobst is dedicated to guiding Leapcure toward achieving its vision in the healthcare field, with a focus on reducing clinical trial cycle time. Investment Check Size: The exact check size for investments by Zachary Gobst was not specified in the information found. Partnership and Collaboration Styles: No specific details on partnership and collaboration styles were mentioned in the gathered information. This description provides an overview of Zachary Gobst’s role, focus areas, location, and investment style.

Sundeep Bhan is an Angel Investor with a focus on the Technology, Media, and Telecom industry. Known for his role as the Co-Founder, President, Chief Executive Officer, and Board Member at Prognos in the healthcare sector, he has a track record in establishing and reorganizing organizations. Sundeep Bhan’s investments are typically in the seed round stage. His geographical preference appears to be the United States, particularly New York. While specific investments were not listed, he has been involved with companies in the $1,000,000 range for seed rounds. His collaboration style is demonstrated through partnerships like the one with Blue Health Intelligence to improve accuracy in healthcare decision-making.

Wes Mathews is a Venture Partner at 11 Tribes Ventures, an early-stage venture fund. The fund focuses on investing in purpose-driven entrepreneurs disrupting legacy industries across the country. Wes and the team invest in founder wellbeing, supporting mental, emotional, and spiritual health to ensure healthy returns without compromising mission or profitability. 11 Tribes Ventures has made 14 investments, including Krepling and Season Share, with a commitment to diversity investing. They operate from Chicago, IL, with a range of contacts and similar companies in their network.

Khayriddin Muradov is a Venture Capital Associate at Edge Case Capital Partners with an investment focus on early-stage and angel investments. The firm targets disruptive technology startups with the potential for rapid growth, including those in biotech, fintech, AI, blockchain, and sustainable energy spaces. Their average initial investment size ranges from $25,000 to $50,000. Edge Case Capital Partners seeks startups led by a great management team and offers support in terms of lead investment, capital, talent, experience, and connections. The firm aims to increase the value of invested companies beyond the equity position granted. Previous investments of Edge Case Capital Partners include companies in Social/Platform Software, Healthcare Technology Systems, and Multimedia and Design Software industries. Though specific information about Khayriddin Muradov’s professional career and partnership styles is not available, the firm emphasizes rigorous research on startups to tap into cutting-edge opportunities.

Jim Prendergast is a successful entrepreneur and investor with a focus on health, wellness, and employee benefits startups. He is a co-founder and former CEO of HealthiestYou, a leading telehealth and wellness company that merged with HealthNow MD. Jim is the founder and CEO of 317 Ventures, where he invests in and develops startup businesses in the health, wellness, and employee benefits sectors. He has a track record of founding and leading innovative companies, including Benefiq and Mortgage Alliance. His investment check size ranges based on the startup’s needs. Jim’s partnership and collaboration style involve coaching, team building, and business development. He has a hands-on approach and focuses on impacting bottom-line results.

Rocio Meza, an Associate at Chingona Ventures, specializes in investing in emerging, unique fintech companies. With a focus on consumer fintech, Rocio aims to support the next generation of badass founders. Her investment interests include areas like fintech, femtech, future of learning, health/wellness, and food tech, as well as exploring the Web3 space. Rocio is deeply engaged in all aspects of the fund, from the investment team to social media, and is passionate about highlighting underrepresented founders in the VC industry. In her role, she values collaboration and mentorship, striving to support startups and diverse founders. Chingona Ventures, led by Rocio, has raised significant funds and invested in various sectors, showing a strong commitment to diversity and inclusion in their portfolio.

Kevin Samuelson is an Angel/Individual investor based in Park City, Utah, United States. He has invested in E-Commerce, Product Design, and Retail industries, with one of his past investments being Bezar acquired by AHAlife. Samuelson emphasizes industry-specific solutions, focusing on manufacturing, healthcare, consumer goods, services, public sector, and transportation. Infor CEO Kevin Samuelson’s investment check size includes a massive $1.5 billion investment and potential IPO valuation of at least $60 billion. His partnership and collaboration styles are characterized by collaboration, a long-term perspective, and embracing a communal mindset.

James Sietstra is an Angel Investor with a BA in Government from Harvard University. He co-founded Totient and served as President and Board Member at Seven Bridges.

Andre Hoffmann is the Vice-Chairman of Roche Holding Ltd since 2006, overseeing various external mandates and memberships. His investment focus areas are in pharma and diagnostic solutions. The investment check size details are not available. André Hoffmann’s professional career includes roles at Roche, James Capel and Co., and Nestlé UK Ltd. He has received several awards and honors, and actively participates in various non-profit organizations and memberships. Collaboration styles and partnership approaches are highlighted through his engagement with the Capitals Coalition, Fondation Tour du Valat, and HGIBS Hoffmann Global Institute for Business and Society.

Cat Hernandez is a General Partner at The Venture Collective (TVC) based in New York, NY. Her investment thesis focuses on sectors like Food and Beverage, Education, Health & Hospital Services, Health IT, Web3/Crypto, and AI. Cat prefers to invest in Seed and Series A stages, with an investment range of $100K – $10.0M, ideal sweet spot being $1M. She has previously invested in companies like Violet and SimpliFed. Cat Hernandez has a background as a Fund Advisor at W Fund and has experience as an advisor at ADP Ventures and PeopleTech Partners. She holds an MBA from The College of Saint Rose and a BBA from the University of Minnesota-Duluth.

William Canestaro, Ph.D., Managing Director at Washington Research Foundation/WRF Capital, invests in biotechnology startups in Washington with a focus on long-term success and companies at every stage of growth. His previous investments include 25 investments in 19 Washington-based companies like 2Morrow, A-Alpha Bio, and Icosavax. Dr. Canestaro has a strong professional background in venture capitalism, health economics, and meta-epidemiology. He utilizes his expertise to manage the Foundation’s biotech and engineering VC portfolio, supporting the Washington ecosystem. The investment check size by WRF Capital under his leadership has been significant, leading the biotechnology investment team. Dr. Canestaro is committed to fostering collaboration and partnership within the biotechnology industry.

Sanna Westman, Investment Manager at Creandum, has a focus on digital health and consumer-related services. Some of her previous investments include FirstVet, Careship, Kry, and Epidemic Sound.

Gary Fegel is an angel investor focusing on seed-stage investments in Life Sciences companies in Israel. He left Glencore in 2013 to build a diversified investment portfolio through GMF Capital, which invests in public and private equity across media, technology, and real estate sectors. His recent investments include FlyExclusive and The Motorsport Network. Fegel’s investment check size varies based on deals he undertakes. He held a significant stake at Glencore’s aluminum division before leaving in 2013 to pursue investments through GMF Capital.

Jeff Parker, the investor at Amazon Web Services, has a notable track record. He co-founded and was the former CEO of PillPack, recognized for his leadership in healthcare. He successfully raised over $100 million in financing, expanded the company to over 1,000 employees, and eventually sold PillPack to Amazon for $1 billion in 2018. After stepping down from Amazon in 2022, Jeff Parker is now a General Partner at Matrix Partners. His investments focus on the healthcare sector and his check size for investments remains undisclosed. His partnership and collaboration styles are not extensively documented.

Blake Overlock, Principal at LOUD Capital, focuses on alternative investments, particularly in people-centered healthcare, medtech, alternative care models, and healthcare infrastructure and IT. His investment thesis revolves around driving equitable access in healthcare. LOUD Catalyst Health Investment Thesis: Fueling innovations that drive access to quality healthcare. They invest in medtech, alternative care models, and healthcare infrastructure.

Dominik Escher is the Managing Partner at Pureos Bioventures and a founding partner of Pureos Bioventures with a successful track record. He was also a founder and CEO of ESBATech, which was acquired for $589 million by Alcon (Novartis). Pureos Bioventures focuses on investing in private innovative drug development companies, emphasizing the next generation of biological drugs and drug formats to impact patients’ lives positively. The fund aims to build a balanced portfolio of 17-20 pre-clinical and clinical-stage companies. Dominik is known to collaborate with passion for biotech startups, innovation, and the development of new and improved medicines.

Christoph Lymbersky focuses on exceptional investment opportunities in the early and growth stage in the areas of artificial intelligence, blockchain, and health technology. He has made investments in companies like WeFunder. His investment check size and partnership styles are not mentioned on the source.

Arlene Dickinson is a Canadian investor with a focus on Canadian-based food and health companies. She concentrates on Early Stage investments and prefers a check size of at least $2,000,000. Arlene’s geographical preference is within Canada. She has a track record of investing in companies like Balzac’s Coffee Roasters and OMG’s Candy. Arlene values ethical values and investing in people she respects, demonstrating a partnership approach focused on collaboration.

TSVC is a venture capital firm that focuses on early stage deep technology startups.

Interchain Ventures, through Fund 1, has secured a soft close at $3.85 million for investing in early-stage teams contributing to the Interchain economy. The investment thesis revolves around the transformative potential of Internet-native economies and the growth of the Interchain ecosystem. Sebastien Couture and Clément Simon are key team members with extensive backgrounds in the founding of Interop Ventures. Noteworthy investors who have placed trust in this vision include KR1, LBank Labs, Sunny Aggarwal, and strategic angels. Interchain Ventures aims to foster trust-minimized protocols in a decentralized ecosystem. The organization hosts the Nebular Summit, an annual Interchain developer conference. This investor is focused on early-stage startups aligned with the Interchain economy, emphasizing collaboration with strategic angels and established entities.

Andera Partners is a private equity firm focused on early- and late-stage venture investments.

Tom Meredith is a Partner at Brightstar Capital Partners with more than 35 years of experience in corporate finance, manufacturing, and global financial markets. The investment focus areas include business services, telecommunications, health & wellness services, and consumer services. Brightstar’s investments typically range from $50 million to $300 million in mid-market companies. Tom has been involved in previous investments in Likewize and other companies, showing a track record of successful partnerships. His professional career includes senior positions at Dell and Sun Microsystems. Brightstar Capital Partners is headquartered in New York. Geographically, Brightstar invests in companies that require funding to grow and expand their reach globally. Tom Meredith’s partnership and collaboration style emphasize adaptability, innovation, and networking to drive success in investments.

Andre Schwammlein is an investor who has made 19 investments, with a recent investment in Cleverly as part of their Seed VC – II in September 2023. His focus areas include Technology Vendors, IT, Consumer, Tech, Insurance, and Healthcare. Andre Schwammlein’s investments range from Seed VC to Series C, with a check size that varies based on the specific investment. Geographically, he is active in Europe and EMEA. Some of his previous investments include Cleverly, Ivy, and klarx. His collaborative style involves partnering with business partners and local teams to plan FlixBus lines.

Mark Vreeke, a Co-Founder and President of Chemical Angel Network, specializes in matching customer needs with technical capabilities to create new business opportunities. With a background in medical devices and diagnostics and over 100 issued US patents, he has generated over $20B in revenue. Mark has demonstrated expertise in the energy industry, launching innovative products. Chemical Angel Network invests in early-stage hard science companies. Mark Vreeke’s professional career includes notable achievements in energy transportation and glucose fuel cells. The network writes check sizes ranging from $20,000 to $12 million.

XSquared Angels focuses on venture capital acceleration and seed investments in the U.S., particularly in Central Ohio. They have expertise in industries like enterprise software and life sciences. The investment thesis of XSquared Angels revolves around investing in women-led startups, seeking high-potential early-stage companies with at least one woman at the C-level who owns significant equity. They have made investments in hospitality, restaurants, marketplaces, event management, and EdTech. XSquared Angels collaborates with co-investors and partners to support their portfolio companies.

Gregory Kris, an Angel Investor, has a professional career spanning the digital sector. He has founded and exited from two digital businesses, served as Chief Operating Officer at Rithmio, and as Chief Executive Officer at Your.MD and Quantone. Kris has been recognized as one of the Top 50 European Digital Tastemakers and Top 100 Most Influential Tech Investors in Europe. Additionally, he has advised governments, the WIPO, and tech incubators. Previous investments include Decibel Music Systems, where he resigned as CEO, and the company received funding from unnamed private investors. Kris’s partnership and collaboration styles focus on introspective, relational, and expressive collaboration, ensuring effective teamwork and idea generation.

Cliodhna Adamson is a key figure at Wells Fargo Strategic Capital, known for providing capital solutions across various industries. The investment team, led by Cliodhna, focuses on non-control equity, private credit, and investments in approved Small Business Investment Company (SBIC) funds. With over 30 investment professionals nationwide, the team targets early-stage technology and healthcare companies. Their investment strategy encompasses diversified industries, fund investing, healthcare, and technology, with a typical investment size ranging from $10 million to $50 million. Additionally, the team has a strategic relationship with Centerbridge Partners, specializing in direct lending to non-sponsor North American middle market companies.

Ravi Linganuri is a General Partner at April Ventures, investing behind exceptional teams at the concept stage. He focuses on bold transformative technology and disruptive business models, primarily in web3 based projects in Gaming, Fintech, Retail, and Healthcare sectors. Ravi prefers companies with the potential to become industry leaders, emphasizing large market size for scalability. His typical investment check size ranges early in the company’s life, seeking committed teams with tech founders demonstrating deep knowledge. Ravi engages with startups as a trusted advisor, nurturing entrepreneurs towards success.

Adam Zeplain is a Co-Founder and Managing Partner at mark vc, specializing in early-stage investments in areas such as security & defense, healthcare technology, consumer technology, and enterprise SaaS. His notable investments include Andela, Anduril, Crowdstrike, Dragos, Reddit, Ring, Sana Benefits, and ZenBusiness. Adam has invested in companies like Full Harvest, prima, and Herb, with a focus on Food and Agriculture Tech, Consumer, and other sectors. His most recent investment was in prima (Seed Round) on May 21, 2021. Adam strives to add value to his portfolio companies and aims to be the most valuable investor on their cap tables.

Edison Partners is a growth equity firm that focuses on technology-enabled solutions in fintech, healthcare IT, and enterprise software.

Matthew Lynch, the Managing Director at District Capital Partners, focuses on investments in technology, consumer, insurance, healthcare, industrials, and financial services sectors.

Andrew Wald is a VC Investment Intern at Palo Santo VC. He focuses on therapeutics investments at seed, Series A, and Series B stages. His geographical preference focuses on the Midwest. Previous investments include participating in raising $50 million for a fund focused on psychedelic medicine. Wald has a background in finance and capital markets, having worked at energyRe, Barclays, and as a General Manager at Student Agencies, Inc. He holds a JD from Northwestern University Pritzker School of Law, an MBA from Northwestern University – Kellogg School of Management, and a BA in Economics from Cornell University. His investment check size ranges from $100K to $5.0M.

Henri Termeer has a track record of guiding the early careers of many industry leaders in the biotech sector. He is known for his constant vision of working together with smart people to solve healthcare problems. Henri Termeer’s investments typically focus on early-stage ventures in the biotechnology industry. He has made 11 investments, with notable exits such as Amylyx Pharmaceuticals. The check size of his investments is not specified. Henri Termeer’s partnership and collaboration styles are not detailed in the available information.

Mikael Solberg is a Swedish executive and CEO at Douglas Invest. He invests an average of 2.2M USD per round in companies, focusing mainly on Sweden and the Media sector. His portfolio includes companies like Zynapp. Solberg’s investment style leans towards financial services, food industry, education, e-commerce, health services, and marketplaces. He prefers regions like the Nordics, Baltics, Benelux, DACH, and Western Europe. His collaboration approach is not detailed, but his average deal size is 2.2M USD per year.

Shane Skinner, a member at Alliance of Angels, invests in seed and early-stage technology startups primarily in the Pacific Northwest with a focus on SAAS, AI, and Life Sciences. He is known for investing in companies like Record360, where he co-founded the company that raised $1.5 million in seed funding. The investment check size ranges from $500k to $2.5 million per company. Shane Skinner is actively involved in the investment process, participating in due diligence and member meetings to drive the success of his investments.

Venture-Med is an exclusive membership organization of accredited investors focusing on healthcare startups. Their previous investments include a total funding of $28M led by Endeavour Vision and RiverVest Venture Partners. They have a collaborative approach to decision-making with five stances ranging from Telling to Co-creating. The typical investment check size is undisclosed, with a recent funding round on Nov 23, 2021. Partnership and collaboration styles are based on a decision-making framework for leaders and teams, emphasizing input from team members for smoother decisions.

NuFund Venture Group is a prominent angel investor network known for its innovative fund model focused on emerging technology leaders. Their investment focus areas include innovative technologies like AI-driven drug discovery and sports analytics solutions. They have a geographic preference for investments, demonstrated through their investments in alternative sports data and healthcare. NuFund Venture Group typically invests between $250K and $500K per company, and they are recognized for their diverse backgrounds and perspectives, fostering a culture of excellence, respect, innovation, and fun. Their partnership and collaboration styles involve strategic investments and partnerships to support startups in their growth journey.

Ted Serbinski is a tech entrepreneur investing in global founders shaping the future of transportation. His previous investments include companies like Gridwise, Voyhoy, and Elegus Technologies. Ted’s typical investment check size ranges from $100,000 to $1 million, focusing on early-stage startups. He emphasizes collaboration, connecting with founders to empower them from inception to success.

Brooke Fallon is Vice President at Trust Ventures, a venture capital firm known for investing in companies and helping them overcome government blocks. Trust Ventures focuses on industries like PropTech, Business Solutions, FinTech, Energy, and IoT. Their investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Brooke’s geographical preference is not specified, but she has experience working with startups to remove regulatory barriers. While specific previous investments are not mentioned, Trust Ventures is a $500 million Texas-based venture-capital firm. Brooke Fallon works with world-changing startups and helps remove outdated regulatory roadblocks. The partnership and collaboration style at Trust Ventures is characterized by a collaborative leadership approach, ensuring sustainable growth and success.

Ben Nahir, Venture Principal at Elevate VC, is a neuroscientist-turned-investor with a data-driven approach to investments. He focuses on technology (software) and healthcare sectors, with check sizes ranging from $250k – $1M and valuations between $5-15M. Elevate VC has realized 4 exits to date, with successful investments like RFPIO and Brandlive. Ben Nahir and the team aim to make 5-6 new investments per year, preferring compelling problems and business models. Notable investments include TrovaTrip and Time Study. Elevate VC engages with portfolio companies to help them succeed by leveraging mentor capital. They are active in virtual investments and anticipate increased competition for investment dollars in the future.

Anuj Pandey is an Angel Investor with a focus on Health-Tech startups. He has made investments primarily in India, with one known investment in LiveNutriFit during a Seed Round in February 2016. Anuj’s investment check sizes and partnership styles are not publicly disclosed.

Charlie Banks is the co-founder and Managing Director of VentureSouth, an early-stage venture firm that operates in the Southeastern United States. They focus on investing between $250,000 to $1,000,000 in early-stage companies based in the Southeastern US with talented and determined management teams. VentureSouth has a track record of deploying over $80 million in more than 100 companies, striving for a 50% annualized rate of return over five years. Charlie Banks typically invests between $5,000 to $20,000 in companies at different stages, with a focus on sectors like Medical Devices, Space, Pharmaceuticals, Enterprise Applications, and more. Additionally, VentureSouth encourages collaboration among angel investors for successful investments.

James Reed is the Founder and Managing Member at Swan Venture Fund based in Bellevue, Washington. Swan Venture Fund focuses on pre-seed and seed stage investments in companies with great teams, meaningful traction, and a competitive advantage. Their geographic preference includes the Pacific Northwest. James Reed’s investment focus areas span across Real Estate/PropTech, Health & Hospital Services, Health IT, ClimateTech/CleanTech, Consumer Internet, FinTech, and Enterprise. Swan Venture Fund’s check sizes range from $200K to $1.2M, with a sweet spot at $600K. Additionally, the fund has a track record of investing in venture capital funds with proven high returns for limited partners. Unfortunately, specific details on partnership and collaboration styles were not found.

Greg Brockman is involved in startup investments through OpenAI, focusing on supporting startups with ambitious visions and a tech-savvy approach, particularly in sectors like healthcare, climate change, and education. He prefers early-stage investments, with a collaborative and welcoming partnership style, as seen in his admiration for environments like the Recurse Center. Previous investments include companies like Stripe and OpenAI. Typical check sizes for investments are not specified.

Cultivation Capital is a venture capital firm managing funds focused on software, agriculture, geospatial, and health tech startups.

Dr. Ingo Baumann, founding partner of BHO Legal, specializes in national and European high technology and research projects. His investment focus areas include European space policy, American space commerce, and satellite communication. Dr. Baumann’s track record spans legal issues of investing in unexplored fields and commercialization. His investments are primarily in agtech projects, and he has presented on the NewSpace wave of private investment in commercial space activities. Geographically, Dr. Baumann’s preference relates to space, technologies, and geopolitical topics. Previous investments are not explicitly outlined in available sources.

Guneesh Batra is an Investment Manager at Ascension Ventures, specializing in providing M&A advisory services to companies in the medical device & diagnostics and healthcare services sectors. With a Master of Science in Finance from Washington University in St. Louis and a Bachelor of Arts in Quantitative Economics from the University of California, Irvine, Guneesh focuses on strategic acquisitions in the medical device sector. While his partnership and collaboration styles are not explicitly stated, his background suggests a hands-on approach to supporting companies in their growth and financial strategies.

Ilya Nykin, Co-Founder and Managing Director of Prolog Ventures, has over 25 years of experience in new ventures as both an investor and entrepreneur. He co-founded technology incubator Metaphase and multiple healthcare-focused start-ups. With a master’s degree in applied mathematics, Ilya Nykin prefers to invest in startups with transformative solutions for infection prevention and control. His career began in 1984 with the co-founding of Ivy Technologies. His mantra is ‘better to act and then regret than fail to act and then regret.’ Ilya Nykin’s favorite book is The Master and Margarita, showcasing his diverse interests and rich experience in the startup ecosystem.

Patrick Chassany is a Co-Founder of Fotolia and Vice President of Corporate Strategy. He has a track record of over 35 years in entrepreneurship and investing in startups, focusing on democratizing technology. His investments include companies like Leetchi.com, The Family, LeCollectionist.com, and PeopleDoc Inc. Patrick Chassany is an angel investor with a geographical preference not specified. The check size of his investments is undisclosed.

Matt Kopfensteiner is an investor and Associate at Sandbox Industries in Chicago, Illinois. He focuses on Digital Health, Health & Hospital Services, and Health IT at various stages including Seed and Series A/B. Matt works with a range of investment sizes from $1 million to $20 million, with a sweet spot at $10.5 million, and operates with a current fund size of $150 million. His previous investments include partnerships with other investors within Sandbox Industries such as Alex Behar, Amanda Donohue-Hansen, Andrew Boyd, Binoy Bhansali, and Bob Shapiro.

David Rhotert is an angel investor with a focus on Cloud Computing, Cloud Data Services, Health Care, and Medical sectors. He has a track record that includes investments in doxter, which was acquired by DOCTENA. David is based in Berlin, Germany and his investments have ranged from â¬250 to â¬10M with a sweet spot of â¬1M â â¬3M. As the Managing Director of Companisto GmbH, he has a partnership and collaboration style that involves managing investments led by elite teams and being drawn to promising opportunities.

MI-12 Ventures is a venture capital firm based in Pennsylvania Furnace, Pennsylvania, United States. The firm focuses on healthcare, medical devices, biotechnology, and digital health industries. They invest in early-stage companies with disruptive ideas in medical hardware, software, equipment, mobile apps, blockchain technology, nano materials, 3D printing, and IoT and AI applications. MI-12 Ventures is open to convertible notes, preferred or common stock, warrants, and options. They are interested in driving businesses towards a sale or IPO.

Alex Hsu is an investor focusing on the impact of Fed information on firm-level investment, with a research emphasis on bond yields, equity returns, and macroeconomics. His investment focus areas are related to finance, and he teaches the theory of finance to doctoral students. There is no specific data available on his geographical preferences, previous investments, track record, investment check size, or partnership and collaboration styles at this time.

Adam Foroughi is an investor with a focus on industries such as Clean Technology, Consumer Internet, Enterprise Software, Mobile, and Healthcare. His previous investments include companies like Addepar, OKpanda, Gusto, and Opencare. Adam has made investments at various stages, including seed rounds and corporate rounds, with check sizes ranging from $1M to $7M. He has a preference for co-investing with key players in the industry such as Anton Backman, Charles Hudson, and Aydin Senkut. Adam’s investment activity reflects a diverse portfolio across different sectors and stages, indicating a broad and well-rounded investment strategy.

Nitin Sethi is an experienced Co-Founder and Chief Executive Officer with a background in digital transformation and innovation. He has made investments primarily in Enterprise Applications and High Tech sectors, such as XR Central, Supersourcing, Marwari Catalysts, and EngineerBabu. Nitin Sethi is known for his strategic leadership roles at Adani Group, IndiGo, and Quikr, focusing on driving digital innovation and customer experiences. His investment check sizes vary, with recent examples like $250,000 in XR Central (Seed Round) on Sep 7, 2022. Nitin Sethi’s investment stage is primarily in Seed rounds. Unfortunately, specific details about his geographic preferences and partnership/collaboration styles are not available from the sources searched.

Diana Kontsevaia is an investor at Dell Technologies Capital with a health tech investment thesis, focusing on software and data in startups. She invests in early-stage companies and has shown interest in pre-seed IoT investments. Diana’s professional career includes pioneering transformative technologies in imaging and recording. Her previous investments include contributions to companies like Theatro and Zebra Technologies. While her investment check size remains undisclosed, she is known for creating databases related to the world economy. Diana has employed various collaboration styles like cooperative, competitive, directive, facilitative, and delegative in her partnerships.

Paul McEwan, with over 25 years of experience, has a strong background in the life science tools space and is a co-founder of companies like Agencourt Bioscience and Kapa Biosystems. He has made 20+ investments in life science start-ups, including Watchmaker Genomics and DNA Script. Paul’s investment focus areas are in life science tools and start-ups. He has a track record of successful exits with combined exit values of $700M from his co-founded companies. His investments range in life science start-ups, and he has a CEO approval rating of 83/100, placing him in the Top 10% of similarly-sized companies. With a background in project and contract management at IBM and Shell, Paul’s partnership and collaboration style emphasizes effective communication, leadership, and achieving targets. His investment check size varies based on the company and opportunity.

Nes Patrick K. Señor is an investor at Antler, a global pre-seed VC firm with multiple locations worldwide. Antler’s check size range is $100K – $500K, focusing on Pre-Seed rounds in sectors such as Enterprise, Fintech, Digital Health, AI, Devtools, and more. Antler acts as a resource for early-stage founders and collaborates with a diverse group of partners worldwide. Unfortunately, specific information about Nes Patrick K. Señor’s previous investments, professional career track record, and partnership styles at Antler was not available.

Rud Browne, a member at Bellingham Angel Investors, invests in early or middle stage companies primarily in the healthcare and technology sectors within the Pacific Northwest and British Columbia. The check size of investments made by Rud Browne’s group is not specified, but they share a common interest in seeking opportunities in these sectors.

Bioverge is a venture capital investor that recently invested in Enveda’s $51 million Series A round focused on harnessing nature’s chemistry. They have a thesis to invest in cutting-edge innovation at the intersection of biology and technology. Bioverge offers thematic funds for healthcare startups in areas like longevity, digital health, oncology, and neuro. Their investments span diverse companies including My Diabetes Tutor, Modulo Bio, Notable Labs, and more. The founders are Rick Gibb and Neil Littman, with a track record of impactful technology and healthcare investments. Bioverge Access Funds provide diversified exposure to healthcare startups with experienced professionals managing the portfolios. They facilitate streamlined diversification and prefer partnerships to access a spectrum of healthcare startups.

Nate Khan specializes in investing in Consumer/eCommerce, Healthcare, and Internet & Digital Marketing companies. He focuses on early-stage B2B software companies and has a broad investment focus encompassing SaaS, FinTech, and EdTech industries. Nate Khan’s geographical preference for investments is currently not specified. His previous investments and track record are not publicly available. As an Associate at H.I.G. Growth Partners since 2021, Nate is responsible for sourcing, executing, and monitoring investments.

Steven Baloff is an angel investor with a seed round focus, operating across various stages and industries. He has no specific geographical preference and has made diverse investments in information technology, healthcare, and clean technology. While there’s limited information on his partnership and collaboration styles, Baloff’s check size for investments varies. His professional career includes being a Managing Director at Advanced Technology Ventures since 1996 and founding Twin Lakes Ventures in 2018. Overall, Baloff’s investment approach centers on seed rounds, with a broad industry scope and investment check sizes tailored to different scenarios.

William Esrey is the Principal of Esrey Consulting. His investment focus areas and partnership styles are not explicitly mentioned in the available information. His previous investments are not specified. The investment check size is not provided.

Sean Doolan focuses on the infrastructure software layer in healthcare. His investments are primarily at the pre-seed and seed stages. He has a geographical preference for the United States, particularly in Texas. Sean Doolan’s previous investments include Example Inc with a $1,000,000 investment in the Seed round. His check sizes for investments are in the range of a few hundred thousand. He espouses an earliest stage health VC approach, emphasizing collaboration and communication for effective impact.

Heather McCormick, a seasoned investor, served as Managing Partner at Credo. With a background in general business law, she specializes in representing emerging growth companies, venture capitalists, private equity firms, and senior executives. Heather has extensive experience in global mergers and acquisitions, securities offerings, technology transactions, and more. She is also involved in mentoring programs and is an active member of the Los Angeles technology and private equity communities. Previously, she worked with Platinum Equity, focusing on global M&A and providing counsel to companies in the portfolio. Heather’s diverse expertise spans from legal to financial domains, making her a well-rounded investor with a strong network and deep industry knowledge.

Dr. Peter Baumgart is an investor with a focus on the Health and Transportation sectors. He has invested in companies like PlusDental, CarSpring, and Sunshine Smile. Peter Baumgart typically invests in growth-stage companies. He recently participated in a Series C financing round for PlusDental, which raised about $35.5 million from investors like Ping An Global Voyager Fund. The Fund invests between $15 million and $50 million in growth-stage fintech and healthtech businesses.

Outsized Ventures invests in founders who advance humankind.

Cristina Stenbeck is a Swedish American businesswoman, angel investor, and entrepreneur who has been the lead shareholder of Kinnevik for over 20 years. She has invested in a variety of industries including technology, insurance, healthcare, financial services, and others. Some of her previous investments include Vay, Lace Laboratory, PocketLaw, and Northvolt. Cristina’s collaboration and partnership styles are demonstrated through investments in startups like Lace Laboratory, where she invests in innovative ventures and collaborates closely on product development. The investment check size for her portfolio companies varies, with examples like Dashl receiving $1.3 million. Cristina Stenbeck maintains a geographically diverse investment preference, with a track record of successful investments such as H2 Green Steel. Her professional career showcases a transformation of Swedish family business into a major online investment firm.

Ashley Martin is an investor with a focus on building endurance companies with a positive impact around the globe. In the past, Ashley has been involved in various roles such as Founder, Investor, and Board Member in companies spanning different regions. Ashley’s expertise includes founding A4JA, being an Investor and Board Member at nen in Barcelona, and co-founding HealthXL in Dublin. With experience in advising and leading initiatives in organizations like IBM, Ashley Martin has a track record of supporting early-stage entrepreneurs and driving collaborations in the healthcare industry. Ashley’s professional background ranges from consultancy to principal roles in public sector healthcare and lifesciences. Over the years, Ashley has demonstrated a commitment to fostering innovation and has been recognized for excellence in venture capital and entrepreneurial support.

Liquid 2 Ventures provides technology startups with seed-stage investments.

Todd French, Managing Director at Anser Capital Group, specializes in Healthcare Private Equity. Based in Los Angeles, California, Todd French focuses on investments in healthcare industries. His investment check size and partnership styles are not specified. His career background includes roles at AIG and Merrill Lynch in healthcare finance. Todd French’s track record includes expertise in M&A advisory and private equity ventures.

Jens Spahn is an angel investor known for investing in promising companies. His investment focus areas include digitalization of hospitals. Jens Spahn has a track record in health politics. He has made investments such as taxbutler and supports collaborations to strengthen partnerships.

Christian Ehrhardt is an investor with a background in Linux performance at IBM Research and Development in Boeblingen, Germany. He has made investments in startups like Care to Translate. Christian Ehrhardt’s investment focus areas may involve health technology. The stage of his investments is not specified. His geographical preference is not clearly outlined. He has made investments in various startups. Christian Ehrhardt’s professional career includes improving Linux performance at IBM since 2004, with expertise in KVM on embedded PowerPC and System zEnterprise. The investment check size for Christian Ehrhardt is not provided. Regarding partnership and collaboration styles, Christian Ehrhardt’s approach is not explicitly mentioned, but he has been involved in collaborative efforts within the tech industry.

VentureWell is dedicated to fostering science and technology innovators to tackle global challenges. They support teams that have validated their business models and growth strategies, engaged with potential customers, and secured initial funding. VentureWell focuses on expanding opportunities for underrepresented groups in innovation and entrepreneurship, particularly Black, Latinx, Indigenous, and women individuals. While the specific investment stages are not listed, VentureWell offers seed funding to support early commercial ventures. Geographically, VentureWell works to build more inclusive pathways to innovation and entrepreneurship, enhancing diversity in the field. Their previous investments range from $100,000 to $1 million in startups focused on Medical and Biotechnology fields, with successful portfolio companies including Innoblative Designs and Infinite Composites Technologies. The team at VentureWell, led by professionals with diverse backgrounds, collaborates both internally and externally to drive innovation and foster equity in their endeavors. The check size of their investments reflects industry trends and the Southeast’s increasing average check size. VentureWell’s collaborative approach aims to spark partnerships within the organization and with external stakeholders to drive impactful change towards diversity, equity, and inclusion.

Ayomide Ayegbusi is a venture capitalist with a focus on Africa. He has extensive experience in startups advisory, angel & impact investing, gender smart investing, and digital commerce investing. Ayomide’s investment thesis is sector-agnostic, encompassing health-tech, edu-tech, climate smart agri-tech, fintech, web3, crypto banking, payments, SME lending, BNPL, retail investing, digital commerce, prop-tech, clean tech, digital trade, logistics, and EV mobility sectors. He has been involved in venture scouting and growth of early-stage startups in Africa for a family office network & venture fund. Ayomide’s expertise allows him to assess investment readiness, venture back-ability, and potential upsides. His interests lie in finance, energy, biotech, AI technology, and emerging industry trends.

Sierra Angels is an angel investment group founded in 1997 and based in Incline Village, Nevada, USA. The group focuses on early-stage investments in technology companies, particularly in sectors like Software, Energy, Health Care, and Information Technology. Sierra Angels typically invests in rounds with 4-5 participants, with an average round size of $1 million. They have made 32 investments, including notable exits like Tivic Health and Breadware Inc. Their investment check size ranges from $250,000 to $2,000,000, targeting businesses with potential for over $50 million in annual revenues. The group prefers collaborations and partnerships with companies in Northern Nevada and the I-80 corridor of Northern California. Additionally, Sierra Angels supports unique products with proprietary technology, sustainable competitive strategies, and realistic financial projections.

Karen Gryga is the Chief Investment Officer at Dreamit Ventures, managing Dreamit Funds with a focus on technology companies in healthcare and education technology. She is known for sponsoring early-stage companies through intensive programs. Her past investments have ranged across various sectors like Consumer Internet, Enterprise Software, Mobile, Healthcare, and more. Karen has a successful track record, holding key positions at Dreamit Ventures, Mid-Atlantic Angel Group, and FashInvest. While the specific check size of investments is not provided, Karen is involved in accelerator programs and initiatives supporting female founders. She has made diverse investments in companies like Lucidity Health, Brideside, Biomeme, and others. Karen is recognized for her collaboration styles and partnerships within the venture capital community.

Sukhi Singh, an entrepreneur and angel investor, focuses on Enterprise Software, Mobile, Consumer Internet, Health and Wellness, Financial Services, SaaS, and B2B sectors in San Francisco. His investment check size is varied, with a track record in these areas. He is known for his collaboration in the investment community.

Mr. Lior Susan is a Co-Founder & serves as a Partner at Eclipse Ventures. He founded Eclipse to meet the unique and unmet needs of entrepreneurs building startups integrating hardware with software and data. Prior to launching Eclipse, Lior was the Founder and General Partner at LabIX, the hardware investment platform of Flextronics. Lior led investments in companies across energy storage, wireless / infrastructure, 3D optics, additive manufacturing, and robotics. He also co-founded Farm 2050, an AgTech Collective, with Innovation Endeavors to address the global food challenge. Lior was part of the founding team of Elementum, Flextronics’ proprietary SaaS platform, which was later spun out. He was a serial entrepreneur in Tel Aviv, where he helped build Intucell, sold to Cisco in 2012. Lior serves on the board of several companies like Cerebras, Flex Logix, Owlet Baby Care, Datorios, Bright Machines, Augury, Swift Navigation, Toka, and Lucira Health. He holds a Bachelor of Arts degree.

Lee Davies, as the Event Manager for Digital Healthcare Show at CloserStill Media, is deeply involved in the digital healthcare transformation sector. With a focus on sustainable digital progression and integration within the healthcare realm, Lee Davies emphasizes the importance of sharing the responsibilities for this critical task. Collaborating with a wide range of experts and organizations, including the NHS, police force, supermarket, and banking communities, Lee Davies aims to alleviate financial pressure on organizations while keeping patients safe. In his role, Lee Davies is dedicated to offering a renewed focus to ehi Live, complementing existing healthcare events, and enhancing the digital healthcare community. By combining expertise and resources, Lee Davies ensures that the event attendees receive mind-blowing ideas and solutions from industry pioneers. Through strategic partnerships and a commitment to global excellence, Lee Davies and the CloserStill team create a platform for knowledge sharing and innovation in the digital health space. For further information, contact: Lee Davies, Event Manager, Digital Healthcare Show Email: lee.davies@closerstillmedia.com Phone: +44 (0)207 348 5278

Rolf Käse is an investor who has made investments in companies such as Transcatheter Technologies. His latest investment was in Transcatheter Technologies as part of their Series B in 2013 with an amount of $3.32M. He exited Transcatheter Technologies in 2016 when the company was acquired by Venus Medtech.

Sarah Guo is a General Partner at Greylock Partners, where she focuses on helping entrepreneurs create and scale the next generation of important B2B companies. She was previously an investor at Goldman Sachs and has a strong interest in companies remaking the landscape of enterprise IT infrastructure, software innovations in healthcare and finance, drones, wearables, robotics, and more. Sarah Guo has raised a $101 million fund for her new firm, Conviction Partners, targeting early-stage artificial intelligence startups. She prefers to invest in AI startups up to Series A with check sizes between $1 million and $10 million. Sarah Guo’s partnership and collaboration style can be seen in her discussions with industry leaders like Figma CEO Dylan Field, focusing on remote work culture, company evolution, hybrid work models, and future policies.

Rucker Park Capital is an early-stage venture capital firm that focuses on finTech, healthcare, transportation, and logistics.

Matt Parmett is an associate at Echo Health Ventures, focusing on investments in companies that personalize health care with insights on telemedicine trends amid COVID-19. Echo Health Ventures operates nationwide with offices in various cities. The investment check size, stage of investment, geographical preference, previous investments, and partnership styles are not explicitly mentioned on the website.

Anahita Nakhjiri, Investment Associate at Echo Health Ventures, focuses on Consumer Health and Digital Health across various stages including Seed, Series A, and Series B. She operates in the Seattle/Portland region with an investment range of $100K – $5.0M and a sweet spot of $1.5M. Anahita has a track record that includes roles in analytics, investor relations, and strategy & portfolio development. Her collaboration style involves working with co-investors like Dusty Lieb, Jessica A. Zeaske, Kurt Sheline, Lindsey Brown, and Matt Parmett, indicating a collaborative and supportive approach to investments.

Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.

KCRise Fund is a Kansas City-based VC firm investing in Seed & Series A stage technology companies in Kansas and western Missouri.

Swan’s Egg is a Venture Capital firm based in St. Louis, MO. Their investment thesis focuses on the team, timing, and technology for making investment decisions, aiming to increase transparency in the basic model of Venture Capital Funds. Swan’s Egg’s investment focus areas include healthcare, information technology, TMT, B2B payments, cybersecurity, industrials, infrastructure, internet of things, and robotics. They invest in early-stage ventures and have a preference for the Midwestern US region. Some of Swan’s Egg’s previous investments cover a diverse range of industries such as healthcare, information technology, TMT, cybersecurity, and more.

Andrés Westerberg is an individual angel investor who focuses on early checks ranging from $250K to $5M. His investment thesis emphasizes ecosystem creation, product stickiness, market size estimation, and founder commitment. Andrés has made investments in sectors such as Consumer Technology, SaaS, Enterprise Tech, Healthcare, Deep Tech, Fintech, Biotech, Climate Tech, and AI. He has a collaborative leadership style, aiming to provide hands-on support to founders, helping them in product-market fit, go-to-market strategies, recruiting, and fundraising.

Deniz Aslandogan, the CEE-focused VC fund manager at Revo Capital, specializes in participating in Series A/B fundraisings and invests in truly innovative early-stage B2B or B2C technology ventures in Turkey, Eastern Europe & Baltics. He has a track record of investing in startups in various sectors like on-demand grocery delivery, AI-enabled app development, fintech services, health IT, and more. Deniz Aslandogan’s previous investments include Getir, Builder.ai, Bumper, Massive Bio, Midas, ikas, and others. Revo Capital is actively investing and looking for the next unicorns of Turkey, CEE & the Baltics.

Yalcin Ayasli, a Turkish-American business executive, is an angel investor with a focus on industries like Biopharma, Biotechnology, and Pharmaceutical. He has invested in Syndexa Pharmaceuticals and is known for his contributions to Microwave Monolithic Integrated Circuit techniques. Yalcin Ayasli’s track record includes founding and heading Hittite Microwave Corporation and founding charitable organizations. His latest investment was in Syndexa Pharmaceuticals in Series B – III on January 05, 2012. Yalcin Ayasli’s check sizes for investments are not specified. His career achievements include receiving awards such as the IEEE Microwave Prize and becoming an IEEE Fellow for his contributions to microwave technologies. He has shown a dedication to philanthropy through organizations like the Turkish Cultural Foundation and Turkish Coalition of America.

Peter Wyles, the Chief Executive Officer at Optovue, has a diversified professional background spanning the pharmaceuticals, medical devices, and consumer health industries. His expertise includes previous leadership roles at companies such as TRIA Beauty and Ventus Medical. Mr. Wyles holds an MBA from Thunderbird School of Global Management and a Bachelor of Arts from Pennsylvania State University. He is actively involved in the San Francisco Bay Area health care sector. With a focus on private equity stage companies, Mr. Wyles brings CEO experience in various regions including the United States, Japan, and Germany. His investment interests extend to medical device companies with private equity funding, emphasizing hands-on engagement and strategic partnerships for company growth. Investment Thesis: Focus on private equity stage companies, particularly in the health care sector. Investment Focus Areas: Medical device companies with private equity funding. Stage of Investment: Private equity stage companies. Geographical Preference: San Francisco Bay Area, West Coast, and Western US. Previous Investments: TRIA Beauty, Ventus Medical. Track Record and Professional Career: Extensive experience in CEO roles in pharmaceuticals, medical devices, and consumer health industries. Investment Check Size: Varies based on company needs and growth potential.

Khan Siddiqui is an entrepreneur, physician, and innovator with a strong background in healthcare IT, medical devices, and supply chain solutions. He is the Founder, CEO, and Chairman of HOPPR, a company focused on transforming medical imaging through AI. Khan Siddiqui’s professional career includes roles as Founder of Althea Health and EyeCheq, Co-Founder Casana, and Advisory Board Member for various companies. With expertise in Artificial Intelligence, Large Vision Models, IoT in health, and more, Khan brings a wealth of experience to his investment ventures. His track record showcases a dynamic and enthusiastic leader dedicated to advancing healthcare technologies globally.

Thomas Goebel is a Principal at Omega Funds with over 10 years of experience in venture capital investing in healthcare in Europe. He has a background as a global biotechnology analyst and holds a PhD in molecular biology. Thomas’s track record includes managing funds for NeoMed and advising on new investments for Omega. While specific investment thesis and check size details are not provided, his focus on healthcare and extensive experience in the field showcase his expertise. His partnership and collaboration styles are evident in his role managing funds and advising on investments, showcasing his collaborative approach within Omega Funds.

Cowtown Angels is an elite Angel Investor Network based in Fort Worth. They invest in diverse startups across various sectors such as medtech and life sciences. With a unique success story like Encore Vision’s $465M exit, they offer superior returns and excitement to their accredited investors. Members can participate in ‘Deep Dive’ or ‘Forum’ sessions. Their investment check size, partnership and collaboration styles can be further explored through their portfolio and sponsored information.

Hans-Jürgen Even, an investor at Project A Ventures, focuses on investing in Pharmaceuticals (Series A), Pharmaceuticals (Seed), BioTech (Series A), Digital Health (Seed), Digital Health (Series A), BioTech (Seed), Health IT (Series A), and Health IT (Seed) sectors. He typically invests in the range of $200K to $10.0M, with a sweet spot at $5.0M. His previous investments include companies in these sectors and stages. Even has a proven track record of success and brings valuable expertise to the companies he invests in. The check sizes for his investments can vary between $500K to $1.5M. His partnership and collaboration styles are characterized by effective communication and equal terms with the stakeholders.

Christoph Massner is an Investment Professional at Earlybird Venture Capital, focusing on European healthtech companies. The investment thesis revolves around delivering robust patient outcomes through investments in digital health, diagnostics, medical devices, R&D tools, and biopharma. Christoph Massner’s investments target companies from early stages up to regulatory approvals and commercialization. Notable previous investments include ImCheck Therapeutics, Oculis, Grey Wolf Therapeutics, and Ariceum Therapeutics. Earlybird Health utilizes the Eagle Eye technology for effective deal sourcing and has public health insurers as cornerstone investors. Christoph Massner manages a fund of â¬173 million for health technology investments, supporting companies in improving patient outcomes. The fund’s check size is around $185 million, with a significant increase from the initial round to fuel healthcare innovations.

Timothy Draper is a venture capitalist known for investments in companies using artificial intelligence, Bitcoin, blockchain, smart contracts, and computational genomics, focusing on industries like finance, health care, and government. He prefers early-stage investments to guide companies from the beginning and has a geographical interest in North America, Europe, Southeast Asia, and Latin America. With a track record that includes investments in prominent companies like Baidu, Hotmail, Skype, and more, Tim Draper is recognized for his expertise in recognizing potential in business ideas. His investment check sizes typically range from $100,000 to $500,000. Draper is engaged in partnerships and collaborations, such as the Gold Star Corporate Innovation Program with TiVo, to support groundbreaking startups in various sectors.

Alda Dennis invests in inspirational founders solving real problems. She focuses on a broad range of areas including space exploration, digital health, fintech, enterprise SaaS, and big data. Her investment check sizes range from $1 million to $5 million. Alda Dennis has a track record of managing investments and professional career in venture capital and startup development. 137 Ventures, where she works, aims to provide structured liquidity products to founders and employees. The geographical preference of the fund covers various sectors and industries with a diverse investment portfolio.

Amit Avner is an active angel investor who has invested in multiple technology startups in the US and Israel, including Plaid, ByHeart, Voca.AI, NYM Health, Custodia, Nirvana Health, Tropic, and Runwise. He has a rich engineering background and has been involved in various engineering and product functions. Amit’s investments range in the cyber security and healthcare sectors. His investment check size typically ranges between $25,000 and $300,000. Although his geographical preferences were not explicitly stated, his investments have been in the US and Israel.

David Whelan is a Founder and General Partner at Town Hall Ventures. He previously served as the Managing General Partner of the Oxeon Venture Studio and has a background in finance and corporate development. Town Hall Ventures, under his leadership, focuses on transforming the U.S. healthcare market through technology. David’s investment check size and specific partnership and collaboration styles are not explicitly detailed on the website. He is based in New York, NY and finds inspiration from his family, enjoying surfing with his son in Montauk.

Chris Kelly is an Angel Investor with a focus on technology companies. He invests in companies such as JUST Goods and has been involved with startups like Haiku and Atigeo. Mr. Kelly’s investment check size varies depending on the opportunity, and he is known for his collaboration style as an Executives In Residence at Progress Ventures. With a background in law and a diverse academic portfolio, Chris Kelly brings a wealth of experience to his investments.

Jonathan Ordway Fackelmayer is a Managing Partner at a Private Family Office with a focus on investments in food and agriculture technology, health and wellness, and blockchain sectors. He has contributed to funding for companies like SEBA Bank, with previous investments in the fintech field. Jonathan’s professional career includes roles at Ordway Capital & Ordway Selections. His investment check size has been noted to be approximately £78M. Known for his partnership and collaboration styles, he is associated with fintech finance endeavors and maintains a high-performance track record in blockchain investments.

5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.

HealthX Ventures, founded by Mark Bakken, focuses on funding digital healthcare startups. They invest in innovative companies making healthcare safer, more efficient, and more affordable by delivering easy-to-use, cost-effective, and scalable solutions. With joint headquarters in San Francisco and close proximity to Epic Systemsâ Madison, WI headquarters, HealthX Ventures is led by successful entrepreneurs and investors. The firm provides extensive operational support, deep industry knowledge, and executive-level networking to portfolio companies. Mark Bakken’s track record includes leading companies to significant growth and success, such as Nordic Consulting achieving a #1 KLAS ranking. HealthX Ventures invests at seed and Series A stages and has invested in companies like Medable, Redox, DotCom Therapy, and more. They prefer to invest in digital healthcare startups in North America.

William Quist, a Partner at Slow Ventures, has a track record in the investment industry. Some of his previous investments include Breakr, Portal, Amper Technologies, Yotta, and Karuna Health. He has a history of providing billions of dollars in early growth capital to over 500 companies worldwide. His partnership and collaboration styles involve strategic alliances, joint ventures, and co-branding partnerships, emphasizing shared vision, clear communication, mutual trust, and continuous evaluation. William Quist focuses on investments in various sectors such as health & hospital services, Health IT, and Web3/Crypto at different stages like Seed, Pre-Seed, Series A, and Series B, showcasing a diverse investment portfolio.

Lars Jörnow is a Partner at EQT Ventures, based in Stockholm, Sweden. Lars co-founded EQT Ventures in 2015 and is known for being one of the most active partners in the European ecosystem. He has collaborated with over twenty early-stage tech companies across various industries such as mobile gaming, consumer health, and travel/mobility. Lars focuses on leading investment rounds at the Seed or Series A stage, partnering with founders to accelerate their journey to the global stage. His previous experience includes working at King Digital, where he managed the team behind the iconic game, Candy Crush Saga. Lars has a track record of partnering with startups like Small Giant Games, Popcore, Lenus Health, Holidu, Dott, Natural Cycles, and others. His investments reflect a geographical preference for opportunities in the European market.

Dave Tucker is a Partner at Next Level Ventures, a venture capital firm based in Des Moines, Iowa. The firm specializes in innovation across various sectors, including Fintech, Biosciences, Agriculture, Manufacturing, and more. Their investment focus areas include Software as a Service, Fintech, Agtech, Artificial Intelligence & Machine Learning, Technology, Media, Telecommunications, and Healthcare Technology. Dave Tucker has a background of supporting technology companies at various stages of development. He has invested in companies like Facteus and Coviance. Dave’s typical investment size ranges from $0.5 to $5 million per business. He is actively involved in helping portfolio companies succeed with financial, operational, and networking expertise.

Greg Johnston is a Principal at Corazon Capital, focusing on early-stage investments across consumer and B2B. Corazon Capital invests in Seed and Series A companies in industries like Consumer Products & Services, IT, Life Sciences & Healthcare, and more. The firm typically favors pre-seed, seed, and series A stages with investment sizes ranging from 10-50 million dollars. Greg has a track record in growth-stage investing and M&A advisory. Previous investments include companies like CFX Labs, Fitplan Technologies, and SpotHero. Greg Johnston and Corazon Capital maintain a partnership style that is geared towards early-stage collaboration and investment opportunities.

Tom Rutledge is a Co-Founder of Wapanda, an Angel Investor, and served as Head of Fixed Income at Magnetar Capital. He is a Wall Street credit veteran with experience at Merrill, Deutsche Bank, and J.P. Morgan. Tom has investments in fin-tech, prop-tech, marketing-tech, second-chance employment, and therapeutic psychedelics sectors.

Tom Singh is an entrepreneur, investor, and philanthropist known for founding New Look, a fashion clothing retailer with over 800 stores worldwide. He has an immaculate track record as an angel investor. His investment focus areas include technology vendors, corporate strategy, venture capital, healthcare, and financial services. Tom’s geographical preference for investments includes the EU region. He has previous investments in companies like Fabacus and Yieldify. Tom Singh’s investment check size and partnership style are not explicitly mentioned in the available information.

Marc Nathan is a venture capitalist who focuses on early-stage emerging CPG brands and invests up to $500,000 in startups. He has led investments into companies in the retail food service, building services, and health care services sectors. Marc Nathan’s partnership and collaboration style emphasize sustainability, partnerships, marketing, and innovative thinking. His previous investments include Community Veterinary Partners, mainly in the Greater Philadelphia Area, Great Lakes, and Northeastern US regions. Marc Nathan’s check size for investments is up to $500,000 in startups.

Ariel Savannah Angel Partners, LLC is one of the largest independent angel investment organizations in the Southeastern USA. Their investment thesis focuses on providing capital, mentoring, and industry expertise primarily to startups in life sciences, biotech, and technology sectors. They have a primary focus on life sciences and biotech but are open to technology deals in all sectors. The firm invests in start-up and development-stage businesses and has a geographical preference for the Southeastern USA region. With over $18 million invested across 35 start-up and development-stage businesses, they offer a minimum group investment of $100k, an average investment of $350k, and have made investments exceeding $2m. Ariel Savannah Angel Partners takes pride in providing not only capital but also mentoring and industry expertise to startups, emphasizing partnership and collaboration for the success of their investments.

Flywheel Angel Network invests in innovative companies through the annual Flywheel Investment Conference. They aim to create momentum for growing companies by bringing investors and founders together, focusing on rural NCW communities for economic development. Previous investments include Cartogram, Betahatch, AgTools, SyncFloor, and more. The network offers over $1.3 million in investment awards at the conference, with additional benefits like relocation offers and cash prizes. The typical investment check size is around $150,000+ at the conference. Flywheel Fund Portfolio showcases investments in tech startups in Indiana, with focus on workplace productivity tools and digital platforms. Partnership and collaboration styles involve supporting startups through funding and resources, emphasizing diversity and positive testimonials from invested companies.

Martin Wos is a passionate entrepreneur, German electrical engineer, Blockchain visionary, and investor. His investment focus areas are not specified. He invests at the Seed stage and has made personal investments including a Seed Round in Trittbrett Helden and Block Stocks. Martin Wos’s previous investments include Trittbrett Helden and Block Stocks. He is located in Karlsruhe, Germany and focuses on the EU and EMEA regions. Martin Wos’s professional career includes being the CEO of Block Stocks Swiss AG. His partnership and collaboration styles are not detailed.

Michael Siefke, a Partner at Bain Capital Private Equity, specializes in healthcare and industrial services. With extensive experience in the Industrial and Healthcare Verticals, Michael is known for his collaboration and partnership styles, focusing on synergizing with customers and partners to create value. His investment check size typically ranges from $100K to $5.0M, with a sweet spot around $1.5M, and he manages a fund of $160M. Michael’s previous investments include ventures in the healthcare and industrial sectors, showcasing his commitment to these areas. With a summa cum laude PhD and MBA from Westfaelische-Wilhelms-University, Michael brings a wealth of knowledge and expertise to his investment strategies. His approach emphasizes strategic collaborations and hands-on involvement to drive growth and success in the German-speaking regions where he operates.

The Wolfpack Investor Network (WIN) is an angel investor group associated with North Carolina State University, providing capital and guidance to NC State connected, early-stage companies. WIN focuses on companies in various sectors including Health Care, B2B, Internet, E-Commerce, and Subscription Service. WIN has a track record of managing cross-functional teams and collaborating with diverse stakeholders. The network has invested in companies like Natrx Inc. and Voxel Innovations, supporting eco-friendly initiatives and innovative technology solutions. WIN’s partnership and collaboration style involve empowering NC State startups by leveraging the university’s entrepreneurial ecosystem and alumni network.

James Lowe is a Senior Associate at Baird Capital, actively involved in the Global Private Equity and Venture Capital investment teams focusing on B2B Technology & Services. Baird Capital has deep investment experience in sectors such as Financial Tech & Services, Healthcare Services & IT, HR Tech & Services, Industrial Technology, IT/Data Management, Pharma Services & IT, Sales & Marketing, Security & Risk, and Sustainability. The investment check size is aligned with their areas of interest. As part of the collaboration and partnership styles, James Lowe leverages his experience and network from previous roles to support the investment process and portfolio companies.

Sunwoo Lee, an Analyst at Atland Ventures, is an investor focusing on fast-growing US-based startups that cater to Gen Z or solve generational challenges. Atland Ventures specializes in seed-stage investments, deploying $25,000 checks to support promising companies. Sunwoo’s previous investments align with themes like Edtech, Consumer/Consumer Social, Marketing/Adtech, Creator Economy, Health and Wellness, and Human-Computer Interaction. His roles include sourcing startups for Atland Ventures and leading portfolio support at Groove Capital. Sunwoo is actively involved in community-building efforts and promoting female entrepreneurship. He exemplifies a passion for creating impact and value through his diverse roles in the startup ecosystem.

North South Ventures is a cross-border venture capital fund that invests in early stage med companies.

Jamie Melzer focuses on pre-seed to Series A investments in Digital Health, Consumer Health, Health & Hospital Services, Health IT, and Consumer Internet. Some of his previous investments include in these sectors. Jamie Melzer’s investment check size ranges from $50K to $100K, with a sweet spot at $75K. He has a background working in roles such as SVP of Investor Revenue at YipitData and experience in investor revenue, business development, and sales. Jamie Melzer’s partnership and collaboration style in investments involves being part of HF Scale Partners, focusing on growth and late-stage venture-backed companies.

Rajesh Agarwal is an Angel Investor with a focus on investments in Software, Edu-Tech, Transportation, Logistics, Healthcare, and Industrials. His stage of investment is primarily in the Seed stage. Rajesh Agarwal’s geographical preference includes the Greater Minneapolis-Saint Paul Area, Great Lakes, and Midwestern US. He has made previous investments in Minneapolis Biomass Exchange. With over 22 years of experience, Rajesh Agarwal has a proven track record in business restructuring, channel management, and information technology. His investment check size and collaboration style were not explicitly available in the sources.

Melissa McCracken, Ph.D., is a scientist with a passion for emerging technologies in cancer therapies. She joined Nextech Invest Ltd. in 2019, a global venture capital firm based in Zurich, Switzerland, focusing on oncology therapeutics. Nextech Invest invests in drug discovery companies in the US and Europe, supporting them through each critical stage of development and growth. Melissa’s previous investments include companies like A2 Biotherapeutics, Autolus, Blueprint Medicines, and Kura Oncology.

Fred Ahlberg is an Angel Investor with a focus on surgical science. His investment thesis involves supporting businesses with an established reputation within the surgery and medical education community. He typically invests in early-stage technology and life sciences startups. The geographical preferences or areas of investment for Fred Ahlberg are not specified. In terms of stage of investment, he is known to primarily invest in early-stage technology and life sciences companies. While his previous investments are not disclosed, his track record includes championing efforts within the surgery and medical education sectors.

Tarek Sherif is an Angel Investor with a stage focus on Seed Round. His investments are typically in Big Data, SaaS, Technology, Media, and Telecom (TMT) industries. Tarek Sherif has led Medidata Solutions to become a global leader in cloud-based solutions for the life science industry. He has a check size of around $1,000,000 for seed round investments. Geographically, Tarek Sherif’s preference is the United States, specifically New York City. His track record includes extensive leadership experience in health-tech and finance. In terms of partnership and collaboration styles, Tarek Sherif fosters a culture of entrepreneurship and collaboration within Medidata Solutions and with customers.

Linda Erb is a VC Investment Associate at Coparion, with a focus on financial decision making and transformation management. Coparion invests in German technology and life sciences companies across various stages from seed to late-stage growth rounds. Linda’s track record includes involvement in financing rounds and collaboration with other top investors. The investment range at Coparion varies from $560K to $18.0M, with a sweet spot at $9.0M. The partnership and collaboration style at Coparion emphasize a culture of continuous improvement and strategic partnerships. Linda Erb’s professional career showcases hands-on involvement in investment activities and collaboration to foster progress in the portfolio companies.

Charlie Macdonald is an integral team member of Giant Leap Fund, Australia’s first venture capital fund dedicated to impact startups that bring real and measurable social and environmental benefits. The fund’s investment thesis focuses on backing mission-driven founders addressing global challenges in climate, health, and education & empowerment. Giant Leap primarily invests in rapidly scalable startups and seeks to complete a portfolio of 20+ startups. The fund’s geographical preference aligns with its mission to invest globally in diverse teams. Previous investments by Giant Leap include companies in sustainable agriculture, waste reduction, health tech, and sustainability. Charlie Macdonald’s role at Giant Leap involves collaborating with mission-driven founders to create transformational change. The fund’s investment check size is dynamic, tailored to the needs of impactful startups, and prioritizes partnerships that drive innovation and social impact.

LRVHealth is an ,ÄúInside Healthcare,Äù venture capital platform established in 2000 by a team of healthcare investors, operators & advisors

Hermann Hauser, through his investment company Hermann Hauser Investment GmbH, primarily focuses on investing in early-stage (seed, Series A) startups from the DACH region. The investment check size ranges from â¬340K to â¬40.0M, with a sweet spot around $20.0M. The geographical preference is Central Europe, specifically the DACH region. Hermann Hauser’s investment focus areas include scalable technologies with high innovation potential in fields like AI, Digital Health, Synthetic Biology, Operating Systems, Electronics, and Quantum Computing. Some of the previous investments made by Hermann Hauser’s company include SEMRON, with a recent investment of â¬7.3M. Collaboration and partnership styles emphasized by Hermann Hauser involve close cooperation between government, finance, and the tech community to foster innovation and growth.

William Lohse, the General Partner at Social Starts, is an experienced investor known for his focus on various sectors. With over 25 years of investment experience, he primarily invests in AR/VR, Social Networks, E-commerce, BioTech, Health IT, and Health & Hospital Services at both Seed and Series A stages. His investments typically range from $50K to $1M, with a sweet spot at $500K. William has a track record of 31 investments, including notable ones like Betrust, Fulcrum, and SmartNews. As a founder at Joyance Partners since 2019, he collaborates with investors such as Andy Nealon and Emi Gonzalez. William’s approach emphasizes strategic partnerships and collaborations, working closely with affiliated scouts and angels like Charles Smith and Ajay Agarwal to drive success in each investment.

Gustaf Lundberg Toresson, a Venture scout at Backed VC, is actively involved in investing in exceptional founders at Seed stage in Europe with an investment range from $25,000 to $100,000, and a sweet spot of $50,000. He operates within a current fund size of â¬150 million. His investment focus areas include sectors like Entertainment & Sports, Retail, Media/Content, Web3/Blockchain, and Web3/Crypto, both in Seed and Series A stages. Notable co-investors and collaborators at Backed VC include Alex Brunicki, Alice Knibbs, Andre de Haes, and Pascal Suhrcke, among others. Gustaf Lundberg Toresson’s investment approach is characterized by a human-centric ethos, where the focus is on supporting founders over markets. This collaborative and community-driven style emphasizes supporting founders throughout their journey, making it a distinctive feature of his investment strategy.

Leo De Luna is a Principal at Split Rock Partners, focusing on later stage and secondary investments. Split Rock Partners primarily targets opportunities in software, Internet services, and healthcare. The firm has raised $575 million over two funds since 2005. Leo De Luna’s previous experience includes positions at Saints Capital, St. Paul Venture Capital, Lehman Brothers, and Advanced Micro Devices. Representative investments by Split Rock Partners include companies like 8thBridge, Ardian, Atritech, Compete, eBureau, Evalve, Flycast Communications, HireRight, Intacct, LowerMyBills, MyNewPlace, QuinStreet, SPS Commerce, and Tornier.

David Liu, a biotech investor, has a background as a Senior Analyst at Velan Capital and as an Analyst at Altium Capital. Previously, he was a Senior Biotech Analyst at Iguana Healthcare Partners, LP. Prior to that, he served as an Equity Research Associate at RBC Capital Markets. David’s career also includes roles as a Research Scholar and Graduate Research Assistant at Memorial Sloan Kettering Cancer Center. He is located in the Greater New York City Area and has experience in long/short equity hedge fund and biotech analysis.

Davina Williams is an experienced investor at iSelect Fund with a focus on food and agriculture, healthcare, food is health, and impact investing. iSelect has made investments in various companies in the agtech, soil health, and crop health solutions to meet global protein demand. Previous investments include over 30 companies aimed at improving food taste, nutrition, and affordability, creating new jobs and adding substantial value to the portfolio. Davina Williams is known for her strategic investments in innovative solutions that drive positive change in the food and health sectors.

Alberto Perlman is the Co-Founder and Chief Executive Officer of Zumba Fitness, a $500 million business with around 14 million people attending Zumba classes weekly in 140,000 locations worldwide. Zumba’s success is attributed to its network of personal instructors who pay for training and support. Alberto Perlman emphasizes the importance of listening to and understanding customer feedback. Zumba Fitness adapts to customer needs, introduced the Strong Nation HIIT program, and values creating in-person group experiences. Alberto Perlman has a CEO approval rating of 68/100, placing him in the Top 50% of similarly-sized companies. Collaboration styles at Zumba include partnering with music producers, such as Timbaland, to enhance workouts and providing a platform for Latin artists.

Andrew Bouldin serves as Principal at FCA Venture Partners. FCA’s investment thesis focuses on the importance of AI in healthcare for a more efficient, personalized, and accessible future. The firm targets healthcare and digital media startups and typically invests $3 to $6 million in companies. FCA VII, a $90M early-stage venture fund, has commitments from leading health systems and individual investors. The fund invests $3-6 million in 5-6 innovative healthcare companies across Series A and Series B stages. Andrew Bouldin’s partnership and collaboration styles involve actively investing out of FCA Health Innovations II, a $71 million seed stage fund, and making strategic collaborations to enhance healthcare technologies.

Leen Kawas, Ph.D., co-founder and managing general partner at Propel Bio Partners, specializes in building a biotech focused fund to support life science innovations. She has a track record of co-founding and leading advancements in late-stage clinical programs, with experience in taking companies public and raising over $400 million. Leen’s previous investments include Athira, where she served as CEO. Her investment check size ranges significantly, with a vision to support impactful research and next-gen innovators. Leen is known for her partnership and collaboration styles, supporting scientist entrepreneurs, particularly women, and focuses on promoting diversity and better company performance.

Charles Thompson is an Angel Investor associated with The White Oak Group, Inc., focusing on management-led buyouts, recapitalizations, and growth capital. Their investments target companies with revenue between $5 million to $100 million, minimum EBITDA of $500,000, in Aerospace & Defense, Healthcare Technologies, and Power & Alternative Energy. One of their funds is The White Oak Guggenheim Aerospace & Defense Fund, LP. Charles Thompson is a Senior Financial Advisor with professional designations CFP®, CEBS, CTFA™, CRPC® from the University of North Carolina at Chapel Hill. The investment check size ranges from £8m to £32m. Partnership and collaboration styles are not available.

Thomas Fisher is a Venture Partner at Lifeforce Capital, investing in software companies reshaping the status quo in healthcare’s largest markets. Lifeforce Capital’s investment check size is not specified. For partnership and collaboration styles, they prefer to invest in companies operating in the healthcare and software sectors. Previous investments and specific check sizes are not available on the website. Contact email: info@lifeforcecap.com

Hannah van Goor is a Venture Capital Scout at Borski Fund, focusing on investments in ClimateTech/CleanTech (Seed), BioTech (Seed), Health & Hospital Services (Seed), Health IT (Seed), ClimateTech/CleanTech (Series A), BioTech (Series A), Health & Hospital Services (Series A), Health IT (Series A). Her investment check size ranges from $25,000 to $100,000 with a sweet spot at $50,000. She has been involved in previous investments such as Closure, Thirona, Soft Revolt, RTI Blockchain, Aiir Innovations, Parfumado, Inne, INNOVO by Atlantic Therapeutics, and The Selection Lab.

Marco Boorsma, a General Partner at Forbion since 2007, has a special interest in bringing his background in biotechnology, operations, and business development to the portfolio. He focuses on companies developing precision treatments for rare diseases. With experience in establishing and managing new companies under Forbion’s build strategy, Marco is involved in board memberships at various companies. Some of his portfolio companies include Precirix, Oxyrane, and Engrail Therapeutics. Forbion has offices in the Netherlands and Germany.

Village Capital builds bridges for entrepreneurs who are creating an inclusive and sustainable world.

Una Ryan is the Managing Director of Golden Seeds, an angel investing group focused on women-led companies, with a background in developing vaccines, immunotherapeutics, and diagnostics. She holds a Ph.D. in Cellular and Molecular Biology from Cambridge University. Una Ryan has made several investments, including RenovoRx, Boston University School of Medicine, Diagnostics For All, Cortexyme, and Management Sciences for Health. She has been actively involved in events and has a partnership and collaboration style that involves supporting startups as a board member and individual investor.

Maurice Gallagher, the Principal of Gallagher Corporation and co-partner of Flynn/Gallagher, is known for his investment thesis that involves focusing on specific industries, notably the airline industry. His approach emphasizes dominating smaller markets to maintain a competitive edge. Maurice Gallagher’s investment focus areas span various sectors, including technology, corporate strategy, venture capital, IT, consumer services, tech, insurance, healthcare, and financial services. In terms of partnership and collaboration styles, Maurice Gallagher’s collaboration with UC Davis in developing a rapid COVID-19 test showcases his commitment to innovation and strategic partnerships. His track record includes successful ventures like ValuJet Airlines, Mpower Communications, and Allegiant Air, reflecting a forward-thinking and industry-specific investment strategy.

Samantha Fernandez is an impact investor with a focus on health, autism, financial & workforce inclusion, education, B2B/SaaS, and B2C/consumer internet for underserved markets in the US and Latin America. She funds seed to growth stage companies primarily via angel groups and syndicates. Previous experiences include roles at Adobe, Acumen, and The Bridgespan Group. Samantha is open to serving on philanthropic boards and advisory councils. She invests in the seed round stage, and her check size has not been specified. An example of her previous investments is supporting innovations in health. Samantha Fernandez values collaboration and partnership to drive impact in the industries she is passionate about.

Arboretum Ventures is a Michigan-based venture capital firm investing in medical technology and healthcare companies.

Ariel Luedi, the founder of Hammer Team, focuses on supporting software companies during their startup and growth phase. His investments include companies like CREAL, Fluent Commerce, Beekeeper, and OXIAL. Ariel’s investment check size varies, with notable investments like CREAL receiving CHF7.3 million. He has a background in e-commerce, having been CEO of hybris software before its acquisition by SAP. Ariel’s angel investments are in sectors like technology, IT, consumer, insurance, and healthcare.

Jacob Peters is a Startup Founder in Longevity Medicine. His previous investments include Stealth Startup, Launch House, and Commsor. Jacob’s career includes roles as a Data Scientist at J.P. Morgan. His investment check size and partnership styles are not explicitly mentioned, and geographical preference is Los Angeles, California, United States.

Howard Goldstein, a Co-Founder and Operating Partner at Vedanta Capital, focuses on consumer and retail investments. He has a track record of over 400 partnership investments and 300 direct investments with top quartile performance. Vedanta Capital invests early and globally, with a focus on venture investments. Howard Goldstein’s collaboration style is extensive as he previously co-founded Invesco Private Capital. However, specific details regarding geographical preferences, check sizes for investments, and partnership styles are not available.

Kushagra Vaid is a Partner at Eclipse Ventures, with a focus on driving innovative technologies from early concept to scale production. He is experienced in cloud-datacenter infrastructure and has led major strategies at Microsoft and Intel. Kushagra has board memberships in several tech companies and strategic advisory roles in the semiconductor industry. Previous investments include Decentriq among others. His partnership and collaboration style involve active board memberships and advisory roles in technology firms, contributing to their growth and strategy development.

Mark Mendoza is an Angel Investor specializing in Seed Round investments in industries such as Personal Finance, Healthcare, Crowdfunding, and more. He co-founded a financial services/business loan corporation. His investment check sizes range from $1,000,000 for companies like Example company Inc to â¬11,000,000 for other ventures. Mark Mendoza is based in Orange, California, United States.

Marina Balcazar focuses on early-stage investments in startups addressing significant market needs, backed by a strong team and unique insights. She prefers investments in the Healthcare, TMT, and Consumer sectors. Marina’s check sizes typically range from $500K to $1.5M. Her track record and professional career details are not publicly available. Marina has a partnership and collaboration style that emphasizes executing on solutions to critical problems with proactive and action-oriented teams.

John Freidenrich, a Partner of Regis Management Company, focuses on seed-stage investments, with previous investments including Salesforce. He maintains geographical preferences outside the United States, specifically in high-quality, non-dollar-denominated debt securities. There is no specific information available about his investment thesis, investment check size, track record, professional career, or partnership and collaboration styles at Regis.

Good Growth Capital specializes in finding, cultivating, and assessing complex science and deep-tech start-ups.

Michael Charles Dearing is an investor known for his investment thesis of turning experts inside larger companies into startup founders, focusing on comparative advantage. His past investments include health tech companies like Grand Rounds Health and PagerDuty. Dearing has a track record of success in startups and emerging growth companies. He has been involved in investing as well as operating a management education program for tech up-and-comers. His investment check size and partnership styles align with seed- and early-stage technology companies, serving the consumer and small business markets. Some of his previous investments include Aardvark, AdMob, DocVerse, Lumos Labs, Polyvore, TownMe, and Widgetbox.

Joseph Choo is an angel investor at Angel Physicians Fund with a focus on life science and healthcare investments. The fund operates in the seed stage, with a geographical preference not specified. No specific previous investments were found on the website.

Jonathan Bik is an impact investor based in Chicago, Illinois. As a Senior Associate at J-Impact Fund, he focuses on investing in various sectors at the seed stage, including Wellness & Fitness, Future of Work, Impact, Medical Devices, AgTech, TransportationTech, Education, ClimateTech/CleanTech, Digital Health, and FinTech. Jonathan’s investment range typically falls between $250K to $750K, with a sweet spot around $500K. With a background at the University of Chicago Booth School of Business and experience in the Israeli Navy, Jonathan has a diverse skill set that enriches his investment approach. His professional career includes roles such as Head of Missiles and Vessels Navigation R&D in the Israeli Navy. Jonathan Bik’s commitment to impact investing and diverse founder support sets him apart as a valuable investor in the startup ecosystem.

Coyote Ridge Ventures is a private equity firm based in San Francisco, CA, USA. Founded by Rahul Prakash, the firm focuses on early-stage technology startups like MeUndies and inDinero. They invest in digital health, with check sizes ranging from $100,000 to $250,000. Coyote Ridge Ventures has a track record of 8 investments, including companies like Expensify and Paintzen. Their collaboration style involves a diverse team including scientists and health tech executives.

Marc-Olivier Turgeon is a Senior Associate at Forbion, specializing in building companies across therapeutic areas and modalities. He has been involved in the development of companies such as Tessellate Bio and has an observer role on the board of portfolio company Pheon Therapeutics. His investments focus on the biotech sector. Marc-Olivier holds a PhD in Oncology and a background in molecular biology. Forbion provides an environment for him to utilize his scientific expertise while learning about Life Sciences venture building. Check sizes and partnership collaboration styles specifics were not available.

Alexis Alston, a Senior Associate at Lightship Capital, focuses on investing in underrepresented founders in the Midwest. She has shown interest in HealthTech and A.I. industries. Alexis values collaboration and seeks to create a more inclusive and open environment within the VC industry. Her previous investments include Kare Mobile, Healthy Roots Dolls, Allergy Amulet, Undock, and FreshFry. Alexis has a track record in sports journalism, working with BTN Student U and Spartan Sports Report at Michigan State University. She also represents distinctive partnership and collaboration styles in scouting and supporting startups across five sectors, having background roles at Google and managing charter schools. Alexis Alston’s investment check size is not specified in the available information.

Mr. Peter Hotz is a seasoned entrepreneur and business leader who thrives on supporting emerging health care businesses. He is the Co-founder and Managing Director of Vynamic X, an early-stage health care investment platform. His specialties include Business Development and Sales Management, Financial Advisory Services, Interim & Turnaround Management, Strategic & Operational Consulting, and Executive Recruitment. He holds a B.A. in Economics from Ursinus College and an MBA in Marketing from the University of Maryland. Peter has served as a consultant, mentor, investor, and board member to several emerging and established innovators. Some of the companies he has been involved with include: EXOS, Inpatient Medical Services, Blueprint Health, and Startup Health. Additionally, Peter was Group Vice President and President of Walgreens’ Take Care Health Systems, and Executive Vice President/Chief Operating Officer of CHD Meridian Healthcare. He also founded and served as Managing Director at 5 Cap Ventures.

Jakob Granqvist, a VC and Investor, serves as an Antler Investor in Stockholm, Sweden. His investment range varies from $100K to $5.0M, with a sweet spot of $1.5M. Jakob is involved in pre-seed investments in sectors like Cybersecurity, Health & Hospital Services, ClimateTech, Web3/Crypto, Marketplaces, Health IT, E-commerce, SaaS, AI, and FinTech. He collaborates with various investors and scouts, showing a diverse partnership and collaboration style.

Roy Martin is the President and CEO of WELM Ventures, LLC. He focuses on industries like Information, Data, Media and Publishing, Software as a Service (SaaS), Data Analytics, Legal/Tax & Accounting, Healthcare, and Medical Device. WELM Ventures prefers companies with revenues ranging from $500,000 to $5 million. Their investment size ranges from $100,000 to $750,000, primarily in equity (common and/or convertible preferred stock) and Mezzanine. Roy Martin’s geographical preference is national, with a focus on Minnesota companies. They do not invest in retail, consumer products, service, or franchise businesses. The expected exit or liquidity potential is within 3-5 years. Roy Martin’s professional career spans various executive roles within companies like Thomson Reuters and Truven Health Analytics, showcasing his strategic leadership and growth achievements.

Daniela Couto, a General Partner at BioGeneration Ventures, has a background in Biomedical Engineering and BioEngineering. She served as the CEO at Cell2B and managed BGV’s portfolio company Staten Biotechnology. Her previous investments include companies like Citryll, Complement Therapeutics, Mironid, and Tessellate Bio. Daniela’s partnership style focuses on leading and executing company strategies, collaborating with industry players, and pursuing buy-out options. She plays an active role in developing therapeutic solutions for various diseases, emphasizing innovation and strategic growth.

Tom Broderick serves as an Angel Investor specializing in seed round investments. His investment focus areas include Healthcare, Digital Media, Photography, Elder Care, Mobile Enterprise, Hardware, Content Creation, Mobile Health, and Consumer Internet. Some of his previous investments include Example Company Inc ($1,000,000 in a Seed Round), Example & Company (â¬11,000,000 in Series C funding), and Example ($524,000 in Seed round A). Tom Broderick’s track record includes investments in markets like Government, Information Services, Information Technology, Marketplace, and Procurement.

Phil McSweeney, an experienced angel investor and Executive Chair, has a strong track record in supporting startups as a business angel with over 20 investments. His investment focus areas include providing mentorship, coaching, and strategic advice to founders and startups, aiming to help them realize their full potential and attract investment from business angels. Phil’s previous investments have been diverse, supporting startups in various industries. He currently serves as the Executive Chair of Patientsource Ltd, a company developing electronic patient records in the healthcare sector. Phil McSweeney is actively involved in mentoring, coaching, and advising startups and founders through platforms like Connectd and Coachpositive Ltd. His partnership and collaboration styles involve providing governance, mentorship, and support in fundraising and procurement activities. Phil has a hands-on approach as an investor, offering guidance and strategic direction to startups. His investment check size ranges based on the specific needs of each company. Phil’s geographical preference includes the UK and beyond, where he provides valuable expertise in scaling businesses and fostering growth.

Steve Kreynin, CEO at Forte Group, focuses on evolving the company’s vision and strategy. Forte Group provides application development services and managed IT services. Steve’s collaboration style emphasizes innovative partnerships. However, specific details on investment thesis, focus areas, stage of investment, geographical preference, previous investments, track record, investment check size, and partnership styles are not available from the search results.

Aline Faivre-Pierret MBA is an angel investor with a focus on investing in startup companies. Her investment portfolio includes businesses in Life Science, FinTech, and Health sectors. As a property expert, she buys houses, refurbishes them to an excellent standard, and rents them out. Aline also serves as a Property Sourcer, assisting property investors in building up their property portfolio to generate passive income. With a background in Property Consultancy, Aline has been recognized as the Property Consultancy Firm of the Year 2023 Hertfordshire Finalist at the Property Deal of the Year 2021. She holds a Master of Business Administration (MBA) from Hanze and a Master of International Business from Anglia Ruskin University. Aline’s investment style and check sizes were not specifically mentioned in this profile.

Deep Nishar is a seasoned investor with a focus on software, frontier tech, and healthcare companies. He has led investments resulting in IPOs and M&A across various sectors. Deep is a Managing Director at General Catalyst, supporting founders from seed to growth stage and beyond. His investment check size ranges depending on the company and stage. Deep’s career spans top executive roles at LinkedIn and Google, where he significantly impacted product strategies and user experiences. He holds an MBA from Harvard Business School and M.S.E.E. from the University of Illinois Urbana-Champaign.

Cliff Sirlin is an active investor with a focus on technology vendors, corporate strategy, corporate venture capital, IT, consumer, tech, insurance, healthcare, determining tech strategy, connecting with tech vendors and partners, and turbocharging digital transformation. His investments typically involve a check size of $4 million in companies such as Flyby Robotics. Cliff has a track record of creating marketplaces and disrupting supply chains across various industries. He has a partnership and collaboration style that involves joining founders and friends in events like the one at the DoubleDutch offices in San Francisco.

Cairn Cross, Co-Founder and Managing Director at FreshTracks Capital, focuses on investments in various sectors such as Advanced Manufacturing, B2B Software, Consumer Products, Energy, Food & Beverage, Health & Wellness, Medical Technology, and Technology. He is actively involved in the boards of portfolio companies like NativeEnergy, Faraday (Chair), and Mamava. Cairn’s investment check size ranges based on the specific startups. He values partnerships and collaboration, evident from his role as a lecturer at the UVM Grossman School of Business, teaching Financing Sustainable Innovation. Cairn’s geographical preference is primarily focused on Vermont and the New England region. Additionally, his professional career includes being named the Vermont, New England, and National Financial Services Champion by the United States Small Business Administration in 2011. He holds a Bachelor of Science from Montana State University and an MBA from Southern New Hampshire University. Contact information: P.O. Box 84929 Harbor Road, Suite 200, Shelburne, Vermont 05482, Phone: (802) 923-1500.

Eckhardt Weber is a Founding Managing Partner at Heal Capital, a venture capital firm based in Berlin. Heal Capital invests in HealthTech startups from Seed to Series A with check sizes ranging from â¬1-5 million. Eckhardt Weber’s professional career includes his role at Heal Capital, where he collaborates with a team to back mission-driven founders with capital. Previous investments at Heal Capital have involved a team of various professionals, suggesting diverse involvement in startup funding. Partnership and collaboration styles include working with a team at Heal Capital, indicating a collaborative approach to investments.

Douglas Leighton is the Co-Founder and Managing Partner at Dutchess Capital Management, a Boston-headquartered global hedge fund. He primarily focuses on investments in the legal marijuana market and pharmaceuticals and biotechnology industries. Dutchess Opportunity Fund II, managed by Altar Rock Capital, which Douglas is associated with, prefers to invest in the United States and Canada. Previous investments associated with Douglas Leighton include CampusTap. Dutchess Capital has made over 400 investments globally, ranging from seed capital for startups to $25 million for more established companies, with a total transaction value exceeding $2 billion. The collaboration and partnership styles of Douglas Leighton are not specifically mentioned in the available information.

Hugo Barra is an investor who has made 13 investments. His latest investment was in Medivis as part of their Series A. He has invested in companies like Medivis, Coderhouse, and Osmo. His co-investors include notable names like Bob Iger, Coalition Operators, and Initialized Capital. Hugo Barra’s investments range from Series A rounds to Seed VC rounds, with undisclosed amounts in some cases. He collaborates with diverse co-investors and brings a wealth of experience from his previous roles at Meta and Xiaomi.

We support exceptional entrepreneurs that are reimagining how consumers do things today.

Harold Primat is an investor interested in companies related to fan engagement, connected athletes, health and well-being, and other sports and health technology sectors. He has made investments in Seed VC and Series A funding rounds in companies like Buzzbike, Phlex, Swiss Craft Drinks, Paired, and GUM Playbrush. His geographical preference is not specified. Harold Primat is a French-born Swiss racing driver competing in the Blancpain Endurance Series and other long-distance events, also serving on the Board of various companies. Investment check sizes range from $3.6 million in Seed VC to undisclosed amounts in Series A rounds.

OS Fund, founded by Bryan Johnson in 2014, aims to benefit society on a large scale by investing in companies related to the biological revolution. The fund focuses on platforms and technologies in genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics. Bryan Johnson’s investment thesis revolves around increasing the probability of human race survival and thriving. OS Fund invests in early-stage science and technology companies with a geographical preference not specified. The fund’s investments include companies like Ginkgo Bioworks and Atomwise. Bryan Johnson’s professional career includes founding Braintree and OS Fund, emphasizing audacious scientists and entrepreneurs. The investment check size and partnership and collaboration styles of OS Fund are not explicitly mentioned.

Dan Walker is an Angel Investor at Angel Physicians Fund with a focus on Seed Round investments. Some of his previous investments include Example example company Inc, Company & Company, and Example. His investment check size ranges from $5K to $50K, with a sweet spot at $25K. He is known for investing in therapeutics, medical devices, pharmaceuticals, marketplaces, bioTech, digital health, health & hospital services, and health IT at the Seed and Series A stages. Dan Walker is affiliated with Angie Willmott, Anil Verma, Ann Weichert, Arshdeep Tindni, and Clay Willmott.

Jason Pritzker is the Co-Founder and Managing Partner of 53 Stations, an early-stage investment firm. 53 Stations targets various startup sectors primarily across North America, focusing on businesses with an enterprise value ranging from $100 million to over $1 billion and EBITDA between $15-150 million. They seek businesses with a defensible niche, significant value-adding products or services, and have a preference for long-term capital investments. In addition to supporting exceptional management teams, TPO has experience in collaborating with like-minded investors.

Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high-growth, early-stage companies. They focus on industries like Biotechnology, Health Care, Therapeutics, and Medical Device Manufacturing. Their typical investments range from $250K to $1.5M, with a check size between $25,000 and $500,000. Boston Harbor Angels engages in early-stage venture, late-stage venture, and seed investments. They primarily invest in the U.S. and Canada, with an emphasis on startups aged between 4-5 years. Some of their previous investments include Daktari Diagnostics, KnipBio, and Vizibility. The team was founded in 2004 by Mic Williams.

Gold Coast Angel Investors is an early-stage investment group based in Miami, Florida that provides funding and mentorship to high-growth potential technology companies. Their investment focus areas include Biotechnology, Consumer Products, Education, Electronics / Instrumentation, Financial Services, Gaming, Healthcare Services, and Industrial/Energy. They have a geographical preference for the Greater Miami Area, East Coast, and Southern US regions. The organization primarily focuses on angel investment, financial services, and venture capital, with investments ranging from $25,000 to $1 million per company. Gold Coast Angel Investors collaborate with successful startups and venture capitalists seeking new opportunities.

Larry Illg is a prominent investor with a focus on the edtech sector, leading global investments in companies addressing various educational needs. He has magnanimously led over $3 billion in investments globally and actively participates in the boards of key edtech companies. Larry’s strategic investments span food delivery, education, healthcare, and more, showcasing his diverse portfolio. He displays a long-term investment approach, collaborating closely with founders and teams. Larry’s involvement in Prosus Ventures and PayU underscores his prowess in the corporate venture capital arena. His extensive background at eBay and Trulia brings a wealth of experience to his investment endeavors.

Lionel Carnot, a Director/Board Member at OCULIS HOLDING AG, has a track record in various roles including Managing Director & Advisor at Bay City Capital LLC, Director at iSTAR Medical SA, Priothera Ltd., and more. With a focus on medical-device companies, biotechnology, diagnostics, and specialty pharmaceuticals, Lionel has made investments in companies like Oculis, Priothera, and Merus, with investment check sizes ranging from $100K to $5.0M. He has a history of collaboration and partnerships within the healthcare and investment sectors.

Adam Struck is the Managing Partner at Struck Capital, a Seed-stage venture capital firm that provides founder-first capital for innovative entrepreneurs. Struck Capital backs bold founders with true information asymmetries and a visceral connection to the problem. Their investment focus areas include technology, insurance, healthcare, and digital transformation. Struck Capital leads seed investments in technology and technology-enabled companies globally. They primarily invest in Pre-Seed and Seed stage companies, focusing on bold founders with a strong connection to the problem. Struck Capital’s geographical preference is global, with a strong focus on Los Angeles as a leading hub for innovation. Some of the notable previous investments by Adam Struck and Struck Capital include Engine, Payitoff, Sequel.io, Zero Hash, and Quilt. Adam Struck’s professional career includes being named in Forbes ’30 under 30′ for his venture capital business. Struck Capital’s check size varies from $100K to $5M, with a sweet spot of $1.5M. Their partnership and collaboration style emphasizes continuous learning, strong relationships in the startup community, and a founder-first approach.

GreatPoint Ventures is an early-stage venture capital firm investing between $250k and $20m into Seed, A, and B rounds.

AlleyCorp is an early stage venture fund and incubator that founds and funds transformative companies, primarily in New York.

SP3NW / WSU, through its programs, supports WSU’s mission by connecting community to academia, entrepreneurs, and innovators. Their investment focus areas include corporate, intellectual property, and technology-focused business incubation. They have invested in WSU research and innovation into biotech, pharma, diagnostics, and medical device companies. SP3NW / WSU’s collaboration styles involve engaging with various service providers and organizations, focusing on economic development, entrepreneurship, and innovation.

First Round is a venture capital firm that specializes in providing seed-stage funding to technology companies.

Incentive Technological Incubator, Israel’s first privatized Incubator, focuses on investing in life-changing healthcare opportunities to enhance patients’ quality of life. They support portfolio companies at every stage of the lifecycle, offering valuable knowledge and assistance in building successful business strategies, forming strategic alliances, recruiting strong teams, and bringing healthcare innovations to fruition. Their commitment is to partner with entrepreneurs, identify promising ventures, and achieve exceptional results.

DigitalUndivided is an incubator that focuses on seed round investments in the Technology, Media, and Telecom (TMT) industry. They provide training in startup methodologies, access to experienced mentors, seed funding, and social support to their startups. Some of their investments include Example company Inc ($1,000,000), Company & Company (â¬11,000,000 – Series C funding), and Example ($524,000 – Seed round A). They offer a 26-week incubator program called ‘BIG’ for tech-enabled startups.

Sridhar Murthy is a Chief Executive Officer with experience in enterprise software and SaaS offerings. His professional career includes leadership roles at companies like Analyte Health and TicketsNow.com. His investment focus areas include Health Care, Medical, and Personal Health, with previous investments such as Retrofit. His track record showcases over 18 years of leadership in high-growth technology companies. Regarding investment check size, investments typically range from $250K to $5M. Collaboration styles and partnership preferences were not specified.

William Rutter is an angel investor and the co-founder of the biotech company Chiron. He has a track record in the academic and biotechnology fields, having played a crucial role in the development of UCSF and Chiron Corporation. His academic career includes key contributions to biotechnology, such as the first cloning of the insulin gene and the development of a vaccine against the hepatitis B virus. William Rutter’s investments are industry agnostic, and he has made significant contributions to the biotech industry. His previous investments include Kainomyx with an investment of $7.5M. William Rutter’s investment check size can vary, and his partnership and collaboration styles involve financial support, shared facilities, and a collaborative environment among member companies within his consortium, Synergenics, LLC.

Daniel Janney, Managing Partner at Alta Partners, focuses on early-stage investments in life sciences. His investment focus areas include novel insights in biology and new approaches to drug discovery. He has been directly involved in the funding and development of 35 companies. Daniel’s investments cover a range of public and private companies, and he has led investments in various pharmaceuticals and biotechnologies. He has a strong interest in working with talented entrepreneurs and is actively involved in the board of directors of several companies. Daniel’s geographical preferences are not specified, and he primarily focuses on early-stage investments.

Aurelia Flores is an Investment Director at Virginia Venture Partners, focusing on equity investments in technology, energy, life science, and scalable startups in Virginia. VVP targets seed and early-seed stage pre-venture opportunities, investing up to $125,000 initially. Aurelia’s previous investments include companies like LearnPlatform, BetterLesson, and Kickboard. Currently, VVP’s investment thesis is centered around enabling company growth through seed and early-stage investments. Aurelia collaborates with co-investors and founders who demonstrate integrity, passion, and high achievement, fostering partnerships for long-term success.

Diede Brunen is a Principal at BioGeneration Ventures with an extensive background in translational biomedical research, oncology, and immunology. He holds a PhD and has a strong track record in identifying novel synthetic lethality targets. Diede has played a significant role in deal flow management and company creation at BGV, working on companies like Artica Therapeutics, Confo Therapeutics, Dunad, Genase Therapeutics, Tessellate Bio, and Tiga TX. His investments are focused on innovative therapies for autoimmune disorders, small molecule inhibitors, and therapeutic monoclonal antibodies. Diede’s investment check size and specific geographical preference are not explicitly mentioned on the BGV website.

Kim de Boer is an investor at Brightlands Venture Partners with an investment focus on Impact, Data Services, BioTech, Health & Hospital Services, Health IT, and FinTech. He typically invests between $100K to $5.0M, with a sweet spot of $1.5M. Kim has made investments in companies such as S+dB, Verdify, and AvL Motion at the seed stage, ranging around $1M each. His co-investors include Casper Bruens, Emma Palmen, Lex Westbroek, Luc Starmans, and Marcel Kloosterman.

TM Lee is a venture capitalist known for investing in mid-stage startups across various sectors like financial technology, services, healthcare, technology, and business solutions. Some of his notable investments include AbacusNext, Aramark, AutoStore, Brooks Automation, Ceridian, Dunkin’ Brands, and Experian. His investments typically range from seed to Series A stages. TM Lee focuses on the Southeast Asia region for investments. He has a successful track record with a check size of $5.6 billion in capital commitments for the Thomas H. Lee Partners fund. His collaboration style involves partnerships with a diverse range of companies to support growth and innovation.

Lihan Yu, a Senior Associate at Monroe Capital, has a diverse investment focus that includes sectors like Retail, EnergyTech, Media/Content, Real Estate/PropTech, Digital Health, Health & Hospital Services, Health IT, and FinTech. His investment range is $2.0M – $15.0M, with a sweet spot at $8.5M, and the fund’s current size is $1.33B. Lihan has a professional career with a track record in multinational businesses, overseeing revenues of up to $400 million USD and balance sheets of up to $1.5 billion USD. He brings valuable experience from various industries and has an MBA from London Business School. Lihan’s partnership and collaboration styles may include Cooperative Collaboration, Competitive Collaboration, Directive Collaboration, Facilitative Collaboration, and Delegative Collaboration.

Ritsaart van Montfrans is the CEO of Incision, a medical education platform offering standardized surgical procedure methods. The platform focuses on sharing experiences, skills, and expertise for rapid and thorough preparation. Incision aims to standardize surgery to enhance the quality of surgical care through global professional collaboration. Ritsaart van Montfrans has a later stage VC focus, investing in companies like Incision. He has previous experience as a partner at H2 Equity Partners in Amsterdam. His investment check size varies, with a recent equity investment of â¬3 million in Incision. Geographically, Ritsaart van Montfrans shows a preference for healthcare investments across Europe, MENA, and the US. His collaboration style emphasizes partnerships with leading European surgeons to map variations in surgical procedures for improved outcomes.

Marianne Wu, a seasoned investor from GE Ventures, is a Venture Partner at Congruent Ventures and Standard Investments. She actively supports portfolio companies entering growth stages, providing financing insights. Marianne has a strong focus on digital disruption and frontier tech in energy, manufacturing, logistics, and healthcare. She collaborates closely with syndicate members to optimize financing paths. With a background as a Partner at Mohr Davidow Ventures and VP of Marketing at ONI Systems, she brings a wealth of experience and strategic guidance to her role. Marianne’s dedication to reinventing and decarbonizing the industrial economy shines through her hands-on approach to investment partnerships.

PREIG is an investor with a well-reasoned investment thesis that supports specific investment decisions. Their investment focus areas include opportunities in energy, health care, and technology. They prefer the value investing strategy, seeking opportunities in both economically sensitive and defensive areas. Previous investments, track record, and partnership styles are available on PitchBook. The check size is determined based on the fund’s size and target, emphasizing the importance of the initial check amount.

Hanns Anders is a Venture Capital Investor at Amazon Alexa Fund with a focus on Series A Hardware, Robotics, IoT, BioTech, Digital Health, AI, Health IT, and Consumer Internet. His previous investments include taking over the Hans Anders Group from Gilde Buy-out Funds and Comnaar Investments. Hanns Anders is an Investor in various companies such as iRobot Ventures, Invisible AI, Synthesis AI, Hasty.ai, Jargon.com, Labrador Systems, and Matterport. His educational background includes an MBA/MS from the University of Michigan and a BS in Business from Wake Forest University.

Dr. Michael Powell, as the Managing General Partner at Sofinnova Ventures, focuses on companies in the therapeutics sector, particularly in cancer, neurology, dermatology, and rare diseases. His investment thesis revolves around drug development, leveraging his extensive experience in the biotech industry. Sofinnova Ventures under his leadership seeks life science companies in clinically later-stage assets. Dr. Powell’s geographical preference leans toward oncology-related fields. He has a notable track record in drug development, having worked at Genentech and various other biotech companies before joining Sofinnova in 1997. Although specific details on investment check size and partnership styles are not readily available, his career showcases a deep involvement in drug delivery, product development, and venture capital. Dr. Powell has been a key figure in the success of numerous biotech companies, reflecting a strategic and hands-on approach to investments.

Noam Gottesman, the co-founder of GLG Partners, focuses on investing in dividend stocks and healthcare stocks through GLG Partners. GLG Partners is a diversified and multi-strategy fund manager, with a history of successful investments. Noam Gottesman’s investment check size is substantial, with a public equity portfolio worth $3.8 billion. His partnership and collaboration styles involve strategic alliances, discussions on potential transactions, and involvement of advisors in analyzing and negotiating terms.

Qidong Jia, a Partner at CentreGold Capital, focuses on early-stage consumer marketplaces and digital health startups in North America and China. CentreGold Capital’s investment thesis revolves around using data-driven technologies for personalized products to enhance consumer well-being. They have funded companies like GrubMarket and prioritize visionary entrepreneurs with innovative solutions. The check size for their investments is not specified on their website. The partnership and collaboration style of CentreGold Capital is not explicitly mentioned on their website.

Italian Angels for Growth is an angel investor network focusing on Medtech, SaaS, e-commerce, Fintech, and high tech startups in the Seed/Series A stage. With a geographical preference for the EU, Europe, Middle East, and Africa, they have invested over 22 million Euros in 41 startups, including Rubedo Life Sciences, Clearbox AI, and Viceversa. They offer support from Investment champions to help startups succeed.

Matthew Strong is an individual investor based in Milwaukee, Wisconsin. His investment focus areas include Healthcare, Consumer Internet, Energy & Clean Tech, Enterprise Software, and Mobile. He typically invests in the Seed Round stage. Some of his previous investments include Agent Ace in a Series A funding valued at $6 million. Matthew Strong has a track record of investing in relevant startups and is known for his involvement in the Series A round of Agent Ace.

Myrto Lalacos, an Investment Executive, is focused on early-stage companies with ticket sizes ranging £1-3m in Northern companies. She transitioned into VC after being part of Campus Capital’s Student VC program. Myrto Lalacos prefers sustainable and community-building investments. She has experience with Praetura Ventures, specializing in early-stage companies in Northern regions. Specific investment check sizes are not disclosed. Partnership and collaboration styles are not explicitly detailed, but Lalacos values sustainable ventures and impactful investments.

Jeff Goldrich is the Managing Director of Technology at Runway Growth Capital. With nearly a decade of experience in the technology sector, Jeff focuses on late and growth-stage investments. He collaborates with technology executives and investors to bring their growth objectives to life, leveraging his analytical skills to simplify complex information. Jeff’s professional career includes roles at CIBC U.S. and The PrivateBank. He is a seasoned professional with a strong background in asset-based lending and factoring business for over 40 years. Jeff has also been involved in various roles at SLR Business Credit and Lakeshore Ventures. His partnership and collaboration style revolves around building relationships and trust to support entrepreneurs in building and scaling dynamic technology companies.

Bessemer Venture Partners is a venture capital firm that invests in enterprise, consumer, and healthcare early-to-late stage startups.

Jeff Aiello, Managing Director at Thompson Street Capital Partners, specializes in investing in Series B Enterprise Infrastructure, Medical Devices, Pharmaceuticals, Enterprise Applications, Consumer Health, Digital Health, BioTech, AI, and Health IT. His investment check size ranges from $5.0M to $50.0M, with a sweet spot at $25.0M. Jeff has a track record in film production, known for works like Motion (2009) and Afterburn: The Creek Fire Documentary (2021). His investment approach emphasizes collaboration and ranges across various sectors and regions within the USA, including the Midwest. He holds an MBA from the University of Pennsylvania – The Wharton School, and has experience at Thompson Street Capital Partners, Audax Group, and in the United States Air Force.

Johnson Yang, a Principal at General Catalyst, is known for his investment focus areas in Seed Consumer Internet, SaaS, and FinTech, covering stages from Seed to Series B. His geographical preference includes the Midwest and New York City. Johnson Yang has made previous investments alongside co-investors like Adam Valkin and has a track record as a sharp investor in both B2C and B2B tech. His investment check size ranges from $500K to $10.0M, with a sweet spot at $2.0M. Johnson Yang is described as friendly, nice, and knowledgeable, making connections even beyond investment opportunities.

Barry Fingerhut, as the Co-Founder and General Partner of Wheatley Partners, heads a New York-based private equity firm established in 1992. Wheatley Partners specializes in funding technology-related companies across various sectors, including information technology, business services, medical technology, healthcare, and education. The firm is actively involved in supporting portfolio companies at all stages of development, providing multiple rounds of financing. Barry Fingerhut has been part of 55 investments with 24 exits so far. Wheatley Partners’ investment focus areas encompass a wide range of industries, and they have a geographical preference for regions like the Greater New York Area and the East Coast. The firm’s standard check size and partnership/collaboration styles were not explicitly mentioned, but the email contact provided indicates an openness to communication and potential collaborations. Barry Fingerhut’s professional career includes a successful track record in the private equity and venture capital space, actively contributing to the growth and development of numerous startups.

Cornelia Hoppe is an investor with a focus on HealthTech, specifically investing in companies like Exakt Health. Her investments are primarily in Seed Rounds, and she has a track record of investing in startups in Germany. Cornelia has made several investments, such as in Exakt Health and eaze, with check sizes ranging from â¬500,000 to â¬1.7 million. She is known for her investments in the HealthTech sector and her collaborative approach in co-investing with other entities like Auxxo and Possible Ventures.

Jay Silverstein is known for making strategic investments and often collaborates with promising companies in the health sector. He focuses on early-stage companies and invests personal money in exchange for equity. His check size for investments varies and he has a track record in the US health industry. Silverstein’s previous investments include companies like Picwell. His geographical preference and partnership styles are not explicitly mentioned in the search results.

Clemens Dietrich is an angel investor focusing on Internet of Things, Financial Technology, and Healthcare IT sectors. He has made investments typically ranging from $500K to $1.5M. His collaboration style is tailored to the specific goals of the startups he supports.

Ark Angel Alliance is a group of business and community leaders dedicated to fostering startup companies in Arkansas and beyond. Their mission is to actively invest in high-potential startups, with a preference for Arkansas-affiliated deals. They focus on helping angel investors make sound investment decisions and build connections. The check size for their investments typically ranges from $50,000 to $1 million. The alliance has successfully raised funds and invested in sectors like healthcare, manufacturing, education, retail, and technology. Their collaboration style involves providing a marketplace for investors to connect with early-stage ventures.

Khaled Badr-El-Din’s investment thesis is in health tech (software + data)

Ryan Malas, an Associate at LOUD Capital, focuses on fueling innovations that drive equitable access to high-quality, inclusive healthcare through investments in people-centered healthcare, including medtech, alternative care models, and healthcare infrastructure and IT. Some of his previous investments include Genetesis, Share Mobility, OFFOR Health, Hyperion Motors, Inc., LiveEasy, Carely, Raydiant Oximetry, 10XTS, Honest Game, Pay Theory, Medzoomer, SupplyHive, Revibe Technologies, Knowwake, Gemelli Biotech, GiftHealth, Carallel, and Beyond Physician. LOUD Capital’s investment check size and partnership/collaboration styles are not specified on their website. Ryan Malas’ geographical preference spans North America and LATAM. For more information, visit LOUD Capital’s website at [loud.vc](https://www.loud.vc/).

Promod Haque serves as a Senior Managing Partner at Norwest Venture Partners focusing on enterprise and healthcare IT. Their investment thesis is motivated by innovation driving new infrastructure and business solutions. Norwest invests in early- to late-stage businesses across key sectors with a focus on enterprise, consumer, and healthcare. Promod has a track record of investing in more than 70 companies with investments worth over $40 billion in exit value. The investment check size ranges from $20 million to $100 million for growth equity investments. Norwest’s partnership and collaboration styles emphasize the importance of diversity and collaboration within the industry.

June Huang is a Director at Bain Capital Credit, focusing on originating, evaluating, and monitoring investments across the Financial Services industry. The investment check size provided by Bain Capital Credit varies based on the specific needs of the companies. June Huang’s professional career involves being part of Bain Capital Credit’s team of over 35 Partners, with a collaborative and performance-driven culture, seeking attractive credit opportunities with the support of robust resources. The partnership and collaboration style at Bain Capital Credit is characterized by a team-oriented and diverse environment, aiming to identify and capitalize on credit opportunities.

Louise Meyer-Schönherr, an Associate at HV Capital, focuses on investments in various sectors including Logistics, Retail, Transportation Tech, Enterprise Applications, E-commerce, Digital Health, Health IT, FinTech, and Health & Hospital Services. Her investment range is $690K to $69.0M with a sweet spot at $25.0M. The collaboration styles she values include assessing team composition, evaluating interpersonal dynamics, and blending communication-oriented and task-oriented collaboration for effective teamwork.

Lars Svensson is an Angel Investor with a focus on the European Union (EU) region. His investment thesis and focus areas are not specified. He has made 3 investments in companies like Interspectral, Skira, and MediCheck. His investments range from SEK 1M to SEK 5M. Lars Svensson is known for his contributions in the field of cardiovascular surgery and is the chairman of the heart and vascular institute at Cleveland Clinic. Additionally, he actively contributes to interprofessional collaboration by bridging professional, social, physical, and task-related gaps in the healthcare sector.

Dan Letizia is a Managing Director at Monroe Capital with an investment range of $2.0M – $15.0M and a sweet spot of $8.5M. He specializes in sectors such as Retail, Media/Content, Digital Health, Real Estate/PropTech, Health & Hospital Services, Health IT, and FinTech across different stages. His previous investments include Seed and Series A investments in various industries. Dan Letizia collaborates with other investors like Alex Patil, Andrew Eck, Andy Kiehl, Casey Vercauteren, and Chase Silverman. He follows an expansive collaboration model in his partnership and collaboration styles.

Holger Johnsson is an investor with a focus on European startups. He has a track record in venture capital investments and collaborates with startups at various stages. His investment check sizes vary depending on the company’s needs. Holger Johnsson’s partnership and collaboration styles involve actively supporting startups to achieve growth and success.

Björn Zethraeus has made 3 investments. Their latest investment was in BrainLit as part of their Series B on June 02, 2021. Investment focus areas include Technology, IT, Consumer, Tech, Insurance, Healthcare, Industrials, and Financial Services. Geographically, Björn Zethraeus invests across Africa with a focus on the main sectors. The specific stage of investment and investment check size are not clearly available. Previous investments include BrainLit.

Moritz Sell is an investor who has made investments in technology, insurance, and healthcare sectors. One of his known investments is in Factory Berlin. He typically invests around $1.05M in companies. Details about his partnership and collaboration styles are not available.

Manyam Mallela, serving as Advisor at Srch2, is primarily an angel investor focusing on personal investments in promising companies. He has not publicly disclosed specific investment focus areas or previous investments. His track record and professional career details are not available. Given his position as an advisor, details like investment check size and partnership/collaboration styles are not disclosed publicly.

Navin Goyal, co-founder and Chief Executive Officer at LOUD Capital, focuses on healthcare in the venture space and aims to shape LOUD as an alternative investment firm combining profit with purpose. LOUD Capital’s investments cover areas like Health Care, Software, FinTech, Artificial Intelligence, and Dental, with an average round size of $3 million. Navin Goyal typically invests in early-stage companies and prefers startups with 4-5 participants per round. Previous investments include companies like SafeChain, Xaptum, and Genetesis. LOUD Capital, based in Columbus, Ohio, USA, usually invests between $1-5 million per startup. Navin Goyal’s professional career includes co-founding a dental anesthesia service, which led to involvement in venture capital and angel investing. With a track record of 24 investments, LOUD Capital strives for diversity in funding decisions without a specific preference for the number of founders. While specific information about geographical preference and partnership styles is not available, the firm’s ethos revolves around merging profit with a purpose-driven approach.

Rosco Hill is a Co-Founder and Chief Executive Officer at Blend, with a background in launching revenue verticals like global banking and regulation. His investment focus areas include Consumer Internet, Enterprise Software, Mobile, Healthcare, Messaging, and Private Social Networking. Past investments include PeopleCo, Karatio, Kik Interactive, and more. He is an Angel/Individual investor based in San Francisco, United States. Rosco’s check size for investments ranges across various sectors, and his partnership and collaboration style are reflected in his leadership at Perpetua, an AI-powered advertising software company.

Bluegrass Angels Inc is a dedicated investor in innovative Kentucky startup companies, aiming to grow quickly into large markets for significant financial returns and job creation. Their investment focus spans healthcare, agriculture, industrial chemicals, manufacturing, biotech, fintech, media, and IT sectors. They invest in high-tech Kentucky start-ups with a goal of long-term success and financially viable exit strategies. Bluegrass Angels prefer investing in local companies across Kentucky and actively seek new investments. Their portfolio includes companies in various industries seeking successful and profitable exits.

Jeffrey Jordan is a General Partner at Andreessen Horowitz with a focus on global health, HIV/AIDS, maternal and child health, organizational management, population, and reproductive health. He invests in companies at the VC stage with a check size range of $500K to $3M. His geographical preference is not specified. Jeffrey Jordan has a track record of providing strategic leadership and vision in the field of global health and population issues. He collaborates with athletes to empower engagement with fans through a consumer-facing community platform under Heir Inc. The platform aims to connect fans with their favorite athletes in various ways, including entertainment and consumer products.

G Squared is a growth stage venture capital firm that invests privately in today’s most dynamic companies.

Robert Soni is focused on investing in AI, Biotech, Cloud, Consumer, Cybersecurity, Deep Tech, Fintech, Healthcare, Marketplaces, and Vertical Software areas at Bessemer Venture Partners. His previous investments at Bessemer Venture Partners include a diverse range of companies such as 2U, Acceleron, Shopify, and Betterment.

Vertical Venture Partners is a venture capital firm investing in enterprise technology companies that target specific vertical markets.

Lars Appelstööl is an investor focusing on sectors such as healthcare, fertility, and education. He has a diverse investment portfolio including Treadwell Therapeutics, TIO Bioventures, VoltSafe, and FYidoctors. Lars has a Master of Business Administration from Simon Fraser University and a Bachelor of Science and Doctor of Optometry from the University of Waterloo.

Christin Godale is a Director at CincyTech USA, focusing on investments in Seed Digital Health, Digital Health (Seed), BioTech (Seed), and Female Investors within the Midwest. She has a broad investment range from $100K to $5.0M, with a sweet spot at $1.5M. Specifically targets the $1.5M range. Christin collaborates with co-investors Carl Labanz, John Rice, Sarah Douglas, and Sean Kwiat. She has a background in Neuroscience and actively invests in the identified areas.

Ross O. Youngs is an investor with a focus on early to mid-stage companies with diverse investments. He has a track record in professional baseball and has a lifetime .322 batting average. His investment check size is around $50k. Youngs emphasizes the power of strategic partnerships and focuses on collaboration in his investment approach.

Brian Yee, the Managing Director at Bradley Woods & Co., specializes in renewable energy, oil & gas, and electric utilities. With a background in investment management, he focuses on consumer, healthcare, fin-tech, and vertical software industries. Brian’s investments include companies like Ever/Body, Forma.ai, Quip, SoLo Funds, Wag!, and Zendrive. He has experience in mid-to-late stage growth investments. Brian values authentic connections and has a strong family history background. His investments are diverse, covering sectors like healthcare, fin-tech, and software.

Highland Capital Partners is a venture capital firm that offers seed, early, and growth-stage funding solutions.

Monty Metzger is a Partner at Digital Leaders Ventures. His investment focus areas include fast-growth tech companies with scalable business models. He invests in startups at the Series A stage, providing growth investment rounds. Monty Metzger primarily invests in European Entrepreneurs going global. Some of his previous investments include PayKey, Cortrium, Snaplytics, and Pingpad. His investment check size and partnership styles could not be determined from the available information.

Craft Ventures is an early-stage venture fund specializing in the craft of building great companies.

Ali Ciğer is an angel investor with a focus on seed-round investments in healthcare, consumer internet, energy & clean tech, enterprise software, and mobile. He has made investments in companies like Example Company Inc, Company & Company, and Example. Ali Ciğer’s professional background includes being a Co-founder at Mesh Stick and serving as the Head of Vaccines at Pfizer. He is known for his active role in investing, particularly in seed rounds. While the investment check size is not specified, his investment focus areas cover a diverse range of industries. With a track record in the healthcare sector, Ali Ciğer is recognized for his commitment to early-stage startups and collaborations within the tech ecosystem.

Kai Bolik, a high net worth individual from Berlin, Germany, is a Co-Founder, Chief Executive Officer, and Managing Director at GameDuell. He is also the Owner and Managing Director of CreateK. Kai Bolik manages his own investment funds. His investments focus on industries such as IT, Consumer, Tech, Insurance, Healthcare, and Financial Services. Notable previous investments include Upland and Subscribe to see more. He is known for his hands-on investment approach and has an investment check size that varies based on the opportunity. Bolik is involved in partnerships and collaboration styles that align with his entrepreneurial and investment endeavors.

Broadway Angels is an angel investment group based in San Francisco, California. They specialize in investments in enterprise technology, consumer, and health and wellness sectors.

Patrick Shannon, an Executive at Lifeforce Ventures, invests in software companies reshaping the status quo in healthcare’s largest markets. His investments primarily focus on healthcare software innovations. Specific investment focus areas include reshaping the status quo in healthcare’s largest markets. The investment check size ranges around $36 million. Partnership and collaboration styles are not specified on the website.

John Garbarino is an angel investor with a focus on seed round investments, particularly in industries such as healthcare, real estate technology, and SaaS. He brings over 30 years of experience in private equity and operation executive roles. John has a strong track record in building, leading, and scaling teams in various tech companies. He is a small business owner of Spiral Array Consulting and has held significant positions in companies like Gremlin, TRUEFORT, and Riverbed Technology. John holds a Master of Science in Computer Science from the Illinois Institute of Technology and a Bachelor of Science in Electrical and Computer Engineering. His investments typically range in the seed round and are up to $650 million. John is known for his strategic partnerships and collaborative approach in building successful ventures.

Fred Thuard is a seasoned app economy entrepreneur and former App Annie EVP. His investment focuses include markets in Mobile, Digital Media, SaaS, and more. He has made 4 investments in various sectors such as mobile gaming, monetization, and healthcare. Fred has built and advised multiple start-ups, holding senior roles in the European broadcast industry. With an educational background from Sorbonne University and Insead, his partnership and collaboration styles emphasize building nurtured professional relationships and leveraging networks.

Kyto Technology and Life Science Inc., operating as K2X Technology & Life Science, Inc., focuses on creating an ETF-like vehicle of diversified and vetted startups for global investors. They target the top <10% of startups, investing in angel-stage startups globally. With a Silicon Valley base, the company is managed by experienced angel investors. Their investment approach ensures a safer, higher-return, non-correlated, and liquid investment in startups. They prioritize double-vetting of all investments. Although the investment check size is not specified, their investment thesis emphasizes providing a diversified and safer investment option in startups. Partnership and collaboration styles are not explicitly mentioned.

Launchpad Digital Health is an early-stage investor and mentor in digital health

Dr. Georg Ried, the Managing Director at Bayern Kapital, focuses on software, bioscience, healthcare, and pharmaceutical sectors. He invests in early-stage ventures in the Bavarian high-tech segment. Some of his previous investments include Ondeso, Mecuris, SimScale, and Veact. Dr. Ried has a successful track record in the venture capital industry. The investment check sizes vary based on the specific opportunity. His partnership and collaboration style involves creating collaborative partnerships with organizations to achieve mutual goals.

Sean Harper, as an investor, has a focus on therapeutics to improve human lives. His previous investments include Uprise, Anzen, Conekta, and WeDeliver. He has made 3 investments and has 1 portfolio exit. The investment check size is undisclosed. Harper’s partnership and collaboration style involves ethical sharks who are team players, persistent, and care deeply about customer impact and fairness. They prioritize teamwork, recognize group efforts, and encourage positive reinforcement within the sales team.

1809 Capital is a financial focused investment firm.

Mark Goldstein’s investment focus areas primarily include health, wellness, and food sectors. He is involved in investments related to health care, SaaS, IoT/devices, energy, and ag tech.

Tom Bunn is a Venture principal at iSelect Fund with a focus on investment due diligence, portfolio maintenance, and deal sourcing. He has a background in Economics from Colorado College and a Certificate in Social Enterprise Management and Impact Investing from The Middlebury College of International Studies. He is based in St. Louis, Missouri. For more information on his investment focus areas, stage of investment, geographical preference, previous investments, track record, professional career, investment check size, and partnership and collaboration styles, visit the iSelect Fund website.

Glenn Frommer is a multifaceted professional with a focus on sustainability and environmental movement. He is the Managing Partner at ESG Matters IVS and has a PhD in Aerospace Sciences. Glenn has a track record of over 30 years working in sustainability and environmental reporting. His investment thesis revolves around “Managing Risk, Return, and Impact Investing Goals.” The investment check size for Milkbox Partners, the VC firm he co-founded, ranges from $25,000 to $500,000 for pre-seed investments. Milkbox Partners focuses on investing in consumer, eCommerce, health tech, wellness, cleantech, sustainability, environmental, clean-energy, transportation & logistics, software, SaaS, real estate & prop-tech, blockchain & Web3, and Industrial Solutions. Glenn’s geographical preference is global, and he has been involved in numerous sustainability projects worldwide. In terms of partnership and collaboration styles, Glenn is known for leveraging his 40 years of business leadership experience to support governance, strategy development, fundraising, and market penetration in various sectors, including healthcare. He is deeply passionate about supporting the PKD community.

Ariel Southeast Angel Partners is an angel investment group that invests in a variety of high-growth areas. They focus on bio-technology, medical devices, health care, therapeutics, and life science. The stage of investment is in start-up and early-stage companies. Their geographical preference is in Savannah, Georgia. Some of their previous investments include bio-technology, medical devices, and health care startups.

Samsara Biocapital, LLC provides investment advisory services.

Richard Forman is a Co-Founder and Managing Partner at MDX Mediccal, serving as an advisor at KICventures. He focuses on technology and consumer-related health care investments. His previous investments include a generative AI engineering design copilot and a software-drug combination platform. Richard Forman’s check size for investments remains undisclosed. He is known for his partnership and collaboration style in the health care sector and has a strong background in technology and engineering, with experience in leading and founding successful companies like Register.com, Inc. He holds degrees in Economics, Electrical Engineering, and Real Estate. Richard Forman values collaboration and actively contributes to educational initiatives at the University of Pennsylvania.

Archangel Global Investors is an angel investor based in Irvine, California. Their investment thesis focuses on scalability, market size, defensibility, and the quality of individuals backed. They prefer companies that are not capital intensive and can scale without significant investment. Archangel’s previous investments include Noa Therapeutics and Bioliberty. The check size for new deals is at least £100,000. The team has an excellent track record in early-stage investing. Their collaboration style is tailored towards scale and generating revenues efficiently.

Adrian Blumer is an investor with a focus on land for multifamily development, value-add retail, and life science properties. He invests in early-stage ventures and has had previous investments in companies like EOS blockchain creator Brendan Blumer. His check sizes range from $250K to $5M, and he follows a collaborative partnership style that may involve connecting with individuals across various teams and external partners.

Kristopher Brown is an Angel Investor based in New York, USA. He focuses on private equity and venture capital financing transactions with a specialty in healthcare, life sciences, financial and information technology, electronics, energy & telecommunications industries. His investments range from seed stage to Series B, with an emphasis on supporting emerging growth companies. While the investment check size is not specified, he has made investments in various companies. Kristopher values collaboration and partnerships and has a track record of strategic alliances and joint ventures. With a background in governance, regulation issues, and securities laws, he brings a wealth of experience to his investments.

Christian Tiessen is an investor who has concluded an international round of Series A financing for a total funding exceeding USD 10M. His investment check size is around USD 10M+ as part of this round. Details of his specific investment focus areas and previous investments are not available. Christian Tiessen’s partnership and collaboration styles are not explicitly mentioned. For more information, the website www.savedo.de / www.savedo.at / www.savedo.nl can be visited.

Casey Vercauteren is a Senior Associate at Monroe Capital, specializing in investments ranging from $2.0M to $15.0M with a sweet spot of $8.5M. His focus areas include Retail, Media/Content, Real Estate/PropTech, Digital Health, Health & Hospital Services, Health IT, and FinTech across different stages. He primarily invests in the Midwest region. His previous investments include Retail, Media/Content, Real Estate/PropTech, Digital Health, Health & Hospital Services, Health IT, and FinTech. Casey works with a team of investors such as Alex Patil, Andrew Eck, Andy Kiehl, Chase Silverman, and DaeYoun Kim.

Dr. Janice Gabrilove is an Angel Investor at Easton Capital Investment Group. She is board certified in Internal Medicine and Medical Oncology, serving as a Scientific Advisor. She has patents related to medical treatments and has advised biotech companies. Dr. Gabrilove’s investment thesis focuses on the healthcare and biotech sectors. However, specific information about her investment stage, geographical preference, previous investments, and check size is not available.

William Hambrecht is the Co-Founder and Chairman of WR Hambrecht + Co. The investment thesis of Hambrecht Ventures is focused on Disruption Theory, collaborating with Harvard Professor Clayton Christensen. Their geographical preference is global for identifying disruptive companies. Past investments include Genentech, Invisalign, and 23andMe. Hambrecht Ventures’ partnership style involves collaborating with experts like Professor Christensen. Hambrecht has a record of identifying early disruptive companies and has various venture funds in healthcare and technology sectors.

Amrinder Singh is a Partner at Vensana Capital with a background as a Senior Investment Director at Medtronic Ventures. He focuses on transformative medical technology innovations with investments in Series A to growth stages. Amrinder’s geographical preference is not specified. His partnership and collaboration style emphasize business news, profiles, and deal flow coverage. The investment check size for his investments is not explicitly mentioned on the website.

Valhalla Angels is an angel network primarily investing in early-stage firms. Founded in 2003 in Calgary, Canada, they have a portfolio of 11 companies in sectors including Enterprise Applications and Life Sciences. Their stages of investment range from Seed to Angel. Valhalla Angels focuses on investments in Canada and the United States. Notable portfolio exits include Nanalysis Corp. and Mobile Data Technology. The team consists of 3 partners, including Grant Lawrence and Colin Holowaychuk. Some of their previous investments include iApotheca Healthcare, Mesentech, and NOBAL Technologies. The average round size of their investments is $733K, with a total of 6 investments and 6 portfolio startups. For more details on their investment style, specific investments, and professional career, refer to their profile.

United Investors is an Angel Group, Micro VC, and Syndicate investing in early-stage ventures, the secondary market, seed, and venture stages. Their investment focus includes medical devices, healthcare, manufacturing, and other healthcare technology systems. Some of their previous investments include Qvalon, imin, and Mo: Meditation & Sleep. They are known for being one of the largest venture syndicates for Russian-speaking angels and VCs, with about 600 members since 2019. Contact email: a@unitedinvestors.ru, Phone: 8(499)350-07-47, Website: unitedinvestors.ru.

Aga Manhao, Co-Founder and Managing Partner of Future Health, is an angel investor with a focus on early-stage healthcare technology startups in Asia. His investment thesis revolves around improving healthcare quality and accessibility through innovative diagnostics, telemedicine, wellness, and more. Future Health primarily invests in HealthTech companies expanding into Asia. With a track record of successful listings and extensive global experience, Aga is positioned to guide startups through growth. The investment check size ranges for startups, offering a platform for pooled funds and risk-sharing. Aga emphasizes building networks and ecosystems to support entrepreneur growth in the healthcare technology sector.

Stefan Muehlemann is an Angel investor with a hands-on approach and a passion for sustainable investments. He focuses on Pre-seed stage startups in sectors such as Medical Devices, Consumer Health, and Health IT. Stefan typically invests between $5,000 and $50,000 per company, with a sweet spot of $25,000. His professional career spans over 25 years in banking and finance, and he holds an M.B.A. from Dartmouth College. As the Co-Founder and Director of Loanboox, Stefan brings a valuable network of investors and borrowers. Additionally, he is associated with redalpine, a Swiss venture capital firm specializing in empowering GameChangers. Stefan’s partnership and collaboration style is geared towards empowering ambitious entrepreneurs to convert their vision into reality through financial investment and operational expertise. redaljsonpine, where Stefan is part of the board, has over 85 companies in its portfolio and invests Europe-wide from Zurich and Berlin.

Amanda Stenbaek is an Associate at INKEF Capital, with an investment range of $100K to $5.0M and a sweet spot of $1.5M. She focuses on Seed BioTech, Digital Health, Health & Hospital Services, and Health IT. Amanda has a track record of investing in startups and collaborating with co-investors like Alice Vickers, Carien Beyer, Corné Jansen, Estelle Botbol, and Ivan Burkov. She operates within a fund size of â¬500M.

Zachary Friedman is a Vice President at RF Investment Partners in New York, evaluating new investment opportunities in sectors such as Software, Healthcare Services, and Business Services. His previous investments include VivoAquatics, MemberClicks, ArchiveSocial, and more. With a background in underwriting credit transactions for technology companies and managing software investments, Zachary brings a wealth of experience to the table. The investment check size and partnership styles are not explicitly mentioned but are aligned with the firm’s focus on innovation and growth.

Herbert Sablotny is a VC Investor and Venture Scout at Picus Capital with an investment range of $250K – $750K, focusing on sectors like Human Capital/HRTech, Insurance, EnergyTech, TransportationTech, Real Estate/PropTech, E-commerce, Health IT, and FinTech. His sweet spot for investments is $500K. Some of his co-investors include Abhijay Thacker, Alessandro Kopp, Alexander Kremer, Alexander Samwer, and Alexander Worbs. Herbert Sablotny’s partnership and collaboration styles are characterized by collaborations with key investors such as Amaan Irfan Furniturewala, Andrea Diaz, Anton Barthelmess, and Carsten Lebtig. He has a track record of successful investments and professional experience at Picus Capital.

Leandro Bedolla at M25 is a venture capitalist specializing in investments in Midwest-based pre-seed and seed-stage founders. His investment focus areas include Entertainment & Sports, E-commerce, AI, FinTech, Digital Health, and more. Bedolla’s investment range typically falls between $250K to $500K, with a sweet spot of $375K. He has a track record of supporting diverse communities and startups, promoting accessibility in the field. Leandro Bedolla’s collaboration style involves active participation with founders, conducting in-depth analysis and due diligence. He is known for investing in various sectors like E-commerce, AI, and IoT, primarily focusing on the Midwest region.

Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.

Alexander Schmoeckel is an Associate at AM Ventures, focusing on technology scouting in North America and integrating ESG aspects into the organization’s processes. AM Ventures invests in industrial 3D printing innovations, with a ticket size ranging from â¬500k to â¬3m, supporting founders in the additive manufacturing space. Schmoeckel has been actively involved in sharing insights and news related to investments in companies like Vectoflow, Evove, Fortius Metals Inc, MetShape, and others. His career at AM Ventures started in 2018 as a student supporting global scouting activities. He holds Bachelor and Master degrees in Management & Technology, specialized in finance, accounting, and mechanical engineering. Schmoeckel is known for his commitment to fostering collaboration and partnerships in the additive manufacturing sector.

The SaaSgarage is a venture capital firm founded in 2008 in Munich, Germany. Their investment thesis focuses on Vertical SaaS solutions tailored to specific industries and niches. They target niche markets in sectors like oil, gold, AI, and healthcare. The firm invests in Early Stage Venture and Seed rounds, preferring startups aged 2-3 years. Geographically, they have a preference for investments in Germany. Some of their previous investments include Loyalty Prime in the Enterprise Applications sector at a Series B stage. The founder, Alexander Bruehl, has a solid professional career, serving as the Founder at SaaSgarage GmbH. The fund typically invests 1 to 5 million dollars per deal, engages in 3-4 partaker rounds, and has had notable investments in companies like Contentful and Softgarden. Their collaboration style emphasizes trust, long-term goals, communication, joint value propositions, and innovation.

Adam Besvinick is the Founder and Managing Partner at Looking Glass Capital, a pre-seed investor focusing on health, climate, and empowerment themes. He has invested in companies like Hone, Framework, [untitled], Basil Systems, Carbon Collective, EnMass Energy, Daily Blends, Therify, Polimorphic, and more. Adam has a background as a venture investor at Anchorage Capital Group and worked at Deep Fork Capital. He also co-led By/Association, an angel investor group, and has experience in business development and partnerships with companies like Wanelo. Adam graduated from Harvard Business School and held roles at Lowercase Capital and Gumroad. His investment approach involves supporting mission-driven founders in the earliest stages of company building.

Russ Nash serves as a Board Member at H2 Wellness and AbleTo. He managed Accenture’s US Health Payer Client Group and was the Global Managing Director of the firm’s Health and Life Sciences Industry Group. His investments include Wellframe, WhiteFox Defense Technologies in HealthTech, Aerospace industries. Russ Nash’s investments are primarily in the United States. He has a Professional Background in Health and Insurance practices and is a Fellow of the Casualty Actuarial Society.

KdT Ventures is an early-stage venture capital firm that invests in startups in the data, engineering, and biology sector.

Bettina Ernst, Vice President and CEO of BERNINA BioInvest, focuses on investing in healthcare companies with an investment range of $100K to $5.0M, particularly in Seed Pharmaceuticals, Digital Health, BioTech, and Health & Hospital Services. Her sweet spot for investments is $1.5M. She has invested in companies like SunRegen at Series A stage. Bettina is actively involved in the Swiss Biotech scene, serving on various boards and being a co-founder of two biotech companies. With a background in immunology and natural science, she brings a wealth of experience to her investments.

Simiat Oluwadare, an investor based in Calgary, Alberta, has an investment thesis focused on SaaS startups and has invested in companies like Deel, CaptivateIQ, and Alto Pharmacy. Their investment focus areas include Agriculture, Education, Clean Energy, Financial Inclusion, Health, Housing, Water & Sanitation, and Workforce Development. Simiat Oluwadare’s preferred stage of investment is not available. The check size for investments can range from $500K to $1.5M. As for partnership and collaboration styles, no specific information is available at this time.

Triangle Angel Partners is a North Carolina-based angel fund specializing in early-stage investments in high-tech and life sciences industries. The firm focuses on companies in or around North Carolina’s Research Triangle Park. Some of their previous investments include Carpe Antiperspirant Lotion, Deep Blue Medical Advances, and Pryon. Triangle Angel Partners was founded in 2011 and has an active portfolio across North Carolina, southern Virginia, and northern South Carolina. The Angel Investor, Kelly Caldwell, has a professional background in various organizations, including serving as a Program Facilitator Coordinator at Cornell University and as a Co-Founder at Sonaya Properties. The investment check size and partnership/collaboration styles are not explicitly mentioned in the available information.

Jeffrey Walker is an Angel Investor with a focus on philanthropy and social enterprises. He is actively involved in various organizations supporting health finance, music education, and social change projects. Jeffrey’s investments typically range from $14 million in Series A funding rounds. He collaborates with a wide range of partners in his investment activities.

Thomas Hirschfeld serves as Chief Operating Officer at Halcyon Asset Management, with a history of leadership roles in prominent firms, including Managing Director at J. & W. Seligman & Co. and Partner at Patricof & Co. Ventures. His investments focus on Digital Health/Healthcare Services. Previous investments include MedPilot and Goldilock. He has an extensive professional career in investment banking and venture capital. The investment check size is not available from the sources. Thomas Hirschfeld’s partnership and collaboration styles are not directly mentioned in the search results.

Simon Kreitmair is the CFO of Dolpheen Global. He has a background in finance and technology, with experience in companies like Qualysoft and Tricentis. He holds a certification as a Test Design Specialist for Tricentis Tosca. Kreitmair pursued Informatik at Fachhochschule Technikum Wien.

Natalie Tydeman, Senior Investment Director at Kinnevik, focuses on growth investments in Europe with a particular emphasis on fast-growing technology companies within entertainment, education, and health/wellness sectors. She has a successful track record in private equity investing and a background in senior executive roles in tech/media companies. Natalie holds an MBA from Harvard Business School and a degree from the University of Oxford. She collaborates with Kinnevik’s mission-driven investment strategy to build sustainable companies with a positive impact. Her investment check size, geographic preference, and previous investments are not specified in the available information.

Sjoerd Rietberg is an active investor and advisor, focusing on Enterprise Applications, High Tech, and other sectors. He has made investments in companies like Zoi Meet and GNX, primarily at the seed stage. Sjoerd holds a Master’s degree in Finance from Erasmus University Rotterdam. He is involved in diverse investments such as Agga Capital, Nectar, GNX, Idris Oncology BV, Interverse #AI, and more. His check size for investments ranges around $1,000,000 for seed rounds. Additionally, Sjoerd has been an Advisory Board member and investor at SmartQare BV. His partnership and collaboration style involve long-term relationships and close collaborations with various companies, demonstrating a hands-on approach to investment.

TPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry.

Dr. Gabriel Otte is an Angel Investor focusing on SaaS startups. He is known for investing in early-stage companies at the seed round. His geographical focus includes San Francisco, California, where he is based. Gabriel Otte has a professional background in mobile development, technology, and machine learning, with a significant presence in the healthcare sector through Freenome. While he does not have specific data available on previous investments or check sizes, his partnership and collaboration styles reflect a strong commitment to advancing early cancer detection technologies through innovative biomarker studies. His track record includes leadership roles as CEO and Co-Founder of Freenome, showcasing his expertise in healthcare innovation and entrepreneurship.

Gary Kunis, a former Cisco Chief Science Officer, is actively involved in supporting biotech companies and aspiring entrepreneurs, focusing on technological innovation and entrepreneurship.

Gopher Angels is an angel investment firm based in Minneapolis, Minnesota. They focus on investing in scalable, early-stage companies in diverse industries, including healthcare, health IT, enterprise and SaaS, food and beverage, medical devices, agtech, and more. The firm prefers to invest in companies at the Seed and Round A stages. Gopher Angels has a track record of supporting companies like CoreBiome, Dispatch, StemoniX, Upsie, and others, with investments typically ranging around $350,000. Their collaboration style involves providing financial support and expertise to early-stage businesses. Although specific details about their investment thesis, geographical preference, and partnership styles were not directly available on their website, their investments and focus areas demonstrate their commitment to fostering entrepreneurship and innovation.

Kristi Daiker is a Venture Partner at Refinery Ventures with over 20 years of experience in the healthcare industry. Refinery Ventures focuses on investing in information technology, digital health, and human capital technology sectors. The firm invests in early-stage companies in the technology sector. Refinery Ventures’ geographical preference includes the United States, United Kingdom, Canada, Spain, South Africa, China, Israel, Taiwan, Latin America, Belgium, Europe, the Middle East, and Asia. Some of the previous investments by Refinery Ventures include Astronomer, bitewell, FRAYT, StoryFit, Redi.Health, Livegistics, and TealBook. Kristi Daiker has a track record of successfully building organizations, growing revenue, turning around operations, and enabling business strategies. The investment check size for Refinery Ventures ranges from $100,000 to $5,000,000. The partnership and collaboration styles of Refinery Ventures were not explicitly found.

Ben Williamson is a seed stage venture capital investor in Nebraska startups at Invest Nebraska. His investment thesis involves supporting high-growth companies in Nebraska and the Midwest, with a focus on AgTech and other sectors such as Consumer Health, IoT, Health IT, Marketplaces, SaaS, and FinTech. His recent investments include Corral Technologies, Retail Aware, and OpsCompass. Ben Williamson’s professional background includes serving as the Principal and General Counsel at Invest Nebraska. He collaborates with startups by fostering the Nebraska entrepreneurial/tech ecosystem, aiming to grow Invest Nebraska’s investments to $10M/year, and proving the thesis about exceptional AgTech entrepreneurs in the Midwest. His investment check size typically ranges from $100K to $250K, with a sweet spot at $250K. Ben Williamson’s partnership style involves actively working with startups to scale their operations and improve the technology ecosystem in Nebraska.

Ken Barnett is a seasoned investor and board member based in Huntsville, Alabama. His investment focus includes health, communication, and technology startups. Ken’s geographical preference is North Alabama, and he serves as a board member for multiple government services companies. His check size for investments remains undisclosed.

Pillar VC invests in seed-stage companies in Boston, supporting unstoppable founders with capital, connections, coaching, and peer support.

Engage Venture Partners, led by Ryan Spanheimer, focuses on investing in the medical device, digital health, healthcare information technology (IT), and healthcare software as a service (SaaS) sectors. They prefer seed to Series A stage companies in Minnesota and the Midwest region of the United States. Specific information on geographical preference, previous investments, track record, investment check size, and partnership styles was not found.

Möçrt Kelder started his investment thesis in 2000 focusing on online/digital/technology, with three broad sectors of interest for the next 20 years: VR/AR, Machine Learning/AI, and Health (with a focus on longevity/anti-aging). His investments include companies like SuperWorld, Ubiquity6, UserMind, Nines, Excision Biotherapeutics. Additionally, he has not included crypto/blockchain in his investment focus. His investment focus areas cover public equities, private equities, bonds, private debt, real estate, and infrastructure. The check size for his investments ranges between $500K to $1.5M per company. Regarding partnership and collaboration styles, there is no specific information available about Möçrt Kelder’s approach.

Gretchen van Steenwyk is a Biotech Investor with an investment range of $100K to $5.0M, specializing in BioTech and Health & Hospital Services sectors. Her notable investments include BioTech (Series A), BioTech (Seed), Health & Hospital Services (Series A), and Health IT (Series A). She is known for her partnership with investors such as Alfred Scheidegger, Gabor Gyulveszi, Jakob Loven, Melissa McCracken, and Niresh Berinpanathan. Gretchen’s career spans roles as an Investment Manager at Archer Fund and as a Senior Analyst at Nextech Invest. Her professional background includes experience in Molecular Biology, Neuroscience, and Oncology, with expertise in health innovation. Gretchen van Steenwyk’s stage of investment ranges from seed to Series A, with a current focus on the Biotech sector.

Northland Angel Investor Network, also known as NAIN, seeks to match financial capital with qualified start-up and emerging-growth companies. They focus on technology vendors, IT, consumer, insurance, and healthcare sectors. Their stage of investment includes Seed VC – II. Geographically, they invest in companies like Mycroft AI. Previous investments include collaborations with Deep Space Ventures, Missouri Technology Corporation, Social Starts, and TechNexus Venture Collaborative. David Palmstein is the current Managing Director of NAIN. The investment check size has been around $1.75M per investment. Their partnership and collaboration styles involve working with various co-investors to support startups.

Lutz Haase is an investor with a focus on HealthTech sectors, having invested in companies like CardioCube and Super Izzy AI. His investment check size typically ranges from $100K to $500K per company. His previous investments include CardioCube (acquired by Voxel) and Super Izzy AI. In terms of partnership and collaboration styles, Lutz Haase demonstrates a cooperative collaboration style, fostering mutually beneficial relationships with portfolio companies and partners.

Jim Corman is a serial entrepreneur and angel investor who has invested in companies such as BuyHappy and Vehcon. He has a background in telecommunications and has started eight companies during his career. He has invested in 46 early stage companies as an individual angel, leading to his appreciation of group investing and the creation of AIM Group.

Buffy Alegria, Managing Partner at SteelSky Ventures, focuses on investing in high-growth companies that improve access, care, and outcomes in women’s health. SteelSky Ventures primarily invests in Women’s Health across various sectors including Digital Health, Consumer Health, Health & Hospital Services, and Health IT at pre-seed and seed stages. Buffy Alegria’s investment check size ranges from $100,000 to $5 million, with a sweet spot at $1.5 million. She brings a wealth of experience, having served in roles such as Managing Partner at LOUD Capital, Board Chair at Signal Health, and as a Strategic Advisor at PregnanTech and Scorecard.vc. Buffy Alegria holds a Master’s degree in Management in Science and Technology from Oregon Health & Science University and a Bachelor’s degree in Psychology, Biology, and French from Pacific University.

Ross Haghighat is a Senior Business Executive, Serial Entrepreneur, and Venture Capitalist with three decades of experience in transforming early-stage technology and life science companies into successful global corporate entities. He specializes in negotiating M&A agreements, strategic planning, and guiding corporations towards successful IPOs. Ross has founded or co-founded several companies, leading strategic pivots, especially in life sciences. With a career impacting markets in biotech, medtech, telecom, ESG, and specialty chemicals, he has been involved in successful IPOs and M&A transactions. Ross has raised over $2B in capital for portfolio companies, contributing to a combined shareholder value exceeding $5B. He holds a BS and MS in Advanced Materials from Rutgers University and an MBA from Boston College Carroll School of Management. Currently, he serves as the Chairman & CEO of Triton Systems, Inc., a global business venture company focusing on innovative products in microsensors, medical devices, immunotherapy, Cleantech, water treatment, and printable electronics. Additionally, Ross is Executive Chairman of Avertix Medical and serves on the Boards of various companies such as Chinook Therapeutics, Electriq~Global, and Fluence Corporation.

Lateef Jackson is a Venture Partner at Elevate Capital, focusing on investments in early stage and growth start-up companies. His investment check size ranges from $100K to $500K. Specific investment focus areas are not available, and his track record and previous investments details are limited.

Kirk Nielsen is a Managing Partner at Vensana Capital, specializing in transformative medical technology innovations. He has led or co-led investments in companies like iVEAcare, Elucent Medical, and Moxe Health. Kirk’s geographical preference includes investments in companies from various regions. His professional career includes roles at Versant Ventures and Medtronic, with a background in healthcare and private equity. Kirk’s investment check size ranges in line with the needs of the companies he invests in, focusing on successful exits and IPOs. His partnership and collaboration style involve active participation in board memberships and strategic guidance for portfolio companies.

Golden Seeds LLC typically invests in B2B & B2C technology, health care, and consumer products or services industries. They focus on seed-stage investments, primarily in women-led startups in the United States. Their investments range from $250,000 to $1 million. Golden Seeds collaborates with a diverse network of angels, works closely with founders who have a track record of success, and values partnership and collaboration in their investment approach.

Stacey Cook’s investment focus is on providing affordable and accessible healthcare financing options through PrimaHealth Credit. They aim to help more patients access healthcare by offering customizable payment solutions with high approval rates. Their approach includes a proprietary credit analytics engine to optimize approvals and reduce risk. Stacey Cook’s partnership style involves offering straightforward payment options, no hidden fees, and real-time reporting to healthcare providers.

Human Ventures is a business creation platform, comprised of a venture fund, studio and enterprise agency.

Bedrock Capital is an investment firm that supports and finances ‘one-of-a-kind companies’.

Alison Lopriore, Director at Rev1 Ventures, is an experienced professional with a track record of driving innovation and entrepreneurship. With a focus on venture capital funding, Alison has played a pivotal role in launching and managing various programs at Rev1 Ventures. She has overseen the creation of internship and fellowship programs, engaged in mentorship initiatives, and facilitated service provider networks, emphasizing the importance of nurturing startups. Alison’s background includes key roles at organizations like Kaiser Permanente and Harvard Business School Executive Education, highlighting her expertise in leadership development and project management. With a history of successful program execution and budget management, Alison brings a strategic and hands-on approach to her investment endeavors. Her engagement style is characterized by a commitment to diversity, providing comprehensive support to entrepreneurs and fostering collaborative partnerships within the startup ecosystem.

Rich Gallun is an angel investor who focuses on promising companies, typically in exchange for equity. His investment areas include technology and healthcare. He has made investments in companies like First Stop Health and Peerfit. Gallun’s professional career includes involvement in Series A and Series B funding rounds. The check size of his investments is personalized based on the company’s potential. Gallun adopts a collaborative approach with companies, employing varying partnership styles to maximize growth and success.

Specialist VC specializes in specific sectors and stages within venture capital, focusing on areas such as Seed Stage, Series A, B, C, and Late Stage/Growth Capital. They emphasize the importance of developing expertise in various sectors like Tech VC, BioTech/HealthTech VC, FinTech VC, Consumer VC, CleanTech, and AgriTech to stand out in the industry. Specialist VC’s investment thesis includes a focus on selecting deals aligned with their fund’s focus in terms of stage, geography, and market segments. The fund aims to provide targeted investments in specific areas to optimize returns and establish credibility as experts in the field.

Breyer Capital is a global venture capital and private equity investor that focuses on catalyzing high-impact entrepreneurs.

Adetunji Eleso is an investment and business support professional with over two decades of experience supporting clients in financial services, manufacturing, and technology sectors in Nigeria and Africa. Managing Partner at Growth Capital, he focuses on early-stage investing and has led the investment team at Co-creation Hub Nigeria, providing capital and support to numerous early-stage enterprises. Adetunji Eleso’s previous investments include companies like GoMyWay and Stutern in the automotive and education industries. He invests in startups with small check sizes in his personal capacity. As Director, Scale and Sustainability at Grand Challenges Canada, Adetunji Eleso is dedicated to creating bridges between the supply of supported innovations and the demand for solutions, focusing on partnerships that accelerate health innovation scaling.

Gary Cohn serves as Vice Chairman at International Business Machines and is Co-Chairman of Cohn Robbins Holding Corp. He invests across cybersecurity, blockchain infrastructure, regulatory technology, and medical technology sectors. His previous role includes President and COO of The Goldman Sachs Group. His investments are done through partnerships with companies like Abyrx, Gro Intelligence, Indago, Nanopay, and Starling. He is dedicated to advancing healthcare and education, serving on boards of NYU Langone Health and NYU Tandon School of Engineering. Gary Cohn’s investment check size can vary based on the sectors, with a recent project in blockchain technology seeking $600 million for an IPO.

Stewart Dixon is the Managing Partner at VentureDNA with a focus on Series A investments in sectors such as wellness & fitness, sales & CRM, cybersecurity, media/content, data services, web3/blockchain, health IT, biotech, digital health, and fintech. His investment check size ranges from $500K to $20.0M with a sweet spot at $1M. Stewart prefers investing in the Midwest and collaborates with diverse investors, including founders. His previous investments align with his expertise and industry connections.

Alec Bowers, CEO of Quantum Dynamics LTD, engages in proprietary investments across asset classes like commodities, real estate, equities, and digital assets. He focuses on venture investments in food and medical sectors. With a professional career spanning various leadership roles, Alec has presented at international forums, advised governments on entrepreneurship, and organized summits. Holding degrees from Babson College and Stanford University, he is heavily involved in genomics and personalized medicine investments. Alec’s partnership and collaboration styles emphasize effective communication and teamwork, driving successful global business expansions. His investments extend to Russia, showcasing a keen interest in emerging markets.

Life Sciences Angel Network is an angel network based in Somerset, New Jersey. The firm prefers to invest in life sciences, healthcare, diagnostics, biotech, drug discovery, drug delivery technologies, alternative energy, cleantech, and agtech sectors. The average startup value when investing from the network is 1-5 million dollars.

Frank Willemsen is the President and Board Member at Sand Hill Angels, with investment focus areas including seeking ‘uncommon’ insights in markets, technologies, or business processes that are not obvious. The investors at Sand Hill Angels look for startups with a real problem-solving aspect, defensible solutions, capable teams, and reasonable deals. They also consider evidence of product-market fit and a narrative for the company’s vision. Frank Willemsen’s investments fall in the range of $300K to $500K per company, with a sweet spot at $500K. Sand Hill Angels’ diverse portfolio spans sectors like AdTech, HealthTech, and FinTech, with a preference for startups that have early progress funded by friends or family to gather feedback from potential customers and limit capital requirements.

Kelly Wittenbrink is the Vice President at Thompson Street Capital Partners. With a background in political roles, including working for a U.S. Senator and involvement in a presidential campaign, Kelly brings a diverse skill set to her investments. Thompson Street Capital Partners focuses on sustainable growth in Life Sciences & Healthcare, Software & Technology, Business & Consumer Services. Kelly’s portfolio includes investments in sectors like Enterprise Infrastructure (Series B) and Medical Devices (Series B). Her check size ranges from $5M to $50M, with a sweet spot around $25M. Kelly is known for collaborating with co-investors and has a track record of successful investments. She is actively involved in the Series B stage, particularly in the areas of Enterprise Infrastructure and Medical Devices.

Artisanal Ventures is an investment firm that focuses on investing in various cloud startups.

Wes Levitt is the Partner: Research & Risk Management at Alpha Sigma Capital Ltd. His previous experience includes roles such as Co-Chief Investment Officer at Alpha Transform Holdings and Head of Strategy at Theta Labs, Inc. He has also worked at Blockchain Moon Acquisition Corp, Mosser Capital Management, LLC, Redwood Trust, Inc., Umpqua Bank, and Pentagon Federal Credit Union. Wes Levitt is based in Amsterdam, North Holland, Netherlands and has a diverse background in finance and investment management.

Lars Rasmussen, co-founder of Google Maps and Director of Engineering at Facebook, has made 20 investments with a focus on venture capital, IT, consumer, and tech industries. His investment check size typically ranges from $1M to $5M USD. Lars invests in companies like Douleutaras, Neptyne, and Fingerprint for Success. He has a track record in the med-tech and pharma industry and has 3 portfolio exits. Lars Rasmussen emphasizes clear expectations and communication in partnerships and collaborations.

Puget Sound Venture Club, founded in 1985, is a group of accredited investors providing a forum to review venture opportunities. They aim to create a community of accredited investors to share ideas, contacts, and resources. With a track record of investing over $220 million in 1,350 companies, including successful IPOs like Starbucks, DocuSign, and Coinstar, they focus on startup investments in software, healthcare, IT, biotechnology, and SaaS. Puget Sound Venture Club prefers seed, early-stage, and first-round deals in most industries, with a particular interest in early-stage tech startups. Their check sizes for investments vary annually, with recent investments totaling $18.1 million in 2021. Collaboration styles involve creating an environment for brave ideas and healthy collaboration to drive their operations and investments.

Ariel Barack is an investor with a focus on private equity and alternative investments. He has a track record of successful investing with a preference for collaborations and partnerships. Ariel’s investment check size has varied, ranging from small to mid-sized capitalizations. His investment focus areas include private equity, life insurance, and growth areas. He has previously invested in Series A AgTech startups and food and beverage companies.

Kevin Parakkattu is a Partner at Plug and Play Ventures with a strong track record. He leads the firm’s Commerce, Media, and Consumer investments, focusing on leading regional entrepreneurs developing innovative HealthTech applications or products. Kevin has sourced and led over 40 Seed and Series A investments exceeding $10MM deployed with a combined market value of >$50MM. His investments span across Artificial Intelligence, Cybersecurity & Privacy, E-Commerce, Enterprise, Real Estate, Retail, and Media & Entertainment. Previous investments include companies like BigID and MANSCAPED. Kevin’s partnership style involves strategic collaborations with companies like Nike, McDonalds, and Ernst & Young, showcasing his expertise in securing customer loyalty and building long-term relationships.

Nika Duan focuses on supporting historically underrepresented founders and improving capital allocation for overlooked ideas from women and people of color. Nika has experience in early and growth stage investing, with a background in edtech, future of work, and healthcare. She is passionate about collaboration and partnership with diverse backgrounds. Nika’s professional career includes roles at Emerson Collective and Psych Hub, showcasing her dedication to supporting startups. Her educational background includes a BS in economics and political science from Duke University.

Jan Bromberger is a seasoned investor with a diverse investment thesis focusing on B2B & B2C subscription models, marketplaces, SaaS, consumer subscription, and New Space. He predominantly invests in Pre-seed Health & Hospital Services startups. With a track record of roles such as Senior Software Engineer, Founder, and Angel Investor, Jan has a professional background in Technology Management. His investments span markets like Content Creators, Education, Media and Entertainment, and Software. Jan’s investment check size ranges from $100K to $1M, with a sweet spot of $1M. He engages in various partnerships and collaborations in the startup ecosystem through his roles at metoda GmbH, EUROPE+EARLY, and DVC, bringing a wealth of expertise and hands-on involvement to his portfolio.

Allison Weil is an investor at Hyde Park Venture Partners with a focus on technology solutions for government-related challenges, healthcare, and data science. She transitioned into venture capital from a background in consulting, government, and startups, driven by a belief in the investment thesis. Allison’s geographic focus is on the Midwest region. With active positions at Hyde Park Venture Partners and Copilot Labs, Inc., she has experience in private equity investments. Her collaboration style aligns with the values of Hyde Park Venture Partners.

Darcy Antonellis is an investor who brings a deep knowledge of the technology and media industries. She has a strategic investment focus in technology vendors, venture capital, and industries like tech, insurance, and healthcare. Darcy’s stage of investment is primarily in seed rounds, as seen in her investment in ICX Media. While her geographical preference is not explicitly mentioned, her collaborative style is evident in partnerships like the collaboration between Amdocs and Liberty Global to enhance customer experiences with digital identity solutions. Her check size for investments is not specified.

Shri Ganeshram is a Co-Founder of Fresh VC, a micro VC fund with investments in Health Care, Marketplace, E-Commerce, Information Technology, and Analytics. The fund focuses on startups aged 1 year or less, with an average round size of $3M. Notable portfolio companies include FiscalNote, Eaze, and Airware. Shri Ganeshram’s partnership and collaboration styles are not available on the searched sources. Fresh VC operates in the early-stage venture capital financing space.

Narayan Ramachandran is an angel investor with a focus on technology-intensive businesses in life sciences, healthcare, and education. He is a pioneer in building inclusive institutions in India and has a strong track record as the Chairman of Unitus Capital. Narayan has invested in startups like Mensa Brands and Jana Small Finance Bank, emphasizing technology and differentiation. His investments typically range from seed to later stages, with a check size that varies based on the specific opportunity. His investments reflect a commitment to sustainable and profitable value propositions from inception. While the geographical preference is not specified, Narayan is known for his impactful investments in India-centric and India-first market opportunities.

Nick Picone is an angel investor with a focus on Cloud Computing, Electronic Health Record (EHR), and Social Impact. He has made past investments in CareShield Health. With a geographical preference for markets like Cloud Computing and Health Care. Although details about his investment thesis, stage of investment, track record, investment check size, and partnership styles are not available, his history indicates a background in high school sports and potential connections to the wine industry.

Dr. Elizabeth Iorns is an investor with a focus on a diverse range of markets, including Mobile, Consumer Internet, Enterprise Software, Healthcare, Clean Technology, SaaS, E-Commerce, Social Media, Marketplaces, and Digital Media. Her investments typically target startups like Notable Labs, Validere, Quero Education, Perlara PBC, NURX, Solugen, Unima, Cambridge Bio-Augmentation, Cambridge Cancer Genomics, Vetcove, Antera Therapeutics, Connecting the Dots, INC, Vinsight, and Konsus. Elizabeth Iorns has a track record in Pre-seed Education, BioTech, and Marketplaces at an investment range of $5K – $25K, with a sweet spot at $15K per investment. Her geographical preference and partnership styles were not explicitly stated in the sources found. Elizabeth Iorns is known for her professional career as the Founder & CEO of Science Exchange, Co-Director of the Reproducibility Initiative, and as a part-time partner at Y Combinator. Regarding the investment thesis, specific details were not available in the sources, but her focus areas and previous investments provide insights into her strategy. Unfortunately, detailed information about her investment check size and partnership and collaboration styles was not found.

Gauri Gupta is a Managing Director at Sandbox Industries with an investment range of $1M – $20.0M and a sweet spot of $10.5M. She focuses on various sectors including Chemicals, AgTech, Health & Hospital Services, Health IT, and Digital Health at different stages such as Seed, Series A, and Series B. Gauri has a current fund size of $150M and co-invests with individuals like Alex Behar, Amanda Donohue-Hansen, Andrew Boyd, Binoy Bhansali, and Bob Shapiro.

Mass Medical Angels, founded in 2007, is a venture capital firm based in Brookline, Massachusetts. They focus on seed and early-stage investments in healthcare, life science, and medical technology sectors. Their investment thesis aims to bring more clinical tools to the marketplace while achieving superior returns. They invest in medical devices, therapeutics, diagnostics, health services, and health information technologies. Mass Medical Angels provides early stage funding ranging from $250K to $3MM and has a geographical preference for the Boston healthcare supercluster. They are known for their track record in supporting companies in the healthcare innovation center.

Thomas Weithman is the Managing Director/VP/Founder at CIT Gap Funds. He focuses on seed-stage venture funds for tech, clean tech, and life science companies in Virginia. Previous investments and professional career details are not available.

Ivan Burkov is a Senior Associate at INKEF Capital based in Amsterdam, Netherlands. His investment focus areas include Seed Digital Health, Health & Hospital Services, and Health IT. Ivan has a track record as a Principal at INKEF Capital and serves on boards of companies like Ambagon and Salvia Bioelectronics. His investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Ivan collaborates with co-investors such as Alice Vickers, Amanda Stenbaek, Carien Beyer, Corné Jansen, and Estelle Botbol in various investment sectors and stages.

Sharon Azulai is a Co-Founder and Managing Partner at KÄTAO Venture Partners, known for his proven track record in building successful startups and his extensive background in global private equity and venture-backed technology markets. He has experience in creating new markets and achieving rapid revenue growth through disruptive technologies and innovation. Sharon has founded five startups, managed four, and sold three, providing significant returns to investors. His investment focus areas include early-stage tech companies, with an emphasis on innovation and impact, especially in the medical technology and diagnostic devices sectors. Combining business acumen, innovation management, collaboration, and negotiation skills, Sharon Azulai is recognized as a dynamic agent of change with an entrepreneurial nature and a high energy level. He also holds a B.A. in Business Management and has served in the intelligence unit at the Israeli defense force.

Christen Governale is an impact investor focusing on companies upholding ethical principles and biomimicry. He advocates for Christian impact investing, emphasizing blended finance strategies to share risks. Governale is known for his interest in companies addressing the climate crisis through biomimicry. His previous investments span various industries, including media, marketing, and public relations. While specific check sizes are not available, Governale is aligned with impact investing values. Regarding partnership and collaboration styles, Governale likely engages in collaborative partnerships centered on the ethic of love and stewarding capital for life-serving purposes.

Maarten Goossens is a Co-Founder and Principal at Anterra Capital with a background in M&A and corporate banking. His expertise lies in deal sourcing, execution, and portfolio management. Maarten focuses on companies leveraging breakthrough biotechnology or digital solutions and typically invests in the food and agriculture sectors. His investment check size is not specified. With a Master’s in Business Administration, Maarten brings a wealth of experience, having started his career at Rabobank and later transitioning to venture capital. His partnership and collaboration style are not extensively documented.

Tyler Dikman is an Angel investor with a focus on markets like Clean Technology, Consumer Internet, Mobile, Healthcare, Online Travel, Social Travel, Mobile Commerce, and Mobile Advertising. He has made past investments in LoungeBuddy. Tyler started his business CoolTronics at a young age, growing it to over $3.5 million in sales. He also co-founded Redux, which raised $1.65 million in venture funding. Tyler is known for his marketing and personal branding skills and has appeared on The Big Idea with Donny Deutsch. His partnership and collaboration style involves providing mentorship, advice, and support to the companies he invests in, aiming for win-win outcomes.

Wendell Lansford is the Co-Founder and Board Member at Wyng, with a focus on investments in energy, network games, healthcare, and internet businesses. The firm typically invests in seed-stage, early-stage, and later-stage companies. His geographical preference is not specified. Some of his previous investments include Offerpop where he participated in various funding rounds such as the $15 million Series C financing. Wendell has over 20 years of industry experience, including roles at Systinet and eGain. The investment check size for Wendell Lansford’s ventures is not available. In terms of partnership and collaboration styles, he emphasizes the importance of user-generated content and micro-influencer collaborations for brand success.

Greg Foster is an investor with a primary focus on technology, digital media, and marketing automation. His past investments include companies in the healthcare, technology, and marketing sectors. Noro-Moseley Partners, with which Greg was associated, has a deep domain expertise in B2B software and healthcare markets. The investment check size for BrightWhistle in a funding round was undisclosed, and the company focuses on healthcare marketing solutions. The partnership and collaboration style of Greg Foster leans towards understanding the three common collaboration styles: introspective, relational, and expressive, to enhance teamwork and effectiveness.

Blackhorn Ventures is an early stage venture firm that invests in companies using cutting edge engineering to improve resource productivity.

Karen Kruger is an Angel Investor based in Silicon Valley, San Francisco Bay Area. Her investment focuses include Education, Clean Technology, Healthcare, Parenting, Women-Focused, Environmental Innovation, Medical Marijuana Dispensaries, and Motherhood Community. Karen has made 4 investments, including companies like Mahmee, Kuli Kuli, and Seven Seas Music. She has invested in startups involved in various sectors including maternal healthcare, social good & consumer packaged goods, and international music licensing.

Anand Swaminathan is an investor with a strong track record and professional background. Currently serving as the Accenture Managing Partner, Anand has a diverse investment portfolio across various sectors and stages. His focus areas include Local Services, Messaging, Advertising, Hardware, and more. Anand’s investments span from pre-seed to seed rounds, backing companies like Yellow Freight, Next Billion, and Ambition. With an educational background in Economics and an MBA in Strategy, Finance, and Marketing, Anand collaborates with investors such as Alireza Masrour, Plug & Play Ventures, and Atomico. Anand’s investment check sizes range from $500K to $500M, indicating a versatile investment strategy. Known for his partnerships in creating social impact, Anand Swaminathan is a seasoned investor with a keen eye for promising startups.

Rob de Ree is a Venture Partner at BioGeneration Ventures (BGV) with a focus on pharmaceuticals, consumer health, digital health, biotech, and health & hospital services. His investments range from $100K to $1M, with a sweet spot at $500K. Rob has made previous investments in companies like NorthSea Therapeutics and SurgVision. He is known for serving on boards and in interim management positions within BGV’s portfolio companies. Rob de Ree’s partnership and collaboration style involve active involvement in the companies he invests in, providing operational support and strategic guidance.

SWAN Funds is a venture fund that focuses on investing in exciting companies with great teams and meaningful traction in sectors such as B2B software, market-accelerating technologies, capital-efficient hard-science, diagnostics & HealthIT, medical devices, scalable IoT, and scalable hardware. They specialize in pre-seed and seed stage investments and prefer companies in the Pacific Northwest where they have established strong relationships with management teams. SWAN Funds aims to provide the first major outside investment and continuous expertise and support to its portfolio companies, fostering growth and success. Previous investments, track record, professional career details, and specific investment check sizes are not provided on their website.

Jeffery Marx is a Chief Scientific Officer at Cerapedics, bringing extensive experience in executive management with medical device companies. With a Ph.D. in Ceramic Engineering, he focuses on regulatory oversight, quality, manufacturing, and R&D. His professional background includes over 13 years at Orthovita and leadership roles at Stryker Orthobiologics. Dr. Marx has a profound understanding of research & development, commercialization, sales management, business development, and strategic planning. His partnership and collaboration styles align with the introspective, relational, and expressive models, aiming to enhance cooperative efforts across different styles.

Uncork Capital is a seed-stage venture capital firm that focuses on SaaS, consumer, marketplaces, hardware, and new technology startups.

Cortado Ventures is a seed-stage venture capital firm investing in overlooked foundational sectors in the midcontinent.

Matt Kozlov is an experienced investor with a focus on rapidly growing deep tech, healthcare, B2B, and ecommerce companies. He supports underrepresented founders solving impactful issues. His investments typically range from $500K to $20 million USD. Kozlov emphasizes partnerships and collaborations to amplify startup growth. His extensive career includes managing Techstars programs and facilitating capital for startups.

Stefan Gabriel is the Managing Director and Chief Executive of Hitachi Ventures. The investment thesis focuses on technologies that can integrate with Hitachi’s products. Stefan’s investment focus areas include Smart Cities/UrbanTech, TransportationTech, Cybersecurity, Robotics, EnergyTech, IoT, and Data Services at various stages like Seed and Series A. With an investment range of $100K to $5.0M and a fund size of $150M, Stefan has invested in companies such as Rescale, Proscia, Sophia Genetics, ThinkIQ, and Taranis. His professional background includes roles at BMW and 3M, specializing in engineering, manufacturing, and corporate venture capital. Stefan Gabriel’s partnership and collaboration style involve forming collaboration projects between Hitachi’s business units and startups, promoting innovation and synergy within the company.

Manish Bhandari, Managing Partner at Angel Physicians Fund, focuses on investing in mispriced securities value based on underlying business dynamics. His investment areas include luxury auto, Arvind Fashions, Saregama India, Muthoot Finance, Home First Finance Co India, and Ajanta Pharma. Manish primarily invests in Series A and Series D stages in the healthcare sector. His geographical preference is Cincinnati, Ohio, USA. Previous investments include PanTher Therapeutics, S4 Medical, and Foldax. Manish’s investment check size ranges from $5,000 to $50,000, with a sweet spot at $25,000. His collaborative style involves strong partnerships and bringing together complementary businesses, as seen with HLI and GE Current.

Richard Setterwall is a Venture Partner at Piton Capital with an investment range of $100K – $5.0M and a sweet spot of $1.5M. His investment focus areas include Pre-seed and Seed stage investments in sectors such as AutoTech, Human Capital/HRTech, Food and Beverage, Real Estate/PropTech, Health & Hospital Services, E-commerce, and Marketplaces. Some of his previous investments are in Wolf Spring and Petbuddy Group. Richard’s professional career includes roles such as Founder & CEO at DogBuddy, General Manager Europe at Rover.com, and Senior Manager at PwC Strategy. His partnership and collaboration style involve entrepreneurship and investment, particularly in the online marketplace and network effects domains. He holds an MSc in Industrial Management and Engineering with specialties in online marketplaces, network effects, business development, online marketing, and financial modeling.

Bahador Biglari is an experienced professional with a diversified background. He is the Founder & CEO of CashZar and an Angel Investor at Alliance of Angels and SWAN Venture Fund. Bahador has held various leadership roles at Axon, Facebook, Uber, Microsoft, and PwC Canada. He possesses a Master of Business Administration from UCLA Anderson School of Management and a Bachelor’s degree in Computer Science from the University of Waterloo. Bahador’s capabilities in technical and business leadership, combined with his educational background, make him a strategic investor, focusing on diverse industries and check sizes ranging from $2,500 to $20,000,000. He values compassion, curiosity, and courage in his approach and is committed to raising others to their best. His experience spans across different sectors, showcasing his versatile partnership and collaboration styles.

Joseph Whitters serves on the board of Accuray Incorporated and has significant public company governance experience in the medical technology and medical device industries. He is associated with Frazier Healthcare Partners and has served on the boards of various publicly traded companies. His investments and involvement focus on healthcare companies and emerging technologies in the medical device sector.

Kalimah Abdul is an angel investor based in New York. She typically invests between $100,000 to $1,500,000 per round in early-stage companies. Her investment focus areas include B2B platforms, digital media, financial services, medical devices, diagnostics, and digital health. Kalimah Abdul values passionate, driven, and coachable management teams and looks for companies with established proof of concept and poised for growth. Some of her previous investments include Vestwell. Her investment approach involves seeking companies with clear potential, protected intellectual property, and strong sales strategies. Kalimah Abdul’s investments are targeted at companies in New York and she collaborates with diverse co-investors with successful track records.

Christian Horn is an Investor at Sandbox Industries, focusing on early stage technology investments in healthcare, sustainability, and insurance. Previously an Investment Banking Analyst at J.P. Morgan, Christian has experience in power, renewable energy, and clean tech sectors. Holding a Bachelor of Business Administration, with a major in Finance and a minor in Accounting, from the University of Miami.

Ralph Arnold is a partner and co-founder of TransAct Advisory Services, with a dedication to the Health Care – Life Sciences sectors. He focuses on the convergence of healthcare and digital technologies leveraging his experience from more than 20 years in life sciences M&A and digital. Ralph’s previous investments include setting up scholarship funds and geological oil mapping. As an American artist, he is known for his masterful collages and assemblages. Arnold’s investment check size and specific partnership and collaboration styles were not found in the search results.

Mr. Gad Liwerant, an inventor and president of VSCM Capital Management LLC, founded VideoShare in 1998 and co-founded eBrick. His investments include companies in industries like Social/Platform Software, Healthcare Technology Systems, and Automotive. He is known for his active involvement in business ventures, serving as a board member at Level 99. Gad Liwerant’s investment check size and geographical preferences are not explicitly stated. His partnership and collaboration styles are not detailed in the available information.

NO/LA Angel Network, now known as Gulf South Angels, is an angel investment group based in New Orleans, Louisiana. Their focus is on evaluating, funding, and nurturing early-stage companies with a specific interest in companies with a potential to scale regionally, nationally, or internationally. Their featured investments include bioaesthetics.com, emberaneuro.com, healionics.com, and altisbiosystems.com. The network seeks to go beyond just investing capital by providing mentoring, business insights, and support for portfolio companies and network members. Gulf South Angels also hosts investor conferences and newsletters to enhance collaboration and success within their network.

Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.

Lucas Bagno is an early stage investor with a focus on mobile, consumer internet, enterprise software, healthcare, clean technology, SaaS, and e-commerce. He operates in New York City, San Francisco, and Minneapolis. Lucas Bagno’s investments include areas such as Mobile, Consumer Internet, Enterprise Software, Healthcare, Clean Technology, SaaS, and E-Commerce. He is also known for running a syndicate on AngelList called Noveus Capital and is dedicated to supporting startups at early stages.

Dr. Nathalie Weitemeyer is a prominent investor at Bayern Kapital, a Venture Capital firm with a focus on innovative, technology-oriented startups in Bayern, Germany. Bayern Kapital, under Nathalie’s leadership, has a strong track record of over 320 investments and manages a substantial â¬700 million in assets. Nathalie’s investment thesis revolves around supporting startups from the Seed to Scale-up phase with investments ranging from â¬250,000 to â¬25 million. Her geographical preference spans all technology sectors, including hardware, software, digital economy, industry, medical technology, and life sciences. With a hands-on partnership style, Nathalie has been actively involved in fostering the growth of startups in various sectors. She has led investments in notable startups such as Insempra, AVES Reality, Smart Reporting, Proxima Fusion, Tubulis, Picture Framing, VITAS, and BOX ID. Through tailored financing concepts like Seedfonds, Clusterfonds, Innovationsfonds, and Wachstumsfonds, Nathalie aims to drive innovation and facilitate the success of early-stage and later-stage companies in the German-speaking region. Her commitment to fostering innovation and supporting technology-driven businesses makes her a key player in the Venture Capital landscape.

John Owen is a seasoned investor with a focus on corporate, mergers and acquisitions, and venture investments. He has a strong background in working with Fortune 500 companies in industrial and manufacturing sectors, as well as in the renewable energy industry. John has held positions as a board member in companies like NeuroEM Therapeutics and HeartSciences, indicating his involvement in healthcare and medical technology. With experience as a Chief Financial Officer at JetBlue and Volotea, John brings valuable expertise in the aviation sector. As an angel investor in Clean Energy Ventures and Clean Energy Venture Group, he demonstrates a commitment to clean energy initiatives. His investment check size varies based on the company and opportunity, and he engages in partnership and collaboration styles that enhance growth and success.

Skip Fleshman, a Partner at Asset Management Ventures, has been actively investing in companies focusing on digital health, mobile, and data analytics. His previous investments include companies like Marley Medical, Autonomize AI, SubjectWell, Outcomes4Me, Carta Healthcare, Reify Health, Arterys, Welkin Health, and RallyPoint Networks. Skip’s partnership style is reflected in his advisory roles at Stanford’s StartX, Rock Health, and Boston Children’s Hospital. His check size and geographical preference are not explicitly mentioned on the website. Skip’s background includes serving in the United States Air Force as a fighter pilot and founding BGI, which develops software for flight simulators. He holds a Bachelor of Science degree in Mechanical Engineering from UC Davis and an M.S. in Management from Stanford University Graduate School of Business.

Simon Rothman, Partner at Greylock Partners, focuses on investing in consumer networks and platforms, particularly network effect businesses, transaction-based startups, and mobile apps with a specialty in marketplaces. His notable previous investments include Convoy, Nuro, and Blush among others. Rothman manages Greylock’s $100 million commitment to marketplace investments, reflecting his belief in the strength and durability of the marketplace business model. Greylock, under his leadership, has a collaborative approach with an advisory network and marketplace conference to support entrepreneurs. Rothman’s collaboration style emphasizes supporting innovative marketplaces in various sectors like transportation, fashion, and health care.

Jim Eberlin is an investor with a focus on industries like Insurance, Healthcare, Industrials, and Financial Services. His previous investments include Juristat and TopOPPS. He has a track record of success in growing early-stage Midwest companies and has experience as a founder of multiple successful ventures. Jim Eberlin’s investment check size ranges based on the stage of the investment. His partnership and collaboration approach are geared towards building successful environments for entrepreneurs and institutions, fostering success through strategic relationships.

Yash Godiwala invests in bold, product-driven founders prioritizing function over form. His investment focus areas include FinTech, SaaS, B2B, Manufacturing, Sales Automation, Healthcare, Infrastructure, Marketing (MarTech), Enterprise, and GovTech. Yash invests in Pre-Seed, Seed, and Series A stages. His portfolio companies include Zeet, Showtime, and Intros.ai. Yash is the General Partner at Brutalist Ventures, based in New York City. He has a track record focusing on fintech products. Yash’s investment check size is not available, and he collaborates with founders across all sectors to solve industrial problems.

David Tolmie is a Senior Partner at Edgewater Funds with a history of successful leadership roles. He has a background in CEO and President positions and is actively engaged in civic and business leadership. The Edgewater Funds, a Chicago-based private equity firm, focuses on executive-led investments, tailoring their approach to each opportunity. Their criteria include target company sizes of $3M – $40M EBITDA and initial equity investments of $10M – $100M in the U.S. and Canada. Edgewater concentrates on business services, healthcare, and industrials, offering varied transaction types. David Tolmie’s collaborative style is evident through his roles on various boards and leadership positions.

Marcel Lubben is a Partner at Brightlands Venture Partners with a focus on the renewable/circular material and pharma/biotech industries. He serves as a trusted advisor to companies in nutrition, personal care, renewable chemicals, and materials. Marcel’s previous roles include Managing Director at Avantium Renewable Polymers and positions at DSM Innovation Center. He holds a PhD in Organic Chemistry. Contact at info@brightlandsventurepartners.com.

Kevin Dee, Vice President at Monroe Capital, focuses on investing in Retail (Seed), Media/Content (Seed), Real Estate/PropTech (Seed), Digital Health (Seed), Health IT (Seed), Health & Hospital Services (Seed), FinTech (Seed), Retail (Series A), Media/Content (Series A), Real Estate/PropTech (Series A), Digital Health (Series A), Health IT (Series A), Health & Hospital Services (Series A), FinTech (Series A), Retail (Series B), Media/Content (Series B), Real Estate/PropTech (Series B), Digital Health (Series B), Health IT (Series B), Health & Hospital Services (Series B), FinTech (Series B). Kevin has a partnership and collaboration style focused on activating transformation through gratitude and appreciation, cultivating cultures where people flourish and thrive. Kevin has a diverse professional background with experience in leadership roles across various organizations.

Guido Magni, M.D., Ph.D., a Partner at Versant Ventures, specializes in seed/early-stage healthcare venture capital investments in the biotechnology and life sciences sectors. He guides on clinical and regulatory strategies for portfolio companies with a focus on novel therapeutics. Investment check sizes range from $100K to $5M. Geographically, the focus is on important unmet medical needs. Previous investments include Aprea, GenSight Biologics, Lava Therapeutics, Nouscom, Piqur Therapeutics, and Tarveda Therapeutics. Guido’s partnership and collaboration style aligns with advancing innovative therapies for unmet medical needs.

Jared Leto is an Angel Investor with a focus on the Financial Services, Financial Software, and Healthcare Technology Systems industries. He has made 37 investments, including companies like X1 Card, 0x, and Rupa Health. His professional career includes founding Adventures In Wonderland, The Hive, VyRT, and A Sharp Knife. He serves as an Advisor at Frame.io. The check size of his investments is not specified. Jared Leto’s collaboration style involves a significant number of investments and portfolio exits.

Mr. Mark Wahlberg is an Angel Investor with investments in companies like SkinnyDipped and StreetTrend. He serves as a Partner at Unrealistic Ideas and also as a Board Member at AQUAhydrate. His investment focus areas include Technology Vendors, Venture Capital, Insurance, Healthcare, and Financial Services. He has a geographical preference for North America and Europe. His check sizes vary based on the investment types and stages.

University of Utah Research Foundation is an angel group based in Salt Lake City, Utah. The firm focuses on investments in science, technology, medicine, pharmacy, engineering, natural resources, energy, business, and education sectors. They prefer early-stage investments and have a track record of supporting companies like Light Line Medical, Converus, and iVeena. The investment check size typically ranges from $20,000 to $150,000. The University of Utah Research Foundation is known for fostering partnerships with various entities to support new ventures arising from the university’s research portfolio.

Oscar Slotboom is a Managing Partner at BioGeneration Ventures (BGV). He is an expert in digital growth strategies and has invested in 50+ startups and scale-ups. Oscar Slotboom’s investments focus on early-stage ventures and company creation. He has a track record of successful investments in the life sciences sector. The check size of investments made by Oscar Slotboom at BGV is undisclosed. In terms of partnership and collaboration styles, Oscar Slotboom actively shapes new life-science ventures. BGV’s investment stage under Oscar Slotboom’s leadership ranges from early to mid-stage ventures, with a focus on creating new ventures in the life sciences sector.

Andrew Kress is an Angel Investor and serves as the President of Surveillance Data, Inc.

Klaus Hommels is a German venture capitalist who founded Lakestar, a venture capital firm based in Zurich. Lakestar invests in European as well as U.S. companies that show fast international growth, focusing on deep tech, digitalisation, fintech, games and media, healthcare, logistics, travel, and mobility. Lakestar invests across all stages from Seed to Growth. Klaus Hommels has an extensive track record in investing in major tech companies like Facebook, Skype, and Spotify. The firm collaborates closely with regulators, emphasizing the need for Europe to find its way of regulating tech to ensure digital sovereignty. Lakestar has a strong partnership ethos, as reflected in collaborations with industry experts and political figures like former UK Minister Sam Gyimah.

James Liken is a seasoned investor with a background in medical equipment services. He served as a Board Member at Cohera Medical and was previously the President and CEO of Respironics. His expertise lies in managing entities related to home oxygen, respiratory, and medical equipment. Mr. Liken has significant experience in the healthcare sector, particularly in Western Pennsylvania, Eastern Ohio, and West Virginia. His collaboration style emphasizes a true partnership approach, focusing on sharing essential information for successful relationships and projects. While specific investment focus areas and check sizes are not available, his track record indicates involvement in healthcare-related ventures and leadership roles in various organizations like the National Association for Medical Equipment Services and The Boy Scouts of America. His notable achievements include founding and expanding Liken Home Medical before selling it to Lincare.

Sharyn Roblom, known as ‘Your Cashflow Angel,’ focuses her investments on agriculture, education, clean energy, and healthcare. She invests in seed-stage companies and prefers collaborations over formal partnerships. Sharyn’s previous investments include efforts to support sustainable and alternative protein industries. With an average check size of $107k, she is actively involved in building and supporting defensible businesses. Sharyn’s professional career showcases a track record of success in building strong Human Resource capabilities. Her investment approach is hands-on, offering support and resources for due diligence to alternative protein startups.

Seattle Angel Conference is a program that trains angel investors and funds startups since 2012. The conference engages in a ‘learning by doing’ pathway for first-time angel investors. It runs from February to May and involves 20-40 participating investors evaluating 60 startups. Participating startups have the potential to win investments between $100,000 to $200,000. Seattle Angel Conference focuses on software publishing, healthcare, SaaS, and artificial intelligence. The average round size of investments is approximately $684,000, with a track record of 17 investments and 1 exit. The conference is geographically diverse and less likely to invest in rounds that range from 100 thousand to 1 million dollars. The organization was formed by John Sechrest and Josh Maher.

Brian Laegeler, Managing Director at Touchdown Ventures, with a focus on tech-enabled solutions for the pharmaceutical sector. Brian brings over 20 years of investment and corporate advisory experience and holds a BS from Indiana University and an MBA from Harvard Business School. He previously worked at Loop Capital Markets and Morningstar, among others. Based in Chicago, he supports the local food movement via their small-scale farm. Touchdown Ventures offers venture capital services for leading corporations.

Hemang Gadhia is an angel investor focusing on seed stage investments across the Washington D.C. Metro Area and Southern US. He has a track record of founding and leading successful companies such as Revmetrix, providing advanced data management platforms for marketing ROI, and Condaptive, which was acquired by Millennial Media. Hemang has experience as a Co-Founder & CEO at Revmetrix, a Founder & CEO at Condaptive, and has served in advisory roles at companies like Zoomdata and TrackMaven. His investment check size ranges based on the specific round and company needs. His partnership and collaboration style involve active involvement and guidance to help startups maximize their potential.

William Cowen, General Partner at Long River Ventures (now LRVHealth), focuses on early-stage healthcare investments in disruptive companies across healthcare IT, technology-enabled services, devices, and diagnostics. The investment check size is approximately $100 million. LRVHealth partners with healthcare industry insiders, national healthcare systems, and the Innovation Institute to fuel its platform. The fund involves over 20 healthcare thought leaders, eight national healthcare systems, and additional partners to identify and invest in innovative startups. William Cowen, along with his team, has a successful 17-year track record of providing institutional investments in market-leading companies such as GetWellNetwork, MedVentive, Phreesia, lifeIMAGE, and Convergent Dental.

Nedermaas Hightech Ventures focuses on pre-seed and seed investment opportunities across a broad spectrum of high technology fields, with an investment range of 150,000 to 500,000 euros. Some of the previous investments by Nedermaas Hightech Ventures include companies in biotechnology, life science, therapeutics, genetics, and pharmaceutical sectors.

Refactor Capital is a seed stage VC firm investing in bio, climate, and health.

Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.

Aline Vedder is an investor specializing in startups addressing social challenges in areas such as education, health, sustainable consumption, future of work, and ageing. She typically invests in seed and Series A rounds and focuses on DACH and the UK. Some of her recent investments include Open Bionics, Talea, HomeTouch, Careship, MobileJob, and Raremark. Aline Vedder has an impressive track record with a Ph.D. in Neuroaesthetics and is known for her partnership and collaboration styles that emphasize impact, sustainability, and diversity in evaluating investment opportunities. The investment check size for Aline Vedder ranges from $100k to $5M per company.

CANCER FUND, an investor, focuses on early-stage companies in the areas of Therapies and Management, Diagnostics & Monitoring, and Preventions & Enabling Technologies. Their investment thesis emphasizes utilizing data to improve patient outcomes and reducing costs in the healthcare landscape. CANCER FUND’s investments range from pre-seed to later stages, managing risk exposure while addressing diverse capital needs. They have made significant previous investments in various institutions supporting cancer research and treatment. The investor accepts a minimum investment of $100, allowing any amount in increments of $100. CANCER FUND is known for its collaboration and partnerships to accelerate progress in the fight against cancer.

Alan Chang, a Partner and Managing Director at Capricorn Investment Group, oversees Capricorn’s multi-asset class and global venture portfolio. His previous investments include Agrica, Builders Vision, NOWDiagnostics, Suminter India Organics, and more. He focuses on sustainable and impactful investments, emphasizing climate solutions, health & wellness, and inclusive capitalism. Alan’s investment stage ranges from early-stage to VC. His geographical preference includes Asia and emerging markets. Alan is known for collaborative partnerships, as seen through a strategic partnership focusing on research, knowledge transfer, and investment opportunities in sustainability and impact.

South Coast Angel Network is an angel investor group that typically focuses on startups aged 6-10 years in industries like Marketing and Human Computer Interaction, with key investments in sectors such as Biotechnology, Health Care, Analytics, and Brand Marketing. They invest in early-stage companies within Louisiana and the Gulf Coast community. The group’s investments usually range from 1 – 5 million dollars per company, with a preference for startups with multiple founders. Some notable portfolio companies include SonarMed and eyeQ.

SLC Angels, an accredited network of angel investors based in Salt Lake City, is focused on investing in emerging technology businesses showing robust revenue and EBITA growth potential within the next 1-3 years. Their investment areas include software, healthcare, artificial intelligence, information technology, and smart cities. SLC Angels have a track record of supporting promising entrepreneurial companies to aid in their growth and success. They have a geographic preference for investments within Salt Lake City and have actively funded companies in these sectors. The firm’s investment style emphasizes providing mentorship and assistance to startups. SLC Angels’ investment check size ranges to support early-stage ventures in their expansion and development, aligning with their goal of fostering innovation and growth in the tech industry.

Richard Spalding, Managing Director at Kearny Venture Partners, focuses the investment thesis on healthcare products. The investment focus areas include medical devices and drugs in stages ranging from early to expansion. Kearny Venture Partners prefers collaborations in the healthcare sector, with previous investments in companies like Aerpio Therapeutics and Akebia Therapeutics. The investment check size typically ranges from $2-8 million for the first investment, going up to $10-15 million per company. Kearny Venture Partners emphasizes partnerships that drive growth and innovation in the healthcare industry.

Richard Kearney is a Partner on the Investment Team at LuminArx Capital Management. His investment focus areas include Seed and Series A/B in various sectors such as GovTech, Space, EnergyTech, Education, Security, SMB Software, Digital Health, Health & Hospital Services, and Health IT. He has a track record of senior roles at Veritas Capital, Reef Road Capital, Marblegate Asset Management, and Barclays. Richard Kearney’s investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. He holds a B.A. and M.A. from Yale University.

Lieven Huang is the Investment Manager Life Science & Medtech at the Brabant Development Agency (BOM). With a background in Bioengineering Sciences, Lieven is passionate about supporting early-stage companies to develop new treatments. His investment focus includes a broad portfolio ranging from discovery to clinical stage companies in the Life Science and Medtech sectors. Lieven’s previous investments and check sizes are not specified. Geographically, Lieven’s preference is not explicitly mentioned. His partnership and collaboration styles are not detailed. Lieven Huang excels in guiding creative problem-solving and ensuring successful outcomes.

James P. is an angel investor specializing in pre-seed companies with a focus on industries like agriculture, business services, education & training, energy & natural resources, entertainment & leisure, fashion & beauty, finance, food & beverage, hospitality, manufacturing & engineering, media, medical & sciences, personal services, products & inventions, property, retail, sales & marketing, software, technology, and transportation. His investments range from CHF 0 to CHF 9,000 per company, and he is geographically focused on the Midwest, South East, West, South West, and North East regions of the United States. James P.’s investment thesis revolves around unlocking opportunities for pre-seed companies, with an emphasis on founders, product quality, and scalability. However, specific details on his previous investments, track record, professional career, investment check size, and partnership styles were not available from the sources searched.

Krish Ramadurai is a Partner at Harmonix Fund, focusing on investments at the nexus of healthcare, life sciences, and deep tech. The fund typically invests between $500,000 and $5 million per company. Recent investments include loft Orbital, bit.bio, Caresyntax, Auransa, and POLARISqb. Krish leads technical due diligence, investment sourcing, and portfolio operational support. His partnership and collaboration style emphasize building strategic partnerships. Krish’s focus areas include healthcare, life sciences, and deep tech. The fund seeks to elevate impactful innovations in these sectors.

Jack Gomer is a Principal at MultiCare Capital Partners in Seattle, Washington. He is a healthcare investor and humanitarian with experience in strategic healthcare venture capital funding. Jack is a member of Alliance of Angels, the largest and most active angel group in the Pacific Northwest. His professional career includes roles such as Program Manager at MultiCare Health System and Board Member at Médecins Sans Frontières. Jack is involved in various projects and certifications, demonstrating his commitment to continuous learning and development.

Xfund is the early-stage venture firm designed to back lateral thinkers.

Nora Doherty, the Vice President of Finance and Managing Director at BioCrossroads, is an investor with a focus on strategic and impactful investments in the life sciences industry. Her investment range typically spans from $100,000 to $5 million, with a sweet spot around $1.5 million. Nora has a track record of investing in companies like Seed BioTech and SonarMed, the latter being in Series C financing in October 2017. She operates from Indianapolis, Indiana, and has a professional career that includes managing key collaborations such as INCAPS and FIHC. Nora’s partnership and collaboration styles are valued in the industry, attracting founders and investors alike, such as Evan MacQueen, Patricia Martin, Anders Richardson, and Alexandre Glaser. Previous Investments: – Seed BioTech – SonarMed Investment Check Size: – Range: $100,000 – $5,000,000 – Sweet Spot: $1.5 million Geographical Preference: – Location: Indianapolis, Indiana

New Enterprise Associates is a global venture capital firm investing in technology and healthcare.

Wouter Gort is a Partner at Hummingbird Ventures with an investment range of $500K – $15.0M. His sector and stage rankings include Hardware (Seed), Consumer Health (Seed), Web3/Blockchain (Seed), BioTech (Seed), Marketplaces (Seed), Health & Hospital Services (Seed), Health IT (Seed), SaaS (Seed), FinTech (Seed), Hardware (Series B), Consumer Health (Series B), Web3/Blockchain (Series B), Marketplaces (Series B), BioTech (Series B), Health & Hospital Services (Series B), SaaS (Series B), Health IT (Series B), FinTech (Series B). He has investing connections with various investors and invests with partners such as Akshay Mehra, Barend Van den Brande, and others.

Ted Hoffman is an investor with a background in auditing and financial services. He has experience in auditing healthcare programs and providing advisory services in risk assurance and financial management. Ted’s investment focus areas and previous investments are not explicitly available. He is known to have worked in positions such as Health Program Auditor III at California Department of Health Care Services and in advisory services at Ernst & Young. His professional career has involved roles in internal audit, forensic consulting, and accounting internships. The investment check size associated with Ted Hoffman is approximately $150,000. Ted’s stage of investment and partnership collaboration style are undisclosed.

Robert Fanini, the General Partner at Inspiration Ventures, focuses on early-stage and secondary investments in healthcare and technology companies across the United States. Inspiration Ventures typically invests in seed-stage tech companies and has a portfolio spanning various sectors like Enterprise Applications and Consumer. Previous investments include companies like DailyPay. Robert Fanini, along with partners, Gady Nemirovsky and Harvey Floyd II, seeks opportunities to support startups in their growth journey. Inspiration Ventures maintains a collaborative partnership style with a focus on nurturing startups in their early stages of development.

Joshua Jones-Dilworth is a visionary entrepreneur and CEO with a focus on health-related quality of life through the Litmus Health clinical data science platform. He has expertise in introducing early-stage technologies to the market and is a skilled storyteller advocating for the impact of science and scientists. His investment thesis centers on making significant advancements in science known and understood, fostering a world where science integrates seamlessly into society. Joshua’s geographical preference is not explicitly mentioned. He has a solid track record in public relations and technology companies. He maintains a self-funded approach at Litmus Health. Specific investment check sizes and partnership styles are not available.

LiveOak Venture Partners is a venture capital firm making early-stage investments in technology and technology-driven services.

Next Wave Ventures is a seed to early stage venture capital firm which focuses on commercializing university research and advanced technologies. Their investment focus areas include Information Technology, Health Care, Consumer Electronics, Higher Education, and Marketing. The firm is based in San Diego, California, United States and has a track record of investing in companies like Resilia, Geospiza, and Apical. Next Wave Ventures typically invests in Seed and Series A stages, with average deal sizes around $1 million. Their partnership and collaboration styles involve partnering with founders and corporate innovators to create new businesses, unlock growth, and build better products and services quickly.

Jouko Ahvenainen is a serial entrepreneur and investor with a focus on digital finance companies in the US, Europe, and Asia. He has a track record of pioneering new businesses and collaborative partnership styles. Jouko has invested in numerous innovative companies and typically supports startups in their early stages with a range of investment check sizes. His investment approach is inclusive and aims to drive innovation and culture change in the industry.

Sirius Seedfonds was established in 2007 as a venture capital firm in Germany. They focus on early-stage ventures in biotechnology, pharmaceutical, chemical, consumer, and business development sectors. Their investments typically range between 1 – 5 million dollars, and they primarily invest in startups aged 4-5 years old. Previous investments include evocatal. Their main geographic focus is within the European Union. Partnership and collaboration involve investing in young innovative companies seeking relevant experience and know-how.

Dan Becker is a driven sales professional with a 10+ year career record of driving rapid medical device sales growth. He has a talent for assessing customer needs and offering innovative solutions, achieving the highest levels of client satisfaction and retention. Dan excels in building close client relationships, identifying opportunities, maximizing sales, and reviving stagnant accounts. He has extensive experience in the medical device industry with consultative expertise in orthopedic surgery, ophthalmic surgery, and training faculty physicians. Dan holds an Executive MBA with an emphasis in Healthcare Management from Louisiana State University. His previous roles include Surgical Academic Manager at Alcon, Account Manager at Avail Medsystems, and Senior Sales Consultant in Orthopedic Trauma at DePuy Synthes Companies.

Jean-Paul Clozel is a seasoned investor with a focus on sustainable value creation. He has a commitment to Idorsia over the long-term and adopts a hands-on investment style. Clozel’s investments are characterized by a check size of CHF 75 million for bridge financing. His partnership and collaboration style involves significant global research collaborations. With a successful professional career, including founding Idorsia Ltd, Clozel is known for his expertise and leadership in the pharmaceutical industry.

Daniel Dillinger, an investment manager at Redalpine Venture Partners, focuses on seed and early-stage investments primarily in disruptive technologies within highly scalable ICT and Health Tech models. His geographical preference lies in the life sciences, digital health, medtech, and biotech industries. He has a track record of leveraging his medical and business background to accelerate innovation in healthcare. Although specific previous investments were not directly available, his role at Redalpine involves supporting companies in these sectors. The investment check size is likely aligned with substantial venture capital investments in health-related technologies. Daniel Dillinger’s partnership and collaboration styles were not explicitly mentioned in the search results.

Minnesota Angel Network, established in 2011, aims to activate the next generation of angel investors in Minnesota. They focus on supporting Midwest startups through angel investments and fostering a supportive ecosystem for founders. The network invests in scalable, early-stage companies in various industries such as healthcare and health IT. Although specific track record details were not found, Minnesota Angel Network collaborates with a network of diverse accredited angels who support companies they invest in. The investment check sizes range from $25,000 to $1,000,000, with an average investment size of $250,000. Their partnership and collaboration style involves making informed investment decisions collectively, committing to the success of invested companies, and providing access to education and deal flow. Previous investments include companies supported through their network.

EQx Fund, led by Ziad Moukheiber, operates an evergreen Angel Fund focusing on early-stage biotechnology companies. Their investments are diversified and primarily target extraordinary Founders. The fund is based in Boston, Massachusetts. They have a partnership and collaboration style that may not be readily available online. For investment check size, they typically invest in early-stage startups with a wide range of investment sizes. Unfortunately, specific details on geographical preferences and previous investments for Ziad Moukheiber and EQx Fund were not found.

Fade Oluokun is the Vice President at Thompson Street Capital Partners. The firm’s investment strategy focuses on sustainable growth in Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services and Products. They target investments in companies with enterprise values between $50 million to $500 million, with a geographic reach in North America, Europe, and Australia. Thompson Street Capital Partners V invests in IT, B2B, and healthcare companies in the US, with check sizes ranging from $25 million to $150 million. Fade Oluokun’s professional experience includes roles at BW Forsyth Partners, and he holds a BSBA in Finance from Washington University in St. Louis and an MBA from the Booth School of Business, University of Chicago.

Mike Schatzman, Co-Founder and Managing Partner at New Leaf Ventures, is an accomplished emerging fund manager, entrepreneur, and investor with over 25 years of experience. New Leaf Invest, a venture capital firm he co-founded, focuses on investing in companies at various stages of development, from seed to series A, with a strategic emphasis on partnering with exceptional founders addressing significant problems. Mike has a successful track record in leadership roles, fundraising, and developing high-performing teams. He has led significant investments and successful exits, demonstrating his ability to grow and manage portfolios effectively. Mike’s collaboration styles center around partnering with remarkable founders and supporting them with a deep understanding of the venture capital landscape, ensuring long-term success for the portfolio companies and investors.

Clement Salque is an Associate at Bioqube Ventures with a focus on sourcing, financing, and developing innovative companies in the healthcare and life science sectors. He translates scientific innovation into therapeutic drugs to maximize value for investors. Previously, he was a Business Analyst at Bioqube Ventures and a Healthcare Venture Capital Analyst at INKEF Capital. His experience includes analysis of investment propositions, due diligence, market research, deal sourcing, and support of portfolio companies. Clement has a background in regulatory affairs and rare diseases. His career shows a dedication to the healthcare and biotech industries, with a track record of involvement in strategic positioning, clinical trial design, and budget reviews. Clement Salque’s current investment focus areas are in healthcare and life sciences, primarily in Europe. He is experienced in supporting innovative companies, conducting due diligence, scientific analysis, and strategic decision-making for portfolio companies. Clement’s professional career spans various roles in healthcare and regulatory affairs, showcasing his expertise in medical innovation and entrepreneurship.

Mary Naylor is a pioneer in the design, evaluation, and spread of health care innovations that have significantly improved the outcomes of chronically ill older adults. She has led research to implement the Transitional Care Model, focusing on the care and outcomes of chronically ill older adults. Mary Naylor’s professional career includes being the Marian S. Ware Professor in Gerontology and Director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania. Her track record includes awards for her work in improving the quality of cancer care and health care for older adults. Mary Naylor has been involved in collaborations that enhance care delivery through advanced-practice provider models. Previous investments attributed to Mary Naylor include involvement with organizations like the Young Presidents’ Organization, Inc., with a focus on leadership development and growth.

Robin Hendrickx, an Investment Manager at BOM Brabant Ventures, specializes in investing in a wide range of sectors, with a focus on Seed and Series A investments. His investment thesis revolves around supporting startups in key areas such as Manufacturing, Logistics, AgTech, Food and Beverage, ClimateTech/CleanTech, Digital Health, BioTech, Health & Hospital Services, Health IT, and SaaS. His investment range typically varies from $100K to $5.0M, with a sweet spot at $1.5M. Robin has a track record of successful investments in both Seed and Series A stages across different industries. He collaborates closely with co-investors within BOM Brabant Ventures to identify promising opportunities and drive growth in the startups he invests in.

Lylan Masterman is a Venture Capital Investor at White Star Capital with a focus on late seed and Series A investments. White Star Capital invests in various industries, including B2B marketplaces, data privacy compliance, digital manufacturing, healthcare, insurance tech, and augmented reality. Lylan typically invests in Series A and Series B stages with check sizes ranging from $1M to $7.0M, favoring a sweet spot of $4.0M. His notable investments include Dollar Shave Club, KeyMe, Freshly, Dialogue, and Mnubo. He has a strong educational background with a Kauffman Fellowship, an MBA from Northwestern University, and a B.Math in Computer Science from the University of Waterloo. Lylan’s professional career includes roles at White Star Capital, StrikeAd, Maxifier, and DoubleVerify, bringing a wealth of experience and a diverse portfolio.

Windcrest Partners specializes in principal investments in energy, network games, healthcare administration, and internet technology.

James Pallotta is the Founder and Managing Partner of Raptor Group, a Boston-based investment management firm primarily focused on technology, fintech, sports, consumer, media, entertainment, and healthcare. Raptor Group invests across various stages and asset classes, ranging from early stage venture to both private and public equity. Their geographical preferences include the East, Midwest, South, and West regions of the United States. Jim Pallotta has a track record as Chairman and Managing Director of Raptor Group, displaying a strong ability to pick successful investments. The check sizes for investments by Raptor Group can vary based on the opportunity and potential value for long-term outsized returns. Raptor Group emphasizes collaborative partnerships and leverages its operating and strategic expertise to drive results for the companies they invest in.

Vipul Patel is an investor with a focus on technology vendors and has made investments in Capstan Medical. He invests in a range from $100,000 to $5 million, with a sweet spot of $1.5 million. Patel’s partnership and collaboration style aligns with introspective teammates who value establishing trust and respect through dialog and discussion. He operates in the sectors of AgTech (Seed), EnergyTech (Seed), Digital Health (Seed), Health & Hospital Services (Seed), Health IT (Seed), AgTech (Series A), EnergyTech (Series A), Digital Health (Series A), Health IT (Series A), and Health & Hospital Services (Series A)

Elise Hoffman, General Partner at Cultivation Capital, specializes in investing in digital health, life sciences, software, IT, agriculture, and food technology startups primarily in the Midwest Seed Stage. She has a track record in health technology and life sciences investments. Cultivation Capital focuses on early-stage investments ranging from seed to Series B. Elise’s investment check size is not specified. The firm promotes collaboration and internal talent to drive partnerships. Geographically, the focus is on the Midwest region. Previous investments are in sectors like digital health, software, and IT.

Marek Poszepczynski, an Investment Manager at SV Health Investors, is known for his specialization in the healthcare sector with a focus on biotechnology, medical devices, and digital health. SV Health Investors has a proven strategy for selecting healthcare investments across various stages, geographic regions, and sectors. Marek has a track record that includes managing the International Biotechnology Trust and working on the Dementia Discovery Funds. The average investment check size from SV Health Investors ranges from 10 to 50 million dollars per startup. Marek’s professional career started as an analyst in 2014 before becoming a named manager of the trust in 2017. His collaboration style is reflected in his active management of diversified portfolios and his optimism about the biotech sector’s recovery post-Covid, emphasizing the importance of humility and appreciating industry trends.

Alexander Tang is a venture investor with a focus on technology, manufacturing, software, medical devices, and healthcare. He is known for delivering multiple bespoke financing solutions on aviation-related assets. Although specific check sizes are not available, he has a history of successful collaborations in the financial and investment sector. His active involvement and leadership roles in various firms demonstrate a strong track record in the industry. His investment thesis centers around opportunities like Stacks, emphasizing a $90 billion potential opportunity. Alex Tang’s approach includes maintaining a leading position in the Bitcoin Layer 2 market cap through innovative solutions and technology adoption.

Kreske Nickelsen has over 20 years of global life science and venture capital experience, working with different funds, 3i Group plc, and The Boston Consulting Group. She has a background in Biology and an MBA, with a strong focus on venture leasing and financing solutions. Kreske has overseen transactions from seed stage to mezzanine, including license agreements, IPOs, and trade sale processes. She has served on numerous boards in Europe and the USA.

Qiming Venture Partners is a venture capital firm investing in the TMT and healthcare industries at the early and growth stages.

Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists.

Galina Rachenkova is a Principal at Hitachi Ventures in Munich, Germany. She focuses on strategic opportunities across Europe, investing in innovative startups in IT, industrial automation, cloud services, cybersecurity, mobility, energy, digital health, and smart infrastructure industries. Hitachi Ventures typically invests in Series A-C companies and targeting funding stages of Early Revenue, Scaling, Growth, and Pre-IPO. The investment check size ranges from $2M to $10M. Galina’s previous experience includes roles at Speedinvest, IBM, and JD Power. She holds a master’s degree in science from Karlsruhe Institute of Technology.

Edward Sullivan is an investor focused on technology vendors, venture capital, consumer, tech, insurance, healthcare, and financial services. His previous investment includes G2Link. He specializes in executive coaching. Edward Sullivan’s investment check size, geographical preference, track record, and partnership styles are not explicitly mentioned in the available information.

Magnus Christerson, an Angel Investor at Alliance of Angels, focuses on MarketingTech and SaaS startups at the Seed and Series A stages. His investment range is $500K to $1.5M with a sweet spot at $1M. Magnus has affiliations with scouts and angels within Alliance of Angels, such as Andrew Wang, Bahador Biglari, Ben Sharpe, Beth Morgan, and Carla Fowler.

Vidinovo is a venture capital firm established in 2013, focusing on early and late-stage financing. Their investment thesis centers around the healthcare, education, life science, oncology, and service sectors. Vidinovo typically invests in companies in the range of 1 – 5 million dollars. The firm’s geographical preference is not clarified, but their previous investments include companies in the Health Care, Software, Machine Learning, Artificial Intelligence, and SaaS fields. Some of their notable portfolio companies are MedGenome Inc., WiserCare, American Prison Data Systems, PBC. Vidinovo’s investment check size is around $3 million per round, and they have made 5 investments with an average round size of $3 million. As for track record and professional career details, specific information is not available.

Jonathan Weiner typically invests in rounds ranging from Seed to Series A with check sizes matching those stages of investment.

Howard Walthall is the Founder and Chief Executive Officer of Lumiheal Therapeutics. He has a track record of leadership roles in various companies, including NuTech Spine, Inc. and NuTech Medical, Inc. Walthall’s professional career includes positions at Organogenesis Holdings Inc. and Burr & Forman LLP. His investment check size is not specified in the available information. Walthall is associated with companies like CHITOGENX INC. and Lumiheal Therapeutics. However, specific details about his investment thesis, focus areas, stage of investment, geographical preference, previous investments, and partnership and collaboration styles could not be found.

Toyota Ventures is an early-stage venture capital firm that invests in startups from around the world.

Justus Klocke is an investor focused on Pre-seed BioTech startups. He invests in startups like Pixtunes and Seniovo, with a check size range of $25K. Justus Klocke’s professional career includes a Ph.D. in Modern German Literature and Culture from Indiana University. His partnership and collaboration styles involve engaging in discussions about AI tools and policies. Justus Klocke’s geographical preference and specific track record are not available.

Marta Mrozowicz is a former Investment Manager at Calm/Storm Ventures, a purpose-driven venture capital firm focusing on founders changing life & health for the better. She transitioned to Heal Capital’s team in Berlin with a focus on HealthTech investments. Marta’s investment range is $25K to $250K, with a sweet spot around $137K.

Young Sohn serves as a Board Member at Oryn Therapeutics and is an Advisor at Unique and MedaSystems. She also acts as an Angel Investor and Co-Founded Vlocity. With a background in leadership roles at various companies, Young has a track record of successful ventures in the pharmaceutical CRM space. She has been involved in acquisitions, innovative solutions, and thought leadership within the industry. With a B.A. in Business Management from Cornell University, Young Sohn brings valuable expertise to the organizations she is associated with.

Oni Chukwu, an experienced global CEO and technology investor, is known for building and growing global technology companies. He served as the Executive Vice President of Triple Point Technology before becoming President and CEO of eTouches Inc. He holds an MBA and an Honorary Ph.D. in Business Administration. Oni is an angel investor providing early-stage capital ranging from $20K to $100K for startups. His professional career spans over 20 years, demonstrating strong leadership in customer growth, financial performance, and operational execution. Oni’s collaboration styles include introspective, relational, and expressive, facilitating effective partnerships and teamwork.

David Mes serves as Director of Private Equity at Total Eren. He serves as Advisory Board Member at Agroecology Capital. He served as Co-Chief Executive Officer at Jasper. He served as Board Member at Bandwagon. He served as Chief Financial Officer at Jasper. He serves as General Partner at Off The Grid Ventures. He also serves as a Venture Partner at US Invest LLC. He served as a Board Member at Migo. He served as an Advisor at Realization Capital Partners. He was also a Co-Founder of Arc Venture Partners and served as a Managing Partner. He also serves as Advisory Board Member at Agroecology Capital.

Sami Inkinen is the CEO & Founder of Virta Health, an online specialty medical clinic that reverses type 2 diabetes safely and sustainably. He likes creating positive disruptive change in business and personal performance through new technologies and hard work. Sami advises, mentors, invests, and starts high-growth companies, especially those focused on healthy living and advancing human health and performance. His past experience includes co-founding Trulia, working at Microsoft, McKinsey & Company, Nokia, and co-founding Matchem. He holds an MBA from Stanford University and a Master’s in Engineering from Helsinki University of Technology. Sami is an investor in health, aiming to reverse diabetes in 100M people.

Kevin Kim is an investor with a focus on the healthcare industry, committing over $4.0 billion to over 100 companies. However, specific investment focus areas, stage of investment, geographical preference, and partnership styles are not directly provided in the available information. Previous investments and track record details are not disclosed on the sources found. Kevin Kim has a background working with big brands like Google, AdWeek, and Bizzabo, managing over $65M in revenue at Google. He has experience in forging partnerships with both internal and external stakeholders, particularly in adtech and advertising.

Joseph M. LaGuardia is the principal of LaGuardia Group, a New Business Development and Strategic Marketing firm serving health plans, hospitals, ventures in the health and wellness industry, entrepreneurs, and start-ups. He has a Bachelor of Science degree in Business Administration from The University of Akron. Previously, Joseph served as the Senior Vice President of Business Development at Pretorian Labs, a large independent lab, and as a Consultant at the Cleveland Clinic. He has also held positions such as Regional Vice President at Anthem Blue Cross and Blue Shield/Wellpoint and VP at Swagelok. LaGuardia’s professional career spans roles in marketing, sales, new business development, and consulting across healthcare and other sectors.

Allan Zeise is an experienced executive with over 30 years of experience in Information Technology. He has led technology-based entrepreneurial ventures from launch to acquisition. As an angel investor, Allan has funded and launched over 9 technology-based companies, with investments ranging across various industries such as motor fuel tax compliance, supply chain management, GPS tracking, and gaming platforms. His angel investments extend to the healthcare sector, including investments like Enlace Health. Allan Zeise’s focus areas include seed investments, with a preference for startups in the Green Bay region, Wisconsin, and the United States. Currently serving as the President of HuTerra, Allan follows a partnership and collaboration style that aligns with cooperative and facilitative collaboration, providing support and guidance to early-stage ventures within his portfolio. The investment check size typically ranges from $250K to $5M, supporting mission-driven founders at different stages of growth.

Dino Vendetti is a General Partner at Seven Peaks Ventures, focusing on investments in AI/ML, Fin-Tech, Healthcare IT, Renewable Energy, Blockchain Enabled DeFi, and Real Estate Prop-Tech. Seven Peaks Ventures partners with entrepreneurs to build and scale disruptive businesses. The partnership team includes Dino Vendetti, Tom Gonser, and Joe Franzi. Dino Vendetti and his team invests in early-stage startups in the Pacific Northwest. Previous investments are not specified on the website. The website does not provide specific details on the stage of investment, geographical preference, track record and professional career, investment check size, or partnership and collaboration styles.

Abbe Held focuses on well-positioned companies with operational and strategic improvement potential in sectors like Business & Financial Services, Healthcare, Industrial, Retail, Consumer & Leisure, and Technology. Their geographic focus includes North America, Latin America, Europe, and Asia. Abbe Held’s previous investments are not specified. As the Director: Creative at Kooba Inc, Abbe Held’s professional career history is detailed on Bloomberg Markets. The investment check size information for Abbe Held is not available. Abbe Held is known for their operationally intensive, sector-focused investing strategy and their collaborative partnership with management teams to drive value creation through revenue and earnings growth.

Moses Lee is a Venture Investor Scout at Grand Ventures specializing in investing in seed stage B2B SaaS companies in emerging regions of the US and Canada. The investment focus areas include Supply Chain, Fintech, DevOps, and Digital Health. Grand Ventures’ geographical preference is in the US and Canada, with a check size ranging from $500K to $2MM for companies raising their first institutional round of funding. Moses Lee has a track record in education, venture capital investing, and strategic advising. The partnership and collaboration style at Grand Ventures involves supporting entrepreneurs from inception through rapid growth to maturity by providing strategic guidance, talent development, and business support.

MacKenzie Bezos is an angel investor based in California, U.S.A. She has made 15 investments, with the latest one in Capital Link on December 7, 2023. Her net worth is $33.5 billion as of April 24, 2024. She donated $640 million to 361 nonprofits in late March, totaling $16.5 billion in lifetime philanthropic giving.

James McKelvey is a Co-Founder and General Partner at Cultivation Capital. He focuses on technology and life sciences investments. Cultivation Capital manages funds in software, agriculture, geospatial, and health tech startups. Recent investments include Lionize. James McKelvey is also involved with SixThirty, a FinTech accelerator making $100,000 investments in financial-based technology startups. He collaborates with local financial services companies and supports startups with training and mentoring. SixThirty addresses the engineering talent gap in the St. Louis startup ecosystem.

Latam Partners is an investment firm focusing on supporting entrepreneurs in Latin America. Their investment thesis revolves around backing exceptional entrepreneurs rather than just ideas, seeking to improve access to products and services for the majority of the population. They target medium-sized companies with growth potential, emphasizing environmental, social, and governance objectives. Their stage of investment includes pre- to post-seed investments in tech sectors like agtech, fintech, and healthtech. Geographically, they focus on tech-hubs in countries like Mexico, Colombia, Chile, and Brazil. Some of Latam Partners’ previous investments include companies like Empresas AquaChile, RV4 Desarrollos, and ProNuvo. With a professional team and solid track record, they tailor their investments to promote growth, profitability, and long-term value creation, offering strategic partnerships and collaboration styles tailored to the needs of their portfolio companies.

Marc Abramowitz is a private investor primarily focused on Enterprise Applications and HealthTech. Some of his previous investments include Aural Analytics and Betable. He has an extensive professional career, having worked as a Program Manager at Telos Corporation with experience in managing various projects. His investment check size can vary, as seen with his investment in Finexio as part of their Series A – II in 2021. Abramowitz’s partnership and collaboration styles are not specifically mentioned in the available data.

Joshua Beebe is a Partner at MK Capital, an established venture capital firm with a focus on multi-stage growth equity and venture capital investments. Joshua Beebe leads the healthcare technology investment practice at MK Capital. The firm’s investment strategy includes a preference for seed-stage, early-stage, and growth-stage companies. MK Capital operates out of Northfield, Illinois, and has a geographical preference for companies in the Great Lakes and Midwestern US regions. The check size for investments at MK Capital varies based on the stage and needs of the companies. The partnership and collaboration style at MK Capital involves active involvement in portfolio companies and advisory roles, with team members providing valuable expertise and guidance to support growth and success.

Rachel Rath is an investor at Johnson & Johnson Innovation – JJDC, Inc with an investment range of $100K to $5.0M, focusing on sectors like Medical Devices, Health & Hospital Services, and Health IT at both seed and Series A stages.

Ryan Retcher is the Managing Partner and COO at LOUD Capital. LOUD Capital focuses on changing alternative investments by leveraging capital to solve global issues. The investment thesis is to create profit with purpose. Geographically, LOUD Capital is based in Dublin, Ohio. The stage of investment and specific focus areas are not provided in the available information.

Roland Zeller is an investor with an investment thesis focused on travel destinations becoming the stars of tourism. His investment focus areas include portfolio investments like Runnr.ai. Previous investments include GetYourGuide. In his professional career, he has held leadership positions at Intergraph and founded Viselio AG. The investment check size ranges between $500k to $1mm. He partners and collaborates with innovative entrepreneurs and supports them within the industry.

Scott Schreer is a highly successful entrepreneur and innovator with a vast network in the television broadcast and music industries. He is known for composing theme songs for various TV programs and has gained six Emmy nominations. His investments include TopCourt and a portfolio exit with Audiam. Scott Schreer has a background in music theory and education, having earned a BA from LIU Brooklyn. His company TuneSat specializes in proprietary audio fingerprint technology for tracking music performances on TV and the internet. His investment check size varies, with recent investments in TopCourt under Seed VC. Scott Schreer has a history of successful investments and a collaboration style focused on strategic partnerships in the tech sector.

Jim Sullivan is a Venture Partner at OrbiMed, based in Chicago, Illinois. His investment thesis focuses on Pharmaceuticals, Digital Health, BioTech, Health & Hospital Services, and Health IT at the Seed and Series A stages. Jim’s investment check size ranges from $1M to $75.0M, with a sweet spot of $4.0M. He has a current fund size of $18B and collaborates with co-investors such as Alexandria Huynh, Anat Nursella, Brendan Weber, Carl Gordon, and Charles Steinman. Sullivan’s partnership and collaboration style involve actively engaging with startups in the mentioned sectors, aiming to contribute to their growth and success.

Emmanuel Osioh focuses on investing in sectors that provide critical goods and services to low-income customers, including Agriculture, Education, Energy, Health, Financial Inclusion, Housing, Water & Sanitation, and Workforce Development. Acumen, a company he is associated with, has invested $154.4M in breakthrough innovations impacting 501M lives with dignity. Emmanuel Osioh has a professional career in rigging and forklift operation, with over 17 years of experience. However, specific information regarding his investment check size and partnership and collaboration styles could not be found.

Bernd Goergen is a High-Tech Gründerfonds Partner with an investment focus in Life Sciences & Chemistry, Digital Tech, and Industrial Tech. His investments typically target BioTech (Seed), Health & Hospital Services (Seed), and Health IT (Seed). Bernd’s investment range is from $100K to $5.0M, with a sweet spot of $1.5M per company. He has a Ph.D. in Virology, Immunology, and Human Genetics and has previous experience as an International Marketing Manager and Postdoctoral Research Scientist. Bernd’s geographical preference is not specified in the available data. His partnership and collaboration styles can be inferred from his past investments in companies like Cunesoft, Fiagon, HUMedics, and Oncgnostics. Unfortunately, specific information on investment check sizes is not available.

Stephen Malik is an Angel Investor with a focus on seed round investments in healthcare, consumer internet, and mobile industries. He has a strong track record in software ventures and successful software firms. His geographical preference is to bring MLS and NWSL teams to North America. Additionally, he has acquired the NASL Carolina RailHawks and rebranded them to North Carolina Football Club. Malik’s professional career includes founding Medfusion and leading the N.C. Courage women’s soccer team. His partnership and collaboration styles involve building organizations that cover various segments of the soccer industry, from grassroots to professional levels.

Thomas Bachem is an Angel Investor who has invested in companies like Doctorflix, Masterplan.com, and femtasy within the Healthcare Services, Education, and Training sectors.

Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM

Desney Tan is an Angel Investor at Alliance of Angels focusing on investments in Hardware, Entertainment & Sports, Retail, Digital Health, BioTech, Health Services, Health IT, AI, and SaaS. Desney Tan’s investment check size ranges from $500K to $1.5M with a sweet spot at $1M. He has made investments in companies like Wrapify, Zero Slant, Clipisode, Signpost, and more. His current collaboration style involves investing in hardware, entertainment, retail, and health services primarily at the seed and Series A stages with a fund size of $100M.

Nils Regge is a serial entrepreneur with a passion for health tech and biotech companies. He focuses on investing in age-related diseases and longevity. Nils Regge’s investment check size is undisclosed, and his partnership and collaboration styles are not specified. His previous investments include Albora Technologies and NUMA Group. He is known for co-founding successful companies and has an aggregated valuation over his entrepreneurial career.

Zeno Ventures invests in early and growth stage technology enabled companies addressing consumer and enterprise markets.

Venrock is a venture capital firm investing in technology and healthcare companies.

Stefan Martinez is a venture capital professional known for investing in innovative and disruptive technologies. He has a background in investment banking and possesses strong analytical abilities in identifying high-growth companies. Stefan’s investment focus areas include SaaS and Human Resources. He typically invests in early-stage startups at the seed round level. Though based in Cologne, Stefan’s geographical preference extends to global opportunities, especially in the EU region. His professional career includes roles such as Stockroom Clerk at LATAM Airlines and Fellow at Venture Hive. Stefan holds a B.S.E. in Mechanical Engineering from Florida International University and has certifications in Insurance Adjuster and Microsoft Office Specialist. His investment check size ranges based on startup needs.

Neil Chheda, a General Partner at Romulus Capital, leads investments in technology-enabled companies across various sectors and stages. Prior to Romulus, Neil advised major healthcare and financial institutions at McKinsey & Company, contributed to product development at Zynga, and successfully sold a healthcare technology and services business. He also established an investment firm targeting B2B businesses in traditional industries. Neil’s educational background includes an A.B. in Political Science from Yale University and an MBA from Harvard Business School. Romulus Capital focuses on leading Seed and Series A rounds for B2B companies offering disruptive technology solutions in traditional industries or deep technology companies arising from top-tier research groups. Neil’s collaborations are geared towards providing strategic guidance and support to founders navigating critical growth phases.

David Scrim is a Limited Partner at New Stack Ventures, a venture capital firm headquartered in Chicago, Illinois. New Stack Ventures focuses on early-stage investments in B2B SaaS, fintech, ecommerce, supply chain, cyber, proptech, and healthcare sectors. David has a track record in partnering with tech startups from the 1st stage of investment. The firm has a geographic focus on Silicon Valley outsiders. They invest in early-stage companies and aim to increase average check sizes from $400,000 to $1 million. Their partnership and collaboration styles emphasize injecting capital into founders to support their growth.

Bronze Valley is a non-profit, early-stage venture investment platform that supports high-growth, innovation, and technology-enabled companies created by diverse, underrepresented, and underestimated founders. Their investment focus areas include industries such as food, sports, software, healthcare, retail, and fintech. They invest in underrepresented founders, especially Black founders, based in Alabama and Georgia, with funding stages focusing on Early Revenue and check sizes ranging from $25k to $100k. Bronze Valley has a track record of supporting companies like City Detect, Pye, Therapy iQ, Accencio, Sweft, and many others. The organization is governed by industry professionals such as John O. Hudson III (Chairman) and Neill S. Wright (President), who guide the partnership and collaboration styles to foster innovation, diversity, and community impact.

Josefin Landgård is a Swedish investor with a focus on health services located in Sweden. She has made investments in companies such as Noala, Medoma, and Ester Care. Her average round investment is $2.68 million USD, with an average of 3.2 investments per year. Josefin’s investment criteria include an average deal size range of 1M – 5M USD, a focus on health services, and investing in companies in Sweden.

Niccolò Colussi is the CEO of a holding company investing in private equity funds and minority stakes in SMEs and startups operating in various markets such as Renewables, Healthcare, Automotive, Food & beverage, Cloud, and IT. His investment focus is in the Pharmaceutical, Education, and Venture Capital sectors. Niccolò Colussi’s partnership and collaboration styles can be explored further by analyzing his team and ecosystem on the LIFTT website.

Greg Kidd is known for investing in Pre-seed Messaging and other investment areas, with a preference for geographical focus on the US. He has invested $48 million in Vast Bank. Greg Kidd’s track record and professional career are not explicitly mentioned on the sources found.

Bluegrass Angels is an angel group investing in innovative Kentucky startup companies aiming for quick growth in large markets, providing strong financial returns and new jobs in the Kentucky economy. They focus on high-tech sectors like healthcare, agriculture, industrial chemicals, manufacturing, biotech, fintech, and media. Bluegrass Angels prefer to invest in companies with viable exit strategies. The group typically invests in early-stage startups and aims to fund 5-7 companies annually. Their geographical preference is Kentucky. The portfolio includes high-tech startups with long-term success goals. The organization consists of volunteer leaders who mentor startups and have a strong track record in funding and supporting Kentucky startups.

Jayde Crystal Wright is a VC Associate at Deerfield Management with a current investing position as an Associate. Their investment range is $10.0M – $50.0M with a sweet spot of $25.0M. Crystal Wright focuses on sectors such as Medical Devices, Pharmaceuticals, Digital Health, BioTech, Health & Hospital Services, and Health IT in both Seed and Series A stages. They have collaborated with various co-investors like Abraham Kometz, Adam Greene, Adam Grossman, Alexis Cazé, and Alison Stamas. Crystal Wright is based in New York, USA.

Alexander Packard is an investor with a focus on high-growth companies in health care and online education. He is the President at Iora Health and has previously worked as COO at Outside the Classroom. Alexander Packard’s track record includes leadership roles at various companies, including advisory and educational firms. His career includes a background in senior operating roles emphasizing innovation and service. While the specific investment focus areas and partnership styles were not available, his experience suggests a preference for innovative ventures in health care and education sectors. Alexander Packard has a history of contributing to ventures with a strong focus on public health. His investment check size and partnership styles were not explicitly mentioned on the sources accessed.

Kathleen Baxley is a seasoned professional with extensive experience in the social work field and program management. Her career includes roles as a Program Specialist at the NIH Clinical Center, Department Chief of Social Work, and Deputy Department Chief at Walter Reed National Military Medical Center. With 29 years of experience in social work, including child abuse, intimate partner violence, and medical social work, Kathleen holds clinical social work licensure in Washington, DC and North Carolina. She has a background in psychology, social work, health care administration, and business administration, with degrees from University of Pittsburgh and University of Maryland University College. Kathleen’s career reflects a commitment to social welfare and healthcare, showcasing her expertise in managing diverse teams and complex programs.

Keno Gutierrez, a Partner at BGV (BioGeneration Ventures), has a background in biotech investments and life sciences. With over 20 years of experience, Keno was previously a Vice President at M Ventures. He holds a PhD in Genetics from University College London and an MBA from INSEAD. Keno has been involved in various biotech companies and research in lipid metabolism published in Nature. His portfolio includes companies like Brenig, Dualyx, Fibrocor, FundaMental Pharma, and Tessellate Bio.

Willemijn Verloop is an investor at Anterra Capital with a focus on Seed to Series B investments. Her investment thesis involves sectors like Supply Chain Tech, AgTech, Food and Beverage, and FinTech. She has a track record of advising companies like V-Ventures, Tony’s Chocolonely, and Rubio Impact Ventures. Willemijn typically invests between $1 million to $20 million, with a sweet spot at $5 million. Her partnership and collaboration styles are aligned with her roles on various boards, showcasing a commitment to impact investing and strategic guidance.

Neil Thanedar is an entrepreneur, investor, scientist, activist, and author. As the founder and chairman of LabDoor, he emphasizes the importance of having a diversified portfolio with at least 34 companies to achieve successful investments. Neil focuses on a seed-stage valuation approach. He has a geographical preference towards North America and has a track record of founding companies like Avomeen Analytical Services. His investment check size strategy outperforms large growth funds by investing in a larger number of startups for higher average returns. Neil Thanedar values partnership and collaboration, as seen in his ongoing work with LabDoor.

Oprah Winfrey is an investor with a successful track record and a focus on sustainability, inclusivity, empowerment, accessibility, and health and wellness. She manages her investments through a family office and has made investments primarily in Enterprise Applications and HealthTech sectors. She has a preference for investing in the United States and Sweden. Oprah’s previous investments include Maven, Apeel, Guild, Oatly, and Spanx. She has a net worth estimated at $2.5 – $2.8 billion and is known for her successful collaborations and partnerships, leveraging the power of endorsements to enhance impact.

Jack Fuchs, Co-Founder and Operating Partner at Blackhorn Ventures serves as a Board Member at Datch, CytoVale, and Aperia Technologies. He was the CFO of NextBio and ForteBio with a track record of successful exits. Previous roles include positions in finance, business development, sales, marketing, and product management at various companies. He has also been an Executive at Pactolus Ventures, an entrepreneur, teacher, and angel investor.

Christopher Kile is the Co-Founder and Managing Partner at Zeno Ventures. Zeno Ventures is a Venture Capital firm that invests in early-stage technology-enabled companies addressing consumer or enterprise markets. Christopher Kile seeks to partner with talented and passionate founders solving difficult problems. Some of the recent investments by Zeno Ventures include Fetch, Mighty Buildings, and Mercury. Christopher Kile is based in Geneva, Switzerland, and the firm operates in Europe, Middle East, and Africa (EMEA).

Franz Salzer, Investment Manager at Bayern Kapital GmbH, focuses on software, bioscience, healthcare, and pharmaceutical sectors. Previous investments are in Series B. The investment check size typically targets the seed round. The partnership and collaboration style information is not available.

Markus Okumus is an investor focusing on Series A investments in Wellness & Fitness, Digital Health, and Health & Hospital Services, with a preference for Swiss and American regions. He has a track record as a Founding Partner at FORM Life Ventures with previous board positions at Baze Labs AG. Markus Okumus’s investment check size is detailed on Signal NFX. He engages in collaborative styles within the industry.

Ero Carrez is an investor focused on successful, robust, family-owned small and medium-sized businesses in the private equity and venture capital sectors. His geographical preference aligns with companies in Europe, the United States, and Asia. Ero Carrez’s investment check size typically ranges between $500K to $1.5M per company. He has a track record of investing in companies like Patriarche, Manufactors Invest, and u201cProjet Etoileu201d. Ero Carrez’s stage of investment is primarily in companies in the digital, smart cities, and healthcare sectors, supporting visionary entrepreneurs to create the champions of tomorrow.

Jeff Hammerbacher is an angel investor who focuses on investing $10k – $50k in young, emerging companies. He has made 21 investments with 7 portfolio exits. Jeff’s investments include areas such as SaaS, Analytics, Big Data, Cloud Data Services, and Machine Learning. Some of his previous investments are Genome Compiler, Casetext, and DataRobot. He typically invests in early-stage startups and values collaboration with co-investors. Jeff’s check size for investments ranges from $10k to $50k, and he primarily invests in seed-stage companies.

Shachar Bialick is a dedicated investor with a focus on innovative technologies. He has a strong background in building successful companies in healthcare, finance, e-commerce, and telecommunications. Shachar’s investment thesis revolves around using technology to improve lives. His investment check sizes vary, with Curve having raised a total of £208 million in equity funding. Shachar is known for partnering with industry leaders like Apple, Google, and wearable companies to foster innovation. He has a successful track record as the CEO of Curve, a financial super-app, and his hands-on collaboration style fuels ambitious goals in the fintech sector.

Marcus Wainwright has made investments, including Maisonette as part of their Series A on May 17, 2018.

Rishi U. Shah, the founder of Outcome Health, is a visionary entrepreneur with an estimated net worth of $3.6 billion. His investment focus areas include healthcare technology, with a stage of investment ranging from early to mid-stage startups. Shah’s geographical preference has been prominent in Champaign, Illinois. His professional career showcases a track record of success in data architecture, research, and collaboration styles focused on building strong relationships. Overall, Rishi U. Shah is a pioneering figure in healthcare technology.

Unusual Ventures is a seed-stage venture capital offering hands-on support and expertise to startups on their early-stage journey.

Laura Waldenstrom, a VC Investor at INKEF Capital, focuses on investing in technology and healthcare sectors within the European Union. The investment thesis is driven by the rapid growth of marketplaces in e-commerce, with a belief that every demand-generating platform will evolve into a transaction-based platform. Laura Waldenstrom’s partnership and collaboration style emphasizes user-friendly and competitive products, leveraging multiple layers of growth, strong commercial traction, and a talented team with high execution power.

Jonas Bergman is the Investment Director at Chalmers Ventures with an investment focus in MarketingTech (Seed), Medical Devices (Seed), Pharmaceuticals (Seed), BioTech (Seed), and FinTech (Seed) sectors. His recent investment includes Embedl AB in the seed stage. Some of his previous investments include companies like Swedish Algae Factory, Metry, Evispot, Micvac AB, and Mevia AB. Jonas has a track record of serving on the board of various companies and has a background in CEO roles, management consulting, and extensive experience in sales and marketing. His investments typically range from $100K to $5.0M, with a sweet spot at $1.5M. Jonas Bergman is an alumni of Chalmers School of Entrepreneurship and Chalmers University of Technology.

Scooter Braun is an active investor with a focus on companies in the Business/Productivity Software, Pharmaceuticals and Biotechnology, and Financial Software industries. He invests in gaming/esports, social commerce, health & hospital services, health IT, consumer internet, and fintech sectors. His investment check size ranges from $250K to $5.0M, with a sweet spot of $1M. Scooter Braun has made 48 investments and partners with other investors such as Lior Shiff, Marlinspike, Larry Marcus, and more. He engages in partnerships and collaborations to support companies at various stages, including seed and Series A.

NELSA, through the North of England Life Science Accelerator (Nelsa), selects and supports startups focusing on life sciences and drug delivery, including companies such as Lightox, Horizon: Therapeutic Microbubbles, StrataStem, and others. NELSA has a background in marketing and digital strategy roles and holds a Bachelor’s degree in International Marketing and a Master’s degree in New Media. NELSA has been involved in various companies such as hellomarketing.ai, HelloMaaS, and Popwallet. The investment check size of NELSA in startups is varied, with previous investments ranging from $64m fund to undisclosed businesses focused on drug delivery. NELSA’s partnership and collaboration styles involve various roles like Co-Founder, CEO, and Advisor & Investor, showcasing a diverse and active involvement in the startup ecosystem.

George Goognin invests in science and tech that produce abundant resources like housing, food, energy, and healthcare. His previous investments include Karma, a cross-border p2p loans ecosystem that raised $10 million in 2017. The typical check size for investments is $100k. George Goognin’s partnership style involves joining forces with companies to revolutionize B2B cross-border trade and manage compliance efficiently.

Falk F. Strascheg is an investor focused on venture capital investments. Operating through Falk Strascheg Holding, the firm’s investment thesis encompasses sectors like healthcare, engineering, technology, medicine, 3D, and science. Their family office, Extorel GmbH, specializes in venture capital investments in electronics, laser, semiconductor, and information technology. Falk F. Strascheg’s professional career and track record include founding TECHNOLOGIEHOLDING, a leading venture capital company in Germany. While specific details on the stage of investment, geographical preference, previous investments, investment check size, and partnership styles were not readily available, Falk F. Strascheg has a history of success and expertise in the venture capital industry.

Geert-Jan Mulder is an experienced life sciences investor who co-founded Forbion in 2006. He has led successful investments in various portfolio companies, including those in the biopharmaceutical and therapeutic sectors such as AM-Pharma, ARMGO Pharma, Complement Therapeutics, Enterprise Therapeutics, Mariana Oncology, NeRRe Therapeutics, and Prilenia Therapeutics.

Martin Velasco is an entrepreneur and Business Angel with extensive experience in the IT, medical, and biotech sectors. He serves on the board of Anecova SA. His previous investments are related to raising capital in companies like Acimmune and Sumerian. Martin Velasco focuses on Pelton turbines performance improvement using reverse engineering, parametric design, and CFD analysis. The specific investment check size for Martin Velasco is not available, and his partnership and collaboration style may involve elements of cooperative, competitive, and directive collaboration.

Tacoma Angel Network is an angel investing group founded in 2006 and based in Tacoma, United States. They focus on backing early-stage tech companies in the Life Sciences sector. With a portfolio of 2 companies, their latest investment was in DesignMedix in a Series A round in July 2014. The team comprises John B. Dimmer and Larry S. Kopp. Tacoma Angel Network collaborates with other investors, with 15 co-investors in their portfolio companies over 18 years. They primarily invest in Series A and Series B stages, with a geographical focus on the United States.

Harbor Street Ventures is a family office based in Chicago, Illinois, founded in 2014. They specialize in early-stage investments in the healthcare sector.

Joey Low, the Founder of Star Farm Ventures, focuses on early-stage investments in Israeli startups to help them expand into the US market. He has a hands-on approach and is involved in guiding the startups through growth. Joey’s preferred geographical focus is in the Northeastern US. His investment check size ranges from $100,000 to $500,000 per company. Joey’s collaboration style involves mentoring and providing strategic support to foster rapid business development. His track record includes successful investments in various sectors, with a primary focus on supporting Israeli startups.

Christopher Miller is a senior portfolio manager and team leader at Allspring Global Investments, with 21 years of experience in the investment industry. He focuses on the Select Equity team and holds a bachelor’s degree in business administration. His investment focus areas include Life Sciences Transactions, Health Care, Technology, Mergers + Acquisitions, Private Equity, and Emerging Companies + Venture Capital. Christoph Miller’s previous investments include Goodbytz, Your Super, and Stenon. He has been involved in Series A, Series B, and Seed rounds with total amounts raised ranging from $1M to $13M.

Rajbir Minhas is an investor at Angel Physicians Fund, focusing on healthcare startups. His investments remain undisclosed. Rajbir’s professional career and track record are not publicly available. The investment check size is unknown, and his partnership and collaboration styles are not detailed in the sources found.

Gillian Sandler is the Managing Partner at Galapont Capital, focusing on investments in healthcare and life sciences with a primary therapeutic focus on autoimmune and neurodegenerative disorders. She has a track record of 25 years as an entrepreneur, CEO, Chairman, investor, and research analyst, among other roles. Gillian’s previous investments include leading roles in companies like Invicro and Molecular Neuro Imaging. While her investment check size is not specified, she has a hands-on approach and collaborates closely with the companies she invests in, aiming to drive transformation in the healthcare sector.

Sean Brecker serves as the Chief Financial Officer at Oura, a health technology company. He has a background in investment banking and holds a Bachelors degree in Mathematics/Economics from Wesleyan University and an MBA from The Wharton School. His previous investments include Headspace Health, ÅURA, CoachArt, Lehman Brothers, Citibank, Nomura, and Nomura Holdings. The geographical preference of his investments covers Canada, United States, South America, and Europe. Sean Brecker’s check size investments are not explicitly stated on available sources. He demonstrates a collaborative and strategic partnership style in his leadership roles.

Brad Gillespie is a General Partner at IA Ventures with a focus on Enterprise, B2C/E-Commerce, Fintech, and Digital Health sectors. He invests in companies at the Seed, Series A, and Series B+ stages, primarily in the USA. His investments range from $0 to $10 million per company. Brad Gillespie has a track record in sales, staffing services, and temporary placement and stands as a highly experienced professional. He is known for notable investments like Datadog and follows a partnership and collaboration style evidenced by his appreciation of outstanding customer service and commitment to collaborative relationships.

Amit Strong, Senior Investment Manager at Globaltrend, is focused on financing and construction projects, preferably above 40 million USD. He seeks shovel-ready projects and works with sincere individuals. Amit has experience in corporate investment as an Independent Investing Associate at CSJL Consulting. He can be contacted at amitstrong@yahoo.com

Alex Marker is an investor with a focus on industries such as financial technology, future of work, future of learning, food technology, and health/wellness. He primarily invests in pre-seed companies raising their first institutional round of capital. His check size ranges between $250k-$1MM as an initial investment.

Tamiami Angel Funds is an angel group based in Naples, Florida, founded in 2010. The firm’s investment thesis involves providing seed and startup capital to emerging companies in sectors like SaaS, fintech, edtech, telehealth, and medical devices. They focus on early-stage ventures, seeking to achieve high returns by actively supporting companies. Tamiami Angel Funds does not have geographical restrictions on investment opportunities. Previous investments include companies in various sectors such as Climate Tech. Matthew Hinderman, a partner in the firm, brings a wealth of experience in tax and corporate planning. The specific check size for investments by Tamiami Angel Funds was not available. The partnership and collaboration styles of the firm align with investments in sectors such as SaaS, fintech, edtech, telehealth, and medical devices.

Thomas Noonan, a General Partner at TechOperators, focuses on investments in software, cloud computing, security, infrastructure, and mobile computing sectors. He has a mechanical engineering degree from Georgia Tech and a business degree from Harvard University. TechOperators invests in growth stage software companies. They prefer investing in North America. Thomas Noonan’s successful track record includes leading Internet Security Systems to nearly $400 million in revenue. He is an active philanthropist supporting education, environmental, and healthcare causes. The investment check size and partnership styles were not specifically mentioned.

Base10 is an early-stage venture capital firm investing in the automation of the real economy.

Daniel Bach is a Board Certified Internal Medicine-Dermatology Physician at Cedars Sinai, with experience as a Dermatologist at Cedars-Sinai and Assistant Professor of Dermatology at UCLA Health. He holds a Doctor of Medicine (MD) from Northwestern University and a Master of Public Health (MPH) from The Graduate School at Northwestern University. Daniel Bach’s previous investments are not available. His investment thesis, focus areas, check size, and partnership styles are not publicly documented.

Kristen Wong is a Principal at Altitude Life Science Ventures, based in Seattle, Washington, USA. Altitude Life Science Ventures is a venture capital firm that focuses on early-stage life science companies. Kristen Wong’s track record includes a philosophy to invest in life science markets with strong demand and growth potential, specializing in the life sciences, biotech, oncology, and digital health sectors. Altitude’s geographical preference for investments aligns with its base in the United States and particularly Kirkland, WA. The firm’s investment check size is in early-stage life science companies. Kristen Wong’s partnership and collaboration style emphasize backing the highest-quality entrepreneurs in the industry. Kristen Wong’s previous investments and specific investment focus areas were not explicitly stated but are in line with the firm’s focus on life sciences with high growth potential and strong demand.

Alister Coleman, the founder and Managing Partner at Tempus Partners, focuses on investments in software and information technology sectors. He has been involved in notable deals with investment check sizes reaching $4M. Alister’s geographical preference is in Sydney, Australia. His professional career is highlighted by a commitment to building a firm of operators and investors, aiming to support tomorrow’s greatest ventures. Previous investments by Alister at Tempus Partners include Swoop Aero. His investment style emphasizes co-leading funding rounds and collaborating with established partners like Right Click Capital.

Atomico is an international investment firm that focuses on helping disruptive technology companies scale globally.

Evan Jaysane-Darr is a Principal at Valor Equity Partners with a managing background at Invesco. With experience in venture and growth funds, he has invested in LifeX. His investment check size is around â¬7.5M. Evan holds a B.A. in History from Washington and Lee University and an M.B.A. from INSEAD in France. He is a CFA charter holder.

Todd Davis is an angel investor focusing on Enterprise Applications and HealthTech. He primarily invests in the United States in sectors such as Enterprise Applications and HealthTech. Todd Davis has made investments in Pyx Health, with a check size offering up to $1,088,300. His professional career includes co-founding LifeLock and serving as its CEO. Todd Davis has a track record of successful ventures and has been involved in philanthropic activities, serving on various boards and contributing to causes like the Sam Schmidt Paralysis Foundation and the Boys & Girls Club. In addition, Todd Davis does not have a strong geographic preference for investments and is willing to travel anywhere in the U.S. for the right opportunity.

Jeff Torrance is a Partner and Chief Financial Officer at Harpoon, focusing on investments in AutoTech, Space, Enterprise Infrastructure, Security, Enterprise Applications, AI, and FinTech at Seed and Series A stages. His investment range is $100K – $5.0M with a sweet spot at $1.5M. Some of his co-investors include Alexa M. Monti, Austin Hays, Chris O’Connor, Jimmy Yun, and Larsen Jensen. Jeff Torrance’s partnership and collaboration style entails working with investors from Harpoon on various seed and Series A investments.

Pia Ghosh is focused on clinical and translational studies in Bronchiectasis. She collaborates with organizations to address strategic alliances and constructive partnerships.

Ketan Yerneni is a Principal at KdT Ventures, an early-stage venture firm focusing on frontier computational technologies and science. He has previous experience in Business Development at Rhaeos, a company developing non-invasive diagnostics for hydrocephalus patients, and Surgical Innovation Associates, which was acquired by Integra. Ketan Yerneni’s track record includes bettering patient outcomes in reconstructive surgery and the development of diagnostic solutions. His investment focus areas include frontier computational technologies and science. Ketan Yerneni’s partnership and collaboration styles reflect a hands-on approach to driving innovation and improving patient outcomes. The investment check size and geographical preferences are not specified in the available information.

NueCura Partners is an angel investment company specializing in healthcare investments, with a portfolio of 16 companies including Babyscripts, Trilliant Health, and Bivarus. They focus on early-stage healthcare ventures and have made 2 exits. The investor operates in seed-stage round financing and has a geographical preference for healthcare investments. The check size for investments made by NueCura Partners remains undisclosed.

Ron Lewis is an MBA Investment Associate at Grand Ventures, an early stage venture fund investing in seed stage B2B SaaS companies in emerging regions of the US and Canada. Grand Ventures focuses on Supply Chain, Fintech, DevOps, and Digital Health sectors. They typically write $500K-$2MM checks for companies raising their first institutional round of funding. Some of their past investments include TealBook, InvestNext, Chain.io, Astronomer, iink Payments, Payload CMS, and Terminal 49. Grand Ventures aims to support entrepreneurs from inception through rapid growth, helping with strategy, talent development, and business growth. The firm is based in Grand Rapids, Michigan, with a geographical preference for emerging regions in the US and Canada. Ron Lewis and the team at Grand Ventures emphasize collaboration and aim to be good partners, supporting entrepreneurs at each stage of their journey.

Jan Adams is a partner at Apollo focusing on company creation. His career spans venture investing, company building, strategy consulting, and basic research in the life sciences. Jan previously headed commercial activities at the Merck KGaA Innovation Center and was a Managing Director with EMBL Ventures. He has a trained biochemist background with degrees from Tübingen University, University of Cambridge, ESSEC (Paris), and Mannheim University. Jan Adams is a Class 11 Kauffman Fellow and a recipient of a Boehringer Ingelheim PhD and an Ernst-Schering Post-doctoral Research Fellowship. The geographical locations mentioned are Berlin, Germany, and Cambridge, MA, United States.

Quyen Nguyen is a VC Investor at Antler based in Sweden with an investment range between $100K to $5.0M. His sweet spot for investments is around $1.5M. Quyen focuses on various sectors and stages, including Pre-seed investments in Health & Hospital Services, Marketplaces, Health IT, E-commerce, AI, SaaS, and FinTech, and Seed investments in Marketplaces, E-commerce, Health & Hospital Services, AI, SaaS, and Health IT. His collaboration includes investing with several other investors like Adele Moynihan, Ahmed Bilal, and Ainaya Tama.

Yuriy Romanyukha, a seasoned investor, focuses on seed and Series A investments in sectors like fintech, mobility, agriculture, healthcare, education, and commerce. With a diverse portfolio, Yuriy has been involved in various ventures such as Mindler, Exeger AB, Nanologica AB, Sigrid Therapeutics AB, and Zibetto Espresso Bar Inc. Additionally, Yuriy has contributed to the success of companies like Exeger AB through his role as a Co-Founder. His investment check sizes vary based on the startup’s potential, with a strategic approach towards supporting innovative and promising ventures. With a track record of successful investments and active involvement in board memberships, Yuriy Romanyukha brings a wealth of experience and expertise to the startups he supports, fostering growth and development in Sweden and beyond.

Boralis is an angel fund with a focus on transforming healthcare through new therapies, digital innovation, and other technologies, specifically in Life Science platforms and Digital Health. They invest in middle market, seed, and early-stage capital. Their geographical preference is not specified, but they have previous investments in Education & Health sectors. Boralis has made 2 investments, with the latest being in The Social Handshake in May 2022, with an investment amount of $1.17M. Their partnership and collaboration styles involve working with co-investors like Golden Egg Check Capital, JEX, and others to provide resources and support to their portfolio companies.

James Kennedy, based in Atlanta, Georgia, is a high-net-worth investor with a focus on education, healthcare, sustainability, and cable television. He has led Cox Enterprises to significant growth, increasing revenues from $1.88B to $20B. Kennedy is known for his contributions to the James M. Cox Foundation, tripling its size. His track record includes successful diversification of Cox Enterprises and notable philanthropy. While specific investment check sizes are not available, Kennedy’s impact on various sectors and startups is profound. He emphasizes partnership and collaboration through initiatives like the Georgia Partnership in Excellence in Education. Kennedy’s commitment to growth and innovation underscores his approach to investment.

Patrick Sullivan is a Managing Partner, Chairman, and Co-Founder at ATON Partners, a Boston-based private management advisory and investment firm focused on healthcare sector-related companies and technologies. ATON Partners invests in companies involved in the development and commercialization of medical devices and in vitro diagnostics. Some of the portfolio companies of ATON Partners include Dune Medical, CereVasc, and Insulet Corporation. Patrick Sullivan’s investment check size is not explicitly mentioned in the available information. The geographical preference of ATON Partners is not specified. The current focus and specific investment thesis of Patrick Sullivan and ATON Partners are on healthcare sector-related companies and technologies.

Mark Kingdon, the founder of Kingdon Capital Management, has a strong focus on healthcare investments. One of his recent funds, Kingdon Healthcare Fund, emphasizes investments in the healthcare sector. His past investments include companies like Xoma Corp and Heron Therapeutics Inc. Kingdon Capital is a New York-based macro and long/short hedge fund that was founded in 1983. Mark Kingdon is known for his expertise in the hedge fund industry and has a track record of successful investments in healthcare companies.

Paige Craig is a Co-Founder and General Partner at Arena Ventures, an experienced angel investor who has invested in over 110 startups including companies like Lyft, AngelList, Wish, Postmates, Twitter, Styleseat, Zenpayroll, Quizup, and more. Paige spent the first half of his career in the Marine Corps and US Intelligence Community, and later launched a defense contractor expanding operations across the Middle East, Afghanistan, Pakistan, Africa, and Southeast Asia. His investment focus areas include IoT, SMB Software, Future of Work, Enterprise, SaaS, FinTech, and Marketplaces. Paige’s preferred geographical preference is across the US. His check size for investments is undisclosed, and he is known for his diverse partnership and collaboration styles, working on various ventures from pillow collaborations to whiskey and restaurants.

Brian Li is an angel investor with past investments in PLAE and crickethealth. He focuses on Clean Technology, Consumer Internet, Enterprise Software, Mobile, Healthcare, Artificial Intelligence, Education, and Social Media. His investment check size and partnership and collaboration styles are not available. Brian Li’s previous roles include Vice President of Finance and Business Operations at Braintrust and Vice President of Business Operations at Dave.

Frist Cressey Ventures is focused on accelerating the growth of high potential healthcare enterprises through value-added partnerships.

Nathan Harrell, Managing Director and Head of Portfolio Group at Monroe Capital, focuses on responsible investing with a commitment to fostering ESG practices. Monroe Capital specializes in private credit markets, offering direct lending, asset-based lending, specialty finance, and more. The firm prioritizes responsible environmental, social, and corporate governance in its investments. Monroe’s due diligence process ensures thorough risk assessment and opportunity evaluation. Nathan Harrell leads a team dedicated to diversity, equity, and inclusion, promoting a culture of equality and respect. Additionally, Monroe Capital actively engages in community support through volunteer opportunities and partnerships with local organizations. The firm’s commitment to responsible investing and community involvement under Nathan Harrell’s leadership reflects a strong dedication to ethical investment practices and social responsibility.

Edoardo Maschio is an investor with a focus on Local Services, Logistics, IoT, SMB Software, Digital Health, Health & Hospital Services, Health IT, E-commerce, SaaS, and FinTech at the pre-seed stage. He has been involved in investments in Accelerator/Inc in the Business/Productivity Software industry. Edoardo Maschio’s professional career includes being a Co-Founder at Diligent, associated with Y Combinator, and having a partnership and collaboration style that encourages collaboration. Geographically, his investments and focus are in Berlin, Germany.

Joseph Walder is the founder of Walder Ventures, established in 2020 to provide mission-driven investments. The focus is on science innovation, environmental sustainability, and supporting the Chicago region. Walder Ventures has invested in companies like Grove Biopharma. Joseph Walder’s track record includes being a professor of biochemistry and founder of Integrated DNA Technologies. The investment check size averages around $4M. Partnership and collaboration styles involve providing capital, infrastructure, and expertise to early-stage life sciences companies. Contact Walder Ventures at Hello@portalinnovations.com or 773.498.5643.

Correlation Ventures finances early, seed, and later stage venture, and debt financing investments and is based in California.

Michael Wortsman is a private venture investor focused on media, technology, and healthcare. His investment check size and partnership & collaboration styles are not specified.

Vivek Garipalli is a Co-Founder of Clover Health and CarePoint Health, with an investment thesis focused on innovating healthcare access and patient outcomes. His investments typically center around Health & Fintech sectors, targeting companies like Clover Health and Ensemble Health Partners. Vivek prefers to engage in pre-seed and seed funding stages, actively participating in the growth of his portfolio companies. His geographical interests span North America, Europe, and MENA. Notable investments include Clover Health, CarePoint Health, and Ensemble Health Partners. Vivek’s professional career showcases a history in healthcare entrepreneurship and financial roles at prestigious firms. As a top shareholder in Clover Health, his partnership and collaboration style emphasize leveraging data and innovation for healthcare improvement.

Daan van Lange is a financial savvy professional with experience in Venture Capital and Private Equity. His focus has been on Deeptech ventures, including hardware, software, and hybrid technologies. Daan is passionate about creating impact and investing in ventures, technologies, and funds that shape the future. His recent investments include Manufacturing, Logistics, AgTech, ClimateTech/CleanTech, BioTech, Health & Hospital Services, SaaS, and FinTech. Daan’s investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. He has an educational background in Finance and Strategic Management, holding a Master of Science degree and a Bachelor of Science degree.

Max Ventures is a seed-stage venture capital firm that invests in consumer tech and health-tech companies.

Hannes Klöpper is a prominent investor with a focus on the digitalization & AI, HealthTech, and Sustainability sectors. He typically invests in companies with revenues ranging from â¬1 to â¬10 million and a proven product-market fit. Klöpper emphasizes impact alongside returns and provides support to entrepreneurs in scaling from $1 million to $100 million in revenue. His investment check size varies based on the company’s growth potential. Klöpper values collaboration and offers not just capital but also his extensive network and experience gained from investing in over 70 private technology companies. His current investment portfolio showcases a diverse range of sectors and countries, highlighting his strategic approach to investing.

Ditlev Bredahl, the seasoned investor, focuses on redefining the boundaries of human longevity through Lifespan Ventures. His investment style revolves around the longevity market, aiming to enhance quality of life, transform healthcare systems, and revolutionize medical technologies. Bredahl’s approach integrates foresight, expertise, and belief in the transformative power of the sector. Lifespan Ventures actively engages in the multidisciplinary field of longevity, intersecting with healthcare, pharmaceuticals, wellness, technology, and insurance. The fund embraces technological disruption, investing in biotech advancements, AI-driven health platforms, and the convergence of technology and biology. Bredahl and Lifespan Ventures seek investments that promise not only financial returns but also profound societal impact, shaping a future where longevity equates to vitality, productivity, and happiness.

Joel B. Braunstein is the Co-Founder of C2N Diagnostics and Tivorsan Pharmaceuticals. He serves as an angel investor with a track record of investments in health-related startups such as C2N Diagnostics and Tivorsan Pharmaceuticals. His investments range from â¬11.6m to â¬47.5m. He has a geographical preference for health-related ventures. Braunstein’s partnership style involves providing early commercial guidance to life sciences discoveries. He has a professional career in the healthcare and investment sectors, demonstrating a specific focus on fostering innovation in the health industry.

Alexander Au focuses on a market-based investment thesis, specifically addressing unmet needs through startups in Latin America. His investment focus areas include industries like insurance, healthcare, and financial services. He invests in diversified portfolio of primarily investment-grade assets and has a minimum initial investment amount of $25,000. Alexander Au has a proven track record and nearly a decade of experience in driving sales growth. His check size typically ranges from $100K to $500K for seed investments. Regarding partnership and collaboration styles, there is no specific information available from the search results.

Dilraj Ghumman is an Angel Investor. He invests in seed-stage companies and has a specific focus area of investing today in the products of tomorrow. His investments include companies like Mycroft with a check size valued at $1.8M.

Kevin Hrusovsky is a Venture Partner at ARCH Venture Partners with a 30-year career leading life sciences companies. He is the Chairman of 908 Devices, with previous roles at Quanterix, Caliper Life Sciences, Zymark Corp. Additionally, he created the Powering Precision Health foundation. Kevin Hrusovsky has a track record of over 25 years in commercializing disruptive technologies in the life science industry, focusing on teamwork and transparency. He has played a key role in building Quanterix into a successful public entity with substantial growth. Kevin Hrusovsky has received recognition for innovation and entrepreneurship awards.

Andy Getsey is a Partner at Theorem Ventures, a value-added early stage investor in technology-related companies. Alongside James Hannon, they have invested in 28 ventures with successful acquisitions and one company going public. Formerly co-founders of Atomic PR, they managed growth to $19+ million annual revenue, advised high-profile tech startups, and co-developed ComContext. Theorem Ventures was founded in 2007, focusing on companies in San Francisco & Silicon Valley. Andy and James look for ventures with significant market potential, committed founders, and well-differentiated solutions.

John Dyett, Co-Founder of Salem Partners, heads the firm’s efforts in the Life Sciences. Mr. Dyett has raised over $500 million of equity and completed multiple merger and acquisition assignments. Notable previous investments include Adams Respiratory Therapeutics and ZS Pharma. He played a key role in investments raising several rounds of venture capital. His partnership and collaboration styles involve active involvement in the investment committee. John Dyett’s track record includes successful IPOs and investment committee roles at Salem Partners. The specific geographical preference is not mentioned.

NMP is a venture capital firm that has invested in more than 160 promising start-ups and early-growth-stage companies in the technology,

Angel Gomez is a VC and Angel investor with a wide range of industry experience in areas including Telecommunications, Internet of Things, Big Data, Cloud, Machine Learning, Energy, Healthcare, Consumer Internet, and CPG. He has worked with companies like NowThis, MobiTV, Mojix, Airspan, Mimosa Networks, NextNav, and others. His investment focus areas span across various industries. Angel Saad Gomez’s investments and mentorship activities demonstrate his commitment to fostering startup growth and innovation.

Tim Streit is the Co-Founder and Managing Partner at Grand Ventures, an early-stage venture capital firm. Grand Ventures focuses on innovative technology companies in various sectors, including Fintech, DevOps, Supply Chain & Logistics, and Digital Healthcare. They invest broadly in the B2B SaaS space and have a specific focus on fintech, devops, the developer toolchain, digital health, and supply chain. Tim Streit has a track record of supporting startups with Series A AgTech investments and has a professional background that includes experience at HSBC Card Services. Grand Ventures, under Tim Streit’s leadership, is a key player in the Michigan venture capital scene, contributing to the growth and development of startups in the region.

Christa Alport is a commercially focused finance and operations leader with a passion for shaping the future of data and customer centricity. Specializing in technology startups, real estate, sports, and entertainment, Christa has expertise in financial management, market entry playbooks, working capital management, statutory and tax compliance, and capital raising. Previous roles include Financial Controller at Hambro Perks, head of various financial positions at Data Republic, and Head of Finance at DesignCrowd. Christa’s investment focus areas include technology start-ups, real estate, sports & entertainment, and pharmaceuticals. Additionally, Christa has been involved in collaborative initiatives in the real estate and consumer services sectors with innovative financing products such as Doorsteps Mover. Partnerships and collaboration styles emphasize transparency and trust in the real estate industry.

McCall McIntyre leads identity partnerships at Google Cloud focusing on building out Google’s strategic partner ecosystem in the IDaaS, UEM, and Endpoint Security spaces. Previous investment roles included leading early stage venture investments in health tech, adtech, and consumer identity for Samsung Electronics.

Dr. Marianne Mertens focuses on high-tech start-ups in digital tech, industrial tech, life sciences, chemistry, and related business areas. She has been involved in investments in companies like Memo Therapeutics, BioVersys, ADC Therapeutics, Mariana Oncology, and more. Apollo Health Ventures, where she is a Partner, has recently closed a $180 million fund. Marianne’s investment check size is not specified. Her geographical preference is not explicitly mentioned.

Julie Vaughan Murchinson is a healthcare enthusiast with a focus on transforming the industry. With a background in Healthcare and Operations Management, she serves as a Partner at Transformation Capital. Her career includes leadership roles in health IT consulting, investment firms, and non-profits. Julie’s geographical preference is in Seattle, WA, where she is actively involved with healthcare-related organizations. While specific investment areas are not detailed, her investments align with the passion for healthcare improvement. Julie’s partnership and collaboration style are not explicitly defined on the available sources.

Petar Tsachev is a VC at LAUNCHub Ventures, with a focus on structuring pricing, sales funnel optimization, storytelling in fundraising, and fostering collaboration. His investment thesis includes agility in the enterprise, with a special interest in GlycanAge’s innovative technology measuring chronic inflammation and biological age. Petar invests in Seed and Series A funding stages, supporting startups like Colossyan and health tech companies addressing chronic diseases. His previous investments include supporting rounds led by Lakestar. With a background in GTM & Operations leadership, Petar brings expertise in commercial team development and content marketing strategies. He engages with founders as partners on a journey to success, emphasizing alignment and collaboration for mutual growth.

Hub Angels is one of the oldest angel groups in the Boston area, investing in young tech and life science companies since March 2000. They focus on industries such as healthcare/life sciences, IT/Internet/communications, and technology. The investment ranges from $250K to $750K, with investments in over 40 companies totaling over $40 million. Their investment stage is 12+ month-old companies, with a geographical preference for Massachusetts, other Northeastern states, and Eastern Canada. Among their previous investments are LifeHarbor, Raven360, Brixton Biosciences, and others. The management team includes Charles Cameron and David Verrill. Hub Angels invests in early-stage technology companies and is led by Mike Krasner, an entrepreneur known for creating and growing innovative businesses in advanced technology markets. The check size of their investments is typically around $250K to $750K. Hub Angels’ collaboration style involves entering due diligence on about 15 companies annually and investing in 3 or 4 of them.

Tony Petrucciani is a Managing Partner at VisionTech Partners. He serves as Chief Financial Officer and Partner at Boomerang Ventures, with a focus on healthcare, information technology, and life science sectors. Boomerang VC Fund I, managed by Boomerang Ventures, makes early-stage investments ranging from USD 0.25 to USD 1.5 million in the Midwest, Great Lakes, and select states in the USA. Tony Petrucciani’s career highlights include founding Single Source Systems Inc., successful exits, and recognized leadership. He has extensive experience in technology, sales, and management, serving on several boards. Tony’s investment style includes mentorship, technology-focused investments, and being actively involved in the growth of startups.

A principal investment firm specializing in Agriculture, Agtech, Biogreentech, Food & Nutrition.

Greg Ennis is the Managing Director at Peninsula Ventures, a venture capital firm specializing in early-stage technology and healthcare companies. The firm was founded in 1991 and focuses on software, infrastructure, services, and healthcare IT. Peninsula Ventures prefers companies headquartered in the Western U.S. The investment team includes Greg Ennis as Managing Director and Ryan Keating as General Partner. Previous investments include Boatsetter, Claravine, Flint Mobile, Pramata, Redeam, Scifiniti, and Soci. The firm follows a collaborative approach, evidenced by funding rounds for various companies like Bumped, Claravine, CloudApp, CoinTracker, Crowd Factory, and Axcient.

M3 Ventures is a strategic investment partner to visionary founders in the fashion, lifestyle and wellness spaces.

Edgar Jannotta is an experienced investor with over 25 years in private equity business, serving as Managing Principal and Co-Manager of the Healthcare Group at GTCR. With a track record of over $7.5 billion in investments in 100 companies, he has a strong background in leading private equity investments. Mr. Jannotta has been actively investing personal funds in private healthcare companies since 2011 and serves on the board of multiple companies. His investment check size varies, with recent investments including Alcyone Therapeutics at $3.64M. His partnership style involves forging strategic partnerships, fundraising, and building world-class teams in the biotech and biopharma sectors.

Lex Westbroek, an Investment Manager at Brightlands Venture Partners, focuses on investments in the chemistry, healthcare, regenerative medicine, and agri-food sectors. Brightlands Venture Partners typically targets ESG and impact investments in 15 to 20 companies. Geographically, they are based in the south of the Netherlands and align their investments with the Brightlands campusses ecosystem. Previous investments include companies like ReSolved Technologies, Aliform, Circularise, and more. Lex Westbroek’s partnership and collaboration style involves supporting innovative companies like ReSolved Technologies with a circular material supply mission to reduce the environmental footprint through investments and industry partnerships.

Michael Burcham is an experienced executive coach, entrepreneur, investor, and strategist with over 30 years of experience. He has successfully scaled and exited three private equity-backed businesses and helped over 100 firms realize their full potential. Michael has a strong background in healthcare innovation, entrepreneurship, and startup venture coaching. He is the President and CEO of Narus Health and serves as a Special Investment Partner at Galen Partners. Michael’s previous positions include President of ParadigmHealth, Professor at Vanderbilt University, and Vice President of Managed Care at HCA Centennial Medical Center. His academic achievements include a Ph.D. in Health Administration, an MBA, and a bachelor’s degree in Physical Therapy. Michael’s leadership and expertise make him a valuable asset in guiding businesses towards success.

Mercedes Tuin, Senior Investment Manager in Life Sciences & MedTech at BOM Brabant Ventures, focuses on investing in healthtech startups primarily at the seed stage. With a track record of successful investments, including contributions to RiboPro’s funding round of â¬1.2 million for mRNA technology advancements. Mercedes has been involved in notable investments like brain health startup Mendi.io, psychologist booking platform Ahum, and drug developer Galecto. Her collaborative style emphasizes finding solutions collectively, leveraging her extensive network and experience to support founders. Mercedes Tuin’s partnership approach includes active involvement in scaling businesses, as seen in supporting RiboPro to expand their high-performance RNA products globally.

Jumpstart NJ Angel Network is a Mount Laurel-based angel investor founded in 2002. They primarily invest in technology sectors such as SaaS B2B, HealthTech, and AgroTech. Their geographic preference is the Mid-Atlantic region, with about a third of investments in New Jersey ventures. Recent investments since 2017 include participation in early-stage tech companies. The network focuses on providing not only financial support but also mentorship and networking opportunities to startups. They engage with the broader investment and entrepreneurial community through events and summits. Jumpstart NJ collaborates with partners like Westchester Angels through a strategic alliance, benefitting members of both groups and startups in terms of increased deal flow and co-investing opportunities.

Side Stage Ventures is an early-stage venture capital fund located in Melbourne, Australia. They invest primarily in pre-seed and seed-stage companies, providing checks ranging from USD 100k to 2M. The fund focuses on industries such as enterprise software, consumer internet, mobile, and healthcare. Their investment thesis is to back Australia’s best founders at the pre-seed/seed stage. Side Stage Ventures has made investments in companies like Leonardo AI and Outstaffer. The founding partner, Markus Kahlbetzer, has a track record of over 12 years in finding successful venture capital investments. The firm operates actively in Australia and has a preference for startups based in New South Wales and Victoria. For partnership and collaboration styles, there was limited specific information available.

Marc Bernegger is a Swiss-based web entrepreneur and Fintech investor. He specializes in longevity technology and investments that aim to extend human lifespan and improve quality of life. As a Venture Partner at Orange Growth Capital, Marc focuses on the fintech sector and has notable investments in companies like Bux, Knip, and Zopa. His investment thesis revolves around supporting innovative startups in the longevity sector to foster groundbreaking technologies for a healthier and longer life. Marc Bernegger’s investment check size is â¬96 million through Maximon, a fund he co-founded. He has a professional background founding successful ventures like usgang.ch and amiando, with a track record of acquisitions and a transition to investing in the Fintech industry. Marc has a proactive partnership and collaboration style, evident in his involvement in events like the Longevity Investors Conference, where prominent investors gather to discuss cutting-edge trends and opportunities in longevity technology.

Kim H. is an Angel Investor with expertise in Human Resources, General Management, and Project Management. Based in Brisbane, Australia, Kim’s investment range spans from ZAR 0 to ZAR 1,300,000 across various stages from Pre-Startup/R&D to Profitable. Kim’s investment focus areas include industries such as Medical & Sciences, Personal Services, Technology, and Finance, with a geographical preference for Australia. Having engaged in investments at different stages of businesses, Kim H. brings a diverse portfolio and hands-on expertise to support startups in their growth journey. With a keen interest in supporting ventures in the mentioned industries in Australia, Kim H. plays a vital role in nurturing and guiding startups towards success.

George Spencer, Senior Managing Director at Seyen Capital, focuses on investing in information technology, software, and telehealth companies at the venture/growth stage. Seyen Capital targets less served markets in cities like Chicago, Nashville, and Minneapolis. George has a track record of successful exits like Knightsbridge, ConV, and GoHealth, with involvement in companies such as TeleTeachers and KnowledgeHound. His partnership philosophy is to support entrepreneurs in building successful businesses by providing strategic growth initiatives and access to various markets. Check size and partnership styles are not explicitly mentioned.

Roman Scharf is an Austrian angel investor with a â¬150m fund size, focusing on seed investments in sectors like Data Services, Enterprise Applications, IoT, Health IT, and FinTech. His recent investments include Pactum ($20M Series A) and Kaia Health ($75M Series C). He has collaborated with co-investors such as Peter Lasinger and Heather Roxborough. Roman’s professional background includes roles like Documentation Specialist at NVIDIA and Lead Developer at Chaotic Formula. Roman is also the Owner of Luxury Bazaar/LuxAge Group, specializing in high-end watches, jewelry, and luxury items.

Shane Johnson, as the Managing Director of Coast to Crest Fund, specializes in providing business advisory services to companies in the biotechnology and healthcare sectors. His investments focus on strategic guidance in regulatory strategy, product development, and launch strategies. Geographically, his preferences align with investing in the U.S., notably in Arlington, Virginia. Previous investments have been in local startups from Lane County. The investment check size for the Coast to Crest Fund is not explicitly mentioned in the available data.

Philipp Wieschalka invests in Series B startups in various sectors including Human Capital/HRTech, TransportationTech, EnergyTech, Insurance, Real Estate/PropTech, E-commerce, Health IT, and FinTech. His investment range is $250K – $750K with a sweet spot of $500K. Some of his previous investments include companies in the mentioned sectors. Philipp Wieschalka collaborates with investors from Picus Capital and works with scouts and angels affiliated with Picus Capital.

Oliver Reuss is the Executive Director and Investment Manager of the Boehringer Ingelheim Venture Fund. With a background in Molecular Biology and a focus on Infectious Diseases, he spent 5 years in academic research before joining Boehringer Ingelheim in 2008. Oliver has held various roles, including business analytics, business development, strategy, and healthcare innovation, before joining the Venture Fund in 2018. His past investments include companies like Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics, Actyme, TheRNA immunotherapies, and STAT-Dx. The investment check size and partnership and collaboration styles were not explicitly mentioned in the search results.

Dietmar Hopp, through dievini Hopp BioTech Holding & Co., focuses on oncology, CNS, cell-based therapies, and personalized medicine. Previous investments include Curevac and investments in various minor companies. Notable investments in sports teams include TSG 1899 Hoffenheim soccer club, the Adler Mannheim hockey team, and the Rhine-Neckar Lowen handball team. He has estimatedly invested over â¬350 million into TSG 1899 Hoffenheim. Dietmar Hopp’s investments have also reached around â¬80 million ($105 million) in CureVac. His partnership and collaboration style are entrepreneurially driven, aiming for organizational synergy in therapeutic and personalized medicine approaches.

Matthew De Silva is a Venture Partner at Builders VC, with an investment range of $100K to $5.0M, focusing on areas like Digital Health (Series A), BioTech (Series A), Health & Hospital Services (Series A), and Health IT (Series A). Recent investments include Eigen Therapeutics, Arpeggio Bio, and Enveda Biosciences. His sweet spot for investments is $1.5M, and he collaborates with various co-investors. His partners include Ludwig Schulze, Josh Kopelman, Milad Alucozai, Kevin Mahaffey, and more. Matthew’s investments are in collaboration with investors like Alison Sunstrum, Jim Kim, and others.

Dr. Robert Pelberg is a new entrant to entrepreneurship and early-stage investing. He is affiliated with Cardioventure Partners LLC and is an angel investor in Foldax Inc. and Atria CV Inc. Dr. Pelberg is an experienced cardiologist and a Fellow of prestigious medical associations. His investments are in the medical and healthcare sectors. Drawing on his medical background, he focuses on early-stage startups related to cardiovascular health. Geographically, his investments align with the US market. Known for his partnerships in medical startups, Dr. Pelberg is likely to collaborate closely with founders to propel their growth. The size of his investment checks may vary based on the specific startup needs.

Dr. Francine Hardaway, a serial entrepreneur, serves as a Co-Founder and Partner at Stealthmode Partners. Her focus areas include enterprise software, SaaS, social media marketing, and software. Dr. Hardaway has made investments in companies like Addvocate. She has a track record of transitioning from hardware to software due to the Internet’s rise and actively engages in online communities. With a history of tech use since the early 80s, she offers private coaching for founders and CEOs. Her partnership and collaboration styles involve counseling and investing in startup entrepreneurs at Stealthmode Partners. Dr. Hardaway’s investments range across various markets and sizes, with a geographical preference towards Phoenix, Arizona, United States. She values tech investments for diversification and supports startup growth by providing coaching services.

Kent Novak, CEO of Valencell Inc., focuses on investments in biometric sensor technology, specializing in wearable biometrics for chronic disease management. His investment check size aligns with funding for companies like Valencell, which develop innovative solutions in electronic equipment and instruments. Kent Novak’s collaboration style emphasizes partnership-driven innovation, as seen in his role fostering collaboration for innovative solutions at Valencell. His track record includes serving as the CEO of Valencell, demonstrating leadership and expertise in the technology sector. While specific details on his investment thesis were not found, his focus areas likely include technology, innovation, and healthcare based on his role and investments.

Nina Neumann is an investor at Picus Capital with an investment range of $250K – $750K, focusing on Human Capital/HRTech, TransportationTech, EnergyTech, Insurance, E-commerce, Real Estate/PropTech, Health IT, and FinTech at Series B stage.

Max Herzberg is a Postdoctoral Research Scholar at Washington University School of Medicine with experience in roles such as Graduate Research Fellow, Graduate Research Assistant, and Evaluation Specialist. He holds a Ph.D. in Child Psychology – Neuroscience from the University of Minnesota and a Bachelor of Arts in Psychology from Grinnell College. Max has a track record of involvement in various research and evaluation positions, demonstrating a collaborative and detail-oriented work style.

Clara Shih is an angel investor with a focus on Seed investments. She has invested in companies like Parenthoods and Gusto. Clara’s investments typically range in the $1 to $6 million range. She collaborates extensively with fellow investors such as Justin Kan and Alex Bard, demonstrating a partnership style that emphasizes co-investment and strategic alliances.

Nicole Junkermann, a German-born investor and entrepreneur based in London, founded NJF Capital, the venture capital arm of NJF Holdings. She specializes in transformative technologies and bridges the gap between traditional business and innovative technologies. With an investment focus on content, media, technology, genomics, virtual reality, and artificial intelligence, Junkermann values strategic insights to make impactful investments. Her geographical preference is international, with notable investments in Swarm Technologies, Bolt, Really Sports, Carbyne, and Gordian Biotechnology. Nicole’s successful career includes founding and selling businesses, co-founding Infront Sports and Media, and leading private equity fund United in Sports. Her investment check sizes range vary based on the stage, with an emphasis on early to late-stage ventures. Nicole Junkermann’s partnership and collaboration styles focus on fostering clear vision, collaboration, openness to different perspectives, practicality, reliability, and investing in people behind businesses.

Felix Krauth is a Picus Capital Scout based in Munich, Germany, with an investment range of $250K – $750K. His sweet spot investment size is $500K, focusing on areas like Human Capital/HRTech, Insurance, TransportationTech, EnergyTech, Real Estate/PropTech, Health IT, E-commerce, and FinTech. He primarily invests in Pre-seed and Series A stages and has collaborated with investors like Abhijay Thacker, Alessandro Kopp, and Alexander Samwer.

Louis Beryl is an investor with a focus on Life Sciences & Healthcare (23%), Consumer Products & Services (21%), and Business Services (16%). His recent investments include companies like Payabli, Kona, and meez, with a check size range that includes Seed and Series A rounds. Louis Beryl’s collaboration style involves investing in startups with potential to address crucial societal challenges, as seen in investments such as Payabli. He actively participates in seed funding rounds, with a recent involvement in Payabli’s $12M seed funding led by TTV Capital, Fika Ventures, and Bling Capital.

Dreamers VC is a venture capital fund for startups that are addressing social problems.

Owen Lozman is the Managing Director of M Ventures, leading the Technology Investments in Electronics, Frontier Tech, and Sustainability. With a background in R&D, he has successfully led projects from concept to commercialization and holds a PhD in Physical Organic Chemistry. Owen has previously worked at Merck KGaA, Darmstadt, and has industry experience with FujiFilm, Avecia, and the University of Leeds. He has published over 50 scientific papers and 15 patents. Based in Amsterdam, Owen focuses on investments in companies like Electroninks, Mosa Meat, and Pacific Light & Hologram within the technology sector. His career showcases a track record of bringing disruptive technologies to market through collaboration with customers and partners.

Manuel Grossmann is a Partner at Amino Collective with a current investing position. His investment range is $5.0M to $10.0M, with a sweet spot at $7.5M. He has 18 investments on record across various sectors and stages, including Pre-seed Digital Health, BioTech, Health IT, and Health & Hospital Services. Manuel collaborates with co-investors like Friedrich A. Neuman, Peter Thiel, Christian Reber, Filip Dames, and Florian Otto.

AICO Angel Investment Club is guided by a strong investment thesis that serves as a compass to guide them on their startup investment journey. Their focus is on building a diverse, impactful, and growing portfolio. AICO Angel Investment Club is dedicated to enabling a more meaningful work life for finance professionals. Unfortunately, specific information on their investment focus areas, previous investments, and partnership and collaboration styles was not available. They adhere to a consistent check size strategy to pace themselves in building a portfolio.

Humboldt Fund is an investment firm that seeks to invests in bio revolution companies.

Wally Wang, a seasoned investor and Managing Partner at Scale Asia Ventures, focuses on AI-powered biotech and health tech startups in the healthcare sector. His investments primarily target Food and Agriculture Tech and Enterprise Applications. Wally Wang invests in early to mid-stage startups, particularly in the Seed stage. His geographic preference includes the United States, with a location in Menlo Park. Notable previous investments include Ceres Imaging and Speedscale. With over 10 years of IT experience and a track record of leading IT and telecom projects, Wally brings a wealth of expertise to his investment strategy. He has been involved in ventures such as InfStones, 8×8, Huawei Technologies, Alcatel-Lucent Enterprise, Avaya, and Nortel Networks, showcasing his diverse professional career in technology and DevOps Cloud engineering.

Mark Gundry is an investor with a focus on Player’s Health, specializing in investments in Midwestern US. His investments are typically in late-stage companies with more than $1M in revenue and in the health care sector. Mark Gundry has participated in the Angel Round for TEAM INTERVAL. He has a track record of working with late-stage companies with fewer than 100 employees, particularly in the Great Lakes region. His collaboration style emphasizes successful partnerships, managing relationships effectively.

Martin R. Felsenthal is a venture capital and growth-stage investor who focuses exclusively on innovative healthcare software and services businesses. His previous investments include the healthcare sector, and he has a track record as a professional journalist. The check size of his investments can be further explored through the PitchBook Platform. Collaboration and partnership styles are not explicitly mentioned, but he focuses on investing in healthcare, suggesting a collaborative approach within the health tech industry.

Andrew Stewart is an Angel Investor with interests in Clean Technology, Healthcare, Clean Energy, and more. His past investments include Faraday Bicycles and The Spring.

Robin Borg, with a Bachelor of Arts in Communications from the University of Minnesota and SPHR Certification, has over 30 years of experience in human capital management. As part of Transformation Capital, she focuses on building strong leadership teams and fostering company cultures to drive growth. Her dedication lies in improving the healthcare industry, emphasizing women’s issues and children’s health. Noteworthy companies in her portfolio include DexCare, Galileo, Bind, PeopleServe, Optum, Boston Scientific, and Abbott. Located in Minneapolis, Minnesota, Robin is committed to evolving the healthcare sector. While specific details on investment focus areas, check sizes, geographical preferences, and partnership styles are not readily available, her track record showcases a passion for supporting companies in achieving their goals.

Tom Demery is a Principal on the Investor Relations Team at Valor Equity Partners. His background includes roles at Monroe Capital, Evanston Capital Management, Fox River Partners, and Putnam Investments. Tom holds an M.B.A. from Kellogg School of Management and a B.A. in History from Hobart College. He is a member of The Economic Club of Chicago and serves on the boards of Metrosquash and The Brinson Foundation.

Felix von Laffert is passionate about exchanging ideas with founders and topics that will shape the future. He focuses on investing in companies that create real value, become established employers, and values analyzing business models. His career background includes previous positions at Bencis Capital Partners, Digital+ Partners, Henkel Tech Ventures, FTI-Andersch, and Hermes-OTTO International. Felix has a BSc. in International Business Administration from WHU – Otto Beisheim School of Management and The University of British Columbia (UBC).

Julianne Roseman is currently a Senior Associate at Plug and Play Tech Center focusing on Health & Hospital Services (Seed) and Health IT (Seed) investments in the Midwest region. Some of her previous investments include Helium Health and Rapicare. She has a track record in leadership, commercial litigation, market research, and analysis. Julianne has experience from previous roles at Plug and Play Tech Center and Harrington Discovery Institute at University Hospitals. Her partnership and collaboration style involve contributing valuable insights to the industry, with a keen focus on innovative healthcare solutions.

Cheryl Zimberlin, Investment Director at M Ventures (Merck), is known for her focus on Digital Health, BioTech, Health & Hospital Services, and Health IT sectors. She typically invests in the Seed to Series B stages with an investment range of $100K to $5.0M and a sweet spot of $1.5M. Her recent investments include ImmuneBridge in the Seed stage, with a total of $12M raised. Cheryl collaborates with co-investors such as Dylan Morris from Insight Partners and other investors like Anique ter Braake, Bauke Anninga, Christian Patze, Christian Uhrich, and Daniel Franke. Her track record showcases a strategic approach to biopharmaceutical investments within these sectors.

Ondrej Smolek is an investor with a focus on Material Science (Series B), SMB Software (Series B), BioTech (Series B), and Health IT (Series B). He typically invests between $100K to $5.0M with a sweet spot at $1.5M. His geographical preference and partnership and collaboration styles are not specifically mentioned in the available data. Ondrej Smolek’s current fund size is â¬24M, reflecting a successful track record in investing.

Tony Ayaz is a driven executive with experience as a Founder/CEO, Board Member, Executive, Sales Leader, and Investor. He focuses on executing GTM strategies to scale companies, particularly in early-stage and hyper-growth environments. With a strong technical understanding of BI, Data Infrastructure, Machine Learning, and more, Tony has a track record of leading and scaling disruptive companies from start-up to IPO. His partnership and collaboration style emphasizes creating equal partnerships and ensuring sales teams buy into the strategy. Tony’s previous investments have been in the software, information technology, healthcare, and energy sectors through Founder.org.

Jeff Ragovin is the President at Fyllo, an innovative data provider focusing on the cannabis industry and mainstream sectors like auto, CPG, and pharma. With a background in technology and business, he co-founded Buddy Media, acquired by Salesforce for $800 million. Ragovin is committed to revolutionizing digital marketing and leveraging AI for scaling businesses. His vision includes reshaping the advertising landscape through privacy-centric strategies and advanced data solutions, targeting untapped markets. Fyllo’s strategic roadmap emphasizes growth, customer success, and continuous product improvement. Ragovin’s partnership and collaboration style focus on aligning with compatible technology providers for revenue generation and portfolio enhancement.

Jakob Loven, Ph.D., a Managing Partner at Nextech Invest Ltd, is an accomplished oncology-focused entrepreneur with extensive experience in creating, launching, and building early-stage therapeutic-based platform biotechnology companies. His previous board seats include A2 Biotherapeutics, Arrakis, IconOVir, Hexagon, Boundless, Laronde, and Scorpion Therapeutics. With a Ph.D. in medical sciences focused on oncology, Jakob has a multicultural background and a successful track record in the life sciences sector. His investment focus areas include creating early-stage therapeutic companies. Check size and partnership style details are not available on the website.

Brewster Kahle is an Angel Investor and a passionate advocate of Internet access. He serves as Board Member & Advisor at Lumeter Networks. Kahle is the founder and Digital Librarian of the Internet Archive, one of the largest libraries globally. In terms of investment focus, his previous investments are in promising companies. His investment check size and geographical preference are unspecified. Brewster Kahle’s partnership and collaboration style emphasize collaboration across research community, research libraries, and data collections to address significant problems and create valuable datasets, particularly in climate research.

Michael L. Mark is a successful entrepreneur with a background in technology companies. He has a strategic focus on investments in the biopharmaceutical and medical device sectors. Michael prefers late-stage growth investments in market-leading companies. His geographical preference spans North America, Europe, and Southeast Asia. Some of his previous entrepreneurial ventures include American Energy Services, Inc., Intercomp USA, Inc., and Cadmus Computer Systems, Inc. Michael’s investment check sizes vary, and he is known for his partnership and collaboration styles that focus on strategic alignment and mutual trust.

Tod Perkins, as a mentor and College of Health Professions at Western Governors University, has extensive experience in healthcare management and compliance. He has collaborated with various departments to ensure seamless interactions with compliance teams for positive student outcomes. Additionally, Tod has served as a Professor of Microbiology and Pharmacology at Carrington College-Boise, delivering engaging lectures to nursing and dental hygiene students. As a Biology Instructor at the College of Western Idaho, he designed and implemented laboratory curriculums and provided valuable support to undergraduates. Tod Perkins’ partnership and collaboration style focus on working closely with colleagues to achieve shared objectives and student success. His expertise in instructional technologies and dedication to student support demonstrate a proactive and efficient approach to collaboration. Through his roles in academia and industry, Tod has shown a commitment to excellence in education and professional development. This comprehensive background illustrates Tod Perkins’ track record as a dedicated educator and collaborator in the healthcare and academic sectors, showcasing his commitment to fostering student success and facilitating effective partnerships within organizations.

Jacopo Leonardi is a Partner at Agent Capital, a biopharmaceutical investment firm. With a 25-year track record, his expertise lies in global commercial operations, focusing on orphan and rare diseases, immunology, and neurology, aligning with Agent Capital’s investment focus. The firm supports disruptive healthcare companies with novel therapeutics, aiming for high returns. Jacopo’s career spans roles at prominent companies like Baxter and Baxalta. Agent Capital’s previous investments include 14 healthcare companies, with four going public. Jacopo’s track record showcases sustainable growth in new ventures. Though specific check sizes are not listed, collaborations align with diverse management teams for superior returns and fostering healthcare innovations.

Vita Advisors, founded by Kevin Roche and Michael Kessler in 2008, provides research-grounded strategic advisory services to select healthcare companies.

Todd Katz is a Partner at Round One Capital, focusing on providing seed capital to firms in pre-seed and seed stages across areas like Insurance, Consumer Health, Digital Health, Health IT, and Consumer Internet. He has a track record of successful entrepreneurship, including founding a medical company and acquiring Bell-Horn for orthopedic manufacturing. Katz’s investment check size ranges from $100K to $5.0M, with a sweet spot of $1.5M. His collaboration style is known to involve active advisory roles and board membership in addition to providing seed capital.

Miles Beckett is an investor with a focus on healthcare, specifically in the dental care industry through Flossy. His investment check size typically ranges from $5,000 to $25,000 per company. His geographical preference includes locations in San Francisco and Los Angeles. Some of his previous investments include Silversheet, Ringadoc, Tradesy, and Chromatik. Miles Beckett’s professional career includes founding and leading companies such as Flossy, EQAL, Silversheet Credentialing Solutions, and LG15 Studios. He holds a BS in Neuroscience from the University of California, Berkeley, and an MD from UC San Diego School of Medicine.

Madeleine Magnerius, Vice President at EQT Partners, possesses a robust investment background with a strategic focus on transformative ventures. With a track record spanning impactful investments, including roles as a Seed Investor in innovative startups like **OCON Therapeutics** and **Fika**, Madeleine demonstrates a keen eye for groundbreaking solutions. Her commitment to sustainability is evident through investments in companies such as **Circulate**, a B2B marketplace driving sustainable packaging solutions. Madeleine’s professional journey includes pivotal experiences at **Goldman Sachs** as an Investment Banking Analyst, shaping her expertise in the financial sector. In her current role at EQT Partners, Madeleine continues to excel in shaping the future of investment landscapes. Her investment check size and partnership approach underline a dedication to fostering entrepreneurial success and propelling forward-thinking initiatives.

Nathan Pierotti, a Principal at New Stack Ventures, specializes in investing in outsiders, focusing on early-stage capital. He typically leads rounds at the angel and pre-seed stages with a geographical preference not specified. New Stack Ventures invests in industries such as B2B SaaS, Fintech, eComm, Supply Chain, Cyber, Proptech, and Healthcare. Nathan has a track record that includes co-founding Monarc, a deepTech/Robotics company, and leading product development. Although the specific check size for investments is not provided, the fund typically ranges between $500K and $1.5M. Nathan’s investment approach is aligned with the mission of New Stack Ventures to invest in founders who don’t follow traditional paths, supporting those with innovative ideas and transformative potential.

Halle Tecco is a healthcare investor with a focus on D2C and patient-centered healthcare innovation. She has made investments in companies like Natalist and Rock Health. Halle Tecco’s investment check size ranges from $10,000 to $250,000. Some of her previous investments include Natalist and Marley Medical. She collaborates with celebrities like Jennifer Lopez, Mark Cuban, and Ashton Kutcher in the healthcare sector.

Jessica Li is a Venture Partner at Predictive VC, with a focus on Series B Data Services, Marketplaces, BioTech, Data Services (Seed), Data Services (Series A), and Digital Health (Series B). Her investment check size typically ranges from $100K to $5.0M, with a sweet spot at $1.5M. Jessica has a track record of delivering large-scale transformation projects and has 15+ years of industry experience. She specializes in Data Architecture, Information Management, and customer data in Finance, Telecom, and Marketing spaces. Her current role is as a Solution Architect at Macquarie Group. Jessica prioritizes building long-term, broad relationships in venture capital and values well-rounded founder teams with a focus on process orientation.

Edward Zuckerberg is known for investing through partnerships and collaborations, aligning with the principles of commitment and value generation. His investment check size has been notable, with successful investments in various enterprises. His track record and professional career showcase his expertise in digital marketing and social media utilization. Edward’s geographical preference and stage of investment remain understated, focusing on strategic investments that yield substantial returns. Previous investments testify to his acumen in selecting promising ventures. His investment focus areas include healthcare technology systems and business/productivity solutions.

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

Elad Gil is a technology entrepreneur, investor, and future optimist, involved in investments, incubations, and operating companies focusing on the technology future. His investment focus areas include AI, longevity research, societal beauty, inspiration, and human capital movements. Elad typically invests at late-stage funding sources. He has made notable investments in companies like Airbnb, Airtable, Anduril, and Coinbase. Elad’s professional career includes significant contributions to major tech companies, founding and investing in startups, and successful entrepreneurial projects. While specific check sizes may vary, he is known for individual check sizes of up to $50 million in a single round, often from a growth fund. Elad Gil’s partnership and collaboration styles emphasize coordination, collaboration, and relationship-building for mutual success.

Scott Weiss is a venture partner at 11 Tribes Ventures, with a focus on investing in Food and Beverage (Seed), Developer Tools (Series A), Web3/Crypto (Seed), Health IT (Seed), and Consumer Internet (Series A). His investment check size ranges from $100K to $300K, with a sweet spot at $200K. As a CEO/President at Semco Capital, LP, he manages a long/short equity hedge fund specializing in companies undergoing transformation. With a background in Managing Director roles at Lazard Capital Markets and Cowen & Co, Scott’s professional career spans across various financial institutions, showcasing expertise in institutional equity sales. His educational background includes a B.A. in Economics from Indiana University Bloomington. Scott’s partnership and collaboration styles focus on facilitating cooperation and directness, ensuring alignment with the goals of both parties.

Sapan Shah is a Managing Partner at Alera Group, Inc., and a Board Director at HPA. He has been involved in various board director roles and has a background in healthcare acquisitions. Sapan Shah’s career showcases experience in healthcare and investment roles, with a focus on board memberships in Chicago-based organizations.

Dr. Richard Ferguson, known for his 35+ years of corporate leadership, has a focus on investments in EdTech and HealthTech sectors, with notable investments in companies like OpenLoop and HLT. He has a track record of 3 investments, including founding IntelliSee, an AI-based weapon detection system. Ferguson’s recent investment in OpenLoop was valued at $3 million. His partnership and collaboration styles are not explicitly detailed in available sources.

Radhika Ramachandran is a seasoned professional with extensive experience in various roles across digital marketing, communications, strategic partnerships, and fundraising. She has served in key positions such as Digital/Strategic Marketing & Communications Consultant, Inbound/Digital Marketing & Social Media strategist, and Chief Marketing Officer. With a track record of successful collaborations, Radhika has worked with a diverse range of organizations and tech startups globally. Her expertise includes driving innovative marketing campaigns, managing digital initiatives, and fostering strong partnerships. Radhika holds advanced certifications in Inbound Marketing and Frictionless Sales, coupled with an MBA and MS in Information Science with a focus on Artificial Intelligence/Expert Systems.

Gad Allon is an angel investor with a focus on the gig economy, platforms, and global supply chains. His investments typically range between $150,000 and $350,000, with previous investments in companies like Loops, ActiveFence, and ReturnGO. Mr. Allon is a professor at the University of Pennsylvania and a renowned expert in operations management, service operations, and operations strategy. He has won awards for his research, including the 2011 Wickham Skinner Early-Career Research Award. Additionally, Mr. Allon is the co-founder of ForClass, an educational technology platform.

Markus Gleim, Principal at Northzone in Berlin, focuses on early-stage companies across enterprise, infrastructure & developers, and healthcare. He is particularly interested in products that evolve established ways of working, bring together communities, or disrupt long-standing value chains. Markus has invested in companies like Microverse, Mimo, Ravio, and Stonly. With a background at digital health scale-up KRY / LIVI and BCG strategy consulting, he holds degrees in business and economics from the University of Cambridge and Bochum University. Markus also has a technology and innovation background, being an early adopter of technology and involved in projects like Fashion for Good.

Pradeep Bekal is an Angel Investor at Angel Physicians Fund, a venture capital firm based in Powell, Ohio. The fund focuses on life science and healthcare investments at the seed stage. While specific investment thesis or partnership styles were not found, the fund’s investment check size and stage indicate a focus on supporting early-stage companies in those industries. The geographical preference and track record of previous investments are not available. Pradeep Bekal is associated with medical centers in Cincinnati, Ohio, and is known for his work in treating GI issues.

John Martinson, the Founding Partner at Edison Ventures, has an investment thesis focused on guiding information technology businesses serving drug, healthcare, and education applications. His investment focus areas are primarily in software companies in Pennsylvania, New Jersey, New York, Maryland, and Virginia. He has financed over 50 businesses and made investments in sectors like application software, human resources, manufacturing, and enterprise solutions. John Martinson’s previous investments include companies like ClassTag, d2i, STRATIS IoT, and HeyKiddo. The total investment ranges are not specified on the available sources.

Gregory D. Wasson is the Co-Founder of Wasson Enterprise, a family office that partners to build sustainable, high-growth businesses aiming to do well by doing good. He collaborates to create disruptive businesses with a lasting impact in industries such as healthcare data analysis platforms, medical waste management, therapies, e-commerce, money transfers, and energy storage systems. Wasson’s investments align with his focus on sustainability and purpose-driven entrepreneurship. He has a wealth of experience in leadership, operations, and governance, contributing to the success of ventures he supports. Wasson’s partnership and collaboration styles involve building legacy businesses, and he serves in leadership roles across various organizations, including the board member at Cooler Screens, Performance Health Systems, and Innovation Associates, among others.

John Burbank is the Founder and Chief Investment Officer at Passport Capital, a San Francisco-based hedge fund managing $4 billion in energy, healthcare, and technology. The firm focuses on sectors like agriculture, basic materials, consumer, energy, financial services, health care, internet/technology, and more. Passport Capital invests primarily in early-stage companies. John Burbank has a successful track record in macro investing and collaborating with early-stage fund managers. His partnership and collaboration style involve direct and co-investments in early-stage and growth startups, particularly in fintech, consumer tech, and health tech. He is a Board Member at NEOS GeoSolutions and holds a BA degree from Duke University and an MBA from Stanford Business School.

Lars Reichelt is an investor with a diverse investment thesis, focusing on Angel Investing (£50k â £500k) and Venture Capital (£500k – £5m). His investment focus areas include enterprise SaaS, cybersecurity, fintech, healthtech, and climate tech companies. He predominantly invests in early-stage startups. Lars has a track record in the telecommunications industry. His investment check sizes typically range between $250K and $2M. Lars Reichelt’s partnership and collaboration styles align with different collaboration styles, emphasizing effective teamwork and communication.

Affinity Capital Management is a Minnesota-based investment company that funds healthcare technology companies.

Melinda Gloriosa, Investment Associate at Rev1 Ventures, focuses on seed-stage investments in Ohio software companies, health diagnostics startups, and life science early-stage companies in the Midwest. Some of her previous investments include Trace, a Columbus AR startup. Melinda emphasizes collaborative leadership and supports industry disruptors in her investments. Although specific investment check sizes are not available, she is known for providing funding that aligns with the learning and execution curve of the team and market opportunities. Her track record includes successful support for startups and active involvement in driving innovation and growth.

Vivien Ho, a Partner at Pear VC located in the San Francisco Bay Area, specializes in investing in health, focusing on human and planet health. With a broad investment range, Vivien seeks opportunities in the early-stage healthcare and life sciences sector, aiming to support innovative solutions that address significant healthcare challenges. Vivien values founders with industry expertise and solutions that have the potential to make a substantial impact in the healthcare space. In her career, Vivien has demonstrated a dynamic track record of leadership and strategic investments.

Daniel Almon is a Principal at Baird Capital. Baird Capital’s investment focus areas include B2B Technology & Services such as Financial Tech & Services, Healthcare Services & IT, HR Tech & Services, Industrial Technology, IT/Data Management, Pharma Services & IT, Sales & Marketing, Security & Risk, and Sustainability. They invest in founder and entrepreneurial led B2B Tech & Services companies across the full capital spectrum, from venture capital to late-stage buyouts. Their investment check size ranges from $15 million to $40 million. However, specific information on Daniel Almon’s investment thesis, geographical preference, previous investments, track record, and partnership/collaboration styles could not be found.

Jennifer Hatchell is a Financial Representative at Fidelity Investments, primarily assisting customers with their Defined Contribution retirement plans. She has a background in healthcare and has worked as a Patient Service Representative at TriWest Healthcare Alliance. Jennifer is currently pursuing a Bachelor of Science in Health Information Management at Southern New Hampshire University. Her previous roles include Medical Assistant positions at Texas Hematology Oncology and Optimal Health Associates. While specific details about Jennifer Hatchell’s investment thesis, focus areas, check size, geographical preference, and partnership styles were not directly available, her career history suggests a background in healthcare and financial services.

Dr. Frank Hensel at HTGF focuses on drug development companies, particularly those in the clinical stage. His professional background includes a Ph.D. in biology and experience as an entrepreneur in a startup developing antibodies for cancer treatment. He has successfully exited companies with deals reaching up to 425 million euros, emphasizing the importance of partnerships in the drug development sector.

Catalyst Investors makes growth equity investments in high-growth, lower middle market companies.

John Racine is an experienced senior executive and former CEO from the payment processing industry, specializing in buyouts and growth equity investments in the healthcare, manufacturing, business services, and technology sectors in the U.S. and Canada. His investment check size is undisclosed. He focuses on commercial real estate investments and possesses a wealth of experience in managing Core Solutions business units. He is known for his expertise in facilitating private mortgage investments as a real estate alternative. Racine’s partnership and collaboration styles align with the three common collaboration styles: introspective, relational, and expressive.

Edward Michael, Managing Partner at LionBird, focuses on early-stage technology startups in healthcare, commerce, and enterprise. The investment check size ranges from $200K to $1.5M. Edward Michael has a professional background of 25 years at Abbott Laboratories, serving as Executive Vice President of Diagnostic Products. Specific previous investments are not available. LionBird’s partnership and collaboration styles involve digital health-focused activities. For more details, visit LionBird’s website at https://www.lionbird.com/

Oliver Heine is an angel investor with a focus on HealthTech, Consumer, and other areas. Known for past investments like WorkGenius, his investment check size varies. Oliver Heine embraces genuine partnerships and collaboration, complementing tasks performed in interfirm collaborations.

Mohit Srivastava is an Angel Investor with investments primarily in Food and Agriculture Tech, HealthTech, and other sectors. Some of his notable investments include Krishi Network, Stayflexi, and Incuspaze. He has provided funding for rounds in Lissun, Incuspaze, The Gourmet Jar, and Stayflexi. Mohit Srivastava’s investment check sizes range from $150K to $1.6M.

Garri Zmudze is an investor and advisor for cutting-edge deeptech companies, focusing on longevity. He supports projects towards a longer and healthier human life. As a seasoned business angel, Garri has an extensive track record in building tech businesses and investing in early-stage ventures. Previous investments include Profi. His investment focus areas include longevity research. Garri’s professional career showcases technology expertise, innovative leadership, and client relations. LongeVC, where Garri is a funding partner, discusses plans for funding sci-fi longevity tech. Collaboration for longevity investments involves joint efforts from VCs, startups, investors, and nonprofits.

Tullis Health Investors is a private equity group that invests primarily in the healthcare sector.

Josh Linkner is the Managing Partner and co-founder of MuditÄ Venture Partners, an early-stage venture capital fund focusing on companies in Healthcare & Biotech, Financial Services, Auto & Manufacturing, Tech & Entrepreneurship, CPG, Real Estate, Travel & Hospitality, and Retail. The fund aims to raise $40 million and primarily invests in pre-revenue companies and companies before a Series A fundraising round. Track record and professional career details are not available at the moment.

Startup Florida is an angel group based in Florida, United States, focusing primarily on companies in the healthcare and information technology sectors. They have a track record of investments in various technology firms, targeting early-stage businesses. Startup Florida has made investments in education technology, fintech, wireless technology, machine-sensor technology, and health tech companies, showcasing their diverse portfolio. The group has demonstrated an interest in innovative startups, particularly in technology-driven fields. Their investment check sizes vary depending on the specific company and opportunity, with a preference for companies with high growth potential. Startup Florida is known for its collaborative partnership style, supporting entrepreneurs with not just funding but also guidance and expertise to help startups succeed. Previous investments by Startup Florida include various technology firms, indicating a commitment to cutting-edge and transformative technologies. With a focus on early-stage ventures and a diverse portfolio, Startup Florida offers strategic investments to drive innovation and growth in the healthcare and information technology sectors.

Roman Huber is the Managing Director of Bayern Kapital, a venture capital firm that focuses on deep tech startups in the software, bioscience, healthcare, and pharmaceutical sectors. The firm invests from â¬250,000 to â¬25 million Euro and partners with startups offering new technical developments. Bayern Kapital’s investments in software startups include Wealthpilot, Daypaio, and Cliniserve. They emphasize on B2B business models with a clearly defined benefit for customers and require a comprehensive business plan with a technical roadmap. Roman Huber predicts growth in machine learning, AI, AR, robotics, and green technology.

Robert Slay is an angel investor specializing in emergency medicine. He is the owner of ROBERT D SLAY, MD, INC. As an investor, Robert focuses on Pre-seed FinTech companies. His investment check size ranges between $250K to $5M. Robert’s professional career includes being Chief of Staff and Chief of Emergency Medicine at Marina del Rey Hospital. He has been actively involved in writing nutrition books, hosting medical television shows, and doing stand-up comedy as a hobby. Robert’s partnership and collaboration styles are not explicitly mentioned in available sources.

Lightspeed China Partners is a leading venture capital focusing on early-stage investments in China.

Sam Blackman, CEO and co-founder of Elemental Technologies, operated within the digital media industry with a focus on video processing. His investments included ventures such as AWS Elemental and Pixelworks Inc. Sam had an exceptional track record and was well-regarded for his innovative contributions to internet-delivered video technology. Investments typically ranged in the multimillion-dollar range, enabling growth on a global scale. His collaborative style facilitated strategic partnerships, evident in successful collaborations with companies like thePlatform and Amazon Web Services. Sam Blackman’s legacy continues to inspire advancements in video processing and digital media technologies.

Daniel Bertholet is the founder of 4See Ventures, a venture capital firm founded in 2019 that focuses on the health tech sector. The firm invests primarily in Enterprise Applications and Life Sciences, with a preference for investments in Switzerland. 4See Ventures typically enters at the seed round stage, followed by Series A rounds. The firm has invested in 14 companies in the last four years, with notable investments such as KeePAP. Daniel Bertholet’s investment check size ranges based on the round of investment, and the partnership and collaboration styles emphasize open dialogue with investors to empower decision-making.

Christian Schuetz is a Partner at b2venture, one of the most active investors in Europe, passionate about venture investing in life sciences, medtech, and health-AI sectors. His investment focus areas include managing the firm’s Industrial Technologies Fund, biotech, and health-related investments. Christian works with angel investors and has a track record of previous investments in various sectors.

RRE Ventures is a Venture Capital Firm.

Brad Charchut is a Partner in the Private Credit Group at Bain Capital, based in the Chicago office. He is responsible for capital markets and originations in North America. He joined Bain Capital in 2011 and previously worked at Cerberus and Heller Financial. Brad Charchut’s previous investments include acquiring Merchants Fleet, a high-growth fleet management company, alongside the Merchants leadership team.

Digital Health Angels is a prominent investor in the Digital Health sector, focusing on seed-stage investments in companies with live MVPs or products in the market. Their investment strategy emphasizes technologies that drive healthcare innovation and transformation. While specific details about their investment thesis, focus areas, check size, geographical preference, and partnership style are not available, Digital Health Angels has a track record of consistent investments in digital health ventures over the years. Their investments are strategically aimed at supporting startups in the Digital Health space, contributing to the advancement of healthcare technologies. The precise size of their investments, previous investment portfolio, and partnership approaches remain undisclosed. This investor plays a vital role in fostering innovation and growth in the Digital Health industry.

Bob Dunn is the Managing Partner at Thompson Street Capital Partners, a private equity firm based in St. Louis. He focuses on companies in Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services and Products with investments between $50 million and $500 million. Some of his previous investments include TA Associates, Hambrecht & Quist, Echosat, BioIVT, Global Software, TierPoint, FocusVision, and Iracore International. The Investment Check Size of the fund managed by Thompson Street Capital Partners is between USD 4 million and USD 15 million.

Michael Oschmann is the CEO of Mueller Medien since 2000, focusing on New Media. His investment focus spans across various sectors like Health Care, Biotech, Community, Marketplace, FinTech, Impact, Proptech, Media, and EdTech. While his geographical preferences are not specified, he has made past investments in Phonedeck and Salonmeister. His partnership and collaboration style emphasizes fruitful collaborations for mutual success.

Penny Pritzker, Founder at Inspired Capital, invests in seed and Series A stage technology-driven startups. Featured investments include fintech company Rho Business Banking, retirement planning company Kindur, task management company Umbrella, and Chief. Inspired Capital’s check sizes range from $1 million to $15 million. The geographical preference is the United States, with a focus on sectors like Artificial Intelligence, Consumer, Education & Edtech, Financial Services & Fintech, Healthcare, Healthtech & Medtech, Industrials, Technology, Software & Gaming. The partnership and collaboration styles are oriented towards promoting cross-sector collaboration and working collaboratively across public and private sectors.

Eli Cole, a Partner at Hyperlink Ventures, focuses on investments in venture capital funds, along with occasional direct investments in technology and healthcare startups. With a background in creating value through venture investing programs, his primary focus areas include technology and healthcare sectors. Eli holds an M.B.A. from UCLA Anderson, a J.D. cum laude from UC Hastings College of the Law, and a B.A. in Mathematics from TCU.

Mai Ho is a Venture Partner at Hustle Fund and has led investments in companies like Fonos and DatBike. She manages a family office’s portfolio in healthcare and renewable energy. Mai Ho was featured in Forbes’ 30 Under 30 – Asia – Finance & VC (2021)

Lee Zapis is the Founder and President of Zapis Capital Group, investing in early-stage technology companies with a focus on Life Sciences & Healthcare, Media & Digital Media, and Software & Internet. Zapis Capital Group prefers investing in the Great Lakes and Midwestern US regions. Previous investments include Axuall and Scout RFP. Mr. Zapis boasts a successful radio executive career and has served on various boards and advisory roles. The investment check size of Zapis Capital Group can range, exemplified by a $500,000 investment in a Cleveland technology business. Collaboration and partnership styles can be seen in Mr. Zapis’ involvement with various organizations and director positions.

RJ Jones is an investor with a diverse portfolio covering startups such as Humi, HUNGRY, SoapBox Soaps, Advocado, Recursive Labs, CYR3CON, RG Fiber, and Kineta. His partnership and collaboration style includes innovative ventures like the HomeHunter partnership to streamline international property search. RJ Jones has over 20 years of expertise in investor relations, finance, strategy, operations, and communications.

Kevin Cook is an Angel Investor specializing in the Healthcare Sector. He has a track record of serving in various finance and investor relations roles at companies like Cloudera, RBC Capital Markets, and Barracuda Networks. His professional career includes positions such as CFO and VP of Finance. Kevin Cook has a successful stock coverage history and focuses on the Consumer Goods sector. His investment check size, geographical preferences, and partnership styles were not explicitly mentioned in the search results.

Alison Schulte is the Vice President at Thompson Street Capital Partners, with an investment range of $5.0M – $50.0M and a sweet spot of $25.0M. She focuses on various sectors including Medical Devices, Pharmaceuticals, Consumer Health, and AI at Series B stage. Alison Schulte’s recent investments include roles at Thompson Street Capital Partners and Panera Bread. She collaborates with investors from Thompson Street Capital Partners such as Alex Mace, Bob Dunn, Bradley Strahorn, Brian Kornmann, and Cathy Bowers.

Rho Ventures is a private equity firm that invests in high growth companies across multiple sectors.

Victoria van Tamelen is an investor at East Los Capital, focusing on technology-enabled lower middle market private equity investments. The firm invests in successful companies in various sectors including consumer, healthcare, internet, media, services, and software. Some of the previous investments by East Los Capital include Basepaws, BeTheBeast, Finix, Glitzi, Nadine west, FLYR Labs, and more.

James Hong is an angel investor who generally invests $25-100k in young, emerging companies with a focus on those located in the Bay Area. His latest investment was in Arcee as part of their Seed VC – II on January 24, 2024, and his latest portfolio exit was Quid on January 29, 2020. He has made 18 investments and has 8 portfolio exits. His investment check size ranges from $25k to $100k.

Marc Solomon is an angel investor with a focus on seed round investments, particularly in innovative early-stage companies. He has a diverse portfolio across sectors such as edtech, healthtech, proptech, AI/ML, RPA, media & entertainment, marketplaces, and fintech. Marc Solomon’s investment check size ranges from $25k to $1M. Geographically, he invests across various countries. In terms of partnership and collaboration styles, Solomon prioritizes transparency, cultural fit, and intrinsic motivation to engage and retain top performers in the investment banking industry.

Toba Spiegel is an Investment Manager at Trill Impact focusing on Impact Ventures. His investment focus areas include Digital Health, Health IT, and Health & Hospital Services for both Series A and Seed stages. Toba Spiegel’s previous investments include companies like Open Cosmos and Autovio. He maintains partnerships and collaborates with investors such as Christian Schulte, Felix von Laffert, and others. Unfortunately, details on Toba Spiegel’s track record, geographical preference, stage of investment, and investment check size were not found.

Chase Petrie, Principal at LOUD Capital, based in Columbus, Ohio, focuses on alternative investments. LOUD Capital’s investment thesis includes fueling innovations for equitable access to quality healthcare. Their investment areas cover medtech, alternative care models, healthcare infrastructure, and IT. LOUD Capital invests in a mix of traditional and alternative assets to reduce risk and enhance returns. Chase Petrie’s investment check size ranges from $100K to $5M, with a sweet spot at $1.5M. He has a track record of investments in sectors like Messaging, AutoTech, Payments, and FinTech at different stages. LOUD Capital’s partnership style is to empower healthcare ventures through resources and advisory support. Their collaboration emphasizes stakeholders’ understanding of healthcare complexities to drive successful ventures.

Razor,Äôs Edge is a multi-stage venture capital firm investing in commercial technology companies supporting the national security community

Dirk Ploss is a venture capitalist with a focus on skin care and beauty startups. His investment thesis revolves around breakthrough ideas in sustainability, life science, biotech, digital solutions, and new business models. Dirk primarily invests in Series A companies with check sizes ranging from 0.5 to 5.0 million euros, taking up to a 20% minority share. His geographic focus includes Europe, North America, Korea, and Israel. Dirk has invested in startups like Dermanostic, Salvalco, LYCL INC., S-Biomedic, and Depoly. With a background in innovation and marketing, Dirk’s professional career includes roles at Beiersdorf, where he served as Senior Early Innovation Manager and held positions in digital technologies scouting, e-commerce, and brand management. Dirk is also known for his involvement in mission-one GmbH and Startup Grind as a board member and Chapter Director, respectively.

Reinhard Ambros served as the global head of the Novartis Venture Fund from 2005-2017, building a billion-dollar corporate Biotechnology Venture Fund. He led numerous investments, exits, IPOs, and M&A deals, with a focus on the biotech industry. Reinhard has a track record in international leadership in venture capital, corporate strategy, and pharmaceutical product development. His geographical preference includes Europe and the US, where he serves on various biotech company boards. His investment check sizes are significant, given his role in managing a billion-dollar fund. Reinhard is known for his partnership and collaboration styles, having established key networks with finance syndicates and pharma organizations.

Borealis Ventures partners with early-stage entrepreneurs to build market-defining companies in information technology and life sciences.

Yinebeb Atel is a Partner and Data Scientist at Tribe Capital based in Seattle, Washington, USA. Tribe Capital is a $1.6B+ AUM venture capital firm with a focus on capturing a perpetual edge in venture and crypto using data science. Yinebeb’s investment range is $25K – $40.0M, with a sweet spot of $6.0M. He has previous investments in the Web3/Blockchain and Crypto sectors across various stages. Yinebeb collaborates with investors like Ailbhe Dempsey, Alexander Chee, Anirudh Pandit, Apolo Ohno, and Arielle Kogut. His partnership and collaboration style involve investing in various sectors and stages, including Seed and Series B, supporting startups in Web3, Crypto, Consumer Internet, Enterprise, and FinTech.

Michael Berman is a Venture Partner at RiverVest Ventures, specializing in medical device investments. His investment focus is on pre-seed to Series B stages, with a range from $100K to $5.0M and a sweet spot at $1.5M. Berman has a track record of investing in companies like BridgePoint Medical, Apnex Medical, and Prospex Medical. His geographical preference includes Israel and the Midwest region. With a current fund size of $184.4M, Berman collaborates with co-investors such as Brian Chee (Polaris Partners). His professional career includes roles as a Board Member at multiple medical device companies, Chairman at Rebiotix, and President at Boston Scientific Cardiology. Berman’s investing strategy involves partnerships with investors like Andrew Kleiboeker, Derek Rapp, Isaac Zike, Jay Schmelter, and John McKearn.

Dr. Martin Pfister was a Principal and an expert for venture capital and investments in Life Science & Chemie startups at HTGF. His unfortunate passing in October 2023 marked the end of his impactful career. During his tenure, he focused on investments in Life Science & Chemie startups and contributed significantly to the growth of the sector. One of the notable successes under his guidance was the acquisition of the biosensor company lino Biotech by Miltenyi Biotec, showcasing his strategic acumen in investment decisions. His legacy includes a strong track record of successful investments and a profound impact on the startups he supported. His partnership and collaboration style emphasized fostering meaningful relationships with portfolio companies to drive mutual success.

Alfred Scheidegger is the Founder and Board Member of Nextech Invest Ltd, focusing on oncology therapeutics, diagnostics, and devices. He has a track record of investing in companies like Agensys, Ganymed Pharmaceuticals, MacroGenics, Sunesis Pharmaceuticals, TetraLogic Pharmaceuticals, and Tracon Pharmaceuticals. Alfred’s investments are known to be substantial, and the check size is not explicitly mentioned on the website.

Castle Island Ventures is a venture capital firm,

Louis Lucido is the Interim President of BioCorRx Inc. and a former Senior Advisor and Chief Operating Officer of DoubleLine Group, LP. He has invested in BioCorRx and has experience in the investment and capital markets. Louis Lucido’s previous investments include rounds in BioCorRx, particularly in the Post IPO Round in 2019. He is known for his collaboration styles focusing on introspective, relational, and expressive approaches to enhance teamwork and productivity.

Keiretsu Forum South-East is a part of the global investment community of Keiretsu Forum, known for its diverse investment opportunities in emerging technologies, healthcare/life sciences, consumer products, real estate, and other high-growth segments. Keiretsu Forum members aim to provide quality deal flow for angel investors globally, having invested over $1 billion in 950+ companies across different industries. With a network of over 1,850 members in North American and international chapters, Keiretsu Forum stands out for its collegial screening process, direct investments in presenting companies, and extensive networking opportunities. This investor emphasizes a mission of ‘Great Association With Quality Deal Flow’ and has a track record of supporting innovative ventures in various sectors to foster growth and success.

Martin Redl is the Investment Director at Bayern Kapital, overseeing the early-stage sector since 2007. He focuses on software, bioscience, healthcare, and pharmaceutical sectors. Previous investments include Shore GmbH, United Maps, and casavi GmbH. Martin holds a track record of successful early-stage investments. His check sizes vary based on the project. With a collaborative and hands-on approach, he positions Bayern Kapital at the forefront of innovative funding strategies.

Naveen Jain is a Co-Founder and Chief Executive Officer at Viome Life Sciences, Board Member of XPRIZE, Advisor at Pegasus Tech Ventures, and involved in various other ventures. His investment focus areas include companies like Particle Network and Proprio. Jain has been active in investments at both pre-seed and seed stages. Some of his previous investments include LS Digital and Onmove. His professional career is marked by a dedication to solving global challenges through innovation, with a particular focus on empowering women and promoting entrepreneurship. The investment check size for Naveen Jain’s active investments is significant, reflecting his commitment to impactful ventures.

Carlos Escapa is a seasoned professional with a strong track record in technology leadership. As the CEO of VirtualSharp Software, he has made investments in technology vendors and has a focus on industries like tech, insurance, and healthcare. His investments are typically in later-stage companies. Geographically, he has a global reach, with successful exits in the past. Previous investments include VirtualSharp Software, with a Series A round in 2012. Carlos is known for his collaborative approach and partnership with firms like Amazon Web Services. The investment check size is estimated based on his previous activities, indicating involvement in multi-million dollar projects.

John Prendergass is an investor who focuses on early-stage digital health, biotech, and medical device companies in the greater Philadelphia area. He seeks solutions that fill unmet medical needs, with investments ranging from $50K to $500K and a sweet spot of $300K. His previous investments include OneForty in a Series A funding round. John Prendergass’s partnership and collaboration style involve investing in startups with specific healthcare objectives and avoiding basic R&D or cost-increasing solutions in the healthcare system.

Btov Partners is a venture capital firm focused on early-stage investments in digital and industrial technology companies.

Måns Ulvestam is an investor known for his focus on the tech, consumer, insurance, and healthcare industries. His investments range from seed to Series A rounds, with his latest investment being in Podspace. He has a portfolio exit with Podspace being acquired in March 2023. Ulvestam’s professional career includes founding Sesamy, a digital content platform, and his involvement in the Swedish startup ecosystem. His investment check size varies based on the round and company. Partnering with co-investors like Karl Rosander, Ulvestam continues to drive growth and expand operations, particularly in the digital content and podcasting space.

Soner Casur is an investor based in Istanbul, Turkey. He has a keen interest in disrupting various industries with technology, focusing on areas such as Health Technology, Messaging, Disrupting consumer verticals, and Fintech. Soner has made investments in Lokum Games and collaborates with co-investors like APY Ventures and Bogazici Ventures. His investment style reflects a preference for deep work, meaningful connections, and creative freedom. While Soner’s track record and professional career details were not accessible, his investment check size typically ranges from $250K to $5M. Through his investments, Soner aims to disrupt traditional sectors and contribute to innovative advancements.

Michael Baum is the founder of FOUNDER.org, a non-profit foundation that invests in student entrepreneurs solving big problems. The organization focuses on industries such as sensors, sanitation, influencer marketing, biotechnology, health, and transportation. FOUNDER.org provides early-stage funding and seed grants to support student entrepreneurs in building great companies. Baum’s track record includes six successful exits, including Splunk. The organization hosts an annual contest awarding $100,000 in grant funding to top student teams. FOUNDER.org works closely with student founders from universities globally, providing hands-on mentorship and support for high-impact companies.

Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies.

Andy Solomon is an Angel Investor with a focus on comprehensive intellectual property, regulatory, and commercial strategies for pharmaceutical products. His previous investments include SoleSociety. He has a track record of creating impactful communication strategies, and his typical investment check size ranges from $5.0M to $50.0M. Andy Solomon’s partnership and collaboration styles involve respect, equity, and empowerment.

John Novak is the Head of Investment Development and Capital Markets at Paine Schwartz Partners. He focuses on identifying new investment opportunities, strengthening relationships with industry stakeholders, and optimizing capital markets and financing activities. Previously, he was with Swander Pace Capital, focusing on consumer product investments. He has a background in economics and has been instrumental in various investment activities.

Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing.

Jim O’Connell serves as Principal at Safeguard Scientifics with over 20 years of operational, financial, and entrepreneurial experience in the life sciences. He has been involved in sourcing and leading investments in companies like Syapse, Quantia Communications, and Alverix. His focus areas include healthcare/foodtech startups, and he typically invests in early to mid-stage companies. While his specific stage of investment is not specified, his check size varies based on the opportunity. Geographically, his investments are not limited to specific regions, with a broad scope of interests. Jim’s partnership and collaboration styles involve working closely with industry experts, guiding portfolio companies, and fostering collaborations between different partners.

Isabel Eberhardt is a VC Investor at DTCP with an investment range of $20.0M – $25.0M. Her focus areas include Series B Enterprise Applications and Cloud Infrastructure. She has co-invested with Alexander Helmke, Bart de Jong, Claudius Laskawy, Irit Kahan, and Joshua Müller. Previous investments include Series B Enterprise Applications. Isabel values long-term partnerships and collaboration, offering operational expertise and aligning interests for lasting success.

Maxson J.Y. Tee is an investor with a focus on tech products for financial services, healthcare, and education. He is a Principal at BNY Mellon, with an interest in asymmetrical returns and pushing boundaries. Maxson’s geographical preference is in the United Kingdom. His professional experience includes working with global banks, co-founding a FinTech startup, and advising on venture capital, product management, and business strategy. In terms of partnership and collaboration styles, he exhibits introspective, relational, and expressive collaboration styles. Specific investment check sizes are not available in the search results.

Lasse Chor is an investor with a diverse investment thesis, focusing on B2B SaaS, health tech, fintech, and gaming sectors. He typically invests in early-stage startups across various sectors, with previous investments averaging N/A USD. Lasse Chor has a track record as a successful Danish businessman with global recognition. His investment check size is not specified, and his partnership and collaboration styles are not explicitly defined.

Bill Gates, co-founder of Microsoft Corporation, is an entrepreneur and philanthropist. He is heavily invested in climate tech through Breakthrough Energy Ventures, participating in 45 deals in the past year across energy, food, and construction. Gates focuses on late-stage life sciences investments and Series A+ venture funding, providing flexible debt solutions. His investments spread globally, fostering partnerships with visionary entrepreneurs for societal progress. Gates has a successful track record, amassing a fortune from Microsoft and leading charitable initiatives through the Bill & Melinda Gates Foundation. His investment check sizes vary based on unique needs, supporting companies committed to long-term impact. Gates promotes gender equality and forms long-term strategic partnerships, offering expertise and add-on project funding for impact evaluations. He advocates for public-private partnerships and collaboration to drive energy innovation and address global challenges.

Shaheen Shamsavari serves as Principal at Xandex Ventures and is also an Angel Investor. He has expertise in business development in Xandex’s Semiconductor, Solar, and Investment Divisions, with a focus on managing Xandex Investments’ portfolio. He is a member and active investor at the Life Science Angels, Keiretsu Forum, North Bay Angels, and HealthTech Capital. Previously, he worked at Gilead Sciences in Formulations and Process Development, specializing in HIV and Hepatitis C therapeutics. Shaheen is a graduate of the University of California at Berkeley in Molecular and Cell Biology with a Neurobiology emphasis. Additionally, he is the Founding member at HealthTech Capital.

Craig Pearlman, Managing Partner at VentureDNA, is focused on investing in innovative technologies and sustainable real estate redevelopment. He targets Technology Innovation and Real Estate Substantial Redevelopment as key investment areas. With an investment range from $100K to $5.0M, VentureDNA’s sweet spot is around $1.5M. Craig’s recent investments include sectors like Manufacturing, Retail, Digital Health, Health & Hospital Services, and Health IT, both in the Seed stage and Series A. His collaboration style involves key co-investors like Joe Brickman, Mark Hahs, Stewart Dixon, and Tom Ramar. Operating out of Chicago, Illinois, Craig Pearlman brings expertise and a track record in nurturing startups in these sectors, providing guidance and strategic input to foster growth and success.

Dharma S. is a prominent investor known for his involvement in various funding rounds. He has been associated with multiple ventures, including Dharma Platform, a travel startup that secured a $4.7 million pre-Series A investment. Dharma S.’s investment focus areas are diverse, spanning industries like travel and technology. With a funding history totaling $7.12 million from 20 investors, Dharma S. engages in investments at different stages, contributing to early and growth-stage ventures. While his geographical preferences are not explicitly mentioned, his investment check size varies based on the funding rounds and specific ventures. Dharma S. is recognized for his partnership and collaboration styles, fostering strategic alliances to drive growth and innovation in the startups he supports.

Okan Erol is an experienced entrepreneur and investor with a focus on technology startups. He co-founded Wordego and is actively involved as the Chairman and CEO. Okan has invested in startups such as Wordego, MD Research & Development, and Nanomik Biotechnology. With a background in Business Development and General Management, Okan has a track record of success in executive roles. He holds a Master’s degree in Business Administration and a PhD in Finance and Banking. Okan Erol’s investment check size varies based on the startup and round, as seen in his investments across different rounds. As an Angel investor, his partnership and collaboration style involves mentoring young entrepreneurs and offering MBA courses at various universities.

Flatley Venture Capital focuses on investing in medical companies, particularly in areas related to cystic fibrosis. Their investment stages may include seed funding, startup capital, early stage, expansion, and later stage. Previous investments include Illumina. The check sizes of their investments vary, possibly ranging from under $300,000 to under $10,000,000. Their partnership and collaboration styles may involve setting up joint ventures and launching companies around interesting technologies.

Robert Kocher serves as a Partner at Venrock specializing in healthcare IT and services investments. His geographical focus includes North America and LATAM. Previous investments include companies like Devoted Health and Aledade. Dr. Kocher has a distinguished professional career leading him to roles in the Obama Administration and McKinsey & Company. The investment check size at Venrock ranges based on the stage of the startup. Partnership and collaboration styles reflect a focus on health tech and services investments.

Larry Bowman is an investor with a profitable engineering services growth story, operating on a low-risk business model. He focuses on quantitative analysis and modeling of complex financial transactions. Larry has experience as a Director at Riviere Securities, LLC and Vice President at Fortis and Societe Generale. His past investments include PlayFab and Popcap Games. Larry’s professional career showcases expertise in portfolio risk management. Financial details such as investment check size and geographical preferences are not available at this time.

Grand Angels is focused on investing in companies that enhance the economic development of West Michigan and prefer investment check sizes ranging from USD 0.25 to 1.0 million in at least 14 investments. They invest in businesses located in Michigan, with a preference for those in Kent, Ottawa, and Muskegon counties. Some of their previous investments include Micro-LAM and Ocuphire Pharma. The organization targets pharmaceuticals & biotechnology, advanced agriculture, software & IT, advanced manufacturing, B2B, and life science sectors.

Bradford Folkens is a Co-Founder and Chief Technology Officer at CloudSight, leading technical aspects of image cognition technology. He has partnered with Braven, focusing on regulated ecosystems like financial services and healthcare, accelerating timelines for companies. Folkens excels in talent selection, assessment, and development, especially in tech and innovation fields. His collaborations extend to advisory roles at the University of Maryland and leadership positions at tech companies like Loadsmart and Collibra. Folkensâ partnership approach involves co-building and de-risking startups, providing capital and expertise for growth. He brings a unique blend of people management and technology expertise to drive strategic advancements.

Michal Tsur is a Co-founder and President at Kaltura, and also the Co-Founder and Chairperson at Remepy. Michal Tsur’s investment focus areas include industries such as hybrid drugs, media, education, and health. He has a portfolio with companies like Kaltura, Remepy, and Cyota. The investment check size of Michal Tsur is undisclosed. In terms of partnership and collaboration style, Michal Tsur values partnerships to bring innovative solutions to customers and focuses on boosting engagement and collaboration in online meetings.

Mehdi Maghsoodnia is a Managing Partner at Combustion Ventures with an investment thesis focused on early stage consumer and health IT startups. His investment check size ranges from $25K to $1M, with a sweet spot at $50K. He specializes in seed stage investments in SAAS platforms and has an expansive background in the tech industry, holding various executive positions. Mehdi has made investments in diagnostics, consumer health, and data services. He has a track record of holding notable roles at companies such as Vitagene, Livara Health, and Trinity Ventures. Mehdi Maghsoodnia’s geographical preference extends to diverse sectors including AI, consumer internet, and bio-tech. His partnership and collaboration style emphasize building relationships and solving complex challenges through innovative approaches.

Danny Zuckerman’s investment thesis revolves around decentralized protocols powering a new generation of decentralized applications and user experiences, particularly focusing on user privacy and innovation through Ceramic technology. His previous investments include projects such as Yup and PowerLoom. The check size for investments managed by Zuckerman Investment Group is significant at $834.28 million for 880 client accounts. Zuckerman’s partnership and collaboration styles emphasize commitment, alignment of interests, and past collaboration between rivals to facilitate cooperation and prevent conflict.

Dr. Johann ‘Hansi’ Hansmann, an Austrian investor, focuses on early-stage companies in Health & FemTech, Fin- & InsureTech. His geographical preference is not specified. Some of his previous investments include RenéSim, Chiesi Pharmaceuticals, busuu.com, and runtastic.com. With a track record in executive roles, he emphasizes early-stage investments. The investment check size varies, with recent undisclosed amounts. Dr. Hansmann’s partnership and collaboration style do not have specific information available.

Akhil Paul, an angel investor based in London, England, has a diverse investment portfolio. He focuses on technology vendors, corporate venture capital, IT, consumer, tech, insurance, healthcare, and industrials sectors. Some of his notable investments include Otterize, Poly API, and Frigade. Akhil Paul’s investment check size ranges between $1.5-3 million for 10-20% ownership. His partnership and collaboration styles emphasize pre-revenue startups with teams of 3-4 people. His track record includes investing in companies like Fi, Credgenics, LocoNav, and Topsort. He has a global investment presence in regions like India, the United States, and more.

Bob Bausmith is a seasoned investor with a deep understanding of the healthcare business. He focuses on companies in the healthcare and technology sectors, serving as a Board Chair at the Hartford Symphony Orchestra. With a proven track record of leadership, strategic planning, and transformational change, Bob’s investment style emphasizes collaboration and mentorship. His investments range from healthcare startups to tech companies, leveraging his expertise and experience to guide portfolio companies towards success. In addition to his role at Hartford Symphony Orchestra, Bob has been actively involved in advising and serving on boards of various organizations, showcasing his dedication to fostering growth and innovation.

TCG is a multi-stage investment firm that seeks to invest in and build these best-in-class companies.

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

Brian Belsky is the Principal at Ascension Ventures, specializing in investments in Consumer Health, Digital Health, Health & Hospital Services, and Health IT. His investment range is $3.0M – $15.0M with a sweet spot at $8.0M. He has a current fund size of $255M. Brian has made notable investments like Strive Health and collaborates with co-investors such as Mohamad Makhzoumi, Sumi Das, and Vijay Patel. His investment style involves partnering with investors like Evan Stoff, Guneesh Batra, and others.

Henrik Torstensson is a Partner at Alliance VC, a Nordic venture capital firm that focuses on investing in early-stage tech startups. He has a strong emphasis on investing in applied AI and open finance, believing in the impact of AI on venture capital, growth investing, and startup funding. Henrik’s investment focus areas include digital/physical and data-driven health. He has a preference for Nordic-based health startups and aims to invest more in this sector in 2024. Henrik typically invests in early-stage tech startups and acknowledges the challenges and timeframe for getting returns from investing in startups. He has a successful track record, having been a board member and investor in various startups. Henrik’s partnership style emphasizes being a true partner to founders, prioritizing a direct relationship with founders, and committing to AI for startup investing.

Arin Ozkula is a General Partner at 500 Startups, with a focus on investment and fundraising, InsurTech, HealthTech, Strategy & Business Development, Business Intelligence, and Retailtech. His investment stage ranges from Pre-seed to Seed, preferring opportunities in Enterprise Applications, E-commerce, Marketplaces, FinTech, and SaaS sectors. Arin Ozkula’s geographical preference is in Turkey and Europe, particularly in Emerging Europe. He has a track record of leading investments in companies like Getir, with previous roles at Revo Capital. Arin Ozkula’s investment check size typically falls in the range of â¬1 million. His partnership and collaboration styles are not explicitly specified on the available sources.

Ijeoma Agulanna@yahoo.com is a Pathologist with a background in various medical fields such as Thoracic Pathology, Anatomic and Clinical Pathology, and Polycystic Kidney Disease. They have pursued degrees in Pathology, Medical Science, Surgery, and Urology Residency, graduating from institutions like New York University and Yale School of Medicine. Ijeoma’s education includes a Doctor of Medicine (M.D.) degree and a Master’s degree. Their career spans roles like Attending Physician and Research Fellowship at esteemed medical institutions in the United States and Brazil.

Matthew McCann is an Investor Relationships Manager at CPI with experience in management consultancy, technology transfer offices, and non-profit life science accelerators. He has a background in biology and bioscience enterprise.

Hatteras Venture Partners is a North Carolina-based venture capital firm that finances biomedical companies.

Karan Kochhar’s investment thesis is in health tech (software + data), and he invests in teams with at least 1 co-founder who has had industry experience in healthcare. His investment focus areas include Southeast Asia. Some of his previous investments include Meta, Zoe Nutrition For Life, Quikr, Indian Realty Exchange, Tyroo, and Libero Sports.

Mark Dyne is the Founder and Chief Executive Officer at Europlay Capital Advisors. The investment focus areas of Europlay Capital Advisors include healthcare, mobile, retail, media, and information technology. Europlay Capital Advisors seeks to invest in seed and early-stage technology-based companies. Geographically, Europlay Capital Advisors is headquartered in Los Angeles, California. However, further specific information on geographical preferences was not found. Mark Dyne has been involved in companies such as Sega Gaming Technologies and Virgin Interactive Limited. The specific investment check size was not directly available. Europlay Capital Advisors has a collaboration style focusing on investments in the healthcare, mobile, retail, media, and information technology sectors.

Merel Keereweer is an investor at Borski Fund, specializing in Health & Hospital Services (Seed) and Health IT (Seed). Their investment range is $100K – $5.0M, with a sweet spot at $1.5M. Some of the investors who collaborate with Merel Keereweer include Aletta Stas-Bax, Bertrand van Leersum, Dagmar van Ravenswaay Claasen, Hannah van Goor, and Laura Rooseboom. Previous investments include projects related to the Future of Healthcare Committee.

Thomas Andrae focuses on investing in tech-forward healthcare entrepreneurs and innovators who are leading the way in biological engineering.

Jonathan Bush is the Chief Executive Officer at Zus Health, serving as an Advisory Board Member at Innovaccer and Sana Capital. He co-founded and was the Chairman of Athenahealth. His expertise covers various areas including care delivery redesign, community-focused health, mental & behavioral health, payment redesign, and organizational transformation. Jonathan Bush’s investments typically target later stage ventures with deal size information not disclosed. He has made previous investments in a variety of healthcare startups. His professional career includes roles as a medic in the U.S. Army, a management consultant at Booz Allen Hamilton, and a founder of Zus Health and Athenahealth.

Aletta Stas-Bax is a prominent investor and Venture Partner at Borski Fund based in the Netherlands. With a focus on ClimateTech/CleanTech, BioTech, Health & Hospital Services, and Health IT at the Seed stage, Aletta has carved a niche in supporting innovative startups in these sectors. Her investment check sizes range from $100K to $5.0M, with a preferred size of $1.5M. Aletta Stas-Bax’s diverse portfolio includes collaborations with notable co-investors such as Bertrand Van Leersum, Dagmar Van Ravenswaay Claasen, Hannah Van Goor, Laura Rooseboom, and Merel Keereweer.

Jonathan Greenfield is an Angel Investor. He served as Executive at Life Science Angels.

Samuel Zises is a Co-Founder of [L]earned Media and serves as its Chief Executive Officer. With a background in marketing and business development at prominent firms, including Ogilvy & Mather and Big Fuel, Sam has a strong track record in the industry. His previous investments include RetailMLS, Kapitall, SocialRank, Quip, Wendr, and Big Fuel. Sam focuses on investments in industries like beauty, dental, e-commerce, and healthcare. His check size typically ranges from $50,000 to $3 million. Sam’s partnership and collaboration styles are geared towards effective cross-cultural networks and community collaborations, aiming to create impactful partnerships for transformative change.

Kevin Frick is a Partner at Serent Capital, leading the Firm’s investments in tech-enabled businesses across various sectors including healthcare, HCM, and insurance tech. He has extensive experience working with CEOs and management teams on strategy, organization, sales, marketing, product road-mapping, and operations. Kevin’s check size for investments is not available. He holds an MBA from Stanford University’s Graduate School of Business and a B.S. in Electrical Engineering from the University of Michigan. He is known for his collaborative partnership style and as a director of several companies like Avionté and KEV Group.

Joseph Whitters is a seasoned investor with extensive experience. He serves as a Board Member at Higher Learning Technologies. Joseph Whitters brings notable public company governance experience in the medical technology and device industries. He is associated with leading healthcare providers like PRGX Global, Inc. and InfuSystem Holdings, Inc. Joseph has a background in venture and growth equity capital, contributing to emerging healthcare companies’ growth. His expertise and experience enhance shareholder value. Known for his public company board roles, Joseph Whitters has prior board experience with various reputable organizations. Recent SEC filings mention his engagements up to 2021-08-30. Mr. Whitters’ collaboration style aligns well with the introspective, relational, and expressive types, with strategies in place to ensure effective collaboration among these styles.

Simon Whitfield is a Co-Founder at Relentless Pursuits Partners, focusing on investments in health, activity, and longevity. He has a commitment to preventive healthcare, disease risk mitigation, and chronic disease management. Simon’s previous investments include a Sport Technology Company called TritonWear. The investment check size for Simon Whitfield at Relentless Pursuits Partners is not specified. His partnership and collaboration styles involve co-founding an angel investment group dedicated to healthy, active living, as well as working with non-profit organizations and receiving awards for his advocacy and mentorship in sport and health.

Landmark Angels actively seeks out investment opportunities ranging from $100K to $2M, with a focus on key industry contacts and conferences. They provide valuable advice and resources beyond capital. The firm has a broad investment thesis focusing on effective scaling companies with exit potential. Landmark Angels accepts applications from all geographic regions and was established in 2008 with substantial investment expertise. Previous investments information is not readily available. The average check size of investments can vary from $100K to $2M. Partnership and collaboration styles are focused on providing entrepreneurs with advice and resources beyond funding.

Edward Van Wezel is the Managing Partner at BioGeneration Ventures (BGV) with a focus on early-stage European biotech companies. BGV’s investment thesis revolves around supporting seed and early-stage pharmaceutical developers working on drugs with convincing experimental data as their basis. Edward van Wezel’s professional career includes serving on supervisory boards of various companies aligned with biotech development. BGV’s investment check sizes range up to â¬105m ($119m) with partnerships involving limited partners like Bristol Myers Squibb (BMS) and others. Edward holds a M.Sc. in chemistry from the University of Utrecht and a M.Sc. in Biochemical Engineering from Delft University of Technology. His collaboration style involves active involvement and support in biotech innovation.

Rafael Damasio, as the Group CEO of Rafael Holdings, focuses on developing novel cancer and immune therapies through investments in clinical-stage oncology companies such as Cornerstone Pharmaceuticals and LipoMedix Pharmaceuticals. The investment thesis revolves around improving and extending the lives of patients with cancer through innovative therapeutics. Rafael Holdings is transitioning to a commercial enterprise from a clinical-stage company with ongoing Phase 3 trials. They are actively seeking a Chief Compliance and Ethics Officer with specific job requirements related to compliance and ethics in the pharmaceutical/biotech industry.

Ricky Thomas is an angel investor with a focus on seed round investments. He has a track record as a football coach in the NFL and has provided mentorship to startups. His previous experience includes working as a tight ends coach for the Indianapolis Colts and the Tampa Bay Buccaneers. His investments span industries such as healthcare, consumer internet, energy & clean tech, enterprise software, and mobile. Ricky Thomas invested in companies during their seed rounds and Series C funding stages, showcasing a commitment to supporting startups at various growth stages. Additionally, his approach includes collaboration and identifying solutions that satisfy all parties involved.

Peregrine Ventures is a venture capital fund for cross-stage investments.

Jim Bullock is the President and CEO of Zyga Technology. Prior to joining Zyga, he was the President and CEO of Atritech, Inc. and Endocardial Solutions, Inc. He has a strong background in the medical device industry and a track record of creating value for startup companies. Jim’s focus at Zyga is on clinically validated products addressing clinicians’ needs such as the SImmetry™ Sacroiliac Joint Fusion System and GLYDER™ Facet Resurfacing System. His expertise and commitment contribute to the company’s growth.

Keiretsu Forum – MidAtlantic is an early-stage investment group focusing on Series A and B rounds with valuations ranging from $2m to $186m. The fund predominantly invests in sectors like Life Sciences and Technology, and has funded companies including Laurent Pharmaceuticals, FemSelect, and IQure Pharma. With a track record of over $1B invested in 1,000 companies since 2000, Keiretsu Forum showcases a strong partnership and collaboration style by completing due diligence before presentations and obtaining collaborative feedback on investment interest. The forum maintains a unique approach to investment, emphasizing ROI, IP protection, and market disruption potential. Investment check sizes typically range from $2m to $186m, with a focus on ROI, strong management teams, and clear exit strategies.

Franz Wocheslander is a Senior Investment Manager at Bayern Kapital. His investment focus areas include technology for stroke prevention. He invests in early-stage startups and prefers cooperative collaboration. Franz has invested in Curefab and has successfully managed a diverse fund portfolio. His check size ranges based on the startup requirements.

David Healey is a Director at Bain Capital Credit who joined in 2018. He focuses on investments in Private Equity, Real Estate, and Life Sciences. The firm’s Private Credit Group emphasizes providing financing to businesses with EBITDA between $10 million and $150 million. Previous investments led by Bain Capital Credit include supporting the growth of various companies. Healey’s professional career includes serving as an Assistant Vice President at Golub Capital. The investment check size by the Private Credit Group of Bain Capital Credit has been approximately $2 billion, investing in middle-market and private equity-backed companies. David Healey follows a collaborative style within the team at Bain Capital Credit.

David Bailey is an Angel Investor focused on Clean Technology, Consumer Internet, Enterprise Software, Mobile, Healthcare, Real Estate, and Property Management. He has invested in companies like ClientSuccess and Room Choice. Based in Salt Lake City, United States.

Fika Ventures is a seed fund that focuses on enterprise and B2B software, FinTech, marketplaces, and digital health.

Mahendra Matta is an angel investor at Angel Physicians Fund, passionate about advancing healthcare through advanced technology. He has invested in startups such as Foldax and Aria CV. Dr. Matta focuses on healthcare advancements and has a track record of supporting innovative healthcare startups.

Cindy Cook, a member of New York Angels, has a background in marketing and strategy, with experience in entertainment, educational publishing, and healthcare. She leverages her expertise to inform her investment decisions. Cook is actively involved with the founders in whom she invests, providing support in growing their businesses. She values collaboration with other Angels for industry expertise during due diligence. As an investor, she focuses on areas she has experience in, emphasizing a strong consumer perspective. Cook’s investment approach involves leading deals, communicating effectively with entrepreneurs and members, and ensuring a quick and efficient investment process. Her strength lies in leveraging her consumer-centric viewpoint to evaluate market opportunities.

Joanna Soroka is a Principal at Hitachi Ventures with a focus on investing in Smart Cities/UrbanTech, Security, Robotics, Cybersecurity, EnergyTech, TransportationTech, IoT, Data Services, and more at Series A stage. She has a current fund size of $150M and a typical investment range of $100K to $5.0M. Her sweet spot investment is around $1.5M. Joanna has a track record of managing technology conglomerate ventures and corporate funds, primarily in the DACH region, providing strategic support to startups and collaborating with other top investors such as Ankesh Madan, Galina Rachenkova, Jan Marchewski, Pete Bastien, and Stefan Gabriel.

Mark McDonnell is the Managing Director, Chief Financial Officer, and Chief Administrative Officer at ARCH Venture Partners. ARCH Venture Fund focuses on early-stage biotechnology companies. The firm’s geographical preference is not specified. Mark McDonnell has a track record in financial management, board membership, and limited partner strategies. Information about his previous investments is limited. The investment check size is not explicitly mentioned. His partnership and collaboration styles are not outlined on the website.

Paul Sethi is a seasoned investor with a focus on AI, digital bioprocessing, and health technologies. His previous investments include UniKey, SmarterX, and Mealco in the Business/Productivity Software and Media sectors. Dr. Sethi is a prominent orthopedic surgeon known for his sports medicine expertise, serving in various medical societies. His investment check size ranges from $300K to $600K, with a sweet spot at $450K. Dr. Sethi’s collaborative style aligns with introspective and relational approaches, emphasizing deep work, human connections, and visual engagement.

Fred Cohen is the Co-Founder and Senior Managing Director at Vida Ventures, active in roles as the Chairman of Monograph Capital and Ascend Gene & Cell Therapies. His previous experience includes being a Partner at TPG and Managing Partner of TPG Biotechnology, focusing on venture efforts in biotechnology and life sciences. Fred held positions like CEO of Management Analytics, President of Keiretsu Forum Pebble Beach, and member of Fearless Security. He served as an SVP and Director of Municipal Bond Trading at AllianceBernstein for 25 years, playing a key role in growing the municipal bond money manager into a leading firm with $44 billion under management. Fred is a respected industry figure and has also been recognized for his knowledge by being named to the MSRB Investor Advisory Group. He holds certifications including CPA (Inactive) and various Series certifications. Fred’s collaborative style involves setting and implementing investment policies, working with various vendors for market efficiencies, and actively engaging with industry experts and organizations.

Wolfgang Reitzle is an investor who actively engages in acquiring stakes in startups, including biotech companies like Tomorrowlabs GmbH. His investment focus areas range from biotech to corporate boards and non-profit organizations. Reitzle’s geographical preference is emphasized in efficient operations in Europe, particularly in Germany. Previous investments involve rounds like Angel – II and Seed Round, showcasing diverse investment interests. With a track record of 5 investments and a collaborative approach, Reitzle demonstrates a hands-on style in his investments, including involvement in wine and oil production in Italy.

Dr. Michael Rundshagen, a Co-Founder at Traxpay and former executive partner at Accenture, has made 2 investments, including Savedroid with a portfolio exit. He focuses on IT, consumer, tech, insurance, healthcare, and financial services sectors. His latest investment was in Savedroid in 2017. Dr. Rundshagen’s professional career includes roles at Advanced Bitcoin Technologies AG and strategic advisory positions. Geographically, his investments align with positive externality games. While the specific investment check size is not available, his collaboration style involves partnering with Account Executives.

Navneet Dalal is a machine vision enthusiast, entrepreneur, and CEO of Matic with 18 years of experience in computer vision. His thesis research on Histogram of Oriented Gradient (HOG) set the standard in object detection, receiving over 25,000 citations. Navneet has a track record of tackling challenging problems and developing production-ready applications. He co-founded Matic to develop robots for home cleaning. As an angel investor, he has made investments in companies like Helm.ai. His investment check size has varied, with recent activities involving around $30 million in funding for Matic. Navneet Dalal’s geographical focus for investments is not specified. His career spans roles at Google, Flutter, Like.com, and Siemens. His educational background includes a PhD in Computer Vision, an MS in Computer Vision & Robotics, and a BE in Computer Engineering. Navneet Dalal’s partnership and collaboration styles are not explicitly mentioned in the available information.

Meeta Gournay is an Angel/Individual investor with a focus on Clean Technology, Consumer Internet, Enterprise Software, Mobile, Healthcare, and Technology markets. Some of her previous investments include Omgito, Andie, JoeyWears, Barrecore, Graine de Vie, and more. She has been involved in a $3 million seed investment round with CircleUp. Meeta has a track record of building early-stage businesses, with experience in partnerships, operations, and finance.

Rex Burgdorfer is a Managing Director at Juniper Advisory, specializing in non-profit health system mergers and acquisitions. He focuses on executing mergers and acquisitions transactions. Rex’s investment focus areas are in non-profit health system mergers and acquisitions. He has a professional career spanning over a decade in this market. Unfortunately, specific details about his stage of investment, geographical preferences, previous investments, investment check size, and partnership and collaboration styles were not found in the available information.

Sacramento Angels is a prominent angel investor group based in Sacramento, California. They focus on investing in startups with the potential to raise significant funds in the near future, with a special interest in various sectors including biotechnology, software, healthcare, energy, and pharmaceuticals. The group primarily invests in early-stage companies, engaging actively in supporting entrepreneurs and startups. Sacramento Angels are known for their preference for local companies and have a track record of investing in innovative startups. Their investment check size typically falls below $1 million, and they collaborate closely with entrepreneurs, providing mentorship and strategic guidance for growth.

Christian O. Edler is an investor with an opportunity-driven, sector- and business-model agnostic investment thesis. He invests in rounds including Seed, Series A, Series B, C, D, E… across countries like the USA, Germany, Malta, Sweden, UK, Colombia, and Switzerland. His investments cover various sectors including Delivery Service, Food and Beverage, Marketing, Supply Chain Management, eSports, and more. Christian has made over 56 investments, with notable ones including AppOnboard, Dreamworx, DOJO Madness, and others. He has a proven professional track record, having invested in over 75 angel startups with several unicorns. Christian Edler’s investments range from $25,000 to $200,000 per company. As an entrepreneur, Christian has recruited and led over 1,500 salespeople with $500M in annual sales. He co-invests with prominent VCs worldwide and focuses on world-class entrepreneurs with massive scale potential.

Brett Martin, Managing Partner of Charge Ventures, focuses on supporting startups, investing $200-500k at pre-seed/seed stages. He prioritizes AI/ML, Data Science, and more in Healthcare, Finance, and Logistics sectors. Brett is an angel investor and adjunct professor at Columbia Business School, with prior ventures including Switch and Sonar. He participated in deal review meetings at Primary Venture Partners and incubated companies at AppFund. Brett’s passion for startups is evident through his diverse professional career and educational background, including Economics and Entrepreneurship studies.

Bain Capital Ventures invests in seed to growth-stage startups that uses tech to disrupt existing markets or create entirely new ones.

Trolley Ventures is a venture capital firm based in central Virginia that focuses on providing funding solutions for early-stage companies. They invest in industries such as B2B, B2C, financial services, healthcare, and information technology, mainly in the Virginia region. Trolley Ventures has made 13 investments, with the latest being in Mobius Materials. The firm has a check size of $0.74M to $7.35M and has a track record of success since its founding in 2017.

Kevin Fryer is a hands-on investor with a track record in the wholesale industry. His investments are industry agnostic, focusing on early-stage internet startups. His investments range from seed to early-stage, and he is a Co-Founder and Managing Director at SparkLabKC in Kansas City. Although his geographical preference is not specified, he has been involved in accelerating startup companies in the region. Kevin Fryer collaborates actively with startups, bridging the experience and capital gaps, and his check sizes typically range from $500K to $750K per company.

Ozan Polat is an investor with Vine Ventures, focusing on novel approaches to conscious health & wellness. He co-founded Dezentrum, a think tank researching positive future scenarios for a digitized society. With a passion for innovative societal approaches, he joined Vine Ventures. Vine donates 50% of profits to mental health and collaborates with Othership, a mental health community. Representative companies include Ryan Zurrer. Ozan’s investment check size, stage of investment, and partnership style were not explicitly mentioned on the website.

Nurture Ventures focuses on working with start-up and early-stage businesses seeking investment finance in the £100k to £1m range. They actively seek ideas in the technology and healthcare sectors. Some of their previous investments include LunaJoy, VeeOne Health, and HuLoop Automation within the Clinics/Outpatient Services and Business/Productivity Software industries.

MJ Eng is the co-founder of ShoeDazzle.com, an internet first shoe brand providing subscription services. Founded in 2009 and acquired by TechStyle, ShoeDazzle has raised a total funding of $66M over 6 rounds from 10 investors. The company’s geographical preference is North America, specifically operating in B2C retail. While there was no specific data on the stage of investment, the investment check size, or the partnership and collaboration styles, MJ Eng’s involvement in ShoeDazzle showcases a successful track record in the retail and e-commerce sector.

Mark Carthy is the Managing Partner of Orion Equity Partners, LLC, a healthcare venture capital firm co-founded by him. Orion focuses on investments in companies developing products addressing major medical or healthcare industry needs. The firm’s geographical preference is not specified. Orion Healthcare Equity Management primarily invests in health-related ventures. The stage of investment by Orion is early, with a focus on the health sector. Previous investments by the firm include companies such as Solexa and PowderMed. However, specific investment check size and partnership and collaboration styles are not readily available.

Anja Konig, as the Global Head of Novartis Venture Fund, focuses on developing novel therapeutics and platforms, with particular interest in patient solutions and life sciences opportunities. Her investment check size involves rounds for companies like Epsilogen and Splice Bio. Anja Konig’s previous investments span pharmaceuticals, biotech, and medical devices. With a background at McKinsey, she has facilitated successful exits for companies like Heptares Therapeutics and Covagen. Anja Konig collaborates through entrepreneurship, venture philanthropy, and impact finance, aiming to create innovative solutions for societal challenges and promote market-led sustainable development.

Matt Sanford is primarily involved in evaluating mid-to-late stage biotechnology investment opportunities. His investment check size typically ranges from $200K-$500K in initial financings. Seattle and the surrounding regions are his preferred geographical areas for investment. Matt has a track record in managing large asset pools and has professional experience in fixed income. He is associated with investment funds such as Maveron, PSL Ventures, and WRF Capital, among others.

William Lighten is a Board Member at Brightwood Capital Advisors LLC. Brightwood Capital Advisors focuses on debt investments and prefers sectors such as business services, franchising, healthcare services, transportation & logistics, and technology & telecommunications. Their investment thesis includes a diverse business mandate with a focus on investing at least a quarter of its capital in diverse-owned businesses. Brightwood Capital Advisors has a track record of investing in middle market businesses and supports initiatives to increase diversity in franchise ownership. They collaborate with organizations like the International Franchise Association to drive strategic partnerships for underrepresented communities.

Arsen Mamikonyan is an Angel Investor with a background as a Software Engineer at Locu.

Jon Belmonte is an Angel Investor with a focus on Seed Rounds in the Ventures for Good and Travel & Tourism industries. He has a geographical preference for North America, specifically California. Some of his previous investments include Example example company Inc and Company & Company. With a successful track record, Jon has been associated with companies like Active Network, Cedar Ridge Ventures, and LeagueLink. His investment check sizes vary, with examples ranging from $1,000,000 in Seed Rounds to $11,000,000 in Series C funding. Jon’s partnership and collaboration style are reflected in his roles as Managing Director at Cursive Labs, CEO, and COO at Active Network, amongst other notable positions.

Mark Burish is a co-founder of a venture capital organization and also a board member at BrightStar Wisconsin Foundation. He has a background in law and serves on investment committees. Mark is known for his active involvement in handling pain and headache-related research. His professional career involves specializing in neurology and pain management. While specific investment focus areas and previous investments were not available, Mark’s involvement in venture capital suggests a keen interest in supporting startups. The stage of investment and check size were not directly accessible. Geographically, Mark is associated with the neurosciences department at the University of Texas Houston, focusing on headache studies. His partnership and collaboration styles reflect a research-oriented approach, engaging in lab-based studies with researchers to analyze circadian and neurophysiologic aspects of headaches.

Mr. Clint Jones is a Co-Founder and serves as Non-Executive Chairman at GoHealth. He is also the Chief Executive Officer at ProspectZone and the Managing Partner at Bridge Ventures. Clint Jones is an Angel Investor with a professional career highlighted by leading roles at multiple companies. He has a notable track record within the industry, including recognition as the Midwest Entrepreneur of the Year and being named to Chicago’s 40 under 40 list. Clint Jones actively engages in industry conferences and insurance regulatory forums. He holds Bachelor of Science degrees in Marketing and Management Information Systems from Miami University.

White Star Capital is an international venture and early growth-stage investment platform in technology.

Stephanie Jin is an investor at Avestria Ventures with a focus on early-stage women’s health and life science companies. Her investment thesis centers around impact investing in female-driven startups. Stephanie prefers to invest in companies prioritizing women’s health, aiming to create a positive impact through entrepreneurship. While her geographical preference is not specified, she is actively involved in the innovation and funding of medical startups that prioritize women’s health. Stephanie Jin’s track record includes cofounding Avestria Ventures to support startups in the digital health sector. She seeks to provide impact-driven investments, with check sizes that can range based on individual funds raised. In terms of partnership and collaboration styles, she is known for her strong support for female entrepreneurs and digital health initiatives.

Beate Hild is an investor with a diverse investment focus, specializing in early to mid-stage innovative entrepreneurial businesses in pharmaceuticals and healthcare products. Her preference lies in the United States and Western Europe. She operates globally with an initial investment size ranging from $1M to $10M. Beate Hild collaborates with top-tier venture capital investors and aims to create a community passionate about healthier futures.

Ken Singer is an angel investor who invests in promising companies typically in the mobile industry, leveraging his extensive experience in executive, product management, and sales roles. He focuses on Security, Social Networks, ClimateTech/CleanTech, Health & Hospital Services, and Enterprise sectors at both Pre-seed and Seed stages. The typical check size of his investments is not specified. Regarding collaboration, Ken Singer has partnerships with academic institutions like IE School of Science and Technology. However, his geographical preference is not explicitly mentioned in the available information.

Maria Salamanca, a former refugee from Colombia, now a partner at Unshackled Ventures, focuses exclusively on investing in immigrant founders entering the U.S. She is part of a select group of Latinx female partners in U.S.-based venture firms. Unshackled Ventures supports founders in the earliest stages and aids them in navigating the immigration process. The firm has filed 150 petitions for founders with consistent approval ratings. With Fund II at $20 million, they invest in 18-20 companies annually, providing an average check size of $250,000. Maria has led investments in startups like Dispo, Aavia, Inspirit Learning, Prismpop, Maximus, The Landing, and Hairtelligence. Active in Out in Tech and LatinxVC, Maria Salamanca showcases a commitment to supporting diverse startup ecosystems and holds leadership roles in various tech and venture capital communities.

Outlines Venture Group is the GP of the Sybilla Masters fund investing in women-led startups in fin-tech, industrial tech, and health tech. They have invested in companies like Fyrii, Cachet Ventures, Yoghurt.io, and brettapproved. Their investment check size ranges from $10,000 to $100,000. Outlines Venture Group collaborates in joint ventures and offers idea & seed stage mentoring in exchange for equity, fee-based coaching, and subscription services for entrepreneurs & investors. They have a global advisory network on four continents.

Corbin Page is an angel investor interested in Technology Vendors, Corporate Strategy, Corporate Venture Capital, Venture Capital, IT, Corporate Innovation, Insurance, Healthcare, and Financial Services. He focuses on seed investments in early-stage startups. Corbin Page has invested in companies like Astaria and Safe. Unfortunately, specific details on his investment thesis, geographical preference, track record, professional career, investment check size, and partnership/collaboration styles could not be found.

Melinda Gates is redefining what a ‘smart betâ in venture capital looks like through Pivotal Ventures. She aims to increase funding to businesses founded solely by women and invests in women-led funds and early-stage companies. Her investment focus areas include family planning, vaccines, and education. Gates provides flexible funding from Series A+ venture funding to private placements. She partners with visionary entrepreneurs globally, aiming for positive societal change. Her investments target long-term strategic partnerships with a commitment to gender equity. Previous investments include organizations such as Surf Bio, Inovio Pharmaceuticals, and Vedanta Biosciences. Melinda Gates’ professional career includes philanthropy, leadership at the Bill & Melinda Gates Foundation, and advocacy for women and girls globally. Her partnership style fosters collaboration with diverse organizations for impactful change.

Jeroen Arts is an Associate Partner at Speedinvest, focusing on marketplace platforms & network effects startups in Europe. He actively supports various startups such as CoachHub, byrd, Smiler, Stotles, Lapse, and Epilove. Jeroen Arts has a passion for exploring personal limits and inspiring others. Speedinvest’s investment thesis includes supporting companies like Stotles that open up the public sector. The geographical focus is in Europe. While the exact check size is not specified, the team invests in early-stage companies. Partnership and collaboration styles emphasize supporting founders in building tomorrow’s marketplaces and enabling technologies.

Andreas Jenne is the CEO of Ventura Biomed Investors, with a focus on the European Union (EU) and Europe, Middle East, and Africa (EMEA) regions. He has current roles as CEO at Ventura BioMed Investors and Co-Founder & Managing Director at SciRhom. Andreas Jenne has a track record of past experiences including being the CEO at RSP Systems A/S. His investment check size and partnership style could not be determined from the available information.

Rajit Malhotra is an investor with a deep expertise in healthcare and experience in industries like Biopharma, Artificial Intelligence, Energy, and Real Estate. He has a background in advising Fortune 500 companies, specializing in healthcare, public sector, and EPNG practices. Rajit is the Executive Chairman of AmperSand Biopharmaceuticals and Tour Engine. His investments are focused on advanced technologies in therapeutics, medical devices/diagnostics, and digital health, with a funding range of $50-$150k per project. He is actively involved in organizations like UCLA Technology Development Corporation and the CAFAM Museum, displaying a commitment to civic and charitable projects. Rajit Malhotra’s approach involves supporting projects with significant commercial potential, promoting collaboration and the commercialization of UCLA-owned technologies.

Lavni Ventures is a venture capital firm.

Kip McClanahan serves as a General Partner at Silverton Partners, focusing on disrupting growth markets and building enduring companies. His investment approach is people-driven, supporting early-stage startups with technology that can create lasting barriers. He has a track record in IT security, networking, media communications, and software industries, with over 30 years of experience. Kip has been involved in raising over $300M in capital, returning over $1B in realized gains, and has a BS in Electrical Engineering from the University of Texas. Silverton Partners primarily invests in startups in Austin, Texas, in industries such as Consumer, Enterprise, Fintech, and Healthcare. The investment check size varies, and they collaborate with bold entrepreneurs striving to break the mold.

Tom Nicholson is a Founding Member at ARC Angel Fund, an angel fund focusing on early-stage and seed investments in Software, IT, Internet, Tech-Enabled Services, Business Services, Digital Media, Mobile, and Healthcare IT. The fund’s investments typically range from $50,000 to $150,000 per company. Tom Nicholson has a professional career as a CEO/President at Nicholson NY, providing capital and advisory services for early-stage companies. He has also served as an advisor at Art.sy and in leadership roles at LBi International AB and IconNicholson. Tom Nicholson holds an MFA from Cranbrook Academy of Art and a B.A. from the University of Detroit Mercy. As for his partnership and collaboration style, there was no specific information available on his LinkedIn profile regarding this aspect.

Ms. Maura O’Neill serves as an Angel Investor at Maura O’Neill and has made investments, including Crowdfunder in a Series A round of $3.48M on October 7, 2014, with various co-investors.

LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.

University City Science Center focuses on investing in health equity startups led by diverse founders in the STEM community to address health inequities for underserved populations. They have a track record of investing over $4 million in 43 companies in the region, with a focus on mobilizing capital in Greater Philadelphia. The VP of government and capital engagement, Heath Naquin, brings experience in VC and government liaison. Their investment thesis revolves around supporting startups addressing health disparities, particularly in the field of health equity.

Clemens Raemy is a healthcare investor focused on professional care services at home in Germany. He co-founded Kenbi to address the shortage of nurses and caregivers, emphasizing a nurse-centric approach. Raemy’s investment check size ranges from pre-seed to Series A with total equity financing exceeding â¬30 million. Kenbi’s partnership style is digitally driven, prioritizing nurse independence through a communication platform.

Soumitra Sengupta is a Venture Partner at Elevate VC located in Kirkland, Washington. His investment range is $25K – $2.0M, with a sweet spot at $1M. Soumitra focuses on sectors such as Pre-seed Biotech, Seed Biotech, and Series A Biotech. He has recently invested in Pre-seed Biotech startups with co-investors like Ben Nahir, Christopher LaMothe, Dipty Desai, Donn Dimond, and Giovanni Magni. Soumitra Sengupta’s collaboration style includes working with investors such as Ben Nahir, Christopher LaMothe, Dipty Desai, Donn Dimond, and Giovanni Magni.

Jan Vichr is a Founding Partner at FORM Venture focused on tech-enabled health, wellness, and longevity companies. His investment check size usually ranges from $250K to $5M. Some of his previous investments include Canopei, Twelve Fifty, and other tech-enabled startups. Jan Vichr has a collaborative approach to partnerships, understanding and leveraging different collaboration styles like introspective, relational, and expressive to enhance teamwork.

Adam Sackstein, the Founder and Medical Director of Innovative Spine and Pain LLC, New Jersey, is a respected healthcare professional with a wealth of experience. As a Co-Founder and Managing Member of Physician Management Services LLC, he demonstrates leadership in healthcare management. With significant roles such as President and Vice President at the NEW JERSEY SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS, Adam has a strong background in pain management. He has served on the Executive Board of multiple healthcare organizations, including The Surgery Center at Hamilton and Premier Surgical Center, showcasing his diverse expertise. As Northeast Medical Director at Prospira PainCare, Adam has enhanced his medical leadership skills. His impressive career includes positions as CEO of VasoPrep Surgical and Owner of The Pain Management Center. Adam’s commitment to healthcare excellence and his extensive involvement in various medical organizations underscore his dedication to the field.

Robert Allison is the founder and managing partner of Innovate Partners, LLC, located in Irvine, California. He primarily focuses on investments in technology, business services, and consumer-based companies in Southern California. Innovate has led investments in various successful companies such as Jabra, InterWorks, Innovate Motorsports, Emisense, and Ultimate Ears. Mr. Allison’s past roles include serving as a General Partner of Edgewater Private Equity Funds in Chicago. His investment check size and partnership styles are not explicitly mentioned but based on his previous investments, he appears to be actively involved in the growth and success of the companies he invests in.

Zeke Trezise is an Associate investor at New Stack Ventures specializing in pre-seed and seed funding for startups, focusing on diverse sectors like B2B SaaS, Fintech, and Healthcare. He comes from a family of entrepreneurs, is dedicated to early-stage investments, and supports the success of startups through deal flow and evaluating potential investments. Zeke is interested in industry trends and democratization of access to investments. New Stack Ventures offers strategic guidance, mentorship, and stays agile in the startup financing landscape.

Christopher W. Capps is the CEO/Co-Founder of KGC Capital LLC, a U.S.-based venture capital firm with a focus on seed- and early-stage venture investments. Some of their previous investments include Highground Inc., Virgin Mobile Central and Eastern Europe, and Advanced Biotherapy Inc. Christopher has a professional career in financial services with board memberships in Lime Energy Co. and Rippleshot Inc. The investment check size is not specified, and the partnership and collaboration styles are not available.

Frederik Groenewegen is a Co-Founder and General Partner of 415 Capital. He specializes in investing in innovative medical technology companies, with investments in companies such as Supira, CorFlow, Cardiac Success, Aktiia, Distalmotion, R3 Vascular, and TRiCares. Frederik has a strong track record and professional career, with experience in business development and finance from roles at Regis Medical and HSBC. His investment check sizes typically range from $250K to $5M per company. In partnerships and collaborations, Frederik emphasizes supporting mission-driven founders and early-stage companies to foster growth and success.

Arthur Kaneko is an executive with a background in Business Operations and Investment. He serves as the Chief Executive Officer at RealScout and has experience as an Investment Vice President at DCM Ventures. His investment focus areas include Pre-seed Games, Games (Seed), Social Networks (Seed), Education (Seed), and Health & Hospital Services (Seed). He is located in Mountain View, CA. Arthur Kaneko’s professional career involves analyzing and sourcing investment opportunities, assisting with financings, mergers, acquisitions, and strategic matters. He has a hands-on partnership and collaboration style, engaging in bartering relationships in the world of investments.

OTV is a global digital health venture capital fund with offices in Tel Aviv, Israel and Shanghai

Piotr Kulesza is a venture capitalist based in Warsaw with a focus on investing in internet/mobile and healthcare sectors. He invests in early to mid-stage startups and operates in the European Union (EU), Europe, Middle East, and Africa (EMEA) regions. Some of his notable investments include AlohaCamp, Typeform (Series A), and DocPlanner (Series B). Piotr Kulesza has a track record of successful investments and collaboration styles that involve actively participating on the boards of companies. He has a Master’s in Banking and Finance from SGH Warsaw School of Economics.

Stefan Peters is a managing director at Holtzbrinck Digital GmbH with an investment thesis focused on digital businesses in Science, Education, Content, and Health. He invests in startups post-proof-of-concept, supports later-stage companies, and acquires profitable businesses with potential for leadership. Stefan has previously invested in gutefrage.net, pflege.de, and netdoktor. He has a flexible investment check size and partners with founders and management teams to provide strategic and operational advice for success. His investment focus areas include AgTech (Series B), Food and Beverage (Series B), E-commerce (Series B), and Digital Health (Series B).

Lex Liao, Co-Founder and Managing Partner at New Highlands Ventures, is an Angel Investor focusing on industries such as Biotechnology, Social Networking, Healthcare, Social Commerce, Consumer Internet, Financial Services, Energy & Clean Tech, and Cybersecurity. His investment thesis centers around the machine economy with a focus on Fintech, Web3, and AI. Lex’s stage of investment primarily targets Seed Rounds. Some of his previous investments include Example company Inc ($1,000,000 in Seed Round), Company & Company (â¬11,000,000 in Series C funding), and a Seed round A investment of $524,000. His track record showcases a commitment to emerging technologies and startups in various sectors.

Reece Chowdhry is the CEO/Founder of RLC Ventures, an early-stage SEIS/EIS VC fund with an investment thesis focused on changing the way people work, learn, and play. RLC Ventures invests in tech companies in the realms of Work, Play, and Finance, primarily seeking UK-based, SEIS-eligible companies with global ambitions. Reece Chowdhry has a track record of investing in over 80 startups, from ideation to unicorns, and has a partnership style that values building strong bonds with lead investors and founders. The investment check size at Concept Ventures, where Reece is the founder, varies according to the stage of investment. Concept Ventures has a focus on tech companies solving impactful problems and aims to have a long-lasting impact on society.

Brian Model, as a Managing Partner at Stonehenge Growth Equity Partners, is focused on growth equity investments in companies primarily in the biotechnology and healthcare sectors, with a typical investment range of $1 – $5 million. Stonehenge Growth Capital, where Brian Model serves, tends to invest in startups that are 6-10 years old, with increased activity seen in 2017.

Alexandr Chernyak is an angel investor who focuses on investing in various sectors like IT, Consumer, Tech, Insurance, Healthcare, and Financial Services. He has previously invested in Allset, a mobile app for restaurants. Chernyak’s investment activities typically involve seed funding rounds, as seen in the $1.5 million seed funding round for Allset. His check size for investments has been around $1.5 million. His investment preferences center around sectors like Consumer, Auto Tech, and more, with a geographic focus on locations like Russia. Chernyak has a track record of founding companies like Travelints and participating in Series B rounds such as CarPrice’s $40 million round. His partnership and collaboration styles are not explicitly defined in the available data.

Sabrina Stöckl is an Investment Manager at b2venture with a focus on early-stage startup investments in the healthcare and life sciences space. She supports portfolio companies at the earliest stages with unwavering dedication and unique expertise. The team at b2venture is seen as entrepreneurs’ long-term partners, emphasizing a supportive and collaborative approach. Their common phrase is ‘Together we fly,’ showcasing a collective attitude towards investment and growth. The diverse team at b2venture, including partners, principals, and analysts, reflects a wealth of experience in investment activities.

LaunchBio is a nonprofit organization connecting life science entrepreneurs and investors with knowledge, capital, and talent. They operate in cities across the United States like Durham, San Diego, and Dallas, offering programs such as ‘Invest in Cures’ and ‘Investor Connect.’ LaunchBio facilitates connections between investors and early-stage life science entrepreneurs through events like the NextGen VC Forum. They are funded by sponsors and partners supporting the life science and healthcare innovation ecosystem, with a focus on strengthening ecosystems and increasing connectivity for entrepreneurs.

Ryan Schaffer is the Chief Financial Officer and Board Member at Expensify. Previously, he led equity buybacks, raised debt financing, and managed financial activities. His experience includes spearheading brand marketing campaigns and driving the company to success in the accounting industry. Specific information on investment focus areas, previous investments, professional career track record, investment check size, and partnership styles could not be found.

Aaron Patzer is known for his successful entrepreneurial ventures, including founding Mint.com and later Vital Software in the healthcare industry. His investments focus on healthcare and AI-driven startups. His previous successful exits include the acquisition of Mint.com by Intuit for $170 million. Aaron’s check sizes are not specified, but his investments align with innovative solutions and disruptive technologies. In his career, he has prioritized creating solutions to real-world problems, exemplified by Mint.com’s success. Aaron’s partnership and collaboration styles emphasize simplicity and innovation, as seen in his leadership at Vital. His career reflects a track record of building successful ventures and transformative technologies.

The Isaac Organization is an international private investment firm with a focus on long-term investments in companies with strong management. They invest in urban development projects, medical, and Federal Government-lease real estate properties. The organization operates worldwide and collaborates with companies to create value through growth and superior performance. Their track record includes strategic investments in companies like Precision Metal Works, Flooring Liquidators, and a Pennsylvania Steel Company. The check size of their investments is not specified on their website.

Alexandra Bause, a Venture Partner at Apollo Health Ventures, focuses on improving health and medicine with an investment thesis in the aging sector. Her geographical preference includes offices in Berlin, Germany, and Boston, Massachusetts, USA. Her track record includes co-founding Apollo in 2017, specializing in biopharma strategy and molecular aging research. She has a background in pharmacy and Harvard Medical School studies. Previous investments are in Series B Biotech and she collaborates in early-stage ventures aiming at molecular-level biotech startups targeting aging processes.

Matthew Upchurch is the Chief Executive Officer of Virtuoso and his investment thesis focuses on luxury travel and growth in the industry.

Anne DeGheest is the founder and managing director of HealthTech Capital, pioneering the HealthTech or Digital Health space. With a background in healthcare, entrepreneurship, and angel investing, she founded MedStars in 1986. Anne’s portfolio companies have generated over $27 billion in market capitalization, including 8 IPOs. In 2010, she founded HealthTech Capital to fund and mentor new HealthTech startups, aiming to reduce healthcare costs and empower patients. Anne holds an MBA from Harvard and a master’s in business engineering from the University of Brussels. She is a recognized artist, speaker at industry conferences, and a guest lecturer at Stanford Business School.

Brightstone partners with bold entrepreneurs creating innovative & disruptive companies in the technology and life science sectors.

Eric Ries is the chairman of the Long-Term Stock Exchange with a focus on fostering socially responsible investing. He invests at the angel stage and is active in the Life Sciences & Healthcare, Consumer Products & Services, and Business Services sectors. His geographical preference is not specified. His investments range in various companies including Aug X Labs, DoubleLoop, and Autio. Eric Ries has a notable track record in the Lean Startup methodology and has transitioned into a full-time commitment to the Long-Term Stock Exchange. The investment check sizes are not explicitly mentioned, but he has been involved in collaborative projects and partnerships within the Lean Startup community.

Sander Slootweg is a seasoned investor and Managing Partner at Forbion. With a background in co-founding ABN AMRO Capital Life Sciences, Sander has established a remarkable track record in the investment field. He specializes in life sciences investments and has been instrumental in the success of Forbion since its inception in 2006. Sander’s investment focus areas include building companies at an earlier stage of development, as evidenced by his involvement in portfolio companies like Azafaros, NewAmsterdam Pharma, NorthSea Therapeutics, Oxyrane, and Replimune. His partnership and collaboration style are marked by a hands-on approach, serving on the boards of various companies to drive growth and success. Forbion’s recent fundraising success of â¬1.35 billion across two funds underscores Sander’s commitment to taking leading positions with investment sizes of up to â¬70 million per deal. Operating in the EU and NA regions, Sander Slootweg demonstrates a keen eye for transformative bio-pharmaceutical opportunities and a proactive investment strategy that positions him as a key player in the industry.

David Litwack is an Angel investor affiliated with Alliance of Angels based in Seattle, Washington. His investment focus areas include Hardware, Retail, and BioTech at both Seed and Series A stages. With an investment range of $500K to $1.5M and a sweet spot of $1M, he operates within a $100M fund size. David Litwack’s previous investments include contributions to startups in the Hardware, Retail, and BioTech sectors. He is known for his collaborative and customer-focused approach, emphasizing integrity in his partnerships. His investment check size typically ranges from $500K to $1.5M.

George Hornig is a venture investor with a focus on sectors like fin tech, manufacturing, healthcare, and cybersecurity. He is the Chairman of The Seed Lab, leading consumer impact fund, and Lasso Partners, an M&A advisory firm. George’s previous investments include Vantage Point, Bond Street Marketplace, and PineBridge Investments.

Tom Meade, an investor at Anterra Capital, primarily focuses on groundbreaking ideas in food and agriculture. Anterra Capital specializes in early-stage investments, particularly in entrepreneurs leveraging technologies underused in F&A. Tom Meade has been involved in previous investments such as Enko, which received funding from the Bill & Melinda Gates Foundation and Nufarm. His investment check sizes align with the sector’s needs, targeting companies in food, agriculture, health, nutrition, and wellness across Europe and North America. Anterra Capital’s partnership and collaboration approach may involve cooperative collaboration, competitive collaboration, directive collaboration, facilitative collaboration, and delegative styles.

Harry Jacobson is a Co-founder and Partner at TriStar Technology Ventures, a venture capital fund based in Nashville, Tennessee. TriStar Technology Ventures focuses on healthcare services and supplies, healthcare technology systems, pharmaceuticals, biotechnology, and life sciences industries in the United States. The fund targets early-stage investments in these sectors with a geographical preference for the United States. Previous investments by Harry Jacobson’s fund include innovative companies in the healthcare sector. The check size for investments made by TriStar Technology Ventures is not explicitly provided on the available sources.

Steven Yaskin is the CEO of Health Gorilla and a Co-Founder of the company. He has a track record that includes roles in companies such as Queplix Corp., Priority Consulting, Inc., and Pfizer. Yaskin is actively engaged as a Venture Partner at Scale-Up Venture Capital, an Official Member of Forbes Technology Council, and an Entrepreneur In Residence at F50. He holds a MS in Physics from Drexel University and dual BS degrees from Brooklyn College and Universitatea TehnicÄ a Moldovei. Health Gorilla has raised $15M in Series B financing and connects patients, healthcare organizations, and medical service providers for data exchange.

US Angel Investors is a group of high net-worth individuals who invest their own money in startups. They prefer to invest in technology, internet, new media, healthcare, and consumer goods sectors. US Angel Investors have a geographical preference for investing outside the US where talented teams with innovative technology, lower costs, and attractive valuations are available. Their previous investments are not specified. Their investment check sizes are advised to be consistent to pace themselves in building their portfolio. Partnership and collaboration styles include referrals, co-investments, follow-on funding, due diligence, mentoring, guidance, and board representation.

Thijs Cohen Tervaert is a Director at INKEF Capital with a focus on Healthcare and ICT/New Media/FinTech. He has been involved in investments like TargED Biopharmaceuticals. INKEF Capital prefers to invest in the Netherlands, aiming for target equity checks of USD 15-50 million. Their collaboration style focuses on cooperative collaboration, competitive collaboration, directive collaboration, facilitative collaboration, and delegative collaboration.

Dr. Jan Bosch serves as Professor of Software Engineering at Chalmers University of Technology. He served as a Board Member at Peltarion. He serves as Chairman of the Board at Remente. He is also an angel investor. He served as Chairman at Fidesmo. He serves as an Advisor at Merkely. He served as a Board Member at Iver (Sweden). His industry background includes positions at Intuit, Mountain View, CA, and Nokia Research Center in Helsinki, Finland. He holds an MSc degree from the University of Twente, the Netherlands and a Ph.D. degree from Lund University, Sweden. He has a strategic partner-funded collaboration between 16 large European companies (including Ericsson, Volvo Cars, Volvo Trucks, Saab Defense, Scania, Siemens, and Bosch) and five universities focused on digitalization. Earlier, he worked as Vice President of Engineering Process at Intuit Inc where he also led Intuit’s Open Innovation efforts and headed the central mobile technologies team. Before Intuit, he was head of the Software and Application Technologies Laboratory at Nokia Research Center, Finland. Prior to joining Nokia, he headed the software engineering research group at the University of Groningen, The Netherlands. His research activities include digitalization, evidence-based development, business ecosystems, artificial intelligence and machine/deep learning, software architecture, software product families, and software variability management. He is the author of several books including “Design and Use of Software Architectures: Adopting and Evolving a Product Line Approach” published by Pearson Education (Addison-Wesley & ACM Press) and ÁSpeed, Data and Ecosystems: Excelling in a Software-Driven WorldÁ published by Taylor and Francis, editor of several books and volumes and author of hundreds of research articles. He is an editor for the Journal of Systems and Software as well as Science of Computer Programming, chaired several conferences as general and program chair, served on numerous program committees, and organized countless workshops. He is a fellow member of the International Software Product Management Association (ISPMA) and a member of the Royal Swedish Academy of Engineering Science. He serves on the boards of Peltarion, and Burt Intelligence and on the advisory boards of Assia Inc. in Redwood City, CA, and Pure Systems GmbH (Germany). Earlier he was chairman of the board of Auqtus, Fidesmo, and Remente. In the startup space, he is an angel investor in several startup companies. He also runs a boutique consulting firm, Boschonian AB, that offers its clients support around the implications of digitalization including the management of R&D and innovation.

Samantha Keil is an investor at Monroe Capital with an investment range of $2.0M – $15.0M and a sweet spot of $8.5M. She is associated with various investors at Monroe Capital like Alex Patil, Andrew Eck, Andy Kiehl, Casey Vercauteren, and Chase Silverman. Samantha Keil’s current fund size is $1.33B, and she focuses on sectors such as FinTech (Seed), FinTech (Series A), FinTech (Series B), and the Midwest region. Samantha Keil’s partnership and collaboration style involve working with a network of top investors in the startup industry to explore investment opportunities.

HNW Angel invests in software companies at the infrastructure-layer specializing in AI/ML, platforms, marketplaces, APIs, fintech, and enterprise software. They are industry-agnostic except for Bio/Med/Health, Climate, Cannabis, and GovTech. Their geographical focus is North America (USA or Canada) with a maximum post-money valuation of $25 million USD. Their check size ranges from $100k to $350k USD. HNW Angel looks for talented teams with strong domain expertise, startups with signs of early traction and revenue, early-stage startups up to Series A, capital-efficient startups with a path to profitability, and companies with meaningful and sustainable differentiation. They invest in startups with unique market differentiation and aim for long-term profitability and sustainability.

Thomas M. Shannon is a prominent investor with a diverse portfolio and a strong professional background. As the CEO of Prodesse, a biotech company, from 2001 to 2009, he has demonstrated leadership and expertise in the industry. With senior management roles in various organizations, Mr. Shannon has a proven track record of successful investments. He serves as a board chairman and lead investor in multiple companies, showcasing his strategic decision-making and financial acumen. His involvement in various boards and committees in Wisconsin highlights his commitment to the local business community. Recognized for his contributions, Mr. Shannon brings a wealth of experience to his investments. His partnership and collaboration styles are characterized by a hands-on approach and a focus on fostering growth and success. For more information, you can contact him at GeneralInfo@brightstarwi.org or visit him at 710 N. Plankinton Ave., Ste. 340, Milwaukee, WI 53203.

Robert Stringer is the Founder and Principal Investor at Crimson Seed Capital, focusing on health and wellness. He supports startups with big ideas and solid business plans. Previous investments include health services, pharmaceutical, and medical device companies. His check sizes average around $100k. Stringer’s investment philosophy places emphasis on good-for-you consumer products, e-commerce, and health-related services. Crimson Seed Capital collaborates with businesses founded and led by women entrepreneurs. Contact: Address – 2 Battery Wharf, Suite 2510, Boston, MA 02109, Phone – 617.797.6154

Dexter Angels is an exclusive network of select investors providing capital to early stage startups. Their investment focuses on Fin Tech, Consumer Brands, Health Tech, SaaS, Ed Tech, and Deep Tech. Dexter Angels is based out of Mumbai and focuses on the Indian startup ecosystem with themes such as SME digitization, tech-based education, and healthcare improvement. The investor has made previous investments in companies like Multibhashi, Rezo.ai, and Flatheads. Dexter Angels collaborates with passionate entrepreneurs in large or new markets, aiming to provide massive value without compromising quality. The partnership and collaboration styles involve providing capital to startups and building ventures with entrepreneurs. The investment check size and professional career details were not found on their website.

Virtual Angels Network, a completely virtual national group of angel investors, focuses on investing in early-stage businesses across various sectors such as Life Sciences. Its members seek to invest in companies all over the country. The network has a track record of successful investments and is composed of experienced MBA investors. Virtual Angels Network follows a partnership and collaboration style that encourages networking, mentorship, and potential partnerships or funding opportunities. The network invests in companies at their seed stage, with investment check sizes typically ranging between $25,000 to $100,000 per startup. Although the geographical preference is not specified, the network accepts applications from early-stage businesses nationwide.

Rolf Ehrnström is a Partner at Ventac Partners with extensive experience in the Life Science Industry. He focuses on early-stage investments in pharmaceuticals, biotechnology, life sciences, and health technology. Rolf has more than 30 years of scientific, technical, and commercial experience from small to large lifescience and diagnostics companies. His previous assignments include Chief Scientific Officer at Immunovia AB and Boardmember at SAGA Diagnostics AB. He holds 72,617 B-shares in a company. Rolf’s collaboration style emphasizes introspective and relational approaches to partnerships, seeking common ground and strategies for effective cooperation.

Caleb Ragan is an Angel Investor with a focus on Seed Round investments, specifically in Fashion, Consumer Internet, Food & Beverage, E-Commerce, and Health & Wellness (LOHAS). Some of his previous investments include Example Company Inc, Company & Company, and other notable ventures. Caleb Ragan’s investment check sizes and partnership styles are not available. Caleb Ragan has a track record as an investor, but specific details on his professional career are not provided.

Marco Pieters is the Founder and Managing Partner at Slingshot Ventures with 20+ years of investing experience. He focuses on B2C and B2B2C businesses, and has invested in early growth companies. Previous investments include companies like Boldking, Swishfund, Temper, Eat Casper, and Eatch. Marco Pieters is known for his hands-on approach with entrepreneurs and enjoys kitesurfing, skiing, golf, and tennis. The investment check size at Slingshot Ventures varies, including investments in healthcare, data analytics, and retail sectors.

Brad Purdy serves as COO at ContextMedia and Partner at Jumpstart Ventures. Jumpstart Ventures focuses on high-potential tech companies led by Black, Latino, and female entrepreneurs in Ohio. Their technology focus areas include B2B software and healthcare. Jumpstart Ventures invests in pre-seed and seed-stage companies with $500K-$2M rounds. Brad Purdy’s investments align with this focus. The investment check size at Jumpstart Ventures ranges from $1,000,000 to $5,000,000. They invest at the Seed and Series A stages. Jumpstart Ventures also partners with corporate innovation partners to source and vet emerging technologies, aiding in their innovation efforts.

Split Rock Partners invests in emerging healthcare, software and Internet services companies in the Upper Midwest and West Coast.

Sam Palmisano is known for managing Wall Street, not being managed by it. His investment focus areas include Tech and Health with an interest in early and seed stage investments. He has made 10 investments with a portfolio exit in Expanse in 2020. Palmisano is the Chairman of the Center for Global Enterprise and had a successful career at IBM. His investment check size ranges from $100,000 to $1 million. Palmisano’s partnership and collaboration style involves a focus on worldwide collaboration, redefining the global corporation. He succeeded Lou Gerstner at IBM and is credited with setting a new standard for corporate leadership.

Craig Shapiro is the Founder and Managing Partner at Collaborative Fund. The fund focuses on for-profit and for-good investments in climate, money, food & agriculture, kids, and health. Their investments include companies like Dandelion Energy and Impossible Foods. Collaborative Fund partners with experts to evaluate new opportunities and unlock growth for portfolio companies. Craig Shapiro’s geographic preference is the East Coast and Northeastern US. The fund aims to invest in entrepreneurs pushing humanity forward and works with industry leaders to understand evolving customer drivers.

Guy Giuffredi is an investor at Serpentine Ventures. Serpentine Ventures focuses on investing in healthcare and information technology industries. They are constantly looking for new founding teams to invest in and leave no stones unturned when evaluating new opportunities. Their previous investments include Cleveron, a smart solution to optimize energy use and reduce CO2 emissions. The investment check size is not specified on the website. Serpentine Ventures emphasizes leveraging their experiences to support founders and investors, bringing wide entrepreneurial and venture experience to their partnerships.

Sonny Ganguly is an individual investor focused on seed-stage investments. He has a track record of investing in companies like Encore Alert and Speek. Sonny Ganguly collaborates with innovative startups, offering seed funding in healthcare technology and communication services. His investments typically range between $200K to $500K. Sonny is known for his strategic partnerships and active involvement in the growth of his portfolio companies.

John Caldwell is an investor with a focus on stock selection and equity strategy, leading the Life Sciences & Healthcare Practice at Caldwell. His investment preferences and geographical focus are not available. John is known for his extensive track record in the Diversified Stock Income Plan (DSIP) List, with 30 years of performance. Information about the stage of investment, previous investments, investment check size, and partnership collaboration styles of John Caldwell is not readily available.

Wouter Verhoeven is a venture partner at BGV since 2021. With over 15 years of Biotech experience, he primarily focuses on Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services. His investment check size ranges from $100K to $1M, with a sweet spot at $500K. Geographically, his preference is in the Netherlands. Wouter’s professional career includes roles at Dualyx, Berna Biotech, Crucell, Rabo Private Equity, Mabxience, and NBE Therapeutics, with a background in business development. He holds a MSc in Technical Management from Delft University of Technology.

Martien van Osch, the Managing Partner at Forbion, has a strong track record in the life sciences industry, with notable exits such as PneumRx, Circulite, Pathway, Impella, and Flowmedica. He leads the medical device-related activities at Forbion, chairs Staten Biotechnology, and has a degree in Econometrics from Rijksuniversiteit Groningen. Martien’s investment style is hands-on, focusing on transformative therapies for cardio-metabolic diseases. His expertise and experience make him a valuable partner for entrepreneurs in fostering healthcare innovation.

Peter Sands is the Executive Director of The Global Fund to Fight AIDS, Tuberculosis, and Malaria since March 2018. He has a diverse professional career, previously serving as the Group CEO of Standard Chartered PLC and a Research Fellow at Harvard University. While details about his investment thesis and focus areas are not explicitly mentioned, his professional background suggests a focus on global health initiatives. Peter Sands has a strategic partnership and collaboration style, evidenced by his leadership at The Global Fund. His investment check size is not specified, but his involvement in significant fund allocations indicates a capacity for substantial investments. Geographically, his work spans worldwide in healthcare. Previous investments and specific investment stages are not directly provided. Additionally, his track record includes successful initiatives at The Global Fund, emphasizing progress and collaboration in the fight against infectious diseases.

Stéphane Mendras is a hands-on medical devices leader, entrepreneur, and business angel investor. With over 20 years of experience in the healthcare industry, primarily in medical devices and supplies, he has significant expertise in medical aesthetics, hyaluronic acid applications, surgical ophthalmology, and advanced surgical technologies. Stéphane has been involved in multinational organizations, entrepreneurial ventures, and consulting for startups and investment funds. He has a partnership and collaboration style that involves corporate business development, funds raising, M&A, strategic partnering, and management of B-to-B commercial activities. Stéphane has a track record of developing commercial subsidiaries with full P&L responsibility. His investments focus on sectors like Medical Devices and Digital Health across various stages. Potential investment check sizes range from $100K to $5.0M, with a sweet spot at $1.5M. Previous investments include collaborations with key investors like Alix Joseph and Armelle Graciet.

Business Angels Frankfurt Rhein-Main, founded in 2000, is an angel network based in Frankfurt, Germany. The firm focuses on technology, nanotechnology, radiolocation in renewable energy, agricultural topics, and new hedge fund concepts. They specialize in seed round investments within the Technology, Media, and Telecom (TMT) industry. The investor network’s active portfolio includes a diverse range of investments in these areas. Their partnership and collaboration styles aim to foster growth and success in the startups they support.

Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and business services industries.

Pallabee Borgohain is an experienced professional with a background in Application Management and Business Analysis. They have worked with companies like NTT DATA Services and University of Texas at Dallas. Pallabee has expertise in data analysis and project management. With a focus on healthcare and technology, they have served as a Graduate Teaching Assistant and Business Analyst. Pallabee’s career includes roles as a Freelance Artist, Consultant in Technology Sales Enablement, and Technical Leader. Their experience spans across telecommunications, healthcare, and technology sectors. Pallabee’s track record includes managing projects, defining strategies, executing test plans, and providing technical consulting. They bring a diverse skill set to the table and have a solid foundation in data management and analytics.

Fabian Wawro is a Senior Associate at FORM Life Ventures, investing in the field of healthcare. His investment focus lies in Digital Health, Health & Hospital Services, and Health IT, with a preference for Series B and Series A stages. Fabian’s investment range typically spans from $500K to $2.0M, with a sweet spot of $1.3M. He has a track record of investing in innovative startups in the healthcare sector, particularly in later-stage opportunities. Fabian is known for his partnership and collaboration style, actively engaging with companies to foster growth and success. Located in Zurich, with a focus on the EU region, Fabian Wawro brings a wealth of experience and expertise to his investments in the healthcare industry.

Compound is a venture capital firm that invests in bleeding-edge technology built by outliers.

George Ribaroff is a Partner at Meridian Street Capital, a venture capital firm focused on early-stage investments in healthcare and technology-related companies across the United States. The firm’s investment focus areas include HealthTech and Enterprise Applications. Meridian Street Capital primarily invests in startups from the seed to series-A stages, with lead rounds in companies such as Isaac Health and Ounce. The check sizes for investments made by Meridian Street Capital range from seed to series-A rounds. George Ribaroff is known for supporting founders from the early stages, often from day one, with a concentrated and steadfast approach.

Deirdre Dellaportas is an Investor at Casa Verde Capital based in Chicago, Illinois. Her investment thesis includes a focus on Pharmaceuticals (Pre-seed) and Transportation Tech (Pre-seed), along with Pharmaceuticals (Seed) and Transportation Tech (Seed) sectors. Her investment range is from $100K to $5.0M, with a sweet spot at $1.5M. Deirdre’s current fund size is $45M. She has a track record of successful investments and collaborates with investors like Calvin Broadus, David Colton, Evan Eneman, John LaViola, and Karan Wadhera.

Neil Vangala is a seasoned investor with over seven years of experience in investing and acquisitions. His investment focus areas include healthcare, healthcare technology, and tech-enabled services. He primarily invests in early to mid-stage startups. Neil’s geographical preference is not clearly defined. His professional career showcases a consistent track record of success. However, specific details on his investment check size and partnership and collaboration styles are not readily available in the search results.

Atland Ventures is a venture capital investor focusing on fast-growing US-based startup companies that address Generation Z’s challenges. They specialize in seed stage investments, providing $25,000 checks to promising entrepreneurs. Their investment themes include Edtech, Consumer Social, Marketing, Health & Wellness, and more. Notable previous investments include TransCrypts, Availyst, BetterYou, Kyndoo, and Recess. Atland Ventures was co-founded by Lucas Bagno, aiming to provide career opportunities in entrepreneurship and VC for students. Their partnership and collaboration styles emphasize student engagement and a rigorous recruitment process to foster a unique team dynamic.

OnePager is an investor that utilizes one-page investment teasers to introduce companies. Their previous investments are displayed in a venture capital portfolio timeline with detailed exit events and participation levels. Jonathan Hung, an expert in angel investing and venture capital, provides guidance on writing investment teasers. OnePager focuses on concise communication, promoting collaboration and encouraging crisp communication within and across teams using one-pagers for effective collaboration.

Tim Roe, Director at Rev1 Ventures, focuses on investing in enterprise software, data analytics, digital health, healthcare IT, life sciences, food tech, ag-tech, advanced materials, and alternative energy sectors. Rev1 Ventures specializes in early-stage investments, primarily in seed and series A rounds. The firm’s geographical preference is for startups located in Ohio, particularly Columbus, with emphasis on healthcare, biotechnology, software, cybersecurity, data analytics, and enterprise software. Previous investments by Rev1 Ventures include Trace, Champ, and Redi. Tim Roe’s career history shows his current role as Director at Empactful Capital LLC. The investment check size at Rev1 Ventures involves funds like Rev1 Fund II, a $20MM corporate-backed fund. Rev1 Ventures follows a collaborative approach, providing resources and education tailored to each startup’s needs.

BIP Capital is a venture capital firm that seeks early-stage and growth investments.

The Baylor Angel Network, led by founder Bob Brewton, provides early-stage capital to entrepreneurial teams. The network has made investments in various sectors, including software, apps, education, health care, and artificial intelligence. With a focus on early-stage ventures, the network has a geographical preference for startups in the Waco, Texas area. Previous investments by the network include VenoStent, Phunware, and SonarMed. Bob Brewton, known for his real estate and venture capital background, aims to make the program a top entrepreneurial initiative. The check sizes for investments are typically around $3 million. The network’s collaboration style emphasizes team building and fostering a culture of innovation.

Tim Crown is known for focusing on early-stage companies in the technology, healthcare, and consumer products sectors. His investments typically range across various sectors, and he seeks to collaborate with founders to help build successful companies.

Investing with conviction in visionary, technical founders inventing the future.

Beacon Angels is a Boston-based angel group that invests in early-stage, fast-growing companies in the $50,000 to $400,000 range. Since their founding in 2006, they have facilitated the growth of successful New England-based startups, resulting in significant returns to member investors. The group focuses on investments in industries such as health care, biotechnology, software, and therapeutics. They have a geographic preference for New England-based companies. Beacon Angels members are accredited investors who actively seek, assist, and benefit from the success of rapid-growth startups. The group encourages collaboration and partnership among investors to enhance portfolio value through shared capital, experiences, and strategic relationships. Meetings are held monthly to engage with company presentations and discuss investment opportunities.

Mike Bollinger is a seasoned executive with 20 years of experience, excelling in positions of increasing responsibility. He is deeply involved in Human Capital Management (HCM) thought leadership events and serves as the VP of Strategic Initiatives at Cornerstone OnDemand. His career spans various roles, from Managing Director in Small Business Banking to Founder and CEO of Livefront. Bollinger’s investment focus areas include providing capital to pharmacy, investment advisory, insurance, and accounting businesses. While his preferred stage of investment is not explicitly specified, his expertise in high-net worth investing indicates a focus on later stages. Bollinger’s geographical preference remains undisclosed. His track record includes achievements such as being a second-team All-America East selection in lacrosse. Regarding investment check size, information suggests he caters to a wide range of clients, from $5-500M for new business accounts. With a collaborative style, Bollinger delivers complex business process improvement recommendations and provides strategic insight to drive business success.

Groove Capital is a Minnesota-based investor focusing on high-growth startups that positively impact local communities. They are known as Minnesota’s first check fund, supporting entrepreneurs seeking their first institutional investment. With an average check size of $50,000 to $100,000, Groove Capital focuses on software, information technology, healthcare, small and medium businesses, and consumer goods. They operate by combining an active angel network with a traditional venture fund to accelerate startups’ first funding. Their partnership and collaboration styles involve offering investors options for angel and venture investing models, fostering connection, learning, and inspiration within the investment community.

Yifang Cui is an Investment Manager at Boehringer Ingelheim Venture Fund, with a focus on early-stage therapeutics and digital health companies. The fund’s investment philosophy includes activating success, adding value expertise, and ongoing investments. They are open to investing worldwide and have a commitment of â¬300 million, offering investments up to â¬3 million per venture and up to â¬15 million per venture over its life. Specific areas of investment include immunomodulation, tissue regeneration, and digital therapy. Regarding previous investments, no specific data is available on the website. The partnership and collaboration style information is not provided on the website.

Julie Whytock is a venture capitalist with a stage-agnostic approach, investing in seed to late-stage technology companies across various sectors. She is interested in bio and healthcare, consumer, and crypto investments. Julie’s investment check size and geographical preferences are not disclosed. There is no specific information available about her previous investments, track record, or partnership and collaboration styles.

No answer

Precursor Ventures invests in people over product at the earliest stage of the entrepreneurial journey.

Dominique Burgauer is an Angel investor with a focus on Enterprise Software, Mobile, Healthcare, Synthetic Biology, Big Data, Personal Health, Mobile Health, Health Care Information Technology, Robotics, Artificial Intelligence, and Education markets. His previous investments include Archilogic, Cambrian Genomics, FELFEL, and HealthCrowd. The check size of his investments is not specified, and no data was found on partnership and collaboration styles.

Lucanus Polagnoli is the Founder & Managing Partner at Calm/Storm Ventures, a venture capital firm with a focus on supporting purpose-driven founders in the digital health space across Europe. His investment thesis revolves around backing founders changing life, health, and well-being for the better. Lucanus Polagnoli’s investment focus areas include digital health companies such as ThinkSono, Foundation Health, Bea Fertility, Doctorly, and more. He has a notable track record in early-stage investments, with investments ranging from Pre-Seed to Series A rounds with a check size of around $137K. Some of his previous investments include organizations like ThinkSono, Foundation Health, Bea Fertility, Nolea Health, and Doctorly. Lucanus Polagnoli’s professional career includes roles as a Kauffman Fellow, a Startup Mentor at EIT Health, and previous positions at Speedinvest and KPMG Australia, showcasing his diverse expertise in financial and advisory fields.

Björn von Siemens, a seasoned investor, has been deeply involved in the digital healthcare technology space since 2007. He is the co-founder of surgical.ai, a healthcare investment group with $150 million in assets under management. Additionally, Björn is the visionary behind Caresyntax, a global leader in surgical analytics and automation, revolutionizing surgeries in 4,000 operating rooms globally annually. His educational background includes studies at the London School of Economics, EBS Oestrich-Winkel, and research in behavioral psychology and entrepreneurship at the University of St. Gallen and Harvard University. Björn has a track record of strategic investments, with a recent notable investment in Lillian Care amounting to $2.92 million in their Pre-Seed round, showcasing his commitment to innovative healthcare solutions. Björn’s collaboration with prominent co-investors in Lillian Care highlights his partnership style and focus on advancing breakthrough healthcare technologies.

William B. Cyr is an individual angel investor with a track record in consumer packaged foods leadership roles. His primary focus areas for investments include companies like Cigent Technology and Qui.lt, with a notable background in leading multinational operations. William Cyr’s investments are typically in seed stage companies. He has a track record of success as the President & CEO at Sunny Delight and currently serves as the CEO at Freshpet. William Cyr’s check sizes for investments are varied, with investments in Cigent Technology at Series A and Qui.lt at Seed Round. As an angel investor, he tends to engage in partnerships and collaborations that facilitate growth opportunities domestically and internationally.

Paul Vernooij is an Investment Manager at BOM Brabant Ventures. The investment thesis focuses on RNA technology and related fields. BOM Brabant Ventures invests in scalable startups and scaleups with growth potential, with investments typically ranging between 150k and 5M EUR. Previous investments include Flindr Therapeutics, Onera Health, and Tidal Control, mainly in the Netherlands. Paul Vernooij has a professional track record in promoting advancements in mRNA, RNAi, and nucleic acids. The partnership and collaboration styles of BOM Brabant Ventures involve facilitating startups with unique knowledge and capital for mutual growth and success.

Purdue Angel Network is a part of the P3 Alliance, providing first looks at companies commercializing technologies from Purdue University. They aim to bring innovative products and processes from Purdue laboratories to the marketplace quickly. The network requires a $500 annual membership fee for participation. Previous investments include Pluto Aerospace, Verility, Insignum AgTech, Adipo Therapeutics, and Skyepack. Unfortunately, specific information about their investment check size could not be found. Purdue Angel Network’s partnership and collaboration styles involve leveraging university resources to solve societal challenges and collaborating with external partners in various sectors such as community and economic development, education, government, and healthcare.

Bobby Sandage, Jr., Ph.D., General Partner at Cultivation Capital LLC, has over 30 years of experience in the pharmaceutical industry. Cultivation Capital focuses on investment in Life Sciences & Health Tech, Software & IT, and Agriculture & Food Tech sectors. Bobby Sandage led a $20 million Series B funding round in 2013. The investment check size and partnership and collaboration styles were not specified on the available sources.

VentureSouth is an early-stage venture firm with a focus on providing risk capital to Southeastern startups. Their investment thesis centers on achieving positive returns without follow-on rounds. The firm typically invests in a diverse range of industries, including software, information technology, life science, and healthcare. VentureSouth’s geographical preference is the Southeastern United States, supporting promising ventures in the region. Some of their previous investments include 6AM City, Case Status, and Emrgy. Their investment check size ranges from $150,000 to $750,000, and they prioritize partnership and collaboration styles through member-led angel groups. VentureSouth has a proven track record of investing in early-stage startups and fostering growth in the region.

Dr. Brad Weinberg, Founding Partner at Blueprint Health, focuses on investing in healthcare startups. Blueprint Health’s investment focus areas include Health Care, Medical, Information Technology, Software, and mHealth. Brad Weinberg typically invests in early-stage companies, providing initial funding within the range of $100,000 to $1 million. He has made 87 investments in 79 portfolio companies. Brad Weinberg’s partnership and collaboration style at Blueprint Health involve launching the Blueprint Health Collective to accelerate the development and adoption of new healthcare technology through collaboration with prominent healthcare organizations.

Julia Bernstein is a seasoned healthcare leader, known for her experience in digital health leadership and advisory roles. She serves as the Chief Operations Officer at Brightside Health, setting strategy and scaling operations. Julia has held leadership positions at Thirty Madison, Tempest, Beacon Health Options, and Ginger. As an active angel investor and board member of PharmaCCX, she participates in investment and advisory roles in startups like Care + Wear, Coral Care, Untether Labs, Violet, and VivorCare. Julia’s investment check size and partnership details were not specified on her LinkedIn profile.

Sımon Saneback is a Founding Partner at Wellstreet with a focus on sectors like health technology, messaging, disrupting old consumer verticals, and fintech. Some of his previous investments include Web3/Blockchain and cryptocurrencies at different stages. His investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Sımon Saneback collaborates within a team of 17 at Wellstreet, where he is one of the 7 Partners. His partnership and collaboration style within the team is not extensively detailed in the available information. For more details, you can visit the Wellstreet team page.

Julien de Salaberry is a healthcare venture investor and founder of The Propell Group, focusing on seed investments in HealthTech startups. With a career in healthcare since 1997, he has a diverse track record, including leading brands like Natixis and AXA. His portfolio includes investments in companies such as Proteus, Glooko, Healint, Omada Health, and more. Julien’s geographical preference encompasses regions like Asia-Pacific, with a specific focus on IoT’s impact on the healthcare value chain. While specifics on investment check size are not found, his emphasis on HealthTech suggests investments likely vary based on startup needs. His partnership and collaboration style appear dynamic, leveraging technology efficiency gains in healthcare and navigating challenges for HealthTech devices to become mainstream in Asia.

Westway Capital, founded by John Levinson, focuses on investments in early-stage technology and healthcare companies. Their investment check size is not specified, but the firm is actively seeking opportunities in the healthcare industry. Westway Capital facilitates collaborations, partnerships, and strategic discussions.

Iesh Shah is a strategic investor with a focus on multiple sectors and strong economics. The investment strategy involves seeking mis-priced assets, turnaround opportunities, emerging growth companies, and disruptive business models. With over 25 years of experience, Shah Capital aims for long-term risk management and multiple paths for exits. While the geographical preference is not specified, the investment approach emphasizes deep research and knowledge. Iesh Shah’s investment thesis emphasizes a clear fund strategy outlining fund size, portfolio companies, industry stages, geographical focus, differentiated support, check size, follow-on investments, return profiles, and fund differentiation. Previous investments include Powerplay. Shah’s track record includes strategic investments and financial solutions. The check size for investments is in alignment with the fund’s strategy and market conditions. Collaboration styles involve various partnership strategies tailored to different stages and companies.

Anna Alex is an investor with a focus on environment tech, enterprise applications, and more. She has founded companies in Legal & Enterprise Software, Fashion, and Energy & Enterprise Software. Anna’s investments range from Environment Tech to Health Care and include companies like Airmo, Filu, and trawa. She prefers venture capital-backed companies and has a debt-related latest deal type. Anna has made seed investments in companies like Airmo, trawa, and Filu. Her investments range from seed rounds to Series A stages with a check size that is private due to Outfittery being privately held. Regarding partnership and collaboration styles, there is no specific information available. Additionally, she co-founded Nala Earth with a focus on climate-tech and digital tools for climate action.

Sanne Weijzen is the Vice President and Head of Corporate Strategy and Global Operations at Neogene Therapeutics. She has over 20 years of experience in the academic and biotech industry. Dr. Weijzen previously worked at Scenic Biotech as COO and Aglaia Biomedical Ventures as a partner. She holds a master’s degree in Biomedical Sciences and completed her Ph.D. research in Tumor Immunology. Neogene Therapeutics is headquartered in the US and EU. Sanne Weijzen’s professional career has been focused on strategic operations and corporate growth within biotech companies.

Founder and Angel

John Troiano is the founder and managing partner of The Beekman Group, a private equity firm that focuses on middle market investments in sectors such as healthcare services, consumer, and business and industrial companies. The firm’s investment strategy involves partnering with management teams of lower middle-market services companies with enterprise values ranging from $15 million to $75 million. The geographical preference for investments includes regions across the United States. The track record of The Beekman Group demonstrates successful partnerships with management teams to support the growth initiatives of middle-market companies. The check size of investments by The Beekman Group typically ranges between $20 million and $150 million. The partnership and collaboration styles involve working closely with management teams to create long-term, sustainable value.

Karl H. Ulrich is an Angel investor, Co-Founder at Xootr, and the Vice Dean of Entrepreneurship & Innovation at the Wharton School of the University of Pennsylvania. He has made investments in companies like Bandar Foods and Jump Bikes. His investment focus areas include Healthcare Services and B2C non-financial services. He invests in the seed stage. Karl Ulrich’s partnership and collaboration styles are not specified.

Ray Wagner is the Managing Director at Thompson Street Capital Partners. The firm focuses on a thesis-driven approach, investing in various key industry verticals such as Life Sciences & Healthcare, B2B services, technology solutions, and software providers across cloud services, insurtech, non-profit software, and supply chain software. Ray Wagner’s investment stage ranges from Series B in sectors like Medical Devices, Pharmaceuticals, AI, Health IT, and more. Thompson Street Capital Partners has a geographical preference for the Midwest. With a track record of nearly $200 million in transactions, Ray Wagner brings extensive experience in due diligence, valuation analysis, and business development. The fund’s investment check size is between $50 million to $250 million, targeting companies with EBITDA between $5 million to $50 million in sectors like healthcare, life sciences, software, IT services, and business products. Thompson Street Capital Partners’ partnership approach is focused on actively working with companies to make a significant impact in their respective industries.

Shubh Anand is an Analyst at City Light Capital with a focus on early stage investments in education, energy, environment, safety, and security. His previous investments include CommSafe AI, Elroy Air, LicenseStream, and more. Anand began his career with seed investments and portfolio management at a family office, co-founded a company in India, and consulted for a NYC accelerator. He holds a B.A. from the University of Virginia in Economics and Statistics. Anand is enthusiastic about mental health and food/agtech innovations. His partnership and collaboration styles align with early-stage investments in various sectors.

Bill Martin is an experienced investor and entrepreneur with a strong track record in wealth creation and investment strategy. As the Chief Wealth Officer at Earned Wealth, he accelerates wealth creation for physician clients using advanced technologies and evidence-based methodologies across various financial domains. With previous roles as Chief Investment Officer at INTRUST Bank and Director at FDx Advisors, Bill has led investment strategies emphasizing client-centric approaches and team development. His professional career spans from being an Investment Analyst at INTRUST Bank to a General Securities Principal at a Regional Investment Banking Firm, showcasing his expertise in fixed income underwritings and client relationship management. Bill’s career progression highlights his dedication to developing innovative investment strategies and fostering financial growth for his clients.

Holger Hengstler is an Angel Investor who is a co-founder of dress-for-less. He has made investments in companies like TextCortex AI, Hedoine, and Idagio. His investment focus areas include technology, consumer, insurance, healthcare, industrials, and financial services. Holger Hengstler typically invests in early-stage ventures, particularly at the Series A stage. While his geographical preference is not explicitly mentioned, his involvement in expanding Privalia in Europe suggests a focus on the European market. Some of his previous investments include TextCortex AI and Privalia. Holger Hengstler’s professional career includes co-founding dress-for-less and holding positions on various supervisory boards. The specific investment check size and partnership/collaboration styles are not available in the search results.

Oliver Abert is an Angel Investor focusing on investments in various sectors including consumer technology, SaaS, enterprise tech, healthcare, deep tech, fintech, biotech, climate tech, and AI. His investment check sizes range from $250K to $5M. Dr. Oliver Abert was a Co-Founder and served as Chief Technology Officer & Chief Executive Officer at Numenus. He is also a Senior Software Development Manager at Autodesk and an Investor at Spintop Investment Partners.

Blaine Vess is an Angel Investor with a focus on investing in Fin-Tech, Health-Tech, and other sectors. His investment thesis involves the power of pivoting business models, using M&A as a growth tactic, and transitioning to a subscription business model. Blaine’s professional career includes being the founder and former CEO of Student Brands, which was acquired by Barnes & Noble Education for $58.5M. He has a track record of successful acquisitions and revenue growth through subscription models. Blaine’s partnership and collaboration style involves valuing growth through M&A and not shying away from recruiters for bootstrapped companies. While there is no specific information on his geographical preference, it is known that he invests in companies like Kodo and Snazzy.

Zia Uddin is the President and Co-Portfolio Manager at Monroe Capital with an investment thesis focused on the private credit landscape, emphasizing technology, software, and healthcare. His stage of investment ranges from Series B to later stage growth equity financing. Zia Uddin’s geographical preference is the Midwest, mainly Chicago, Illinois. Some of his previous investments include Snowden Lane Partners and Amelia in debt financing rounds. He collaborates with a variety of partners and co-investors from Monroe Capital. Zia Uddin’s investment check size ranges from $2.0M to $15.0M, with a sweet spot of $8.5M. His partnership and collaboration style involve driving global sales certification and nurturing a performance-driven culture. Throughout his career, Zia Uddin has managed complex projects internationally with various organizations like Marubeni Corporation and Ericsson.

North Country Angels is an angel group that focuses on invests in Enterprise Applications, Life Sciences, and more. They primarily invest in Series A and Angel stages in the United States, with a partnership style that involves early-stage ventures and seed investments.

Arielle Zuckerberg focuses on investments in the consumer and health sectors at Kleiner Perkins Caufield & Byers. She has made angel investments across the food tech and health sectors. Arielle has been involved in early-stage consumer investments with a track record that includes investments in companies like The Wing, Willo, and Voodoo Manufacturing. Kleiner Perkins Caufield & Byers aims to bring in the highest caliber new partners with expertise in enterprise and consumer digital industries. Arielle’s investment thesis is focused on spearheading early-stage funds alongside other partners. The investment check size at KPCB ranges based on the specific firms and industries targeted.

Moneta Ventures is a venture capital firm that invests in early-stage technology and healthcare businesses.

Thomas Lips is a General Partner at Nextech Invest specializing in BioTech investments at Series A and Seed stages with an investment range of $100K – $5.0M. He has a sweet spot investment size of $1.5M and has experience as the Chief Investment Officer at AIG Private Bank. Thomas Lips’ geographic focus is not specified. He is known to invest in companies with a strong track record and maintains a partnership and collaboration style that aims to work with others to identify solutions that satisfy everyone involved.

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

Michael Faunce is an investor focused on mission-driven projects in education, health, and family economic stability. He invests in early-stage technology companies, especially those with the potential to transform industries. Faunce is known for investing in companies that develop products and services to improve urban poverty. His investments typically range from $250K to $5M per company. Regarding partnership and collaboration, Faunce likely values clear distinctions between collaborations and partnerships, emphasizing the importance of ethics and effective problem-solving strategies for smooth running relationships.

Moritz Kittler is an investor at Picus Capital, an early-stage technology investment firm with a focus on Real Estate, Finance & Insurance, Human Resources, Renewable Energy, Mobility, and Health. Picus Capital invests in pre-seed, seed, and series A ventures, with a long-term investment philosophy. They aim to be close partners with their portfolio companies, providing strategic advice, HR management support, networking opportunities, and assistance in fundraising. The geographical preference of Picus Capital is not specified. Some of Picus Capital’s previous investments include companies like Truck It In, Telos Brands, Multiplier, Homeday, and more. Unfortunately, specific information about Moritz Kittler’s track record, professional career, and partnership and collaboration styles could not be found.

Tarik Abbas is the Managing Director of Saola Ventures, a venture capital firm founded in 2020. Saola Ventures focuses on startups in fintech, healthtech, edtech, and enterprise solutions sectors. They invest in early-stage startups in Southeast Asia with a check size ranging from 10K to 100K. Tarik Abbas typically invests at the Seed stage. He has a track record as an investor at Saola Ventures and previously as a Partner at Interplay Ventures. Saola Ventures prefers collaboration with startups in sectors like B2C, healthtech, mobility, B2B, food and beverage, sustainability, silvertech, and agtech.

Harry Shum is a strategic investor and visionary known for his work in Microsoft’s Artificial Intelligence and Research. He focuses on industries such as education, automotive, financial services, government, healthcare, manufacturing, and retail. Harry has a track record in driving AI strategy, research, and development efforts. He has invested in startups like Asensys and Moqun, primarily in the Blockchain Technology and High Tech sectors. With investments in early-stage startups, Harry collaborates with partners to empower every person for the future. His investment check size varies, with specific data unavailable. Harry Shum’s career spans working on Bing, leading Microsoft Research, and contributing to the advancement of AI technologies.

Colin George is an Angel Investor with a focus on building in healthcare and software innovation in the healthcare sector. He serves as a Director of Enterprise Sales and Business Development at EverString and has a track record of investment activities in North America, Europe, and Asia. Colin George has been actively involved in various firms including Delphix and Summit Partners, where he held a senior associate position. His educational background includes a BS in accounting and a BA in philosophy with Honors from the University of Southern California.

Thies Sander is a General Partner at Project A, specializing in investments in Payments, Digital Health, Health & Hospital Services, and Enterprise at Series A and Seed stages. His previous investments include Kry, Spryker Systems, and Barzahlen. Thies has an extensive track record, having co-founded Project A and worked as a CEO at a German online comparison startup. With a focus on early-stage investing, his investment check size ranges from $200K to $10.0M, with a sweet spot of $5.0M. Thies values human connection and enjoys meaningful work in smaller groups. He co-founded Project A in 2012 and holds a double master’s degree from WHU and Kellogg Graduate School of Management.

Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.

Lukas Scherzenlehner’s investment thesis focuses on Health Care, Software, and Fitness. He has previously invested in Record Bird on Feb 10, 2016. The investment check size is not specified.

Jeffrey Maters is the founder and Managing Director at Network Ventures, a Midwest-based seed-stage venture capital firm. His investment thesis focuses on B2B fintech companies solving problems for institutional investors. Network Ventures invests in internet and technology sectors, with a preference for businesses building network effects. They typically invest in seed-stage companies. Jeffrey Maters has been actively involved in diligence, investment, and oversight of over 20 companies, with past investments in consumer internet, clean technology, location-based services, and healthcare information technology. His professional career includes roles at Johnson & Johnson Innovative Medicine and leadership positions in software engineering, architecture, and technology development. Network Ventures’ investment check size ranges between $60-$200 million. Collaboration at Network Ventures is characterized by a focus on interpersonal understanding, maximizing contributions, and creating an environment that minimizes worker frustration.

Lasse Lehtinen is a General Partner at Icebreaker.vc, an investor focusing on early-stage tech companies. His investment focus areas include Consumer Goods, Energy & Greentech, Fintech, and Healthcare & Life Science among others. He has invested in companies like Flowhaven, HoxHunt, Valpas, Logmore Oy, Aibidia, and Cerenion. Lasse Lehtinen’s track record includes chairmanship and partnerships at Nord Growth and Frontier. Icebreaker.vc typically invests between â¬100,000 – â¬500,000 and in countries like Finland and Sweden. The fund has a community of over 1,000 professionals with 5+ years of industry experience. Lasse Lehtinen’s approach involves initial investments varying between â¬150,000 – â¬800,000 with follow-on investments. The fund’s primary markets include Consumer, Companies, and Marketplace, and they have a hands-on approach to helping companies succeed.

David Selverian is an experienced investor with a focus on Human Capital/HRTech, Health & Hospital Services, Health IT, and Enterprise sectors. He evaluates early-stage startups with an investment check size in the Pre-Seed, Seed, and Series A stages, specializing in areas like AI/ML and B2B. David shows a preference for female and underrepresented founders and has a track record in successful acquisitions. His collaboration style is marked by a commitment to partnership and patient care, evident in his involvement in healthcare startups. With a background in investing and healthcare, David engages in a broad range of investments, aiming to support and grow promising ventures.

Robert Wiesenthal, the Founder and CEO of Fly BLADE, has a diverse investment portfolio that includes companies like Secret, Fundera, Splice, and Activate. With an emphasis on healthcare and technology sectors, he maintains a strategic partnership approach focused on early-stage investments. His investment check size varies per company but is substantial, as shown in the public sale of shares of Blade Air Mobility Inc. Wiesenthal’s professional career is marked by successful ventures such as Blade, showcasing his expertise in transforming businesses. While specific details on stage of investment and partnership styles are not available, his track record and involvement with high-profile companies demonstrate a hands-on and innovative approach to investing.

Markus Enzelberger is a Partner at Versant Ventures with a current fund size of $102.2M. His investment range is $100K – $5.0M, focusing on Pharmaceuticals (Seed), Pharmaceuticals (Series A), BioTech (Series A), and BioTech (Seed) sectors. He has co-invested with Alexander Mayweg, Beckie Robertson, Bill Link, Brad Bolzon, and Brian Atwood. Markus Enzelberger’s professional career includes a role as Chief Scientific Officer at MorphoSys and involvement in a Series A funding round for Vector BioPharma. He collaborates with entrepreneurs, industry, and academics to create and operate innovative biotech companies in Basel, Switzerland through Versant Ventures. Ridgeline, a Versant Ventures Discovery Engine, works closely with Markus Enzelberger in company building, with a focus on biotechnology companies discovering and developing novel therapeutics.

Bread and Butter Ventures is a venture capital firm that focuses on early-stage companies. Their investment thesis revolves around supporting amazing founders in core sectors like food/ag tech, health tech, and enterprise SaaS. They have a geographical focus on digital health tech and invest globally in sectors such as software, SaaS, food and beverage, AgTech, and Internet. Bread and Butter Ventures typically invests in the agriculture technology, food technology, health technology, and enterprise SaaS sectors. Their check sizes range from $100K to $500K, with a collaborative partnership style that values hiring individuals with diverse strengths and styles.

Business Angels Club Berlin-Brandenburg supports young companies with experience, contacts, and capital. They invest in various sectors including Ads & E-Commerce, Media, Music & Audio, Energy & CleanTech, Health Care, FinTech & InsurTech, and Sustainability. Some of their portfolio startups are eco:fibr, fainin, and Aivy. Recent investments include Rausgegangen GmbH. They typically invest in startups that are 4-5 years old. Geographically, their focus is on Europe. The club has a professional track record and partnership style that involve experienced entrepreneurs and successful investments. The specific investment check size is not available on their website.

Hooman Borghei is an investor with a focus on IT, tech, insurance, healthcare, industrials, and financial services sectors. His previous investments include Egomotion Corp. with a Seed VC – II round investment of $0.75M in 2014. He has a track record as the founder of B2 Investment Group and has held board and advisor roles in various companies. While detailed information on the check size and partnership styles is not available, his geographical preference appears to be in San Francisco, CA. Hooman Borghei’s portfolio showcases a strategic approach to investments with a significant contribution to Egomotion Corp.

Joe Amadio, the Managing Director at Thompson Street Capital Partners, specializes in Series B investments with a focus on Pharmaceuticals, Medical Devices, Consumer Health, Digital Health, BioTech, AI, Health IT, and more. He has a sweet spot investment range around $25.0M, and a current fund size of $1.2B. Joe’s track record includes successful investments in the Midwest region. He collaborates with investors like Alex Mace, Alison Schulte, and others. With a background as a Private Equity Investor, his partnership style is characterized by a strategic and collaborative approach, leveraging his vast experience in the industry.

Henric Enhörning is a Partner at Wellstreet, a Venture Capital firm in Stockholm, Sweden. His investment thesis includes MarketingTech, Education, Media/Content, Real Estate/PropTech, ClimateTech/CleanTech, E-commerce, Health & Hospital Services, and FinTech startups at both Seed and Series A stages. Henric typically invests in the range of $100K to $5.0M, with a focus on an average of $1.5M per investment. Wellstreet, where he is a Partner, operates with a fund size of $40M. His collaborative network includes investors like Ann Áberg, Armando Coppola, Christian Zanders, Evelina Anttila, and Jessica Rameau.

Sciety is the Nordic region’s leading life science investment company, investing in unlisted life science and health tech companies. They focus on biotechnology, medical technology, pharmacology, diagnostics, ICT in healthcare, and health tech. Their investments range from the product development phase to expansion phase. In pharmaceuticals and biotech, they invest from late preclinical phase to Phase II, whereas in health tech and medtech, they invest in late development phases or companies with market traction.

Gary P. Pisano focuses on investing in science and technology-based industries such as aerospace, biotechnology, pharmaceuticals, specialty chemicals, healthcare, nutrition, computers, software, telecommunications, and semiconductors. His investment strategy includes early-stage funding in the biotech industry. Gary P. Pisano’s geographical preference is evident in his contributions to European co-inventorship location and co-patenting networks. His past work has involved nearly 100 articles and case studies on leading corporations like Amazon, BMW, IBM, Merck, Pfizer, and Virgin Group. While details on his investment check size are not specific, he emphasizes the importance of strategic investment decisions in SMEs. Pisano promotes strategic collaborations and partnerships, recommending an understanding of the four basic collaboration modes in business relationships.

Andy Ziolkowski is a Managing Partner at Cultivian Sandbox Ventures, based in Chicago, Illinois. He has made investments in sectors such as Food and Beverage (Seed), AgTech (Seed), Health & Hospital Services (Seed), Digital Health (Seed), BioTech (Seed), Health IT (Seed), Food and Beverage (Series A), AgTech (Series A), BioTech (Series A), Digital Health (Series A), Health & Hospital Services (Series A), and Health IT (Series A). One of his notable investments is Descartes Labs. Andy typically invests in the range of $1M to $10.0M, with a sweet spot at $5.5M. He has a track record of 2 total investments on record and is connected to investors like Rob Trice, Ludovic Copéré, and Phil Boyer. Co-investors in Descartes Labs include Eric Chin, Venky Harinarayan, Collin West, and Omar El-Ayat.

Jenny Lane is the Chief Executive Officer of Ohio Impact Fund, focusing on putting capital into startups that solve social, economic, or environmental issues. The fund targets financial services, climate tech, sustainability, healthcare, LOHAS, and wellbeing sectors. The investment check sizes for the Pride and Impact fund were $10M and $5M, respectively. Jenny Lane’s key focus is on startups that address societal challenges through their products or services.

Juliette Audet is a Partner at Forbion, with an investment focus on Pharmaceuticals and BioTech sectors at seed and Series A stages. Her investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Some investors who collaborate with her at Forbion include Antoine Boulanger Piette, Audrey Cacaly, Dirk Kersten, Dmitrij Hristodorov, and Geert-Jan Mulder.

Brian Bispala is an Advisor and Investor at Great North Ventures, with a focus on enabling next-generation digital manufacturing and logistics innovations in the Upper Midwest region. His investment thesis revolves around community-driven applications, solving labor problems, and digital transformation through AI. Brian’s investment focus areas include Human Capital/HRTech, TransportationTech, Real Estate/PropTech, Health IT, Consumer Internet, Enterprise, and FinTech at both seed and Series A stages. His preferred investment check size ranges from $1M to $10M, with a sweet spot at $5M. Brian has a strong track record in technology, having been involved in various ventures such as Colaboratory and Foodsby. He emphasizes brand x brand collaboration and partnerships. While his geographical preference is not specified, he has shown interest in startups in Minnesota. Previous investments include Series A Human Capital companies.

Crosscut is a seed-stage venture capital firm partnering with early-stage founders to build extraordinary high-growth tech companies.

Fireside Ventures is an investment firm specializing in early stage and seed investments.

Vera Mehler has a scientific background in regenerative medicine and stem cell therapy. She focuses on life science companies at Coparion. Vera Mehler invests in early-stage companies in software and biotechnology sectors across Germany. Her track record includes representing Coparion in eight portfolio companies and serving as an Investment Manager. While specific investment check sizes were not found, her partnership and collaboration style involves conducting research, projects, and reform initiatives in partnership with officials. Geographic focus was not specified in the search results.

Dr. Jonathan De Pass is an Angel Investor who founded Evaluate and served as Board Member at Advera Health Analytics. He is known for market intelligence and analysis in the life science sector, setting new industry standards. Jonathan De Pass has a strong track record in guiding investments and created EvaluatePharma in 1996. His investments include Evaluate Ltd. where he secured additional funding from HgCapital for growth. Jonathan De Pass has a collaboration style that involves leveraging new technology and unparalleled information assets to bring innovation to clients. He prefers a partnership approach that focuses on building on unique business offerings with new capabilities.

Will Anderson, an Associate at Possible Ventures, leads sourcing, due diligence, and the investment process for early-stage investments across Europe, the US, and Australia. With a focus on mission-driven teams using frontier tech, Will backs startups in Europe and Australia. His previous investments include Sorare. Will’s professional career includes roles in business development for a health and education consultancy and working with startups in multiple regions. At Possible Ventures, he supports deal flow, research, and marketing. Investment check size ranges based on startup needs.

Lennaert Jonkers is a Venture Partner at Social Impact Capital. He focuses on sectors such as AgTech, Consumer Health, ClimateTech/CleanTech, Digital Health, BioTech, Health IT, and FinTech. His investment range is $100K to $5.0M, with a sweet spot of $1.5M. Lennaert’s geographical preference is Amsterdam, Netherlands. He has a strong track record in seed and Series A investments in various sectors, collaborating with co-investors like Aaron Hurst, Jason Paragas, Julie Majorelle, Laura-Marie Töpfer, and Lauryn N. Nwankpa.

Ken Goulet is an investor who primarily focuses on HealthTech and Enterprise Applications sectors. He has made investments in companies like Centivo and XP Health. His recent investment check size was $17.1 million in XP Health as part of their Series A round. Mr. Goulet has a track record of investing in companies in the HealthTech sector, specifically supporting growth and product development initiatives. His geographical preference seems to be focused on North America, particularly investing in companies that align with his vision of making the home a reliable alternative to care facilities. He fosters collaboration and partnerships with a keen focus on structural dimensions, norm (trust), personal relationships, and organizational trust to ensure successful investments and growth.

Alpha Edison is a venture capital firm that focuses on technology-driven innovation.

David Lee is the Chairman of Refactor Capital, a $50M early-stage venture capital firm that invests in areas such as applied biology, healthcare, crypto, food, wellness, transportation, and aerospace. The average check size for investments is around $500,000, with a portfolio typically consisting of 40 to 50 companies. Refactor Capital primarily focuses on seed-stage companies in various sectors, including healthcare, life sciences, agriculture, financial, and legal services. Some of the previous investments by Refactor Capital include Headspace, Tempest, Lucy, Kin Euphorics, Cambridge Cancer Genomics, Cofactor Genomics, Notable Labs, Verge Genomics, and more. David Lee has a background in venture capital and startups, having co-founded and served as Chairman of Refactor Capital. He has a professional career that includes previous roles at SV Angel, Google, and StumbleUpon. Refactor Capital’s partnership and collaboration style involves active engagement and support for early-stage ventures, particularly in healthcare, life sciences, and technology sectors.

Kay G. Balster is a Principal / Prokurist at HTGF, specializing in venture capital and investments in Life Science & Chemistry startups. With a focus on biotechnology and medical technology sectors since 2009, he brings 20 years of experience in advising technology startups. Kay’s background in economics and training as a banker complements his daily interactions with founders in the HTGF portfolio. Contact information: HTGF Bonn, SchlegelstraÁe 2, 53113 Bonn, Telephone: +49 228 823 00 â 100.

Lukas Speiser is an individual angel investor known for his investments in various startups. His investment focus includes health care, medical devices, and biotechnology. Lukas Speiser prefers to invest in companies in the EU and MENA regions. Some of his previous investments include dunatura, Cleveron, Findependent, Sleepiz, and Testmate Health. With a track record in finance and founding Amorana, Lukas Speiser maintains a collaborative approach in his investments, engaging in partnerships to propel startup growth. He typically invests in the seed stage with check sizes that vary based on the company’s needs.

Next Floor is a venture capital firm based in Salzburg, Austria, founded in 2015. The firm focuses on investments in the med tech, health care, and social impact sectors. They prefer to invest in Convertible Note and Seed stage startups. Next Floor’s geographical preference is Salzburg, Austria. Some of their previous investments include RateBoard, Seasy.com, and AVISIO. The firm has invested in 6 companies since 2016 and led 2 rounds as the lead investor. For more information, you can visit [Next Floor Website](http://tacc.next-floor.at/).

Chicago ArchAngels is a preferred provider of risk capital focusing on early and seed-stage companies in the Midwest and nationally. They engage with a wide range of industries, including medical devices, healthcare, digital technology, manufacturing, green technology, and more. Their investment focus is on innovative companies aiming for technological proof of concept and market dominance. Chicago ArchAngels seek companies looking to raise between $500,000 and $3 million in their current round. Members bring valuable business and entrepreneurial experience, collaborating with various angel groups and accelerators. They host monthly meetings with presentations from companies with global potential and are affiliated with Washington DC ArchAngels, operating since February 2012.

Kirk Ouimet is a successful entrepreneur, inventor, and investor who founded Scan, a computer vision company that created a popular app with over 250 million downloads. He sold Scan to Snap Inc., generating over $100 million in returns for his team and investors. Kirk now focuses on investing in and advising startups, with over 250 investments, including Giddy, a mobile app facilitating mainstream DeFi adoption. His investment check size varies, as seen in his $8 million seed funding in Giddy. Kirk’s investment focus areas include tech, consumer, insurance, and healthcare sectors. He is primarily active in seed VC investments. While his geographical preferences are not explicitly stated, his investments indicate a strong focus on the US market. Kirk Ouimet’s partnership and collaboration styles involve engaging with innovative technologies such as GPT-3 and fostering a collaborative spirit in his interactions.

Tobias Teuber is an investor with a focus on personalized nutrition concepts based on blood and DNA tests. He invests in health tech startups, with a check size ranging around early-stage VC funding. Tobias Teuber’s investments have primarily been in companies like Thiocyn and Lykon. He is the Co-Founder and CEO of Lykon, a company offering personalized nutrition products and services. Tobias Teuber’s collaboration style involves seeking community partners to support the shared vision of the companies he invests in.

Dr. Michael Burstein is an investor with a background in healthcare investments, focusing on outsourced business services, payers, and care provision. He has a track record as an American writer of science fiction, winning awards for his works. Michael has served in various roles with the Science Fiction and Fantasy Writers of America and engaged in speculative storytelling. As an investor, Michael Bernstein operates as an Angel Investor. His investment check size and partnership styles are not explicitly stated in the available information.

Issam Dairanieh is a Venture Partner at Piva Capital, bringing a strong track record of creating financial and strategic value through technology investments. His expertise lies in converting carbon and exploring CO2 utilization. Issam holds a Ph.D. in Chemical Engineering from the University of Illinois, Urbana-Champaign. While details on specific investment focus areas were not available, his past involvement with carbon conversion initiatives indicates a keen interest in sustainable technologies. Issam’s partnership and collaboration styles are not explicitly outlined, but his background at BP and CO2 Sciences suggests a collaborative and innovative approach to investments. Specific details on previous investments and investment check sizes were not found, but his track record points to successful investments in technology-driven ventures. Overall, Issam Dairanieh’s career showcases a commitment to sustainable technologies and creating value through strategic investments.

Kathy Quigley focuses on tech-based investments in the pharmaceutical space, her professional career background includes being appointed to the Pima County Juvenile Court Bench and later as the Presiding Judge of Pima County Superior Court, Juvenile. She graduated from the University of Arizona Law School and worked as a trial attorney at the Pima County Attorney’s Office. Her previous investments are not available, and her partnership and collaboration style are not specified in the search results.

Targets investments in Climate Tech, Quantum Tech, Generative Design, Business Intelligence, Health Tech, Metaverse and B2C sectors.

Sasha Saberi, as an investor at LOUD Capital, focuses on Seed and Series A investments in sectors like Lodging/Hospitality, AutoTech, Digital Health, Health IT, and Health & Hospital Services. Notable co-investors include Blake Overlock, Brian Penick, Chase Petrie, Darshan Vyas, and David Hunegnaw. His investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Sasha Saberi has a diverse professional background, including roles at companies like Zigabyte, LOUDX Studio, The Venture Atlas, HYPEBEARS NFT, and One Identity. He holds certifications in Agile Foundations, Project Management, Scrum, Design Sprint Facilitation, and Enterprise Design Thinking.

Lee Shapiro is a Managing Partner at 7wire Ventures, with a focus on building collaborative partnerships to achieve health moonshots. He has a background in commercial law and is dedicated to supporting startups with a mission beyond monetary success. Lee’s investment check size and specific geographical preferences were not available, but he has been involved in strategic partnerships to ignite the growth of Israeli digital health companies. Lee Shapiro’s past investments include Livongo Health and Allscripts, where he held positions such as Chief Financial Officer and President. His partnership and collaboration style emphasize shared values, complimentary skills, and a long-term commitment to realizing a company’s vision.

AMV is a venture capital firm investing in early-stage digital health, tech, and life sciences companies.

Jasper Bos is a General Partner at Forbion, focusing on the firm’s Growth Fund. He has been involved in notable transactions including the sale of Prexton Therapeutics and Epitherapeutics, as well as the IPOs of Translate bio and Progny. With a background as a former Merck executive, Jasper Bos holds a PhD in Pharmacy from the University of Groningen. His investment check size, geographical preference, and partnership styles were not explicitly mentioned in the available information.

Stefan Gutsch is a healthcare VC who focuses on developing multiple investment theses to drive his investments. His investment focus areas include deep tech and digital transformation startups. He invests in companies at a mature enough stage to draw investor interest, preferring to fund projects that align with the regional and continental development goals. Stefan’s check sizes typically range between $500K to $1.5M. Through his well-respected professional career, he has demonstrated a track record of successfully managing projects on time. His partnership and collaboration style emphasize cooperative and directive collaboration styles.

FinSight focuses on FinTech & Enterprise Software companies bringing digital transformation to Banking/Finance/Insurance & related sectors.

Dave Sachse is a Co-Founder and Partner at Sachse Family Fund, a family office investment firm based in Milwaukee, Wisconsin, established in 2017. The fund specializes in investing in various sectors, including medical devices, virtual reality, augmented reality, biotechnology, life sciences, pharmaceuticals, CPG, and hardware. Dave Sachse’s investment focus areas are broad and diverse, covering a range of innovative industries. The fund actively seeks opportunities in early-stage companies in these sectors. While specific details about the stage of investment were not available, the firm is known for its interest in cutting-edge technologies. Dave Sachse’s approach reflects a commitment to social consciousness and community-oriented investments. The fund’s partnership and collaboration styles emphasize creating a sense of community and adapting to the evolving needs of different demographics. In the dynamic landscape of the apartment market, Sachse Family Fund recognizes the importance of smart technology, energy efficiency, and community-building events to meet the preferences of modern consumers.

Lina Behrens, CEO of Flying Health, is focused on investing in Nordic Health Tech companies. She has a background in healthcare and consumer goods, with experience at Boston Consulting Group and Polymath Ventures. Lina supports startups in digital healthcare and is actively involved in industry associations and advisory boards. Her investments target Nordic Health Tech and FemTech sectors. Lina Behrens has a track record of supporting companies in medtech and consumer goods sectors, demonstrating a hands-on approach to investment.

Alex Khein is a Chief Executive Officer at BlueBay Asset Management with an investment thesis focused on technology vendors, venture capital, IT, corporate innovation, consumer, tech, insurance, healthcare, industrials, and financial services. He has made investments in MediaCore, Mile High Organics, Believe.in, Talkdesk, and Storybricks. Alex Khein’s professional career includes being the Co-Founder and CEO of BlueCove and a past role as CEO at BlueBay Asset Management. He holds a Ph.D. in Physics from Cornell University. Alex Khein has a Seed investment stage, a preference for Europe, Middle East, and Africa (EMEA) regions, and a typical check size ranging from $450K to $1.5M. His partnership and collaboration style are not explicitly identified.

James Bachman is the COO of SynerZ Medical, a company developing an alternative to gastric bypass surgery for obesity and Type 2 diabetes patients. He has a track record of leading innovative medical device solutions, securing investments to support research and development efforts aiming for safer and less intrusive solutions in the healthcare industry.

Beatrice Aliprandi is a Principal at Talis Capital with a focus on investing in construction and femtech industries. She has a track record of investments in companies like Andium, import.io, CensorNet, Darktrace, and more. Beatrice is known for her professional career in high-growth startups and her strategic collaboration style, as seen in her participation in industry analysis and fostering the women’s healthcare revolution. Talis Capital, under her guidance, invested around $110 million in 2020, supporting 14 new companies. Geographically, Beatrice’s preferences include Europe and the United States. Her investment check size aligns with this strategy, emphasizing early-stage investments. Beatrice Aliprandi’s approach involves creating the #1 destination for games industry analysis and working towards the growth and success of startups in her portfolio.

Richard Easton is a venture capitalist with a focus on healthcare and life sciences. His investment thesis revolves around improving healthcare services and reducing costs. Easton Capital, where he is a key figure, has a history of investing in healthcare and currently concentrates solely on this sector. The firm aims to maximize returns by financing companies with capital-efficient models. Richard Easton’s geographical preference leans towards West Wales, where he has significant experience in commercial and corporate banking. He invests in various stages, including early stage, development capital, and succession and acquisition. His professional career spans 31 years in banking, with roles in credit risk assessment, portfolio management, and mentorship for local businesses. Richard Easton’s investment style focuses on maximizing returns while minimizing risks on a reasonable capital base.

David Meister is an angel investor with diverse investments. His investment focus areas include technology, corporate strategy, corporate venture capital, venture capital, and various industries like IT, healthcare, and financial services. He typically invests during the Seed to Series A stages with a check size ranging between $150,000 to $400,000. David Meister has previously invested in Powder. With a background in fashion design and a track record of dressing celebrities for red carpet events, he has demonstrated a strong professional career. Geographically, David Meister is based in Los Angeles, California.

Ethan Meyer is an investor associated with a firm that is stage-agnostic, investing from seed to growth stage. His investment focus areas include personalized asset allocation strategies, ETF models, Socially Responsible Investing, Custom Built portfolios, and Tax loss harvesting. The firm’s geographical preference is flexible, and previous investments by Ethan Meyer are not publicly available. Ethan Meyer has a strong track record in track and field. Specific information about the investment check size and partnership/collaboration styles attributed to Ethan Meyer is not available.

Cat Catherine Kennedy is an active Angel Investor at Alliance of Angels, with a focus on seed and early-stage investments ranging between $500k to $2.5 million. She seeks extraordinary founders in various sectors, including SAAS, AI, Life Sciences, and other industries like manufacturing and retail. Preference is given to companies with a connection to the Pacific Northwest, but Cat also considers investments across the US and Canada. She has a hands-on partnership style, participating actively in the investment process. Cat has a proven track record within the investment community and is known for making quick decisions within approximately 6 weeks of the screening meeting. Additionally, she is involved in the Alliance of Angels Innovation Fund, making $150k investments in about a dozen companies annually, emphasizing a sector-agnostic approach towards early-stage ventures.

SOSV is a global VC firm with $1B AUM and 1,000+ investments, that operates HAX, IndieBio, Chinaccelerator, MOX, and dlab.

Alex Bard is an entrepreneur and investor who believes values and people are crucial for building great companies. He has been part of starting 4 technology companies in the enterprise software space. His investment focus areas include healthcare, applications, fintech, consumer services, infrastructure, and blockchain. Geographically, his preference aligns with San Francisco Bay Area and Austin, Texas. Some of his previous investments include Hims, Kustomer, AppZen, Coder, and NorthOne, spanning various stages from Seed to Series A. Alex Bard’s partnership and collaboration style involve working closely with entrepreneurs, providing mentorship, and leveraging his expertise to foster growth and success.

Andrew Schwab is the Co-Founder and Managing Partner at 5AM Ventures, a venture capital firm specializing in seed and early-stage life sciences companies. The firm focuses on building next-generation life science companies and has a geographic preference for Canada, Mexico, and the United States. 5AM Ventures typically invests in companies in the early seed stages within the life sciences category, including therapeutics, tools, and technologies like genomics and proteomics. Andrew Schwab has an impressive track record of leading investments in companies such as Biodesy, Cleave, Flexion, Ilypsa (acquired by Amgen), Panomics (acquired by Affymetrix), Precision NanoSystems, and Synosia (acquired by Biotie). The firm is known for being entrepreneur-friendly and building long-lasting relationships with entrepreneurs to achieve success.

Dr. Robert Lufrano served as Chairman and Chief Executive Officer of Blue Cross and Blue Shield of Florida and has been an Advisor at RubiconMD. His investment focus areas include healthcare and technology, with a particular interest in companies driving change in the healthcare industry. He has been involved in Series A funding rounds, as demonstrated by his $4M investment in RubiconMD in 2016. Robert Lufrano’s geographical preference and previous investments are not explicitly stated. His professional career involves leadership roles in healthcare organizations, showcasing his extensive experience. The investment check size and partnership/collaboration styles of Robert Lufrano are not specified.

Berkeley Angel Network is a group of angel investors associated with UC Berkeley. They focus on investing in companies primarily belonging to sectors like Health Care, Medical Device, E-Commerce, and Food and Beverage. Some of their previous investments include Alpaca Securities, HealthCrowd, and Bone Health Technologies. Berkeley Angel Network invests in startups at the Seed and Series A stages, with a check size usually ranging between 1 to 5 million dollars per deal. Their geographical preference is not limited to a specific region, aiming to connect global entrepreneurs with industry experts and professionals.

David Anderman is an investor with a focus on markets including Mobile, Consumer Internet, Enterprise Software, Clean Technology, and Healthcare. He has made 7 investments primarily in the Media & Entertainment and Enterprise Applications sectors, with notable investments in companies such as Haystack TV and Meograph. Anderman’s investment check size is not specified. His professional career includes roles as the Chief Legal Officer of Surf Air, General Counsel at SpaceX, and COO/GC at Lucasfilm. Anderman’s partnership and collaboration style involves providing guidance on business strategy for companies expanding globally, leveraging his experience in dealmaking and negotiation.

Beam Angel Network is an angel network focused on supporting early-stage, Texas-based, women-founded companies with high potential. They are committed to investing a minimum of $250,000 in women-founded companies through the network.

Jonathan Ozeran is a Vice President of Generative AI at Tempus, an investor, and advisor. His current investments include companies in various sectors such as Hardware, Pharmaceuticals, IoT, Consumer Health, BioTech, Health IT, AI, Consumer Internet, and Enterprise at Seed and Series A stages. His investment check size ranges from $5,000 to $20,000 with a sweet spot at $10,000. One of his recent investments is in Tribe XR. As a Venture Partner at Good Growth Capital, Jonathan Ozeran is involved in supporting startups and has a track record of making impactful investments.

C. Victor Brick is the CEO of Ohana Growth Partners, LLC (OGP) which owns 100 Planet Fitness health clubs throughout the United States and Australia. He is also the founder of the John W. Brick Mental Health Foundation, advocating for mental wellness integration in the fitness industry. Victor Brick is involved in promoting research for wellness integration into healthcare and active collaboration for industry improvement.

Nimay Parekh is a prominent investor with a focus on digital health solutions addressing clinician burnout. He invests in teams with industry experience in healthcare. Nimay’s investments are on stage at Affiliate Summit, indicating his interest in supporting startups in their early phases. Based in Cape Town, South Africa, Nimay has a geographic preference for this region. His professional career includes roles at Accenture Song and Jivox, with a background in commerce marketing. While there is no specific information on check sizes, Nimay is known for his work on SaaS pricing intelligence. His collaboration style emphasizes personalized commerce marketing.

Robert Fabbio is a venture capitalist with a primary focus on digital health, health services, and health IT in seed to Series B stages. His investment range is $100K to $5.0M, with a sweet spot at $1.5M. Geographically, he is active in Austin, Texas. Some of his previous investments include WhiteGlove Health, Ventix Systems, Agere Systems, and DAZEL Corporation. Fabbio is known to collaborate with partners such as Bart Robertson, Bernie Brenner, and Courteney Real, among others. He has a strong track record in founding companies and working in the technology and healthcare industries.

Vertex Ventures is a global network of operator-investors that manage portfolios.

Carla Fowler is an Angel Investor affiliated with Alliance of Angels based in Seattle, Washington. She focuses on Digital Health, BioTech, and Health IT at both Seed and Series A stages. Carla’s typical investment check size ranges from $500K to $1.5M with a sweet spot at $1M. Her previous investments include a diverse portfolio in the healthcare technology sector. With a fund size of $100M, Carla actively collaborates with other investors within Alliance of Angels, demonstrating a strong commitment to fostering startup growth through strategic partnerships. Her track record reflects a successful career in supporting over a dozen startups in the MedTech and biotech fields.

Angie Willmott is an Angel Investor at Angel Physicians Fund based in Cincinnati, Ohio, USA. With 14 years of experience in the field of medical research, Angie brings valuable expertise to the table. Her professional career includes working at Ethicon Endo-Surgery, a Johnson & Johnson company, which demonstrates her deep industry knowledge. While details about her investment focus areas, previous investments, and investment check size are not readily available, her background in medical research and real estate investments suggests a diverse investment approach. Angie’s successful track record may indicate a strategic investment style, potentially focusing on opportunities that align with her industry experience and interests.

Barak Diskin is an angel investor focusing on healthcare, fashion, consumer internet, real estate, and more. He has made investments in companies like FabFitFun and MeUndies. Barak’s professional career includes being the Co-Founder of MeUndies and the Global Head of Real Estate at CloudKitchens. He has a background in real estate development and internet ventures. With a track record in building and investing in companies, Barak’s investment check size varies based on the round. His geographic focus is in the United States, particularly California, and he has a background in real estate and technology. Barak Diskin is known for his seed round investments and seeks collaboration opportunities for investment opportunities.

Reinhardt Karpenko is an investor associated with Picus Capital, an early-stage technology investment firm with a focus on daring technology companies. He has experience as a Venture Scout at Picus Capital, an Entrepreneur In Residence at Luminovo, and a Founders Associate in various startups. Reinhardt has engaged in investments at pre-product, pre-seed, and seed stages. His geographical preference is in Munich, Bavaria, Germany, with a track record of supporting startups such as Nao Drinks GmbH and Quicket GmbH. Reinhardt Karpenko’s investment check size typically ranges from pre-product to seed stages.

A3 Ventures is an innovation lab and capital investment engine of AAA Northern California, Nevada & Utah. They focus on industries such as transportation, mobility, home, leisure, travel, financial services, healthcare, insurance, and retail. Some of their previous investments include companies like Zippity and RapidSOS. The Chief Executive Officer of A3 Ventures, Satisha Narahari Murthy, has over 20 years of professional experience. A3 Ventures’ investment check size is undisclosed. They emphasize deep human work to improve collaboration, identifying three collaboration styles: introspective, relational, and expressive.

Charles Boorady is the Founder and Managing Partner of Health Catalyst Capital Management. The firm focuses on investing in growth-stage healthcare technology and technology-enabled services businesses in an effort to improve healthcare outcomes. Mr. Boorady’s investment thesis is centered on promoting value-based care and enhancing the human condition through innovative healthcare solutions. Some of the previous investments made by Health Catalyst Capital Management include Insightin Health, Clearsense, and Vivante Health. The investment check size typically varies based on the specific opportunity and growth stage of the company. Additionally, the partnership and collaboration style at Health Catalyst Capital involves leveraging a deep network of C-level executives from healthcare organizations to support portfolio companies, aiming to create long-term value.

7wire ventures focuses on investing in early and growth-stage companies focused on healthcare IT, digital healtcare and mobile health.

Jos Feijen is a VC and Investment Manager at BOM Brabant Ventures in the Netherlands. He focuses on EnergyTech startups at Seed, Series A, and Series B stages. Jos has a diverse portfolio with co-investors like Bart Mul and Bart van den Heuvel. His investment range varies from $100K to $5.0M, with a sweet spot at $1.5M.

Dulcie fforde is an experienced professional with a background in product management, venture capital, and operations. She has worked at companies like Uber, Homebound, Baillie Gifford, and Modern Fertility. Her roles include Senior Product Manager, Experience Operations Lead, and Venture Capital Principal. Dulcie brings a wealth of expertise from her diverse career, making her well-equipped for investments in various sectors. She has strong experience across different industries and regions, including the San Francisco Bay Area and London, United Kingdom. Her previous positions demonstrate a track record of successful roles in well-known companies, showcasing her ability to contribute effectively to startups and investment projects.

Patricia Cruise is an investor with previous investments in various areas including dance, musical theater productions, modeling training, music showcase, and more.

New Era Capital Partners is a venture capital firm that invests in technology-focused and global enterprises.

Timothy Young is a Co-Founding General Partner at Eniac Ventures, leading in strategic seed-stage investments. Eniac Ventures has a focus on companies in areas such as AI, consumer, deep tech, fintech, healthcare, SaaS, sustainability, and Web3. The average check size for investments is around $1.5 million. Timothy Young collaborates closely with co-founder Tim Young and plays a significant role in managing and tracking new investment opportunities, conducting market research and due diligence, and supporting Eniac’s portfolio companies. Eniac Ventures emphasizes partnering with bold founders who utilize technology to drive transformational change.

Katie Tyler invests in Series A, B, and C startups, and her preferred investment amount is $100,000. She holds a Master’s degree in geography with a concentration in GIS and a Bachelor’s degree in environmental studies. Katie has experience in strategy development, change management, and data analysis. Her previous investments include businesses in the health tech sector. Katie focuses on addressing gaps in public transit service. She has a strategic collaboration and partnership style to accelerate transitions in the public sector towards sustainable investing.

Amirhossein Malekzadeh is an investor with a focus on Technology, Corporate Strategy, Corporate Venture Capital, Venture Capital, IT, Corporate Innovation, Insurance, and Healthcare industries. His previous investments include Koyeb and ProcessOut. He has a track record in artificial intelligence engineering and is known for co-founding Logmatic.io. Amirhossein’s approach to partnership and collaboration shows experience as a Co-Founder and CEO at Logmatic.io. He has also been involved in strategy consulting for Monitor. Additionally, his investment check size was $7M for the latest investment in Koyeb’s Seed VC – III round. His portfolio exit with ProcessOut was acquired by Checkout.com.

Nils Winkler is an investor with a focus on creating value from societal externalities through startup investments. His investment portfolio includes ventures in ELUXR, ShareIQ, and Semasio. Nils operates mainly in the European Union and has a track record of exits in ShareIQ and Semasio. His investments span across HealthCare, Identity, Infrastructure, and The Digital Commons. Nils Winkler’s check sizes vary, with the Semasio investment amounting to â¬600K. He has a collaborative relationship with startups, aiming to drive innovation by capturing market externalities for societal growth.

Citrine Angels is an angel investing group for women by women, based in Washington, DC. They provide early-stage investment opportunities and education to female investors interested in supporting female-founded startups. Their mission is to support the growth and success of female-founded businesses, increase access to investment opportunities for women, and offer investor education to their members. The management team has prior angel investing experience, substantial business acumen, and enthusiasm for their mission.

Eric Dobkin is a New York-based angel investor serving as Board Member at Strategic Growth Banking. He has invested in companies like OROS, Ready4, Shareaholic, and Searchable.ai. Eric Dobkin is known for his significant contributions to the IPO market and has a track record in the capital markets division. His investment check size and partnership styles align with strategic collaborations focusing on the healthcare sector. He plays a key role in the newly formed private equity firm by Whistler Capital Partners.

Tommy Ahlers is a European angel investor who has shown interest in gaming and sports industries with investments such as RFRSH in the gaming industry. He focuses on industries like venture capital, consumer, insurance, healthcare, financial services, and has a knack for determining tech strategy. Tommy Ahlers typically engages in early-stage investments and has a geographical preference within Europe. Some of Tommy’s notable previous investments include Ento Labs, Wavepiston, Zliide Technologies, Coach Solutions, and Peakon. His investment check sizes vary across Angel, Series A, and Corporate Minority rounds. In terms of partnership and collaboration styles, Tommy Ahlers has discussed enterprise adaptation, team dynamics, integration in enterprises, and future trends in technology.

Civilization Ventures is a venture capital firm focused on cutting edge innovations in exponential health tech and biology.

Tapio Tolvanen is the Co-Founder and Chief Technology Officer at Elo Health. He has invested in companies like BetterDoctor. He focuses on healthcare and wellness sectors. His track record includes successful investments such as BetterDoctor, with one exit. Tapio Tolvanen’s investment check size ranges based on the company and opportunity. He has a collaborative partnership style, seen in his involvement in companies like BetterDoctor and Elo Health.

David Ebsworth is an experienced investor with a diverse portfolio. He has made investments in companies like Small Pharma. David Ebsworth’s investment focus areas include Biotechnology, Pharmaceutical, Therapeutics, Biopharma, and Health Care. His investment check size varies based on the opportunity. He has a track record of over 35 years in the global pharmaceutical industry and currently serves in leadership roles at Verona Pharma Plc. David Ebsworth’s geographical preference is not explicitly stated, but his investments indicate an international focus. He has a partnership and collaboration style that emphasizes connecting with other companies.

Bo Shi is a Vice President at Sandbox Industries specializing in investments in digital health, SMB software, and health IT, with a focus on Series B startups. He has an investment range of $1M – $20.0M, with a sweet spot at $10.5M. Bo Shi’s previous experience includes roles at Waud Capital Partners and Microsoft. He holds an MBA from the University of Chicago Booth School of Business and is involved in the Blue Venture Fund.

Ben Sharpe is a member at Alliance of Angels, the largest and most active angel group in the Pacific Northwest. Alliance of Angels focuses on financing and supporting high-growth startups in technology, hardware, consumer, and the life sciences. They have made seed and early stage investments totaling over $100M in 200+ portfolio companies, with 40+ successful exits. Ben Sharpe and the group prefer companies connected to the Pacific Northwest but also invest across the US and Canada. Their investments range from $500k to $2.5 million for the first investment. They are sector agnostic but have a majority in SAAS, AI, and Life Sciences. The partnership style involves an investment process from introductory meetings to due diligence, with decisions typically made within 6 weeks.

Mark Suster is the Managing Partner at Upfront Ventures, a venture capital firm that invests in early-stage technology companies. Upfront Ventures focuses on a variety of sectors including healthcare, defense technologies, computer vision, ag tech & sustainability, fintech, consumerization of enterprise software, and gaming infrastructure. They invest approximately $3 million per company at the earliest stages of formation. Upfront Ventures returns investments to LPs and has a history of substantial funding rounds. The team consists of 10 partners and maintains a strong presence in both Los Angeles and San Francisco. Collaboration and partnership styles at Upfront Ventures prioritize diversity of thought, experiences, and dedication to funding founders across different backgrounds.

Peter Pham is known for primarily investing in HealthTech, Enterprise Applications, and other sectors. His investments are focused on early-stage startups such as Mate Fertility and theMednet. Peter Pham has experience leading series D rounds and follows a barbell approach in his investment strategy. While there is no specific data on his geographical preference, Peter Pham’s past investments and experience indicate a strong focus on the United States market.

Michael Madanat is an Angel Investor with a focus on pediatric care. His investments include serving as a Board Member at Heal and leading Foothill Pediatric and Adolescent Clinic. He has a background in pediatrics, completed his MD and MBA in Healthcare Management, and holds multiple degrees in related fields. His investment focus areas include pediatric healthcare. Previous investments are not detailed. Dr. Madanat’s partnership and collaboration style align with introspective, relational, and expressive approaches, aiming for better collaboration between different styles.

Founders Capital Partners is a venture capital firm and an angel group founded in 1988. They specialize in early-stage technology-based businesses focusing on industrial products and services. The firm primarily engages in follow-on rounds with occasional new startup investments.

Michael Braun is a seasoned Senior Venture Partner at 415C, actively involved in technical evaluations of new portfolio prospects. With a professional background as the CEO of CoRRect Medical GmbH and founder of Symedrix GmbH, Mr. Braun has co-founded successful medical device distribution and consulting companies, offering support to multiple startups. His career began at Rüsch AG / Teleflex, where he invented the Polyflex™ stent. Holding a B.Sc. in Biomedical Engineering, Michael Braun demonstrates a hands-on approach to partnerships and collaboration, ensuring strategic guidance and support to emerging ventures.

Atland Ventures, led by Hunter Babcock, invests in fast-growing U.S.-based startups focusing on Gen Z problems. Their investment thesis includes sectors like Edtech, Consumer, Marketing, Creator Economy, Health, and Wellness. They provide $25,000 seed stage checks to Gen Z founders solving relevant issues. Previous investments include ConverSight, TransCrypts, FranShares, among others. Atland Ventures typically invests in early-stage disruptive technology companies. The check size ranges between $25,000-$50,000. Hunter Babcock’s professional career is associated with Babcock and Wilcox. Their partnership and collaboration styles aim to be a real value add on the cap table, assisting portfolio companies with a network of talent, resources, and VC connections.

OCA Ventures is a venture capital firm focused on equity investments in companies with dramatic growth potential.

Alexander Mayweg, Ph.D., is a Managing Director at Versant Ventures and the head of Ridgeline Therapeutics, the Basel-based Discovery Engine of Versant. He excels in drug discovery and medicinal chemistry, drawing on his experience at Roche Pharma Research. Mayweg’s investment focus areas at Versant Ventures are in early biotech investment and company creation, with a keen interest in sourcing innovative opportunities globally within the healthcare industry. His geographical preference spans Europe, the U.S., and Asia. Since 2016, Alexander has been involved in launching and investing in companies like Black Diamond, Monte Rosa, Bright Peak, Enterprise, T-knife, and Matterhorn. With a Ph.D. in organic chemistry from Oxford University, Alexander brings deep operating capabilities and a strong track record to his role, reflecting his commitment to fostering partnerships and collaborations within the industry.

Winston Ibrahim is a purpose-driven entrepreneur and investor with a focus on sustainable products and health and wellness initiatives. He is the Founder and CEO of Hydros, a water filtration startup with a mission to reduce disposable plastic bottle consumption. Winston has a track record as an investment banking analyst and has led financing for companies like BioReset Medical. He has geographical preferences in San Francisco, California, and serves on various boards and projects, showcasing his collaborative and partnership-driven style. With a background in Political Science from Johns Hopkins University, Winston’s investment check sizes vary based on the round, with a focus on seed rounds. His diverse portfolio includes companies like Ribbon and others.

Samantha Fernandez Keys is an angel investor and operator with a focus on maximizing human potential and livelihoods. She supports startups in various industries including health, autism, financial inclusion, and education for underrepresented markets in the US and Latin America. Samantha funds seed to growth stage companies through angel groups and syndicates, has a background in product, operations, and strategy roles, and holds an MBA with a focus on technology, marketing, and impact investing. She has previously worked at Adobe, The Bridgespan Group, Root Capital, Acumen, and the U.S. Social Innovation Fund. Samantha is passionate about the intersection of tech, business, and impact.

Jeanette Welsh, Partner & COO at Telegraph Hill Partners, has a focus on private equity investments in the life sciences and healthcare sectors. She specializes in early-stage investments ranging from $2-8 million. Jeanette has a background in private equity, mergers & acquisitions, and securities law. She has been involved in companies such as Three Cities Research and has represented THP on the boards of various firms like Interface Associates and AngioScore. As a Partner at THP, she collaborates with professionals in advancing human health through life science and technology, fostering innovation in the healthcare sector.

Franklin Johnson is a venture capital pioneer, known for founding Asset Management Ventures in 1965. The firm focuses on early-stage investments in digital health, technology, and life sciences. Previous investments include companies like basys.ai and SubjectWell. Franklin Johnson’s investment check size ranges from $200,000 to $2,000,000, with a sweet spot of $1 million. He has a diverse portfolio of over 200 tech startups, displaying a strong track record in the industry. Johnson’s partnership and collaboration style emphasize value-added relationships with firms offering broader investment capabilities.

Coyote Ventures is a venture capital company that invests in early-stage companies focused on women’s health and wellness.

Alastair Rampell is a General Partner at Andreessen Horowitz where he focuses on investing in financial services. His investment focus areas include sectors like AI / Devtools, Cybersecurity, Web3, Deeptech, Biotech, Digital Health, Consumer, Fintech, and Gaming/VR. He invests in Seed, Series A, and Series B+ stages with check sizes ranging from $500,000 to $50 million. Alastair has a track record of co-founding Affirm, Inc. and serving on the board of various companies such as Rocket Companies, Loft, Descript, Wise, and Propel, Inc. He is known for his partnership and collaboration styles focusing on long-term relationships and mutual success.

Mike Collett, the Founder and Managing Partner at Promus Ventures, focuses on investing in early-stage DeepTech companies run by visionary and tenacious founding teams. Promus Ventures’ previous investments include Rocket Lab, ICEYE, Halter, and Gauss Surgical. The investment check size ranges from seed rounds like Halter’s in 2017 to later-stage investments like Iceye’s Series D of $136 million. Mike Collett’s partnership and collaboration style involve supporting innovative technologies for sustainable farming, human spaceflight, AI mapping, and healthcare innovations.

Go Beyond invests in European startups that generate positive impact for people or the planet. They focus on companies in the environment, health, education, food, housing, services, medtech, biotech, technology, and luxury sectors. Go Beyond invests in the seed stage or later, with smaller angel tickets, aiming to support founders in fundraising for seed rounds or later. The founding team includes Kart Siilats and Kadri Harnak. They seek commitments from eligible professional investors for private limited partnership funds. Previous investments information is not available, but they have a track record in investing. Check sizes and partnership styles are not specified on the website.

Robert Schier is a Senior Investment Director at Zürcher Kantonalbank Asset Management (Swisscanto Private Equity) with a background in pharmacy and biotechnology. He has significant experience in investing in healthcare and life sciences sectors, managing investments in private start-ups, and serving on the boards of numerous life sciences companies. Robert’s investment focus areas include healthcare and life sciences. He has been involved in investments in over 20 start-ups and 25 companies as part of an investment committee. His check sizes for investments range from CHF 8 million to CHF 16 million. Dr. Schier is known for his hands-on partnership and collaboration styles, bringing expertise and strategic insights to his portfolio companies.

JaxAngels is an angel group based in Jacksonville, Florida, founded in 2019. The firm specializes in early-stage investments focusing on sectors like Enterprise Applications and EdTech. They prefer investing in companies in the United States. JaxAngels has made investments in companies like Call Simulator Inc., with recent seed investments of $575K and $500K. With an average single investor check size of $35,000, they have completed multiple rounds for various startups in the medical technology and financial services sectors. JaxAngels is known for its commitment to growth and innovation and has a track record of supporting startups through early-stage funding.

Sean Lauber is a founding partner at Korify Capital, a venture capital fund focused on investing in innovative and visionary companies in the biotechnology sector, specifically in cutting-edge technologies in longevity, mental health, and regenerative medicine. The investment thesis of Korify Capital revolves around three core focus areas: Distributed development companies, Enabling technologies, and Domain-specific platforms. They invest in the biotech sector in the US, Europe, and Israel, selectively in fintech and blockchain opportunities. Korify Capital targets late-stage/pre-IPO venture opportunities as well as event-driven investments in smaller public companies.

Gene Matsutani is known for his investments in gene therapy and targeted toxins for glioma. His investment focus areas are related to these medical advancements. The stage of his investments is not specified. Gene Matsutani’s geographical preference is not readily available. He has a professional career background in IT and helpdesk administration. Unfortunately, details about his previous investments, investment check size, and partnership collaboration styles are not currently accessible.

Fred Khosravi is a seasoned medical device entrepreneur with a focus on the healthcare industry. He is involved in Imperative Care and Tulavi Therapeutics as Chairman & CEO and Executive Chairman, respectively. He has directed organizations like Instylla Medical and Ostial Corp. Fred’s geographical preference centers around California, particularly Campbell and Santa Cruz. His professional career spans over several successful ventures in the medical technology space, showcasing a solid track record. While specific investment focus areas are not detailed, Fred Khosravi’s leadership style emphasizes collaboration and innovation, evident in his various chairmanship roles and involvement in cutting-edge medical advancements.

John Daly, an angel investor with Alliance of Angels, focuses on investments ranging from $500K to $1.5M, with a sweet spot at $1M. His investment thesis includes sectors like Hardware (Seed), Energy, Tech (Seed), Cloud Infrastructure (Seed), SaaS (Seed), and specific focus on Hardware (Series A), Energy, Tech (Series A), Cloud Infrastructure (Series A), SaaS (Series A). John Daly’s recent investments include Seed rounds in various sectors. His professional career is based in New York, New York, where he has made notable investments, with TMRW Sports being one of his latest Seed VC investments.

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies.

Amit Tiwari, Managing Partner at Tiger Iron Capital, boasts over 17 years of private equity experience. Specializing in Biotechnology, Informatics, and Clinical Services, he oversees operations with a focus on Strategy, Business Development, and Operational Excellence. Amit holds an MBA from the University of Michigan and is a Certified Professional in Healthcare Information and Management Systems. His investments remain undisclosed publicly, emphasizing a long-term partnership and collaboration style with a track record of innovation and excellence.

William Tai is a prolific individual investor and entrepreneur with a focus on Medical Device and Medical Technologies investments. He has a diverse portfolio of investments that includes companies like Blaze, Tract, and Fairmatic. His investment considerations prioritize the potential for companies to become great as standalone entities rather than focusing on acquisitions. Mr. Tai has a track record of funding numerous start-ups since 1991, with over 23 IPOs from early-stage projects. He has had involvements in companies such as Blackbird Ventures, Canva, SafetyCulture, Zoom, and TweetDeck. His check sizes for investments vary based on the round and company, with recent investments like Blaze totaling $3.5 million in the Pre-Seed round. Bill Tai has a collaborative approach akin to an orchestra conductor, bringing together diverse strengths for impactful collaborations.

Volition Capital is a growth equity firm that principally invests in high potential, founder-owned companies across different technology.

Zhou Zang is a Senior Associate at Corazon Capital, focusing on investments in early-stage companies spanning health and wellness, consumer-facing tech, and urban tech. Zhou Zang’s professional career includes previous positions at Polsky Holdings, L.E.K. Consulting, and Home Partners of America, with an MBA from The University of Chicago Booth. Corazon Capital’s investment check size has expanded with its recent fund raises, and Zhou Zang is known for collaboration and partnership styles that support portfolio companies at various stages.

Anne Wojcicki is an angel investor with a focus on Diagnostics, Human Capital/HRTech, BioTech, Digital Health, and Health IT. She invests at the seed stage in companies like Brightside Health, Ezra AI, Orchid, Eureka Health, Calypso AI, Helium Health, Nest Genomics, and Wisdo Health. Previous investments include Freenome, Doctor On Demand, and SpoonfulOne. Anne is the CEO and Co-Founder of 23andMe, with a track record in healthcare and biotechnology investing. She takes initiatives to disrupt the healthcare experience and prefers collaboration with partners. Anne’s check sizes vary based on the round of investment, and she is open to partnerships and evolving leadership styles.

Jack Oliver is an investor with a focus on business services, industrials, software, technology, digital infrastructure, education, and healthcare sectors. He has made investments in Juristat. His investment check sizes range from $20 million to $40 million in equity size. His professional career includes being a Senior Policy Advisor and Team Leader at Bryan Cave Leighton Paisner. Jack’s investment approach is industry agnostic, with a particular interest in startups at the seed stage. His geographic preference and partnership styles could not be determined from the available information.

Ehud Barak focuses on distressed debt, has previously been a partner at SCP Partners, and has landed a $125 million investment from the teachers’ pension fund in Pennsylvania for his private investment fund. He has a partnership with Jeffrey Epstein for investments in Barak’s startup, Reporty Homeland Security.

Stuart McClure is the Chief Executive Officer at Qwiet AI and serves as a Board Member at CyberGRX. He has a track record of founding and leading successful technology companies. Prior to his current roles, he was the EVP, Global CTO, and General Manager of the Security Management Business Unit for McAfee/Intel. Stuart has a background in psychology and computer science from the University of Colorado. He has made investments in companies like Nightfall AI and JASK. Stuart’s investments are primarily focused on companies in the cybersecurity sector. His collaboration style is characterized by a strong vocal variety and the ability to simplify complex concepts in public speaking.

Endeit Capital is a growth capital firm fueling internationalization and innovation.

Matthew Vettel is a Managing Partner at Great Hill Partners with a focus on financial technology and software. His investment experience spans various industries including supply chain planning, identity verification, B2B accounts receivable, payment solutions, and online global payment services. Some of his current board memberships include Blue Ridge, Jumio Corporation, VersaPay, One Inc, Paytronix Systems, and Network Merchants, among others. Great Hill Partners typically targets investments between $100 million and $500 million in high-growth companies across software, digital commerce, financial technology, healthcare, and digital infrastructure sectors.

SoundBoard Angel Fund, led by the Managing Partner, strives to invest in exemplary leaders founding dynamic companies. The fund seeks start-up entrepreneurs who are open to coaching, collaboration, and embracing change in their business and personal growth. They prioritize individuals who exhibit a desire to be deeply involved beyond idea generation, showing a willingness to take risks and a strong passion for their ventures. The ideal investments for SoundBoard Angel Fund are within the Food/Beverage, Education, Healthcare Services, Consumer Products, and Technology sectors. While the majority of opportunities are near the metropolitan NYC area, geographic proximity is not a strict requirement for consideration. Past investments by the fund include companies like Otonomi, SunRay Scientific Inc., and RoadBotics by Michelin. The typical check size for investments by SoundBoard Angel Fund ranges around $100,000 or more, focusing on ventures with clear competitive advantages and revenue models. Additionally, the Managing Partner is actively engaged in various advisory roles and networks, demonstrating a commitment to collaboration and mentoring within the entrepreneurial ecosystem.

Jürgen Rauch is an Austrian investor with a focus on seed-stage investments, having funded startups like presono with check sizes around â¬1M. He brings experience in Production, Distribution, Marketing, and Branding. Rauch is known for his cooperative and directive collaboration styles, emphasizing teamwork, trust, and leadership where needed.

Porter Ontko is a Venture Capital Associate at VU Venture Partners. VU Venture Partners is a multi-stage global venture capital fund with a focus on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech. The fund invests in a wide range of industries and has a diverse investment portfolio across various sectors including Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech. Previous investments by VU Venture Partners include a portfolio of over 90 companies spanning different sectors. They have partnership and collaboration styles that support customer acquisition, partnerships, capital raising, hiring, marketing, and exit strategies. VU Venture Partners primarily invests in early-stage companies with an initial investment of $200K – $1M and follow-on investments up to $10M.

Joost Holthuis is a Venture Partner at BGV (BioGeneration Ventures) with a focus on Seed and Series A investments in Pharmaceuticals, Consumer Health, Digital Health, BioTech, and Health & Hospital Services sectors. His investment range is from $100K to $1M, with a sweet spot at $500K. Joost has a geographical preference for investments in the Netherlands. BGV has a strong track record of successful divestments, including Dezima Pharma to Amgen for up to USD 1.55 billion and Acerta Pharma for up to USD 7 billion. Joost’s background includes founding OctoPlus and serving as the CEO for 14 years, leading to a successful listing on Euronext and acquisition by Dr. Reddy’s in 2013. He holds a PhD from the University of Utrecht.

Andres Avendano is a Venture Associate at Chingona Ventures, focusing on industries like financial technology, future of work, learning, food technology, and health/wellness. He primarily invests in pre-seed companies with an initial check size ranging from $250k-$1MM. His previous investments include Pre-seed opportunities, and he has a professional career in venture capital with a track record in FinTech. Andres Avendano collaborates with partners within the Midwestern region and is part of a diverse team at Chingona Ventures.

Manuel Antunes, an investor at Triple Point Ventures, focuses on early-stage investments with specific interests in climate tech and healthcare. He has previously led investments in businesses addressing environmental or social problems. Manuel’s track record and professional career are detailed on LinkedIn, highlighting his involvement in various funding processes. In terms of collaboration style, he emphasizes building a disagreement framework between founders and promoting non-violent communication. However, specific information about his investment thesis, previous investments, and investment check size is not available on the provided websites.

Lokman KURIS is an investor with a focus on Seed Round investments in areas such as Big Data, Marketplaces, and Healthcare. He has made previous investments in Logan Wood Technologies and held positions like International Expansion Manager at UberEATS. While his investment check size is not specified, he operates in locations like London, United Kingdom, and has a partnership style focusing on cooperative collaboration.

Spandan Innovators is an innovative startup that designs R&D based projects focusing on Power Electronics, Solar field, and Agricultural automation products to address the needs of Indian farmers. Their previous investment, the ‘Spandan’ portable ECG device, received international recognition for detecting early heart attack symptoms. The investment stage, geographical preference, investment check size, and partnership styles are not explicitly mentioned in the available information.

Sequoia Capital India is a venture capital firm that invests in consumer, technology, and healthcare.

Alsace Business Angels is a French angel investment firm that offers business development services and provides early stage investments in high growth potential companies. The firm is an active member of France Angels, the body federating the French network of business angels. It is an association of individuals who invest a part of their personal assets in startups. The firm was established in 2007 and is based in Strasbourg, France with an additional office in Mulhouse, France. Alsace Business Angels invests in biotechnology, health care, software, medical, and agriculture startups within the EU region. They focus on early stage investments ranging from prototype to scaling stages, with check sizes varying from $60,000 to $200,000 per company. Their partnership and collaboration styles involve strategic partnerships with major organizations to support entrepreneurship and provide personalized services for business managers and entrepreneurs.

Constantin Bisanz is an investor known for his diverse portfolio across various markets including Consumer Internet, Financial Services, Location-Based Services, Retail, B2B, and Health and Wellness. He has made 7 investments in companies like Harry’s, Printi, ALOHA, Brands4friends, secretsales.com, truckscout24.com, and fairplane.net. Constantin’s professional career includes selling his fifth company to eBay for $220 million in 2011 and founding Aloha, a wellness company. He maintains a holistic approach to life and business. The investment check size is unspecified, and there is no specific information available regarding partnership and collaboration styles.

Michael Slade is a Co-Founder and Partner at Second Avenue Partners. The investment thesis of Second Avenue Partners is to provide management, strategy, and capital for early-stage companies. The focus areas of investment include Rubicon Interactive, Sports Technologies Inc., Ice Energy, Newsvine, and others. Second Avenue Partners focuses primarily on early-stage deals in Seattle and engages in strategic consulting assignments. Michael Slade’s past experiences include roles at Microsoft, NeXT Computer, and Starwave Corporation. He holds a BA in Economics from Colorado College and an MBA from Stanford University Graduate School of Business.

Harry Welten is a life science entrepreneur and business angel with over 15 years of experience, specializing in seed-stage financing for life science startups. His investment areas include biotechnology and health sciences, focusing on early-stage companies with high growth potential. Harry Welten’s investments have primarily been in Europe and involve IPOs, mergers, and acquisitions. He has a track record of raising significant funds from private and public investors, with a preferred check size in the range of CHF 100K to CHF 500K. Harry Welten’s partnership and collaboration styles are characterized by strategic alliances and business combinations to drive innovation and market expansion in the life science sector.

Neil Kataria is an entrepreneur and angel investor known for his involvement with various startups. He is the CEO and Founder of Basket and Basket Savings. Additionally, he is the Founding Partner and Chairman at Blue Tiger Ventures. His portfolio includes investments in companies like Blue Tiger Labs and newBrandAnalytics. Neil has a background in founding and selling software companies, such as Conformia Software. He is also recognized for pioneering social operations intelligence with newBrandAnalytics. Neil Kataria’s investment style ranges across Fintech, Food, Media, Marketing, and Health sectors. While the investment check sizes vary, he has been involved in funding rounds like $4 million for Blue Tiger Labs and $1 million for Squadle. Through his ventures, Neil Kataria has shown a proactive and hands-on approach to partnerships and collaborations, focusing on creating innovation and value in the startup ecosystem.

John Fein is a Managing Partner at Firebrand Ventures, with a focus on healthcare, IT, and startups. He served as a Managing Director for Techstars, running three accelerator programs and investing in 30 startups. John’s average first check size is around $150,000. His partnership and collaboration styles involve fostering entrepreneurship through partnerships with universities and communities, aiming to help ventures accelerate their growth. His professional background includes managing large-scale projects in the healthcare sector.

Joel Mezistrano, a member at Alliance of Angels, focuses on seed and Series A investments in sectors like Data Services, Enterprise Applications, Real Estate/PropTech, Digital Health, Health IT, Health & Hospital Services, Enterprise, and FinTech. His investment range is $500K to $1.5M with a sweet spot at $1M. Joel’s partnership and collaboration styles involve working with various scouts and angels, including Andrew Wang, Bahador Biglari, Ben Sharpe, Beth Morgan, and Carla Fowler.

Sinan Güler focuses his investments primarily in the Consumer and HealthTech sectors with a geographic preference for Turkey and the United States. He has made investments in companies such as Meditopia and Monument. His investment check size is around 250,000 Tl or 50,000 US Dollars. Sinan Güler’s collaboration and partnership styles were not explicitly mentioned in the available sources.

Frank Groenewegen is a Co-Founder and General Partner of 415 Capital with almost 40 years of experience in investing, management, sales & marketing in the medical technology space. He has funded over 40 companies and founded successful European medical device distribution companies. His companies established new clinical standards of care in Europe. As an investor, Frank has a stage of interest in early to mid-stage startups. His geographical preference is Europe. Previous investments include CoRRect Medical, Regis Medical GmbH, and more. Frank’s investment check size can be obtained by contacting info@415capital.com or calling +49 (0)89 628 346 116.

Walter Jin is the Chairman and CEO of Pager+Onlife, with a background in private equity and venture capital, investing over $1 billion across more than 40 healthcare companies. He is a Co-Founder and General Partner of Three Fields Capital, specializing in mezzanine debt, distressed debt, and public equity investments in healthcare, life science, and health tech sectors. Previous investments indicate a focus on Pager with a Series B investment of $22M. Walter Jin’s investment check size aligns with mezzanine debt and distressed debt investments.

Viet Le is an investor who holds long monologues about his 3 Ds: design, data, and dev tools. His previous investments include Ozone. He focuses on design, data, and dev tools in product deep-dives. The specific check size of his investments is not available. Viet Le’s partnership and collaboration styles are not explicitly provided in the available information.

Kevin Fox is a Vice President at Thompson Street Capital Partners. The investment thesis at Thompson Street Capital Partners is focused on sustainable growth across Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services and Products. The investment focus areas include these industries. The firm targets investments ranging between $50 million and $500 million in enterprise value. Thompson Street Capital Partners seeks partnerships globally and has successfully partnered with companies in North America, Europe, and Australia. Kevin Fox’s previous investments include Sabai Global. The partnership and collaboration styles at TSCP emphasize adding value to management teams. The investment check size for Thompson Street Capital Partners V is $1.15 billion.

Niels Sharman is a Senior Investment Manager at HTGF with a focus on Life Sciences and Chemie. He supports high-tech start-ups in digital tech, industrial tech, life sciences, and chemistry. His educational background includes a Biology Bachelor’s from Ludwig-Maximilians-Universität München and a Management Master’s from Technische Universität München. Niels has experience in the pharmaceutical industry and biotech startups. His investments reflect a strong interest in Digital Health.

Harald Nieder, a General Partner at Redalpine Venture Partners, specializes in investing in disruptive technologies with a focus on highly scalable ICT and Health Tech models. His investment thesis centers on empowering game changers and supporting big ideas to create a better tomorrow. Harald’s investment focus areas include consumer internet alongside AI middleware, vertical/applied AI, new data solutions & infrastructure, and future trends like automation, mobility, and sustainability. He primarily invests in seed-stage startups and maintains a hands-on approach to support founders from day one. Notable previous investments include companies like Taxfix and Inkitt. Redalpine’s portfolio comprises over 95 companies, with a total amount raised of 2.7bn CHF and a total value created of 11.6bn CHF, highlighting the success and impact of Harald Nieder’s investment strategies and partnership styles.

Joakim Karlsson, a Senior Partner at Nordic Capital since 1998, focuses on Healthcare, Technology & Payments, Financial Services, and Services & Industrial Tech sectors. Nordic Capital typically targets mid-market companies in Northern Europe and North America. Joakim has been involved in Fund VIII with EUR 3.5 billion in committed capital, and has completed 10 exits since 2011. His check size for investments is in the mid-market range. He brings a wealth of experience and expertise to the private equity industry.

Michael Galgon is an Angel Investor with a focus on Consumer Lending, Real Estate, Smart Home, Analytics, Information Technology, Software, Beauty, Retail, Employee Benefits, Financial Services, Automotive, Electric Vehicle, Health Care, Psychology, Hospital, EdTech, FinTech, Artificial Intelligence, Machine Learning, SaaS, E-Commerce, and Logistics. He specializes in seed round investments and his previous investments include companies like Ampd, AppVirality, PipelineDeals, Ripl, EnergySavvy, SquareHub, and buuteeq. His check sizes vary depending on the round, with examples ranging from $1,000,000 to $11,000,000. Mike Galgon’s professional background includes being the founder of Pioneer Square Labs Holdings LLC. For partnership and collaboration, detailed information is not available. However, his investment thesis and stage of focus indicate a keen interest in early-stage startups and a wide range of industries.

Tripti Thakur is a VC Investor and Limited Partner at Emmeline Ventures. Her investment focus areas include Consumer Health, Digital Health, BioTech, Health & Hospital Services, and Health IT at both Seed and Series A stages. She prefers investments with check sizes ranging from $100K to $5.0M, with a sweet spot at $1.5M. Tripti Thakur is geographically focused on Los Angeles/Southern California and the San Francisco Bay Area. Her previous investments include Seed Digital Health and collaboration with investors like Azin Radsan van Alebeek, Hayal Koc, La Keisha Landrum Pierre, Mary Zoumas, Naseem Sayani. Her investment style involves partnering with individuals from Emmeline Ventures and other key co-investors.

Michela Grimaldi, a Former Investment Associate at Calm/Storm, a venture capital firm focused on purpose-driven founders, has a background that includes operational experience at a digital startup in Berlin and a market research firm in Buenos Aires. She also has experience at a company builder focused on healthcare. With a Master’s Degree in Finance and IoT from ESCP, Michela has studied and worked in six countries. Her investment focus areas align with purpose-driven founders who are changing life and health for the better. Michela has transitioned to a fund in Italy focused on agritech after her role at Calm/Storm. Her previous investments cover a wide range of sectors such as mental health, reproductive healthcare, chronic conditions, digital therapeutics, and healthcare access. Michela’s professional career embodies a unique blend of social interactions and analytical skills, showcasing a diverse and impactful track record in the venture capital landscape. The partnership and collaboration styles at Calm/Storm emphasize an exclusive founder network and a boutique venture capital approach, indicating a strategic and hands-on investment strategy.

Ken Holec is an investor with a focus on Seed & Series A stages, industry agnostic, and covering multiple geographies. His specific investment thesis emphasizes ecosystem creation, upmarket potential, high lead sales velocity, and product/solution stickiness. Ken Holec has been involved in companies like Jobs2Web and Lawson Software. He has a varied collaboration style that encompasses introspective, relational, and expressive aspects, emphasizing deep work, human connection, and visual engagement in collaboration.

Scott Flanders is an individual angel investor with a focus on seed investments. He has invested in companies like Better Health, UPshow, and SNAZ.com. His investment check size for Better Health’s Seed Round was $3.5 million. Scott Flanders is based in Beverly Hills, California, USA, and has a total of 3 investments. He is the CEO at eHealth and has a track record in both healthcare and entertainment industries.

William Banks is an angel investor with a focus on High Tech and HealthTech sectors. His previous investments include Luna Lights. He prefers investing in startups in the United States and has made a significant investment in Luna Lights in a Seed Round in 2016 that resulted in an acquisition in 2020. William Banks’ partnership and collaboration styles are not explicitly mentioned in the available information.

Larry Sonsini is the Founder and Managing Director at WS Investments, a venture capital firm located in Palo Alto. The firm’s investment focus areas include Health Care, Software, Biotechnology, E-Commerce, and Enterprise Software. WS Investments typically invests in startups in the Medical and Marketplace fields that are around 2-3 years old. Some of its notable investments include Alias Technologies, Smartlens, Holocron Technologies, Crowdz, and Driveroo. Larry Sonsini’s partnership and collaboration style involves co-investing with funds like Next Coast Ventures, Maveron, Khosla Ventures, and Stanford University. WS Investments’ portfolio companies are often funded by TCV, Wayra, and Sequoia Capital in subsequent rounds. The fund is mostly active in the United States with a geographical focus similar to Benchmark, Canaan Partners, Menlo Ventures, RRE Ventures, and Tech Coast Angels.

Camille Hunt PT, CSM is an impact investor with a focus on healthcare, venture fundraising, and food. She prioritizes investments that positively impact women and the underprivileged. Camille serves as the Director of CYH Consulting, supporting clients in raising capital, business strategy, and operations. Her strong collaboration style emphasizes working with the right people to bring about positive change. As the Vancouver Chapter President at Valhalla Private Capital, she facilitated investments and mentorship for startups, showing a track record of $71+ million invested across 238+ deals. Camille’s investment check sizes are aligned with impact investing, with a strategic and futuristic approach to creating a better world through her investments.

Hakan Goker, Managing Director at M Ventures, heads the Biotechnology Investments covering Healthcare and Life Sciences. He has invested in several companies such as Asceneuron, F-Star Therapeutics, Ribometrix, and Storm Therapeutics. His expertise spans 18 years in the sector, with previous experience at Aescap Venture and Atlas Venture. The investment check size for M Ventures is â¬600 million, and Hakan Goker’s collaboration style focuses on innovation in drug discovery. He is known for active participation and guidance in portfolio companies.

Launchpad Venture Group, LLC is a nationally-recognized leader among angel networks, providing human and financial capital to entrepreneurs. They focus primarily on high tech and life sciences startups. They have invested over $125 million in more than 150 startups since 2001, with investments ranging from 1 to 5 million dollars per company. Some of their previous investments include 7AC, 3Play Media, and Boston Heart Diagnostics. Launchpad Venture Group fosters a culture of respect and professionalism in the startup ecosystem, aiming to build long-term relationships with startups. The group supports its capital investments with advice and mentorship.

Pegasus Tech Ventures is a Silicon Valley-based global venture capital firm.

John McIlwraith is the Co-Founder & Managing Director of Allos Ventures with a background in corporate law. His investment focus includes B2B software companies at Series A or B stages. He has a track record of investing in software, business services, and healthcare technology companies. John’s professional career includes involvement in early-stage venture initiatives in the Midwest and board memberships. He holds a JD from Case Western Reserve University and a BA from Hillsdale College. Contact: 317.275.6800